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Summary
Summary
Drug Related Deaths
An investigation was carried out into all drug-related deaths that occurred within the
Strathclyde Police region of Scotland over the 17-year period, 1985 - 2001. Deaths
involving heroin, methadone, dihydrocodeine or cocaine were the focus of this thesis. In
total, more than 1,000 cases were reviewed. By extracting data from the toxicology report
and police sudden death report, changes in patterns and trends of drug misuse were
highlighted which coincided with concurrent changes to legislation and medical care. This
is a novel approach to the investigation of drug-related deaths within this jurisdiction.
Deaths involving heroin
Over the study period 869 heroin positive drug-related deaths were identified, in 95% of
which that drug was the sole or the major contributory causal factor. The majority of these
deaths involved males. The average age of all individuals increased slightly from 26 years
to 29 years over the study period. The individual had a history of drug misuse in 95% of
cases and of those, 92% were known to abuse drugs intravenously.
Approximately one quarter of individuals resided alone and over one-half resided with
other people, primarily their parents or (common law) partners/spouses. The individual
was homeless in 14%of cases. Of this group, 70% resided in a hostel. The remainder had
no fixed abode. Of cases where the postal code was known, 74% resided within the
Greater Glasgow Health Board area. In the last year of the study deaths of individuals
residing in the Ayrshire and Arran Health Board area increased sharply compared to a
decrease in deaths reported in all other areas. Approximately two-thirds of individuals
resided in areas of high deprivation (categories 6 and 7). The locus where the body was
found was primarily in a dwelling (73%), usually the individual's own home. From the
circumstances surrounding the deaths it was ascertained that the individual was alone at the
time of death injust under half the cases, highlighting the risk of taking drugs in isolation.
Attempts to revive the deceased prior to the arrival of paramedics occurred in only one
fifth of cases where this information was available. An ambulance was summoned in
approximately three-quarters of all cases where this information was available.
Resuscitation attempts were more likely to be initiated by paramedics if witnesses were
present at the locus.
xi
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A period of drug abstinence shortly before death was noted in one fifth of cases, the
majority of which related to a period of incarceration. Of the deaths involving recently
released prisoners, over half overdosed within one week of release highlighting the risk of
reduced tolerance following a period of abstinence. The median blood morphine
concentration detected amongst deaths where heroin was the sole cause of death was
significantly higher than deaths where heroin was a contributory factor (0.33mgll versus
0.23mgll). Polydrug use accounted for 91% of cases and this was primarily a cocktail of
two or three drugs. Benzodiazepines and alcohol were the most frequently detected drugs
taken concurrently with heroin. Prior to 1996, the most frequently detected
benzodiazepine was temazepam. However, a legislation change resulted in this drug being
re-scheduled and consequently, the supply of temazepam decreased. As a result, the
number of diazepam positive cases increased post 1996. Methadone was detected in 13%
of polydrug cases. However, this had been obtained by the diversion of legitimate supplies
in the majority of cases. Speedballing was noted in 3% of all polydrug cases, the majority
of which occurred in the latter two years of the study.
Heroin remains the most frequently detected drug amongst drug-related deaths in the West
of Scotland and at present, its incidence shows no signs of subsiding.
Deaths involving methadone
The methadone maintenance programme was introduced to Glasgow in 1994 and
subsequent to this there was an increase in the number of deaths involving this drug. In
1996, a confidential enquiry was established to assess the clinical care provided in these
deaths. The findings of this were reported in 1999 and showed that 93% of GPs
interviewed "definitely" intended to change their future management of drug misusers.
Supervised consumption was promoted heavily from 1996 and from this time deaths
involving methadone were shown to decrease.
Methadone was detected in 271 drug-related deaths over the study period, 72% of which
were due to methadone alone or in combination with other drugs. Between 1991 - 1995,
62% of methadone deaths in Strathclyde occurred in the Greater Glasgow Health Board
area and this decreased to 45% between 1997 - 2001. This indicated that methadone
deaths were occurring throughout the rest of the Strathclyde area. Methadone had been
obtained by the diversion of legitimate supplies in over half the cases where this
information was available. By calculating the number of patients enrolled on a methadone
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programme within each health board area, a methadone death rate was obtained for each
year. This was shown to fall sharply after 1996 and remained low thereafter. In 2001, the
death rate calculated for individuals on a methadone programme in the Greater Glasgow
Health board area was lower than the other three health board areas, but in general rates
were low, indicating a good safety profile for the methadone programme.
A common observation in methadone deaths was that the deceased had been witnessed to
be intoxicated prior to falling asleep. Witnesses then reported heavy uncharacteristic
snoring in these cases. This suggests that some of these deaths may have been preventable
had medical intervention been sought on first signs of overdose. The deceased was a
recently released prisoner who overdosed within 2 weeks of release in 11% of cases. The
median blood methadone concentration detected amongst deaths where methadone was the
sole cause of death was significantly higher than deaths where methadone was a
contributory factor (0.7mgll versus 0.3mgll). Polydrug use was evident in 85% of blood
drug positive cases and the most frequently detected additional drug group was the
benzodiazepines. The most frequently detected benzodiazepine up until the legislation
change in 1996 was temazepam and from 1997 onwards this was replaced with diazepam.
In 30% of heroin positive cases, the deceased had been prescribed methadone which
suggests that they were being non-compliant with the methadone programme guidelines in
that they continued to use illicit drugs. In general, over the study period, the proportion of
all illicit overdose deaths where methadone was detected increased to 42% in 1996 and fell
on a year-to year basis to 16% in 2000 and increased again slightly to 20% in 2001.
Despite initially receiving much criticism, this study has shown that with efficient patient
management to establish the compliance with the guidelines of the programme, methadone
can be a safe drug for substitution therapy.
Deaths involving Dihydrocodeine
During the period in which methadone deaths were decreasing, the number of
dihydrocodeine (DHC) positive drug-related deaths increased. This drug is sometimes
prescribed as a substitute for methadone for a number of reasons, one being that several
days supply can be dispensed at the one time, owing to the short half-life of this drug. This
can be problematic, however, as there is potential for diversion of legitimate supplies.
DHC was found in 99 drug-related deaths over the study period, 59% of which were due
wholly or partially to the effects of dihydrocodeine. Over two-thirds of cases involved
xiii
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illicitly obtained dihydrocodeine and approximately one third involved the deceased being
in an intoxicated state prior to falling asleep. The median blood DHC concentration
detected amongst deaths where dihydrocodeine was the sole cause of death was
significantly higher than deaths where dihydrocodeine was a contributory factor (3.8mgll
versus O.9mg/I). Polydrug use was evident in all cases and this was primarily with
diazepam or morphine (heroin).
Dihydrocodeine as a drug of misuse was highlighted and requires monitoring to establish
whether this is a real trend or a fashionable phase.
Deaths involving Cocaine
Information relating to seizures, reported cocaine use within a population and individuals
being registered for treatment as a result of cocaine and crack addiction have shown an
increasing trend in the use of this drug. This has been corroborated by the number of
cocaine positive cases detected amongst drug-related deaths in the Strathclyde region. The
first cocaine positive case in Strathclyde was reported in 1993 and increased on a year-to-
year basis. Cocaine was detected in 37 drug-related deaths, in 51% of which cocaine was
the sole or a contributory factor in death. In approximately one third of cases where
cocaine was the sole cause of death, the circumstances were uncharacteristic of a stimulant
type death. Of the cocaine related deaths, heroin was a contributory factor in 80%. A
median blood cocaine concentration of 5.23mg/1 was recorded for deaths where cocaine
was the sole cause of death and O.17mgll in cases where cocaine was a contributing factor
in the death. Polydrug use was evident in 84% of all cocaine deaths and the most
frequently detected drug in combination with cocaine was morphine, indicative of heroin
use, followed by diazepam.
The occurrence of cocaine amongst drug-related deaths in the Strathclyde region IS
increasing, however it role in causing death remains negligible.
Drugs and Driving
A review of 1,195 biological samples received for the analyses of drugs obtained from
drivers suspected of driving whilst under the influence of drugs was carried out between
1995 - 2001. The majority of samples were blood (84%). Drugs were detected in 82% of
the blood samples and 94% of the urine samples. Polydrug use was prevalent amongst
xiv
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these samples and the proportion of poly drug use cases increased over the years. The most
frequently detected drug groups were initially the benzodiazepines, followed by
cannabinoids and opioids. In later years, opioids superseded the cannabinoids. The
proportion of drug positive blood samples that contained morphine (indicative of heroin)
accounted for 12% of all drug positive cases in 1995 compared to 42% in 2001. The
benzodiazepine most frequently detected was initially temazepam. However, following the
legislation change in 1996, temazepam positive cases decreased and diazepam positive
cases increased. Methadone positive cases were shown to decrease and dihydrocodeine
cases to increase following 1996, the year when methadone supervision was heavily
promoted. Drug combinations were similar to those found in drug-related deaths with the
concurrent use of opioids and benzodiazepines being prevalent. The concurrent use of
methadone and morphine (indicative of heroin) was confirmed in approximately one third
of all methadone positive cases. However, no information was available regarding whether
this had been prescribed to the individual. Cocaine had been taken in combination with
heroin in 31% of all cocaine positive cases between 1999 and 2001. All drugs detected
have impairing effects that can be detrimental to driving performance and the combinations
of drugs detected in this study have been reported to enhance the disruptive effects of an
individual drug.
The police officer's suspicion of drug induced impairment was confirmed in the majority
of cases reviewed. The drugs detected paralleled the situation of drugs involved in drug-
related deaths over the same time period.
As a result of the increasing prevalence of drugs detected amongst drivers, a pilot trial was
initiated by police forces in the UK using the field impairment test. This battery of tests is
based on those used in the United States and was modified for use in the United Kingdom.
The Department for Transport commissioned a study to evaluate the use of these tests and
the results obtained from eight Scottish police forces are presented. Of those drivers who
were judged to be impaired, 95% were found to test positive for drugs. However, of those
who were judged to be unimpaired, only 19% were found to be drug free. This could be
explained by the driver's personal tolerance to the drugs detected. The drugs detected in
all biological specimens were indicative of drugs being misused rather then the medicinal
use of prescription drugs. Amongst the blood and urine samples (obtained from drivers
who were judged to be impaired) the most frequently detected drug group was
benzodiazepines and this was followed by opioids. The concurrent use of methadone with
heroin was confirmed in 91% (n = 10) of methadone positive urine cases and in 38% (n =
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5) of methadone positive blood cases. The next most frequently detected drug group was
the cannabinoids. However the presence of the active component, THe, was confirmed in
only 44% of these cases. Polydrug use was detected in 69% of drug positive blood and
urine samples. Drugs detected in the saliva samples were indicative of drug misuse both in
the actual drugs found to be present and drug combinations detected. Opioids were the
most frequently detected drug group, followed by cannabinoids. The drug recognition
skills of the police officer was generally shown to be very good, both in identifying the
presence of a drug and the type of drug suspected to be causing impairment. Drug use was
confirmed in 92% of cases and drugs suspected to be causing impairment were confirmed
in 69% of cases where this information was available.
Within the battery of five tests (involving four divided attention tests), the sensitivity and
specificity revealed that some tests contributed more diagnostic value than others. For
example the pupillary examination had an overall accuracy of 48%, showing that it
contributed little to the overall FIT, whereas both the one leg stand and the walk and turn
test had an accuracy of 83%.
This study showed that the use of saliva is an effective and practical alternative to blood
and preferable to urine as a biological specimen for the purposes of Section 4 of the Road
Traffic Act. It also showed that the use of FIT is a useful adjunct to present procedures
that are utilised by the police.
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Introduction
1 Introduction
Drug misuse refers to the improper use of drugs (both illicit and prescription type drugs)
and is a pandemic affecting all levels of society in almost every country. From the
recreational ecstasy user to the heavily addicted heroin addict it is estimated that
approximately 200 million people abuse drugs throughout the world 1. The United Nations
Drug Control Programme estimated that the world trade in illicit drugs now stands at £250
billion per annum, accounting for 8% of international trade 2. Addiction has been referred
to as the biggest preventable killer in the United Kingdom resulting in over 150,000 deaths
per annum 3. Whilst the majority of these deaths are either tobacco or alcohol related the
number of drug-related deaths should not be ignored. The latest Government funded
research estimates that annual health and crime related costs arising from the most serious
drug misusers alone are in excess of over £4 billion 4. It has been estimated that the
number of years of working life lost from drug misuse deaths is now approaching that of
road traffic fatalities 5. Alarming findings of a recent study involving secondary school
children throughout Scotland revealed that approximately one in ten pupils, aged between
11-12 years, had already initiated illegal drug use. Whilst cannabis was the most widely
reported drug used amongst this group, temazepam, magic mushrooms and amphetamines
were also reported 6. Drug addiction in the United Kingdom is clearly a problem and with
the total number of seizures of controlled drugs having increased by 293% from 1985 to
1999, it appears to be an increasing problem that shows no signs of subsiding 7.
The number of seizures of controlled drugs throughout Scotland increased by 422% over
the years 1985 to 1999 and the number of general acute hospital admissions for drug
misuse and of drug-related deaths (DRDs) have continued to increase over the years. This
increase in drug deaths has resulted in initiatives introduced by the Scottish Executive. A
target set out by them, in 2000, was to reverse the upward trend of DRDs and reduce the
number ofDRDs throughout Scotland by 25% by the year 2005.
As drug misuse increases in society, it is necessary to have methods of recording and
monitoring the situation at an international, national and local level. On a European level,
information relating to drug misuse is collected and analysed by the European Monitoring
Centre for Drugs and Drug Addiction (EMCDDA). This agency became fully operational
in 1995 and was established in response to the escalating drug problem in Europe with the
aim of providing an accurate picture of the extent of the drug problem in the European
Union. The EU Action Plan on Drugs (2000 - 04) calls for member states to provide
reliable and comparable information on five key indicators as proposed by the EMCCDA.
Introduction
Therefore, in addition to a measure of drug use among the general population (population
surveys), the prevalence of drug-related infectious diseases, incidence estimates and
surveys among drug users, another key indicator is that of drug-related deaths and
mortality of drug users. With respect to the latter, the EMCDDA have implemented "The
DRD-Standard" which enables the harmonised collection of internationally comparable
data 8. On a national level, a record of all Scottish drug-related deaths is provided by the
General Register Office for Scotland (GRO). However, both the definition of a DRD
employed by the GRO and data collection methods have altered over the years and hence
care must be taken when comparing trends in DRDs published by them. In addition, the
GRO includes deaths in which a drug listed under the Misuse of Drugs Act (1971) was
known to be present in the body at the time of death. The presence of a drug does not
always infer that the drug was involved in causing death. Hence, in these instances,
statistics relating to drugs involved in deaths can often be misleading. With the exception
of the GRO procedure, there is at present no protocol for monitoring drug-related deaths at
a local level. Therefore, one aim of this study was to analyse the DRDs that occurred in
the Strathclyde region of Scotland with the intention of providing a chronological timeline
of changing patterns and trends of drug misuse. For this purpose, the definition of a DRD
and methods used for data collection were established and remained consistent throughout
to provide data over a 17 year study period. Whilst DRD data can be used for estimating
the extent of drug misuse in a population with respect to changing patterns of use, it has
limitations. For example, the use of cannabis and stimulant type drugs, such as ecstasy, in
a population cannot be extrapolated from DRD figures. Cannabis is reported to be the
most commonly misused illicit substance" and yet it was mentioned as a substance causing
death (concurrently with other drugs, mainly opioids or stimulants) in only approximately
3% of all "deaths by poisoning" as recorded by the GRO in 2000 10. Similarly, deaths due
to ecstasy use are comparatively low when there is estimated to be in excess of 500,000
individuals consuming ecstasy in the UK every weekend 11, 12. Hence, DRDs as an
indicator of drug misuse in a community is more useful for frequent problematic drug use
as opposed to drugs associated with recreational use.
The driving population is another group where drug misuse can be monitored. An
increasing number of studies show that drug use is detrimental to traffic safety. Two
recent studies in Scotland have focused on the nature and extent of driving and recreational
drug use. The first, a household survey, aimed at estimating the prevalence of driving
whilst under the influence of recreational drugs among 17 to 39 year old drivers revealed
that 5% of the study sample had reported ever having driven under the influence of a drug
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within the previous 12 months. Of these cases, the majority reported having driven under
the influence of cannabis only. Less than one half of those who had reported drug driving
within the previous twelve months also felt that the drugs had no effect on their driving 13.
Secondly, a qualitative study whereby 61 semi-structured interviews were conducted with
individuals who had recently attended nightclubs at various locations throughout Scotland,
revealed that 85% had driven after recreational drug use and 31% did so on a weekly basis.
Cannabis use prior to driving was reported in 72% of cases and this was followed by
ecstasy, in 43% of respondents 14. Focusing on problematic illicit drug use, a recent study
investigated the prevalence of drug driving amongst 585 new treatment clients in Scotland.
This revealed that approximately 16% of clients had driven in the last 90 days. Of these
cases, one fifth had been arrested for drug driving and despite drug driving being reported
on numerous occasions an arrest had been reported on average only once 15. These studies
have all been conducted using data collated by survey and interview techniques. Whilst
the information provided by these is of extreme importance, there is no way of
corroborating alleged drug usage against that actually detected. A poor correlation
between self-report data and laboratory testing has been shown in the past 16. Another way
of estimating the prevalence of drug driving is to analyse samples obtained from drivers of
populations suspected to be "at risk". For this purpose, this study aimed to show the
prevalence and extent of drug misuse amongst individuals who were suspected to be
driving whilst under the influence of drugs in the Strathclyde region of Scotland. In
addition to actual drugs and concentrations detected, the combinations of drugs consumed
were summarised. As an adjunct to the drug driving section, an evaluation of the field
impairment test in Scotland was given. It was not possible to provide an accurate
evaluation of the Strathclyde area alone due to an insufficient number of cases.
Nevertheless, this section monitors the use of the field impairment test by police officers
and also establishes the nature and extent of drug use by both drivers who were judged to
be impaired and those who were judged to be unimpaired.
In excess of 1000 DRD cases that occurred over a 17-year period were studied in order to
ascertain the role of heroin, methadone, dihydrocodeine and cocaine in these deaths. In
addition, approximately 1200 cases of drivers suspected to be driving whilst under the
influence of drugs were studied between 1995 - 2001 to ascertain the nature and extent of
drug use amongst this population. Finally, 736 cases involving an individual who
participated in the field impairment test were studied in an effort to evaluate the use of this
procedure when identifying the drugged driver and also to determine the extent of drug use
by these drivers. Varying drug trends over the years were noted amongst both the DRD
3
Introduction
cases and the drivers. These trends and possible reasons for the changes in demand and
supply of the various drugs will be discussed.
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2 Drug Misuse
2.1 A brief history of Drug Misuse
The most ancient drug known to man is probably opium with its use dating back to
antiquity. An extract derivative of the seedpods from the opium poppy Papaver
somniferum, opium was discovered in the lands of the eastern Mediterranean basin around
the 16th century B.C. 17 and has been referred to as the "joy plant" 18. It has been utilized by
many civilisations and cultures from as far back as neanderthal man and Egyptian pharaohs
19. Throughout time, the somnolent and medicinal properties of the opium poppy were
noted in writings from the classical period of ancient Greece 20 and Homer referred to it as
"a drug to lull all pain and anger and bringforgetfulness to every sorrow" 21. Medically, it
was used freely to allay not only the suffering of pain, but also diarrhoea, insomnia and
neurological and psychiatric disorders 22 and was even used to calm children who cried
excessively (Mrs Winslow's Soothing Syrup and Mother Bailey's Quieting Syrup) 23.
Pioneers of the medical world such as the Swiss physician, Philippus Aureolus
Theophrastus Bombastas Von Hohenheim t (1493 - 1541) and Thomas Sydenham t (1624
- 1689), the founder of clinical medicine and epidemiology, both have been viewed as
having had promoted the medical use of opium. It was this duo who were responsible for
the invention and introduction of laudanum, the alcohol tincture of opium, into the medical
practice. In fact, it's use was so extensive and acceptable that vials oflaudanum and raw
opium could be purchased at any English pharmacy and grocery store up until the
Pharmacy Act was passed in 1868 24. On the whole, opium's popularity was widespread
and even Victorian authors were documenting their own experiences of the drug 25.26.
Limitations of its use were however noted and in the first half of the 19th century, medical
textbooks were reporting on dissociation produced by the drugs",
Extract from Confessions of an En~lish Opium Eater by Thomas de Quince}' 25
" ... here was the secret of happiness, about which philosophers had disputed for so
many ages, at once discovered: happiness might now be bought for a penny and
carried in the waistcoat pocket .... "
The 19th century marked some important and what were to become detrimental advances in
terms of drug misuse. The isolation of morphine (so called after the Greek God of Dreams,
t Also known as Paracelsus
t Also known as the "English Hippocrates"
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Morpheus) by the German pharmacist Sertiimer occurred in 1805. This was followed by
the invention of the hypodermic needle (1857) to allow injection of pure morphine and
whilst this was not believed to be addictive, it led to a rapid increase in the use of opium.
The use of injecting morphine increased so much during the American Civil War that
morphine addiction became known as the "soldiers disease" 28. The synthesis of heroin
occurred at St. Mary's Hospital in London in 1874 by the English pharmacist C.R. Wright
who had been conducting studies on the naturally occurring alkaloids 29. It wasn't until
1898 that it was synthesized and marketed by the German pharmaceutical company, Bayer.
Heroin was initially believed to be a useful treatment for morphine and opium addiction,
however, it soon became apparent that heroin itself was very addictive and it was not long
before it was seen not as a cure but as "another curse" 30. These "advances" could be
regarded as the precursor of what was to become a major health problem and cause of
otherwise preventable deaths on a world-wide scale.
Marijuana and cocaine, both naturally occurring psychoactive drugs have both been used
for their recreational and medical properties. Medically, cocaine has been used in the
treatment of depression and for a time, opiate withdrawal and was even heralded as the
official remedy for "hay fever" by the American hay Fever Association due to its ability to
shrink nasal mucous membranes and to drain sinuses 31. Marijuana was utilised for its
analgesic, hypnotic and anticonvulsant properties 21. The presence of cocaine and
marijuana have even been detected in the hair of Egyptian mummies (1072 BC - 395
AD)32.
From the above it can be seen that the drugs which are widely misused today were
originally applied in medical situations. However, mans ignorance as to the extent of their
psychoactive properties was conducive to the phenomenon of addiction. As addiction of
these drugs became more widespread, it became clear that something had to be done in an
effort to control the use of drugs and unsocial behaviour associated with it.
2.2 Drug Legislation
In the United Kingdom there have been many statutes passed over the years in an attempt
to regulate the supply and manufacture of both licit and illicit substances. The Pharmacy
Act 1868 was passed in an effort to control the sale of opium to those who were
knowledgeable of its properties. This Act stipulated that in order to retail, dispense or
compound "poisons" the individual had to be registered by the Pharmaceutical Society 33.
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Heroin, opiates and cocaine were made illegal in 1920 under the Dangerous Drugs Act.
This Act was passed in order to implement the findings of the International Opium
Convention 1912 (the Hague Convention) and required states party to it to limit the
manufacture, trade and use of opiates and cocaine to medical purposes as well as prohibit
the sale of opium to unauthorised users.
Presently there are two principal statutes which regulate the availability of drugs in the
United Kingdom, they are (i) The Medicines Act 1968 and (ii) The Misuse of Drugs Act
1971. These two statutes govern the manufacture, licensing, prescription, supply and
administration of medicinal products. The Medicines Act 1968 classifies medicinal drugs
into one of three categories:-
o Prescription-Only Medicines: This is the most restricted category in that these
medicines can only be dispensed from a pharmacist working for a registered pharmacy
on instruction of an appropriate practitioner (doctor or dentist).
o Pharmacy-Only Medicines: These medicines can be purchased without a
prescription provided a pharmacist working for a registered pharmacy supervises the
sale.
o General Sale List Medicines: This is the least restricted category in that these
medicines can be bought without supervision or a prescription from retail outlets.
Continued drug misuse resulted in the Misuse of Drugs Act (MDA) being passed in 1971.
This is the major act controlling drugs and has brought together earlier legislation under
one Act of Parliament and is the one that is most referred to today. It was established in
response to the increasing trend of drug misuse in British Society and in order that the
United Kingdom fulfils its obligation to control drugs in accordance with international
agreements. The main aim of this Act is prohibition at all levels i.e. possession, supply,
production (including cultivation) and trafficking of all drugs it controls. The MDA
contains three classifications of drugs to which the Act applies and are defined according
to the harm they impose on individuals at the time of inclusion. They are defined as Class
A, B and C with Class A being thought to be the most harmful when misused and therefore
carry the highest penalties through to Class C which includes drugs with the least potential
harm to health and the lowest penalties. These penalties are outlined in Table 1.
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Table 1: Maximum penalties incurred dependent on offence and where case
contested
Offence Court Class of Drug under MDA 1971
A B C
Magistrates 6 months &/or 3 months &/or 3 months &/or
Possession £5000 fine £2500 £1000 fine
---_ ------------ ~ -----_._-------------- -- ------ -----_"-------._--_---- ..- - .._----------------- --_-.
Crown 7 years &/or 5 years &/or 2 years &/or
unlimited fine unlimited fine unlimited fine
Magistrates 6 months &/or 6 months &/or 3 months &/or
Supply/ £5000 fine £5000 fine £2500 fine_ .._-_ ...-~-~- ~- ------~-
Trafficking Crown Life &/or 14 years &/or 5 years &/or
unlimited fine unlimited fine unlimited fine
Exemptions to the general prohibition governed by the MDA do exist, for example, in
cases where drugs are utilised for scientific and/or medical purposes. In these cases the
Government is able to authorise a Home Office licence under the Misuse of Drugs
Regulations 1985 which allow professionals to possess such drugs for research purposes in
a controlled environment. These regulations are divided into five schedules with schedule
1 being the most stringently controlled and can only be supplied, possessed or administered
in accordance with a Home Office licence. Schedule 5 lists preparations considered to
pose minimal risk of abuse and those that can be bought over-the counter at a pharmacy
without a prescription. The majority of controlled drugs available for medical use are
included in schedules 2, 3 and 4. Table 2 illustrates the main types of controlled drugs
abused in Strathclyde by schedule and class.
Due to the widespread misuse ofTemazepam in the early nineties, this benzodiazepine was
transferred from schedule 4 to schedule 3 in 1996. This meant that the possession of this
drug without a prescription or other authority was illegal". More recently owing to the
increase in misuse, diazepam has been rescheduled from Schedule 4 part II (Misuse of
Drugs Regulations 1985) to a revised Schedule 4 part I (Misuse of Drugs Regulations
2001) 35. This now means that a person can be arrested and charged if found to be in the
possession of just one tablet without a prescription. Most recently, on 10 July 2002, it was
announced that cannabis would be reclassified from Class B to Class C, under the Misuse
of Drugs Act 1971. Although this change was scheduled to take place by July 2003 36, it
actually took effect from 29th January 2004. Despite this declassification, production,
8
Drug Misuse
possession and distribution of cannabis is still illegal and persons found in possession of
this drug are still liable to be arrested and charged under the Misuse of Drugs Act 1971.
Table 2: Commonly abused drugs in Strathclyde classified by schedule and class
Schedule Class
A B C
1 MDMA (Ecstasy) Cannabis and cannabis
Opium (Raw) resm
Coca Leaf
--- ...-------~- ...--- --.---~~--------- ---- -.-------------~---~---- 1--------------------
2 Heroin Amphetamine Dextropropoxyphene
Methadone Dihydrocodeine (DFl18)
Cocaine
----------_-----._ -------------- -~
3 Barbiturates Temazepam
---------- r----- -- ..--------------------,._-----------_ ..- f--------------------------------
4 Benzodiazepines (except
Temazepam)
--- ------------ --------------------- - ----------~-
5 Preparations Non-injectable preparations Preparations containing
containing opium, containing codeine and dextropropoxyphene to
morphine, certain other weak opiates and be taken by mouth
opioids and opioids
cocame
2.3 Drug Misuse in Scotland
The misuse of drugs has a detrimental effect both to the individual and to society as a
whole and is an everyday problem encountered globally, Scotland being no exception. The
use of drugs has always been present in society, albeit to a lesser extent some twenty years
ago than in comparison with today. In the seventies, for example, drug use was mostly
confined to bohemian groups experimenting with "love drugs" and other psychoactive
drugs such as LSD and amphetamine. In those days there was little evidence of the hard
core illicit drug injector that has emerged in today's society.
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2.3.1 Number of Drug Addicts in Scotland
During 1968, it became statutory for general practitioners (GPs) to notify an individual to
the Home Office addicts index if they were known to be addicted to anyone of fourteen
specific opiates and/or cocaine'. As well as monitoring the extent of drug misuse in the
UK, this index acted as an extra source of intelligence to prevent double prescribing
occurring 37. In 1980, there was a total of 126 drug addicts notified to the Chief Medical
Officer at the Home Office for the whole of Scotland (2 drug addicts per 100,000
population). Of these, 26 were from the Strathclyde region (1 drug addict per 100,000
population). Over the sixteen-year period the total number of drug addicts notified rose
approximately 35 fold to 4516 for Scotland (89 drug addicts per 100,000 population), 2467
of which were in the Strathclyde region (107 drug addicts per 100,000) 38. Since these
figures relate to individuals who have voluntarily presented themselves for medical
treatment at their GP, it can be assumed that the figures are an underestimate. For
comparison, in terms of the national prevalence of problematic drug misuse, Hay et al have
estimated that 55,800 individuals were misusing opiates and benzodiazepines in Scotland
in the year 2000 and approximately 53% of problematic drug users were resident within
the Strathclyde Police Force Area. 39.
Figure 1 shows the total number of drug addicts who had been notified to the Chief
Medical Officer at the Home Office on a year to year basis (figures for 1986 and 1991
were not available) and include both new and re-notified drug addicts. Over the years
shown, between 5% and 12% of all UK figures were from Scotland. The vast majority of
Scottish drug addicts notified resided in the Strathclyde area and accounted for between
32% - 65% of all drug addicts notified in Scotland.
t Dextromoramide (Palfium), Diamorphine (Heroin), Dipipanone (Diconal), Hydrocodone (Dimotane DC), Hydromorphone,
Levorphanol(Dromoran), Methadone, Morphine, Opium, Oxycodone, Pethidine, Phenazocine (Narphen), Piritramid (Dipidolor),Unspecified
Opiates
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Figure 1: Number of drug addicts notified to the Home Office Addicts Index (new
and re-notified) for the United Kingdom, Scotland and Strathclyde
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2.3.2 Trends and Patterns of Drug Misuse in Scotland
Trends and patterns of drug use in the West of Scotland have been well documented in the
literature40,41,42,43,44,45,46. Drug abuse as a problem in the region dates from the early 1980s
when the black market in heroin and trend of injecting drug use emerged in Edinburgh and
Glasgow 47.
From 1985 to 1990, the abuse of buprenorphine (Temgesic™), an opioid analgesic,
purported to be approximately 25 - 40 times more potent then morphine, spread
throughout the Glasgow area. In addition, evidence pertaining to the abuse of temazepam,
a benzodiazepine tranqui1iser prescribed for the treatment of anxiety and insomnia, was
present indicating that it was being misused throughout Glasgow". This transition in drug
use occurred as a result of a decrease in the quantity and quality of street heroin at that
time. These two drugs were popular choices due to their ease of both availability and
administration. Buprenorphine, at that time, was not a controlled drug and was easily
available. As a consequence of solubility it became a preferred choice by the intravenous
drug user. Temazepam, which once was the most widely prescribed hypnotic in the UK48
and was initially manufactured in a liquid filled capsule, providing a "ready to inject"
formula to the abuser. This era also saw the emergence of the opiateibenzodiazepine drug
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cocktail that remains a popular choice with drug users in the West of Scotland today. In an
attempt to decrease the abuse of temazepam, the manufacturers changed the formulation of
the liquid filled capsule to one filled with wax (Gelthix'P') in 1989. However, abuse
continued as users applied heat to the capsule in order to melt the wax prior to injecting.
This led to undesirable consequences in that the wax solidified in the individuals vein and
in extreme cases led to amputations. In September of that same year, buprenorphine
became a controlled drug and as a result the supply of this drug decreased and
consequently, the price increased. As the supply of buprenorphine decreased, drug users
resorted back to using heroin. Cassidy et al revealed an absence ofbuprenorphine amongst
individuals dying of a drugs overdose in the Strathclyde region during 1992. Instead, the
majority of deaths were due to the concurrent use of an opiate and benzodiazepine, with
the opiate of choice being heroin", This substitution of opiate is further substantiated by
the results of a survey carried out by Forsyth et al". Having interviewed imprisoned drug
users at a local Glasgow prison regarding their drug habit, it emerged that there was an
apparent decrease in the use of buprenorphine with respect to that of heroin and that the
preference to mix this with temazepam was still present. These results in combination with
an elevated presence of media attention surrounding the increasing number of drug related
deaths (DRDs) at that time highlighted the danger of mixing these two potentially lethal
drugs. In contrast, this trend of drug use was not noted in Edinburgh, a city not more than
48 miles East of Glasgow. A study of DRDs from 1989 - 1994 revealed that heroin was
involved in very few deaths in the South-east of Scotland with heroin overdoses having
peaked in this area in 1984 and fallen rapidly from 1986. The commonest drug implicated
in causing death was methadone, which had been vigorously promoted since 1986 in
response to the high prevalence ofHIV experienced by the city 49. These changes in drug
misuse are summarised in Figure 2.
Methadone as a drug of misuse did not go unnoticed in Glasgow. An increase in the
misuse of this drug became evident in the early 1990's following the introduction of the
methadone maintenance programme (MMP). A substantial increase in the number of
heroin addicts being prescribed this drug together with a lack of supervision of
consumption were to blame for the initial increase in methadone deaths observed around
that time. In the late 1990's an increase in the number of dihydrocodeine (DHC) positive
drug related deaths was noted 50. 51. Consumption of this drug has been reported in times of
heroin deficit or when there is poor quality heroin on the streets 52. It has been increasingly
prescribed over the years and can be purchased very cheaply on the streets.
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The increase in drug misuse has resulted in an increased workload at Forensic Medicine
and Science at the University of Glasgow. During 1985, there was a total of 1005 post
mortems carried out by pathologists within the department. By 2001 this figure had
increased by approximately 107% to 2076. During this time period, the annual proportion
of post mortems which were drug related increased from 0.9% to 8%. Of 758 biological
samples received by the laboratory in 1985, 31% were Strathclyde cases requesting a drugs
screen. The vast majority (91%) of these cases required a general drugs screen to detect
the presence of prescription drugs, only a very small number were specifically analysed for
heroin (3%). Over the years, an increasing number of samples were being sent to the
laboratory and a drugs of abuse screening method was utilised due to the ever increasing
requests for the analysis of street drugs. The screening and confirmation of drugs of
misuse is now an essential part of all routine analyses in the laboratory.
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2.3.3 Drug Treatment Services Available to Drug Misusers
The widespread and preferred intravenous route of administration of drugs resulted in the
spread of HIV infection becoming a major health issue in the late 1980's. The provision of
sterile needles and syringes in order to discourage such behaviour was highlighted as an
important part of the United Kingdom's strategy to prevent the spread ofHN infection.".
As a result a pilot needle exchange was initiated in June 1987 in the Ruchill area of
Glasgow. By 1992, there were 8 needle exchanges established in the city with attendances
having risen approximately 32-fold from 880 in 1988 to 27, 990 in 199254• By 2001/02, a
needle exchange service was provided by 4 key facilities namely pharmacy needle
exchanges, the Glasgow Drug Problem Service, Base 75 and the Glasgow Drug Crisis
Centre. The total number of attendances at these facilities in the Greater Glasgow area was
126,967, with over half of these involving the pharmacy needle exchanges 55.
The overall increase in drug misuse which had risen in epidemic proportions led to the
Advisory Council for the Misuse of Drugs to conclude that general practitioners should
participate more in the care of drug misusers'". In the early nineties, it became evident to
the small group of Glasgow general practitioners who chose to prescribe the opiate
substitute methadone that there was a need for a greater professional involvement in the
care of drug misusers. As a result, the Glasgow Drug Problem Service and the General
Practitioner Drug Misuse Clinic Scheme were established in 1994 whose objectives were
to reduce drug-related harm to health 57. The former was established in January 1994 with
an aim to ''promote better management of drug injectors by general practitioners through
a system of shared care,,58. A condition for receiving treatment at the GDPS is that the
individual is referred by his/her GP, the GP agrees that the patient may receive methadone
for a considerable time and that they will agree to share in the continuing care of the
patienr", In addition to the shared care by staff in the GDPS and in general practice,
community pharmacists were recruited to supervise the consumption of daily doses of
methadone. In early 1994, approximately one fifth of all Glasgow community pharmacies
had become involved 60 and this has increased to approximately two-thirds today 61. In
1996, 99% of all methadone that had been prescribed by the GDPS involved supervised
daily dispensing", a figure that remains unchanged".
2.3.3.1 Drug Action Teams
Drug Action Teams (DATs) in Scotland resulted from a recommendation of the Scottish
Executive's Task Force Report in 1994. Each health board area was given the task of
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establishing a DAT that would be responsible for planning action against drugs (and
alcohol) misuse in their local area. They are multi-agency partnerships made up of local
professionals who advise the DAT on policy and practice including medical, law
enforcement and social work agencies. Some are involved with tackling issues on both
drugs and alcohol and some are solely concerned with drug prevention and educational
Issues. There are 22 DATs in Scotland and four of these are encompassed by the
Strathclyde Police region of Scotland:
Greater Glasgow DAT
Ayrshire & Arran DAT
Lanarkshire DAT
Argyll & Clyde DAT
Following the launch of the national drugs Strategy, "Tackling drugs in Scotland" in 1999
by the Scottish Office, a local strategy was agreed by the Greater Glasgow DAT which
included five action plans:
• Understanding the drug problem
Protecting young people
Reducing drug related crime
Treatment, support and rehabilitation
Effective communications and co-operation
•
•
•
•
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3 National Statistic Sources
There are various resources providing information on the extent of drug misuse within a
community. Some examples are summarised below and include data pertaining to the
number of drug-related deaths and the number of individuals who are known to be drug
misusers within a population.
3.1 The Annual Report of the Registrar General for Scotland
Around 400 years ago, the General Assembly of the Church of Scotland, decreed that
parish registers of baptisms, burials and marriages should be kept by every minister in
Scotland. This was the responsibility of clergymen until 1854, when parliament passed an
Act "to provide for the better registration of births, deaths and marriages in Scotland".
This meant that the responsibility was passed from the Church to the State and that it was a
statutory obligation for individuals to register such vital events. Consequently, the General
Registry was established and a Registrar General appointed, who was responsible for the
compilation of an annual report which was to be laid before Parliament. The very first
annual report produced by the General Register Office for Scotland (GROS) was produced
in 1855 and has been published every year since then'",
Presently, legislation requires that all deaths in Scotland be registered within 8 days of the
event. Data included in the main register include personal details of the deceased such as
name, occupation, marital status together with the certified cause of death. Once the cause
of death has been established, the deaths are then coded in accordance with the
International Classification of diseases.
3.1.1 International Classification of Diseases
To enable statistical comparison of morbidity and mortality, both nationally and
internationally, the first International Classification of Causes of Death was devised in
1893. Since then it has been revised and published approximately every 10 years, latterly
being co-ordinated by the World Health Organization (WHO), with the latest version
(ICD-lO) having been published in 1992. In order to encompass a broader range of disease
and health issues and also to update in terms of medical advances in disease identification,
the current version has been renamed as the International Statistical Classification of
Diseases and related Health Problems. The ICD classification constitutes the means for
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coding deaths depending on the cause of death issued on the deceased's death certificate,
the codes being universal throughout the many countries which employ this system as a
means of classifying both morbidity and mortality patterns and trends within that specific
country. These codes are used as the means for listing the frequency of deaths in the annual
report. Whilst the ICD-10 has been available since the early-nineties, it should be noted
that the GROS converted to this version as recently as the year 2000.
3.2 The Home Office Addicts Index
Under the Dangerous Drugs Regulations of 1968, it became statutory for general
practitioners (GPs) to notify an individual to the Chief Medical Officer at the Home Office
if they were known to be addicted to anyone of fourteen specific opiates and/or cocaine'.
The results of all registered drug addicts were published in Statistical Bulletins to aid
epidemiological research. However, certain limitations existed in that the list of drugs did
not cover all drugs to which addiction is possible and hence did not reflect present day
drug trends. In addition a person could only be notified if they presented themselves at
their GP thereby omitting those who had approached other drug agencies directly. Finally,
it had been noted that, despite the legal requirement, there was a significant number of
addicts who, although identified by doctors, remained un-notified on the Home Office
Index 63. As a result of these factors together with the development of the regional Drug
Misuse Databases, the Home Office Addicts Index was discontinued in April 1997. As of
l"May 1997, the legislation to remove the statutory duty of GPs to notify the Home Office
of a known drug addict came into effect. From this date, the only information available as
to the prevalence of known drug addicts seeking treatment is collated by the Department of
Health's regional drug misuse databases (DMDs) and the Scottish drug misuse database.
3.3 The Scottish Drug Misuse Database (SDMD)
In 1982, the Advisory Council on the Misuse of Drugs (ACMD) published a report entitled
"Treatment and rehabilitation" which highlighted the widespread misuse of drugs in the
United Kingdom. It also drew attention to the fact that users' problems reached beyond
present medical treatment available to them. Consequently, this promoted the
t Dextromoramide (Palfium), Diamorphine (Heroin), Dipipanone (Diconal), Hydrocodone (Dimotane DC), Hydromorphone,
Levorphanol(Dromoran), Methadone, Morphine, Opium, Oxycodone, Pethidine, Phenazocine (Narphen), Piritramid (Dipidolor),Unspecified
Opiates
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development of multidisciplinary problem drug teams to be established locally within each
Health Authority 64.
Following a request from the Department of Health and Social Security in 1984 asking the
National Health Service to review the prevalence of drug misuse locally, a DMD was
developed by the University of Manchester Drug Misuse Research Unit (DMRU) in
198664• Consequently, the Department of Health funded the DMRU to develop a DMD to
be utilised on a national level which in turn led to its distribution to all English regional
health authorities around 1990, Scotland followed shortly after. The 1986 DMD was really
the nucleus of something that was to become a valuable tool to monitor the nature and
extent of drug misuse amongst individuals' who presented themselves to a wide range of
drug services nation-wide. The Drug Misuse Information Strategy Team are part of The
Information & Statistics Division Scotland within The National Health Service in Scotland
and have managed the Scottish DMD since it formally began in August 1990. They are
responsible for the production of an annual publication to disseminate the data to the public
and in addition, contribute summary statistics for Great Britain in the Department of Health
Statistical Bulletin".
The information of interest relates to new patients/clients whom present themselves at an
agency with a drug-related problem of any kind, whether it be physically, legally or
psychologically related. A new patient/client is defined as "Any person who is attending
the service for (a) the first time ever or (b) it has been at least six months since the last
attendance at the service": A form (SMR24) is completed by the agency/doctor and
returned to the SDMD for collation, processing and analysis. Types of agencies returning
forms include penal establishments, general practices, police surgeons and specialist drug
services, with the latter being the main source of data by far.
In addition to the prevalence of new individuals presenting at various agencies, the SDMD
bulletin also provides information on the extent of infectious disease, the number of drug
seizures and other drug related crime figures for the whole of Scotland. All such data is
broken down by individual health board and council areas.
3.4 The Scottish Drug Enforcement Agency (SDEA)
The SDEA is an organisation established and maintained by the Scottish Ministers under
Section 36(1) of the Police (Scotland) Act 1967 (the 1967 Act). The Agency was launched
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on 1 June 2000 by the then Deputy Minister for Justice, Angus MacKay, and formally
established on 1 April 2001 on the basis of an Agreement of the 8 Scottish Chief
Constables in terms of Section 12(1) of the 1967Act.
By working together with all eight police force areas in Scotland, the SDEA publish a
quarterly drug trends bulletin providing information regarding drug trends, seizures and
enforcement issues at local levels. This is distributed to police forces, drug agencies and
DATs. They also established a national drug related death database on behalf of the
Scottish Police Service and in collaboration with Forensic Medicine and Science at the
University of Glasgow produced a joint report on all drug-related deaths in Scotland during
200165• The aim of this document was to enhance analysis of drug related deaths from a
police perspective and to include accurate interpretation of pathology and toxicology
findings and assist DATs, drug agencies as well as police and law enforcement agencies.
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4 Methodology for Drug-Related Deaths
The area of study is the Strathclyde police district which encompasses a large portion of
the Southwest of Scotland and has a population of approximately two and a quarter million
66 (Figure 3). There are four health board regions that fall within the boundaries of this
geographical area, namely the Greater Glasgow Health Board, Lanarkshire Health Board,
Argyll and Clyde Health Board and Ayrshire and Arran Health Board.
Figure 3: The Strathclyde Police Region of Scotland
The population and estimated number of problem drug users within each of these health
board areas for the year 2000 are outlined in Table 3.
21
Methodology for Drug-Related Deaths
Table 3: Populations and estimated number of problem drug users in each health
board area encompassed within the Strathclyde Police region, 2000
Population 66 Estimated number of problem drug users 39
Greater Glasgow
Lanarkshire
Argyll and Clyde
Ayrshire & Arran
~900K
~560K
~420K
~370K
-15,975
-5,076
-5,405
-3,058
4.1 Investigation of a Drug Related Death
Following the event of a suspected drug related death the Police Service has an established
duty to investigate the death on behalf of the Procurator Fiscal (PF)67. They are required to
compile a death report summarising the deceased's background, their medical history and
the circumstances of the death. This is then submitted to the PF who in turn instructs
whether or not a post mortem examination is carried out. Approximately 90% of
Strathclyde drug-related deaths are referred by the Procurator Fiscal to Forensic Medicine
and Science at the University of Glasgow for post-mortem examination. The remaining
10% of suspected drug-related deaths are examined by hospital pathologists. All
biological specimens procured at the post-mortem examination are submitted to Forensic
Medicine and Science at the University of Glasgow for analyses. This department is
responsible to the Crown Office (the department of the Scottish Executive which provides
Scotland's death investigation service) for the provision of toxicology services throughout
the West of Scotland. The information available in the police sudden death report can
provide vital evidence and aid the pathologist and toxicologist when assigning the cause of
death on completion of all post-mortem examinations.
4.1.1 Standardised medico-legal protocol of the investigation of a drug-
related death
In response to recent guidelines published by The Royal College of Pathologists, a full
post-mortem examination is carried out on all suspected drug-related deaths regardless of
infectious status 68. The guidelines note that "a refusal to perform an autopsy purely
because of perceived risk of exposure to a serious communicable disease would have to be
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justified". In previous years, it was generally accepted that in such infectious cases, an
external examination would suffice.
In addition, an agreed procedure has been established with the Procurator's Fiscal for
sample retention with regards these deaths. Presently, the following samples are retained:
2 x Blood Samples (peripheral)
Small Tissue Samples for Histology
2 x Urine Samples
2 x Head Hair Pluckings
One of these duplicate samples is analysed on behalf of the Crown whilst the other is
retained in the event that it may be required for analyses by future defendants.
On completion of the post-mortem examination, biological specimens are retained and
submitted to Forensic Medicine and Science at the University of Glasgow for full
toxicological and histopathological analysis. The current investigative procedures
implemented by Forensic Medicine and Science are illustrated in Figure 4.
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Figure 4: Overview of the Investigation of a Suspected Drugs Related Death.
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A recent Crown Office recommendation in the procedure of investigating a DRD has
resulted in the requirement for a full post-mortem examination to be carried out by two
pathologists regardless of the infection status. Presently Crown Office is in agreement that
this method of investigating drug related deaths is both thorough and concise and
facilitates corroboration in the likelihood that a supplier may be charged for culpable
homicide. However this practice is not consistent and can vary depending on the PF who
instructs the post-mortem to be carried out.
The requirement for a double doctor post-mortem examination m possible culpable
homicide cases came about following a Lord Advocate's reference in response to the
acquittal of an accused male who was charged for supplying amphetamine to a female who
subsequently died. It was contested that the accused did not instigate, suggest or
encourage the ingestion of the drug, other than by the actual supply of it. However,
following the decision of Ulhaq v HMA 1991 SLT614, it was accepted that "if a person
supplies to another a substance which is capable of causing injury if abused, in the
knowledge that the recipient intends so to abuse it and the supply can properly be
regarded as a cause of the abuse, the conduct of the supplier is criminal" 69.
4.1.2 Toxicological Examination
Forensic toxicology is defined as the study of the effects of drugs and poisons on human
beings and the investigation of fatal intoxications for the purpose of some sort of medico-
legal enquiry 70. The role of the forensic toxicologist is to determine:
Q If any poison/drug is present?
Q Ifpresent, was the amount detected enough to impair / cause death?
The results of a toxicological investigation are of extreme importance when investigating
all sudden and unexpected deaths. The results of such an investigation have been noted as
being the major element in diagnosis of a cause of death 71 as well as indispensable for the
final clarification of the cause of death in overdose cases 72. In order to interpret the
toxicology findings appropriately, there are a few factors which have to be taken into
consideration 73.
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1:1 The degree of tolerance the individual had developed
1:1 The phase of absorption or elimination of the drug
1:1 The additive or potentiating effect of the drug with other drugs and/or alcohol that
may be present.
There are many biological matrices that can be utilised for the analyses of drugs today.
However, blood remains the gold standard for detecting, quantifying and interpreting drug
concentrations in post mortem toxicology. Blood is not always available, for example, in
cases where the body is badly decomposed or the deceased has survived for a period of
time in hospital and the admission sample has been disposed of. Post-mortem changes can
profoundly alter the concentrations of many drugs and so blood taken from a peripheral
site is preferred for estimating toxicity as these sites are usually less affected by post-
mortem redistribution. In addition the common practice in forensic toxicology is to
analyse whole blood compared with clinical cases where plasma is usually analysed. Other
matrices used in forensic toxicology are outlined in Table 4. '
Table 4: Alternative matrices used in the application of forensic toxicology
Has the greatest potential of any specimen to provide the
toxicologist with qualitative ante-mortem drug exposure
Urine information. The accumulation of drugs and their metabolites
result in relatively high concentrations which can facilitate the
detection of an exposure to a particular drug. It should be noted,
however, that this is only qualitative and not quantitative.
Provides a diary from which chronic drug use may be determined.
Hair Hair grows at a rate of approximately lcmlmonth, therefore, hair
samples can be sectioned allowing for each month to be analysed
separately
Nails Again can, provide a diary of chronic drug exposure
Principally used to assess in-utero drug exposure m newborn
Meconium babies so that treatment may begin as early after birth as possible.
Can also be used to determine drug exposure in stillborn infants
Stomach Contents Sometimes analysed when an oral tablet overdose is suspected
All drugs of misuse (opiates, cocaine, buprenorphine, cannabinoids, benzodiazepines and
methadone) are screened using enzyme immunoassay techniques. All positive samples are
then confirmed and quantified. Analytical procedures remained consistent throughout the
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study period and there were no major changes to the protocol that would radically change
the sensitivity and specificity for a certain drug. Therefore, there were no analytical factors
which would have a direct effect on the trends of drugs detected.
4.1.3 Retrieval of Cases
In order to identify a drug-related death several sources of departmental administration
were searched. Initially, a search was made of the "post-mortem book". This book
contains all cases investigated by pathologists within Forensic Medicine and Science and
lists the deceased's name and their cause of death and was used to search for cases
retrospectively. Prospectively, all completed toxicology reports were perused and cases
that were positive for drugs of abuse were identified. Cross-reference was also made to the
departmental diary which records the day and date for which a post-mortem is booked in.
If the deceased is known to be a drug user, the details are highlighted accordingly. In the
latter years of the study, all deaths were recorded on a departmental database which
replaced the need for the "post-mortem book". This was used as a cross-reference source
for any toxicology report that was positive for drugs of abuse. The criteria for identifying
cases were consistent over the study period in that retrospectively, the cause of death was
used and prospectively, the toxicology report and cause of death was used. All deaths
which fell into one of the four categories highlighted in section 5.2 were included in the
study.
As mentioned previously, a small number of PMs are carried out by NHS hospital
pathologists. It was therefore necessary to identify these cases and locate the relevant
documentation. Drugs of abuse positive cases were identified from the toxicology reports
that also gave the name of the pathologist who requested the anlayses and the Fiscal
instructing the analyses. It was necessary to liase with the various Procurators' Fiscal
offices to access the relevant documentation, namely the police sudden death reports and
post-mortem reports. In these cases, the cause of death was reported in a more general
manner than was the practice used by pathologists based in Forensic Medicine and
Science. For example, a common cause of death was "Toxic Effects of Drugs". In these
instances, having reviewed the circumstances, the drugs involved in the death were
determined and these were confirmed by a forensic toxicologist.
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All information was stored in a Microsoft Excel spreadsheet which provided a
departmental database of all drug related deaths within the Strathclyde police area.
Information was extracted from each case relating to:
D Demographic information
D Medical history
D Circumstances of the death
D Toxicology Results
D Cause of Death
4.2 Statistics
The t-test was used to analyse continuous variables, except where data was highly skewed,
in which case, medians were reported and analysed using the Mann-Whitney U test (a non-
parametric analogue of the t-test). Categorical variables were analysed using the chi-
squared test. For dichotomous categorical variables, Odds Ratios (OR) and 95%
Confidence Intervals (95% Cl) were reported. All statistical analyses required for the chi-
squared test was carried out using MiniTab, Version 9.2 for Windows and all other
statistical analyses was carried out using SPSS, Version 9.0 for Windows. Statistical
significance was assumed when p<O.05.
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5 Drug-related deaths
5.1 Why study Drug Related Deaths?
In addition to seizures, drug related criminal offences and the price and purity of a drug,
the Pompidou Group classified drug-related deaths as a useful indicator in determining the
extent and nature of drug abuse in a community". This has been backed in the literature
where mortality studies involving drug related deaths have been used in assessing the
extent of drug abuse, changes in patterns of drug misuse and the efficacy of prevention
treatment programmes and changes in clinical care within a population". In addition to
drug-related morbidity, drug consumption among the general population and service
utilization for drug problems, drug-related mortality was listed as a core indicator of drug
abuse at the Lisbon Consensus in 2000. This was in conjunction with the Global
Assessment Programme which intends to harmonise global drug abuse data and was
supported by the United Nations and hosted by the EMCDDA and involved experts in the
field of epidemiology from key regional and international organisations 75.
5.2 What is a Drug Related Death?
The definition of a drug related death (DRD) varies greatly throughout the literature
making it somewhat difficult to carry out comparative studies. Some studies include
intentional overdoses of any drug, some include fatal accidents where a drug of misuse was
involved and some include deaths of known drug users due to natural causes (Table 5).
In Scotland, there is presently two main data sources for DRD statistics, the General
Register Office for Scotland (GRaS) and individual police forces, although since 2001, all
the police forces report their drug-death statistics via the Scottish Drug Enforcement
Agency (SDEA). The GRaS uses data obtained from death registrations which is
supplemented by a Medical Enquiry form (ME4) that is sent to the investigating
pathologist for completion. This highlights specific drugs involved in the death and, in
particular, the ones which were considered to be responsible in causing death. The SDEA
gathers its data from cases that have been reported to the police and sources of information
include the police sudden death report, toxicology examination report and the post-mortem
report.
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Table 5: Examples of varying Definitions ofa DRD
Author Definition
Shai D. 76 Deaths due to psychoactive drugs, legal
or illegal through natural causes (chronic
or acute narcotism) or accidental or
purposive overdose
Puschel K.71 Deaths due to intentional or accidental
overdose, the long term abuse of drugs,
suicides connected with drug dependence
or fatal accidents influenced by drugs
Risser D. and Schneider B.77 Deaths due to a narcotic overdose, long
term effects of drug abuse, suicides in
connection with drug abuse or
withdrawal, violent deaths under the
influence, deaths due to medication
overdose whereby medication was used
as a drug substitute or deaths of known
drug users although actual CoD was not
directly related to drug abuse
In order to disseminate statistics, the GROS produces an annual "occasional" paper 78 and
the SDEA produced its first annual report in 2002 for DRDs that occurred in 200165• There
were however, discrepancies in the number of DRDs reported by both sources for the year
2001, where the GROS recorded 332 DRDs in Scotland compared with 223 confirmed
DRDs by the SDEA. A possibility for the difference is that both agencies use quite
different methods for case capture and more pertinently different definitions. The GROS
definition was recently changed in 1998 and includes:
(a) deaths where the underlying cause of death has been coded to the following
sub-categories of "mental and behavioural disorders due to pscychoactive
substance use":
(i) opioids (F11);
(ii) cannabinoids (FI2);
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(iii) sedatives or hypnotics (F13);
(iv) cocaine (FI4);
(v) other stimulants, including caffeine (FlS);
(vi) hallucinogens (FI6); and
(vii) multiple drug use and use of other psychoactive substances
(FI9).
(b) deaths coded to the following categories and where a drug listed under the
Misuse of Drugs Act (1971) was known to be present in the body at the
time of death:
(i) accidental poisoning (X40 - X44);
(ii) intentional self-poisoning by drugs, medicaments and
biological substances (X60 - X64);
(iii) assault by drugs, medicaments and biological substances
(X85);
(iv) event of undetermined intent, poisoning (YIO - YI4).
The SDEA use the definition which is utilised by The Chief Association of Police Officers
in Scotland (ACPOS) who adopted the definition which was defined in the 1994 Scottish
Office 'Ministerial Drugs Task Force Report'. In this report, a DRD was defined as a
death:
, where there is prima facie evidence of a fatal overdose of controlled drugs.
Such evidence would be recent drug misuse, for example controlled drugs
and/or a hypodermic syringe found in close proximity to the body and/or the
person is known to the police as a drug misuser although not necessarily a
notified addict. '
With respect to published statistics, it is clear that discrepancies will arise due to the
different definitions used. The GROS will, for example include all intentional self-
poisoning cases and those whereby a drug governed by the Misuse of Drugs Act (1971)
was known to be present in the body (accidental or intentional). The SDEA omit known
suicides from their study and may also omit cases where the person was not known to be a
drug user.
For the purposes of this study, all DRDs investigated by Forensic Medicine and Science
that occurred in the Strathclyde Police Region were recorded on a database. If a drug
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governed by the Misuse of Drugs Act 1971 was detected in a case following a toxicology
examination and the death fell into one of the following four categories, that case was
classed as a DRD.
o A sudden or unexpected death where drugs of misuse were implicated as a
cause of death either through toxicology or circumstance
o Death as a result of chronic drug misuse (e.g. septicaemia)
o Death of a known drug user as a result of an overdose of non-illicit drugs
o Solvent abuse deaths
A death was only classed as a DRD once all investigations had been completed. Over the
years there have been instances where the cause of death was amended and despite "prima
facie evidence of a fatal overdose of controlled drugs", was actually found to be not drug
related (e.g. cause of death amended from suspected DRD to hypoglycaemic ketoacidosis).
Drug related deaths have increased substantially over the study period and the majority of
these deaths were due to the overdose of an illicit drug (Figure 5).
Figure 5: DRDs reported by Forensic Medicine and Science categorised by definition
classes.
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The incidence of DRDs in general in the Strathclyde Police Region as described by this
definition has been previously reported 79.
5.3 Discrepancies between statistics published from three
different sources
Figure 6 shows the total numbers ofDRDs as reported annually, where available by:
o Forensic Medicine and Science, University of Glasgow (FMS)
o General Register Office for Scotland (GROS)
o Strathclyde Police Force (SP)
All data sources show an increasing trend for DRDs in the Strathclyde Police Region of
Scotland
Figure 6: Total number ofDRDs reported by three different data sources
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Figure 7:
Drug-Related Deaths
Percentage differences in figures published annually when GRO figures are
taken as the baseline
200
en
Q)
en
CISo
'0
oz
1996 1997 20001998 1999 2001
Year
By comparing the figures over the past six years obtained from FMS and SP with those
figures which are published by the GROS, Figure 7 shows that the discrepancies between
the GROS and FMS varied from -15% to +2% and between the GROS and SP varied from
-50% to -10%.
For the remainder of this chapter, deaths as a result of the effects of heroin, methadone,
dihydrocodeine and cocaine within the Strathclyde Police region of Scotland will be
discussed.
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5.4 Heroin
Street names: Brown, Junk, Smack, Scag, H
Heroin is, globally, a widely misused drug. It is estimated that about 8 million people
(0.14% of the world's population) use heroin each year 80. The main source of illegal street
heroin in the United Kingdom is the Golden Crescent countries of South West Asia,
mainly Afghanistan, Iran and Pakistan". It is typically self-administered mainly by
intravenous injection but can also be snorted or smoked (also known as "chasing the
dragon"). A study of 200 heroin users reported in 1992 that heroin taken by injection was
associated with more severe dependence than smoked heroin 82. Interestingly, a study of
400 heroin users with a wide variation of the first year of use of heroin revealed that
"chasing the dragon" was the route of administration in a minimal number of addicts up to
the late 1970s. It was shown that this had become an increasingly common route of
initiation since 1975 and by 1988, 94% of heroin initiations were by "chasing" 83.
In Scotland, heroin misuse has become problematic in society. The number of heroin
seizures by Police and other authorities in Scotland was shown to increase by more than
540% over the years 1989 - 199984• Heroin accounted for 39% and 52% of all Class A
seizures carried out by Police and other authorities in the years 1989 and 1999
respectively.
Table 6: Number and Quantity of Heroin Seizures in Scotland, 1989 and 1999.
1989 1999
Number of Seizures by Police & other authorities 2,320 14,950
Quantity of Seizures by Police & other authorities (kg) 20.8 1,493.7
Number of Seizures by HM Customs & Excise 408 158
Quantity of Seizures by HM Customs & Excise (kg) 330.6 848
5.4.1 Legal Status
Heroin is a Class A drug under the Misuse of Drugs Act 1971 (i.e. thought to be the most
harmful when misused and hence carries the highest penalties). If convicted for possessing
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or supplying/trafficking the drug carries a maximum penalty of 7 years imprisonment plus
an unlimited fine or life imprisonment and an unlimited fine respectively. It is categorised
as a schedule 2 drug under the Misuse of Drugs Regulations 1985, hence a Home Office
licence is required to produce, import, export or supply it.
5.4.2 Prescribing
Following it's launch by the pharmaceutical company Bayer, heroin was initially thought
to be an effective cure for morphine addiction. However, it soon became apparent that
heroin itself was very addictive. Excessive prescribing by a small number of doctors
together with the potential for abuse of the system resulted in prescribing restrictions
which were enforced in 1968 85. This meant that only doctors with a special Home Office
licence were allowed to prescribe heroin to addicts. Indeed, the prescribing of heroin to
addicts is rarely exercised in the United Kingdom. Strang and Gossop reported that only
approximately 100 doctors were entitled to do so in 1996 and at that time only
approximately 300 addicts were in receipt of prescribed heroin".
Due to certain factors including addicts relapsing after detoxification or other drug
treatments failing addicts, prescribed heroin as a treatment option has been considered in
Switzerland. The Swiss study showed that it was feasible and politically and socially
acceptable to establish a heroin injection clinic. It revealed that retention in treatment was
reasonably good and no overdose deaths occurred among participants whilst they were
receiving treatment. The outcome of the Swiss trials has encouraged proposals from other
countries such as Australia, Denmark, Luxembourg and The Netherlands 86.
5.4.3 Identification in samples
Post-administration, heroin is rapidly hydrolysed in blood to an active metabolite, 6-
monoacetylmorphine (6-MAM) which in tum is hydrolysed to morphine. However, the
conversion to morphine occurs within minutes. It is believed that the two metabolites
account for all or most of the narcotic activity of heroin.
• • Morphine(Tth 2-3 hrs)
Tth = half life of a drug, i.e. the time it takes for the concentration to fall by half the
original value
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Following toxicological analyses, heroin consumption can be ascertained by the presence
of morphine and possibly codeine which is derived from acetylcodeine, a by-product from
opium processing which is often carried over to the final heroin product. The presence of
6-MAM, the first breakdown product of heroin is indicative that death occurred either
instantaneously or within a few minutes of administration. The metabolite 6-MAM is
further broken down to two major metabolites morphine-3-glucuronide and morphine-S-
glucuronide, both of which have found to be pharmacologically active. The action of the
former is not entirely understood, however, morphine-6-glucoronide has been reported to
be more potent than morphine in producing analgesia and in addition, its potency in
depressing respiration has been reported to be greater than morphine 87
5.4.4 Toxicity
The concentrations of morphine in post-mortem fluid of individuals who have died from a
heroin overdose are known to vary considerably depending on prior narcotic history. In
addition, the levels measured in overdose deaths are known to overlap deaths where the
presence of morphine was incidental. This is also the case between overdose levels and
concentrations detected in living people. For example, a mean morphine concentration of
0.67mgllitre was measured in a study involving seven cases of suspected fatal heroin
overdosage 88. This compares to a mean concentration of 0.41mg/litre (range 0.01 -
2.8mgllitre) amongst a study of drivers killed in Australian road traffic crashes 89. In the
Strathclyde region, a level of 0.8mg/litre morphine was detected in a male who had been
arrested for suspected drugged driving. Darke et al also showed that there was a
substantial overlap between the blood morphine concentrations between those found in
living users and those detected in overdose fatalities 90. Hence, the interpretation of all
morphine concentrations must be considered carefully and once all information regarding
the case circumstances are known.
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5.4.5 The Incidence of Heroin in Drug Related Deaths in the Strathclyde
Police Region of Scotland
The incidence of heroin in drug related deaths investigated by Forensic Medicine and
Science at the University of Glasgow has increased significantly and in a similar fashion to
all drug-related deaths over the study period. On a year on year basis, heroin was found to
be present in between 35% (1989) and 86% (2001) of all drug-related deaths that occurred
within the Strathclyde Police region (Figure 8).
Figure 8: Number of morphine positive cases in relation to all drug-related deaths
investigated over the study period, 1985 - 2001.
200
180
160
'" 140Q,j
'" 120CIS
U.. 100e
Q 80
Z 60
40
20
0
Year
I ..... AllDRDs-Heroin positivecases 1
5.4.5.1 The Role of Heroin in Drug Related Deaths
Over the study period, 1985 - 2001, a total of 869 heroin positive drug related deaths were
identified. All heroin positive cases were classified into one of three groups according to
the cause of death assigned by the investigating pathologist. Table 7 shows that 43% (n =
375) of cases were certified to be due solely to the effects of heroin, 52% (n = 452) were
due to heroin in combination with other drugs and despite its presence in the biological
sample, a further 5% (n = 42) were due to the effects of a drug other than heroin (n = 23)
or due to the adverse effects of heroin injecting such as septicaemia, hepatitis or multiple
organ failure (n = 19).
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Table 7: Heroin positive cases classified according to cause of death as certified by
the investigating pathologist
Year Heroin Only Heroin Related Not Heroin Related Total
1985 5 1 0 6
1986 5 1 0 6
1987 6 2 0 8
1988 5 2 1 8
1989 2 4 0 6
1990 5 8 0 13
1991 10 11
I
0 21
1992 15 24 0 39
1993 13 17 1 31
1994 16 31 1 48
1995 33 33 2 68
1996 39 30 2 71
1997 25 24 4 53
1998 38 46 3 87
1999 54 63 6 123
2000 49 78 8 135
2001 55 77 14 146
Total 375 452 42 869
Heroin Deaths = 827
The number of heroin positive cases and heroin deaths as a proportion of all accidental
drug overdoses per annum is shown in Figure 9. This shows that between 1985 - 87,
heroin misuse was accountable for 100% of all accidental illicit overdose cases. From
1988 - 1994, the proportion of heroin positive cases amongst all illicit overdoses was
shown to decrease, however heroin, when present, was still a contributory factor either
alone or in combination with other drugs in the vast majority of cases (88% - 100%). By
1994 less than half of all overdose deaths involved heroin, possibly due to the increased
misuse of benzodiazepines at that time as well as the increasing use of methadone. This
trend reversed post 1995 when heroin positive cases were shown to increase. In the vast
majority of these cases heroin was considered to be the cause of death alone or as a
contributory factor.
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Figure 9: Heroin positive cases and heroin deaths as a percentage of all accidental
illicit overdoses
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5.4.5.2 Heroin as a Cause of Death
In order to study deaths where heroin was considered to be the cause of death either alone
or as a contributory factor in combination with other drugs, all deaths classed as "heroin
only" or "heroin related" will collectively be referred to as "heroin deaths". The vast
majority of all heroin positive drug related accidental overdose cases were found to be due
wholly or partially to the effects of heroin (95%, n = 827). Of this group, males
outnumbered females by a ratio of approximately 5 to 1. The mean male age was 29 years
(14 - 39 years, std. dev. 6.9) and the mean female age was 27 years (15 - 42 years, std.
dev. 6.6). This mean difference of 2 years was statistically significant (p = 0.004). The
majority of individuals in each four/five year block were aged between 20 and 29 years
where between 48% and 78% of individuals fell into that age category (Figure 10). Of all
heroin deaths over the study period, 30% (n = 248) occurred amongst individuals who
were aged between 25 and 29 years and this age group accounted for the highest
proportion of males and females compared to the other age groups (29% of all males and
34% of all females). The next most common age group were people aged between 30 - 39
years and accounted for between 15% and 37% per four/five year block. From 1997
onwards, the number of individuals aged 40 years and older was shown to increase,
although accounted for only 3%,5% and 11% of all deaths between the years 1989 - 1992,
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1993 - 1996 and 1997 - 2001 respectively. Over the study period, the annual average age
observed increased significantly from 26 years in 1985 - 1888 to 29 years in 1997 - 2001
(p = 0.02).
Figure 10: Age ranges of deceased persons whose death was heroin related
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5.4.5.3 Drug history of deceased
The deceased was known to be an intravenous drug user at the time of their death in 92%
(n = 762) of cases. A further 2% (n = 20) had a history of drug misuse, however drugs
were administered by methods other than intravenous injection, such as smoking or
snorting. There was no history of drug misuse noted in the police report for 44 cases (5%)
and finally in one case it was noted that the deceased had injected heroin for the first time
on the day they died. Information relating to the length of time the deceased had been
known to inject drugs was available in 294 cases (39% of known drug injectors). In the
majority of these cases, the deceased had been injecting for a considerable length of time
and were by no means novice users (Figure 11). In fact, of these 294 cases, 97% (n = 286)
had been injecting for 2 years or more. Of those that fell into the 0 - 5 years category (n =
106), only one individual was known to inject for less than one year.
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Figure 11: Length of time deceased was known to inject drugs
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5.4.5.4 Living Arrangements of Deceased
It was possible to ascertain the deceased's living arrangements from information provided
in the police sudden death report for 90% of cases (n = 745). Just over one-quarter of
individuals lived alone (27%, n = 201). Over one-half (58%, n = 430) lived with other
people and this was primarily their parents (n = 199) or (common law) partners Ispouse (n
= 169). In 14% (n = 108) of cases, the deceased was homeless at the time of death, 70% (n
= 76) of whom resided in a hostel and the remainder were of no fixed abode. The deceased
was a serving inmate at the time of death in 1% (n = 5) of cases. In one additional case the
deceased was a long-term patient within a hospital but was allowed daily horne visits.
With the exception of this case, Figure 12 shows the distribution of living arrangements for
the 744 cases where this was possible.
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Figure 12: Living Arrangements of deceased
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5.4.5.5 Health Board Area of Residence
Using the postal code of the address as a reference, it was possible to identify the health
board area within Strathclyde in which the deceased resided in 93% of heroin deaths (n =
772). The reason why this was not achieved in the remaining 55 cases are as follows:
o 32 individuals were of no fixed abode at the time of their death (it is important to note
that this does not include people who were residing in a hostel or care of an
acquaintance, the postal code area of such an address would have been used to identify
the health board area in such cases)
o In 11 cases, although the deceased died within the Strathclyde jurisdiction area, the
deceased resided either in another Scottish health board area or in England or Ireland
o In five cases, the deceased was an inmate at the time of death.
o In seven cases, it was not possible to obtain a post code for the address given on the
police sudden death report
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Of the 772 cases where it was possible to identify the health board area, three quarters of
cases (74%, n = 572) involved the deceased residing within the Greater Glasgow Health
Board Area (GG). Between 1985 and 1994, 87% (n = 159) of individuals resided within
the GG health board area and between 1995 - 2001 this decreased to 64% (n = 413). This
illustrates that in the latter seven years of the study, heroin misuse was no longer confined
to the GG health board area but showed evidence of spreading throughout the Strathclyde
region. This dissemination is illustrated in Figure 13 and shows that between 1996 and
2000, with the exception of GG health board area, most individuals were residing in the
Argyll & Clyde (A&C) area. Individuals residing in this area tended to be significantly
younger than those residing in the GGHB area (31 years v. 28 years, p = 0.02,95% Cl 0040
to 4.08). However in 2001 there was a sharp increase in the number of heroin deaths
amongst individuals residing in the Ayrshire & Arran (A&A) area.
Figure 13: Health Board Area in which the deceased resided
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5.4.5.5.1 Deprivation Category
A measurement of deprivation was determined usmg the Carstairs & Morris Scottish
Deprivation Sore Index 199191 which was developed for the analysis of Scottish health data
and is the most widely used scoring system to measure deprivation in Scotland. The index
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assigns postcodes within defined geographical areas into 7 categories, using a combination
of four variables derived from the National Census (car ownership, overcrowding, male
unemployment and proportion of people in social classes IV and V). These are judged to
determine material disadvantage. Categories 1 and 2 represent the most affluent and 6 and
7 the most deprived.
It was possible to ascertain the deprivation category of residence in 92% of heroin deaths
(n = 763). Of the remaining 64 cases, 32 were of no fixed abode and hence had no postal
address and for another 32 cases, there was either no corresponding deprivation code
available or it was not possible to obtain a sufficient postal code from the address given on
the police report (in order to obtain a match, it is necessary to have the first part of the
postal code in addition to the first number of the second part, e.g. G14 9). Figure 14 shows
that in approximately two-thirds of cases (69%, n = 524), the individual resided in areas
associated with high deprivation (i.e. categories 6 and 7).
Figure 14: Breakdown of deprivation categories of area where deceased resided
Dep Cat 7
39%
Dep Cat 1
1%
Dep Cat 2
Dep Cat 5
13%
In terms of individual health board areas, the proportion individual fatalities from
residences in deprivation categories 6 and 7 were higher than is estimated for the general
population. That is, the distribution amongst the general population for Argyll & Clyde,
Ayrshire and Arran, Lanarkshire and Greater Glasgow is estimated to be 19%, 13%, 21%
and 50% of the total population respectively 91. In this study, the proportion of fatalities
from residences in deprivation categories 6 and 7 for Argyll & Clyde, Ayrshire and Arran,
Lanarkshire and Greater Glasgow was 46%,27%,25% and 81% respectively.
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5.4.5.6 Locus of Death
The locus where the deceased overdosed was established in 818 cases (99%), unfortunately
there was no police report available in the remaining nine cases. The locus was a dwelling
abode in approximately three-quarters of cases (74%, n = 605) and this was primarily the
deceased's own dwelling abode (63%, n = 380). Figure 15 shows the other types of locus
involved. The outside locations tended to be quiet inconspicuous places where it would be
less likely to be disturbed, for example, under railway bridges, pathways. The public
toilets included those found in railway stations, public houses and fast food restaurants.
There were an additional two cases where the deceased had been admitted to hospital for
unconnected reasons and died within, in one of these cases the deceased was suspected to
have been using heroin whilst in the ward.
Figure 15: Distribution of locus where deceased fell unwell / found dead
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46%
Other Dwelling
Abode
27% Outside location
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Close/Stairwell
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Public Toilet
~------ 5%
------ Hostel Room
8%Police / Prison
Cell
1%
Other
1%
Other: 3 cases whereby the deceased was taken to hospital, the circumstances leading up to the death were
not known; 3 cases where the deceased was found within a disused / derelict flat, 2 cases where the
deceased was found in a hotel room they had booked into the previous night; I case where the
deceased was found within their car
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5.4.5.7 Circumstances of Death
From the police sudden death report, it was possible to ascertain the deceased's last
movements prior to death and all deaths were grouped according to the categories outlined
in Table 8 and these are summarised in Figure 16.
Table 8: Categories of Activities Prior to Death
A Not seen for a while (long enough for relative/friend to become concerned) and
found dead at locus
B Gone elsewhere within locus long enough for witness to become concerned
C Witnessed to be intoxicated prior to following asleep and never wakes up
D Witnessed to take drugs prior to collapsing
E Witnessed to take drugs and witness fell asleep. Deceased found dead when
witness awoke
F Death in Police Custody
G Exact Details Not known - either taken to hospital by witnesses or anonymous
phone call made to emergency services
H No details regarding circumstances leading to death known
I Found at locus (not dwelling abode but outside locus)
J Hostel death
K In another room in locus from witnesses. No intoxication / consumption
witnessed. Found dead when checked on by witnesses
L Witnessed to be intoxicated prior to collapse
M No intoxication witnessed but deceased collapsed / feeling unwell
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Figure 16: Number of cases classified by type of death and category of circumstance
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(N.B. The above diagram excludes the two cases where the deceased was already within
hospital for unconnected reasons.)
The most common scenario was where the deceased had not been seen or in contact with
family/friends for a while (category A, 26% of heroin deaths, n = 213). More often than
not, relatives/friends became concerned and after receiving no response by phonelknocking
on door, access to their home was gained/forced. This scenario suggests that it was
probable that the deceased was alone at the time of drug administration but one can not
preclude the possibility that witnesses present panicked and left the locus. Other instances
that are suggestive that the deceased may have been on their own at the time of ingestion
are those that fell into circumstance category I and J (20% of heroin deaths, n = 165), i.e.
those found at the locus by a witness who was passing by and those who died within a
hostel setting. More often than not, the circumstances surrounding hostel deaths were very
similar. Hostel staff have to carry out routine bed checks every morning, and it is at this
time that the deceased is usually found. From close circuit television screens installed in
the hostels, the deceased was last seen to enter their room alone the previous night. These
types of deaths in the West of Scotland have been previously reported in the literature 92.
The deceased was definitely in the locus with other people at the time of collapse/death in
categories B, C, D, E, K, L and M (51%, n = 419). The next most common scenario after
category A were those that fell into category C (17% of all heroin deaths, n = 143).
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Witnesses who allowed the individual to sleep whilst obviously intoxicated may think they
are doing the right thing by allowing them to "sleep off' the effects of the drugs.
However, some of these deaths may have been preventable had medical assistance been
sought immediately. Drug misuse was definitely witnessed in those that fell into
categories D and E (16% of all heroin deaths, n = 128). The deceased had been in another
room within the locus and drug misuse was not witnessed in categories B and K (16% of
heroin deaths, n = 131). For category B, the most common scenario was that the deceased
had gone to the bathroom and remained within for a long enough period for the witness to
become concerned. Finally in categories L and M (2% of heroin deaths, n = 17), collapse
was witnessed although in the case of category M, the deceased had not been reported to
be intoxicated. The remaining scenarios (categories F, G, H) involved death within police
custody or cases where the exact circumstances were not known/available (3% of heroin
death, n = 28)
Innine cases (8 male: 1 female) there was indication that death may have been intentional.
The deceased had a history of drug misuse in seven of these cases, 86% (n = 6) of which
was intravenous. A suicide note had been found at the locus in five cases and in the
additional four cases the deceased had spoken to a relative or friend shortly prior to being
found stating they had intention to take their own life.
5.4.5.8 Drug Paraphernalia
There was note of drug paraphernalia being found at the locus in three-quarters of all cases
(75%, n = 624) and of these, 29% (n = 183) and 4% (n = 25) were found either adjacent to
or under the body respectively. A needle and syringe had been found in situ in a further
16% (n = 100) and this was primarily in the arm or groin area (91%, n = 91). In an
additional 42 cases (7%), the needle and syringe was found still grasped in the deceased's
hand.
In one case six heroin deals wrapped in a cellophane package were found in the rectum of
the deceased at autopsy. These were all found to be intact and the death was classed as a
heroin only death.
5.4.5.9 Medical Intervention
From the circumstances of death, it was possible to ascertain whether or not any medical
intervention had been initiated on discovery of the body and prior to the arrival of the
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emergency services in 815 cases (99%). In the vast majority of these cases, there was no
effort to resuscitate the deceased (80%, n = 658), however, an attempt was made either on
the witnesses own initiative or by instruction via the phone in 19% (n = 154) of cases. In
the remaining 1% (n = 3) of cases the witness placed the deceased in the recovery position
but there were no attempts at actual resuscitation. There was an association between being
in the locus with people and resuscitation attempts being initiated prior to the arrival of
paramedics eX- = 47.4, p<O.OOI) in that this was more likely to be carried out if witnesses
were present within the locus with the deceased (OR 3.74, 95% Cl 2.5 to 5.47). In
particular, there was an association between resuscitation being attempted and if drug
consumption or actual collapse had been witnessed eX- = 4.73, P = 0.03) whereby this was
more likely to be carried out if witnessed as opposed to a witness merely being present at
the locus (OR 1.67,95% Cl 1.04 to 2.66).
It was also possible to determine what form of action was taken upon discovery of the
deceased in 99% (n = 815) of cases. Of these, only the police were summoned due to the
deceased being obviously dead in 20% (n = 162) of cases. The deceased was either
already in hospital, driven to hospital by the witness( es) or the deceased's GP called in 1%
(n = 9) of cases and in the vast majority of instances, an ambulance was summoned (79%,
n = 644). Of these, despite efforts of cardio-pulmonary resuscitation at the locus, the
paramedics were unable to revive the deceased in 17% (n = 108) of cases and in a further
54% (n = 348), there were no attempts made to revive the deceased due to external
indications of obvious mortality (e.g. colouration of skin and lips, rigor mortis established).
The deceased was conveyed to hospital for further resuscitation in only 29% (n = 188) of
cases. The deceased was pronounced dead on arrival (DoA) at hospital in 69% (n = 129)
of these cases and despite further efforts at resuscitation, life was pronounced extinct in
22% (n == 41) of cases. The deceased was only transferred to either the intensive care unit
or a ward in 9% (n = 18) of cases. There was an association between resuscitation being
attempted by paramedics and whether or not a witness had been present within the locus
(t = 14.7, p == 0.0001), in that this was more likely to happen if a witness was present and
the paramedics were more likely to do nothing if the deceased had been alone and found
some time later. A summary of medical intervention is shown in Figure 17.
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Figure 17: Breakdown of cases where medical intervention was sought
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5.4.5.10 Recent Period of Abstinence
Information relating to the deceased having undergone a recent period of abstinence was
available in 22% of cases (n = 178). This was in relation to release following a recent
custodial sentence in 164 cases (92%), recent release from drug rehabilitation programme
in nine cases (5%) and the individual being incarcerated at the time of death in five cases
(3%). Of the drug rehabilitation cases, 56% (n = 5) of deaths occurred within one week of
leaving and in two of these cases, the deceased had discharged themselves. Three of these
five deaths were classed as heroin only deaths.
Of the 164 recently released prisoners, 95% (n = 156 (88 HO : 68 HR» of deaths occurred
within one month of the deceased's release date, of which 79% (n = 123) occurred within
two weeks of release (68 HO: 55 HR). Figure 18 illustrates the time between release from
prison and death. It can be seen that of those deaths occurring within one week of release
(n = 95), just under one half occurred within the first two days of release (49%, n = 47) and
were primarily heroin only deaths (28 HO: 19HR). Of these, 66% (n = 31) occurred either
on the day of release itself or the day following release. During 1999, approximately three
DRDs per month involved an individual who had been liberated within two weeks prior to
their death.
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Figure 18: Number of weeks (and days within one week) between release from prison
and date of death
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5.4.5.11 Methadone Maintenance Programmes
From the police sudden death report, information was available as to whether the deceased
ever had been or was enrolled on a methadone maintenance programme (MMP) at the time
of death. The deceased had been enrolled at the time of their death in only 7% of all cases
(n = 60). There was one individual who had been enrolled on an MMP in 1989 and one in
1993. Hence the majority had been enrolled from 1994 onwards, the year the MMP was
introduced into Glasgow (i.e. only 8% of deaths between the years 1994 - 2001). Of those
apparently enrolled on an MMP at the time of death, methadone had been detected at
toxicology in only 53% of cases. There was also evidence that the deceased had been
enrolled on an MMP in the past in 5% of all heroin death cases (n = 38). The main reason
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why this was no longer the case was that the deceased had defaulted from the programme
by either continuing to use heroin or failing to keep appointments.
5.4.6 Results of ToxicologicalAnalyses
A blood sample was obtained in 98% (n = 814) of cases, however, an alternative matrix
was obtained in the remaining 13 cases (urine in 8 cases, liver blood in 2 cases and serum,
plasma and pleural fluid in one case each). In 3 of the blood samples, there was no
quantified morphine level available, however they were still included in this study as
heroin was mentioned in the cause of death. Therefore a mean, median and range of
morphine concentrations detected for 811 blood samples are shown in Table 9.
Table 9: Blood Concentrations of morphine detected in heroin positive cases
Not Heroin
related
Heroin Only Heroin Related
n 369* 442**
All Cases {n = 811} Mean 0.5 0.33
Median 0.33 0.23
Range 0.01 - 12.3 0.01-4.04
42
0.11
0.07
0.002 - 0.96
*6 cases not mcluded - 2 x unne, 1 x pleural fluid, 1 x plasma, 1 x hver blood, I x only a trace detected
which was not quantified.
** 10 cases not included = 6 x urine, 2 x unknown quantity (cases from 1985), 1 x serum, 1 x liver blood
The median blood concentration detected in heroin only deaths was significantly higher
than those found in heroin related deaths (p < 0.001, Mann Whitney). And similarly, the
blood concentration for heroin related deaths was significantly higher than the not heroin
related deaths (p<0.001, Mann Whitney). The median blood morphine concentration was
significantly higher in females compared to males (0.39mg/litre v. 0.26mg/litre, p<O.OOl,
Mann Whitney).
The identification of the first metabolic product of heroin 6-monoacetylmorphine (6-
MAM) and also codeine, from the breakdown of monoacetylcodeine, an impurity in street
heroin occurred in 1997. Prior to this, these were not routinely reported in toxicology
reports. Codeine was detected in 316 heroin deaths between 1997 - 2001 (62% of deaths
over that period). A mean codeine/morphine ratio of 0.2 was noted and this varied
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between 0.03 to 1.52 (median 0.1). This is in keeping with a general finding that the ratio
of monoacetylcodeine to heroin in street deals is approximately one to ten. A ratio of
greater than 1.0 was noted in 10 cases suggesting the deceased had also taken codeine.
The presumption that only codeine had been taken in these cases can be excluded due to
the fact that the concentration of codeine exceeds that of morphine by a factor of
approximately 19 when only codeine has been administered 93 in addition to the presence
of drug paraphernalia which was found in all 10 cases. In seven cases this involved a
needle and syringe either located adjacent to the deceased (3 cases), found still within the
injection site (2 cases) or the deceased had been found earlier with the syringe held within
their hand/in injection site a short time prior to unconsciousness (2 cases).
The presence of 6-monoacetylmorphine was noted in 62 cases and was indicative of a
sudden death. A mean 6-MAMImorphine ratio of 0.08 was noted, ranging from 0.003 -
1.17 (median 0.04). The blood concentrations of free morphine and 6-MAM in these cases
averaged 0.4 and 0.03mgllitre respectively which is similar to findings of a study where
blood concentrations averaged 0.36 and 0.019mgllitre in eight individuals who died within
15 minutes of injecting heroin intravenously",
There was no toxicology report available in two cases. Of the remaining 825 heroin
deaths, polydrug use was evident in 91% (n = 748) of cases (79% and 100% of heroin only
and heroin related deaths respectively) and this involved the concurrent use of two or three
drugs in three-quarters of all polydrug cases (76%, n = 572). Figure 19 shows that heroin
was the only drug detected in 9% (n = 77) of heroin deaths and a cocktail containing as
many as six or seven drugs had been consumed in eight cases.
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Figure 19: Number of drugs detected in biological samples
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There was a total of 2,254 drugs detected amongst all 825 cases. The frequency of drugs
detected are shown in Figure 20. The benzodiazepines were the most frequently detected
drug group and were found to be positive in over four fifths of polydrug cases where a
toxicology report was available (85%, n = 638) and this was predominantly temazepam or
diazepam (32% and 62% respectively). In fact, the prevalence of temazepam and
diazepam were seen to significantly decrease and increase respectively from 1997 onwards
(p<0.001, chi-squared). This was as a result of a legislation change in 1996 whereby
temazepam was rescheduled from schedule four to three of the Misuse of Drugs
Regulations 1985. There was no association between the presence of a benzodiazepine and
gender and unlike other studies, females were not more likely than males to have
benzodiazepines detected (OR 0.667, 95%CI: 0.44 to 1.01).
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Figure 20: Drugs found to be positive in heroin deaths
,- Heroin Only • Heroin Related I
Other: Phenobarbitone (6 cases); F1uoxetine (4 cases); Nitrazepam (3 cases);
Paroxetine (3 cases); Citalopram (3 cases); Cyc1izine (3 cases); Dicona1 (2 cases);
Phenytoin (2 cases); Amylobarbitone (2 cases); Buprenorphine (2 cases); Propoxyphene (2
cases); Promethiazine (2 cases); Amitriptyline (2 cases); Dothiepin (1 case);
Ch1ormethiazo1e (1 case); Prothiaden (1 case); Imipramine (1 case);
Gammahydroxybutyric Acid (1 case); Quina1barbitone (1 case); Solvents (1 case);
Venlafaxine (1 case); Doxipin (1 case); Cyanide (1 case); Primidone (1 case);
Butobarbitone (1 case); MDEA (1 case); Oxazepam (1 case); Sodium Valproate (1 case);
Thioridazine (1 case); Co-proxamol (1 case); MDA (1 case); Procyc1idine (1 case)
56
Drug Related Deaths - Heroin
Alcohol was found to be present in just over one half of polydrug cases (53%, n = 397)
where a mean and median BAC of l20mgllOOmi and 85mgllOOmi was measured
respectively (ranging from 3 - 525 mg/lOOml). An association between the presence of
alcohol and gender was shown C)( = 5.7, p = 0.02) whereby males were more likely to have
alcohol detected than females (OR l.59, 95%CI 1.07 to 2.32). Despite this, there was no
statistically significant difference between males and females with regards to median blood
alcohol concentration observed (p = 0.14, 94mgllOOmi v 64mg/l00ml). A median BAC of
47mg/lOOml was noted amongst the heroin only deaths (ranging from 3 - 275mg/l00ml)
compared with a median BAC of l43mgllOOmi (ranging from 4 - 525mgllOOml) amongst
heroin related deaths. This difference was shown to be statistically significant (p<O.OOOl,
Mann- Whitney). Contrary to other studies 95. 96 there was no significant difference between
the median concentrations of morphine detected depending on the presence of alcohol (p =
0.63, Mann-Whitney, 0.34mg/litre versus 0.36mg/litre).
The next mam group of drugs detected were the opiates, where methadone and
dihydrocodeine were found to be positive in 13% (n = 98) and 7% (n = 54) of polydrug
cases respectively. Their role in deaths in the West of Scotland have been cited in the
literature 50.51.97. 98 and will also be discussed later in this chapter. However, it is worth
noting that of the methadone and DHC positive cases, only 35% (n = 34) and 33% (n = 18)
of cases involved these drugs which had been prescribed to the deceased.
Cocaine had been taken concurrently with heroin in 24 cases (3% of polydrug cases), the
majority of which the deaths occurred in the latter two years of the study (58%, n = 14).
This indicates an increasing trend for this practice that is also known as "snowballing" or
"speedballing". It is noted that cocaine use, particularly that of crack, is initiated by
individuals who are already heavily using opiates and those whose primary drug of misuse
is crack, often use opiates to counteract its unpleasant effects 99.
5.4.7 Contaminated heroin
In 2000, the total number of illicit overdoses was seen to decrease by 10%, although the
total number of DRDs that year did not show signs of subsiding. That was because in the
same year, the number of individuals dying from the adverse effects of drugs increased by
475%. In May 2000, the media reported the deaths of six addicts who all died in quick
succession all of whom showed similar symptoms which were non characteristic of a usual
DRD and seemed to occur only in skin and muscle poppers 100. Initially, the problem was
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thought to be localised, however, over a period of a few weeks, there was a total of 60
outbreaks in Scotland, 23 of which resulted in fatalities. There was also similar deaths in
Dublin, England and Wales. At the time drug users were reporting having to use excess
amounts of citric acid to dissolve the heroin and this along with presumed contaminated
citric acid or heroin was originally thought to be the cause. All investigations, however,
came back negative. Eventually it was found that the heroin had been contaminated with
an anaerobic bacteria known as Clostridium Novyi. This was an anaerobic bacteria which
grew in the absence of oxygen and released powerful toxins into the circulation leading to
multiple organ failure and death. Whilst the bacteria was antibiotic sensitive, this form of
intervention was effective only if initiated immediately and before the toxins were released
into the circulation. In order to save those who were infected, surgical intervention was
necessary. This ranged from incision of the affected area to extensive skin excision.
These horrific deaths were not categorised as a DRD by the police or the GRO despite
heroin being the obvious cause of death.
These deaths were not included in this study as the mechanism of death was not that of
intoxication but rather due to the adverse effects of taking a drug. However, they
constituted 15% of all DRDs in the year 2000. They were endemic to skin poppers and
generated much media attention that it was felt they could not go unnoticed.
5.4.8 Discussion
Heroin misuse is a growing concern throughout the world. Numerous mortality studies
have shown an increase in the number of premature overdose deaths as a result of this drug
in Europe 77. 10!. 102. 103, Australia", America 104 and elsewhere in the Untied Kingdom 105. 106.
These overdose deaths also remain the most common cause of death among heroin users
107. In Scotland, statistics show that heroin is problematic to society and shows no signs of
curtailing. For example, there has been a 625% increase in the number of heroin seizures
in Scotland from 1985 - 2000, illustrating the sheer abundance of this drug. Despite
increased efforts by law enforcement agencies, the number of individuals who are starting
to take heroin is also escalating as the percentage of new individuals attending drug
services, who are reported to be using heroin has risen over the years from 67% in 1997-98
to 79% in 2001-02 108. A possible reason for this could be that individuals are enticed into
the heroin scene by means of smoking the drug, a route that is perceived to be less
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addictive than if injected. This route of administration is particularly apparent in younger
heroin users particularly in the last few years of this study. ISD Scotland reported that
prior to 2001/02, heroin users aged under 20 years were more likely to inject, however, this
trend has reversed and a preference for non injecting routes amongst this age group
persists. This increase in heroin use is also corroborated by the results presented in this
study where an increase in heroin death mortality rate throughout the Strathclyde Police
region increased from 0.2 per 100,000 in 1985 to 5.9 per 100,000 in 2001.
Of all heroin positive cases identified over the study period, 95% were due to the effects of
heroin either alone or in combination with other drugs. Also, these heroin deaths
accounted for approximately two-thirds (69%) of all illicit overdoses that occurred within
the Strathclyde police region of Scotland over the study period. In the early nineties, it was
shown that heroin positive cases decreased, possibly due to changes in availability and
costs of various drugs around that time. For example, between 1985 - 1992, temazepam
abuse was shown to increase in the West of Scotland and indeed, most illicit overdose
deaths were due to the effects of the illicit use ofbenzodiazepines. In addition, in the early
nineties a trend was emerging for the use of methadone, the majority of which had been
obtained by the diversion of legitimate supplies. Heroin began to play an increasing role in
the majority of illicit overdose cases from 1995 onwards. This re-emerging trend was
probably due to a lack of availability of both temazepam and methadone. A legislation
change in 1996 resulted in the re-scheduling of temazepam which had a direct effect on its
availability and methadone was being advocated as an opiate substitute around the same
time with tighter controls on supervision of consumption being heavily promoted.
Between 1985 - 1988, approximately three-quarters of all heroin deaths (78%) were due to
the effects of heroin alone. By 1997 - 2001, this proportion had decreased to 43% of all
deaths during that time showing that a trend for polydrug had emerged. This increase in
heroin related deaths over the years was shown to be statistically significant cl' = 13.4,
p=0.003).
When comparing individuals who died from a heroin overdose with other studies, the main
factors in the death do not vary significantly. Our study showed that the majority of
individuals were male and aged in their twenties, similar to studies of heroin deaths in
France 109, Croatia llO and Australia". This over-representation of the male population has
been noted to reflect the greater likelihood of opioid dependence among males compared
to females III as well as greater risk taking among males than females 112. There was also
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evidence to show that the mean age of victims was slightly older in the latter years of the
study compared to the mid-1980s. Certain risk factors may exist amongst the older drug
using population such as pulmonary and hepatic dysfunction resulting from disease which
may increase susceptibility to both fatal and non-fatal overdose. For example, hepatic
disease may result in reduced metabolism of an opiate, decreased drug clearance and hence
may prolong the period of heavy intoxication with a greater risk of respiratory depression
113. The deceased was not a novice drug user in the majority of cases, which is reflected by
the average age observed in addition to the length of time the deceased was known to
abuse drugs. It has been noted that most deaths occur amongst those who have a definite
dependency for heroin and have been using the drug for 5 - 10 years 114. In this study, the
average length of time that the deceased was noted to have abused drugs was 8.2 years.
This was slightly lower than that recorded amongst heroin death victims over a similar
study period by Quaglio et al where an average duration of addiction of 11.7 years was
noted, however this study also included deaths due to AIDS and cases where the presence
of heroin was incidental to death.!".
The majority of individuals in this study lived with people whether it be relatives or
partners (58%). Just over one-quarter (27%) lived alone and an additional 14% were
classed as homeless (10% of all individuals lived in a hostel and 4% were of no fixed
abode). Approximately 1% of deaths occurred whilst the individual was serving a prison
sentence. Most people resided in the Greater Glasgow Health Board area of Strathclyde,
however in the latter years of the study it was shown that drug deaths were spreading into
the three other health board areas encompassed by the Strathclyde boundary. This was
particularly evident in Argyll and Clyde which showed the second highest number of
heroin deaths until the penultimate year of the study. Increasing drug misuse within this
latter area is further supported by data on the percentage of new individual patients
reporting the use of heroin which increased from 78% to 83% from 1997/98 to 2001/02.
There was a 212% increase in the number of heroin deaths in Ayrshire and Arran in the
latter year of the study. This was in contrast to all other health board areas where a
decrease in numbers was noted ranging from a 3% decrease in the GGHB to a 33%
decrease for both Lanarkshire and Argyll and Clyde. The reason for this increase is
unexplained particularly since individuals commencing methadone prescriptions in the
Ayrshire and Arran area was shown to increase on a year to year basis from 1999-00 to
2001 -02 115. The increase in deaths within this area did however result in a Drug Death
Review Group being set up whose remit was to consider all DRDs, identifying potential
for intervention and amending future practice for the benefit of others 116.
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In addition to these geographical differences over the study period it was noted that
approximately two-thirds of individuals resided in areas of high deprivation. This suggests
high unemployment, low social class and high morbidity and mortality rates. This is
supported by statistics from the Office of National Statistics that shows a strong positive
relationship between deprivation and incidence of drug-related deaths by "accident" 117.
The ACMD has also stated that "the rate of premature deaths among drug misusers is
strongly and positively related to social deprivation" 117. People residing in these socially
deprived areas may be more susceptible to dealers, pressure from peers or pressure to
conform to groups where drugs are misused.
In the majority of cases (73%), the deceased was found to have overdosed within a
dwelling abode and this was more often than not the deceased's own house. This is similar
to heroin deaths in Australia 95.118 and America 119. In a further 17% of cases, the deceased
was found in an external locus, mainly a public toilet, common stairwell, disused building
or under railway bridges, pathways or cemeteries. Most of these locations would indicate
that the deceased had chosen them as an inconspicuous place to inject their drugs. Whilst
choosing such locations would suggest the need for "privacy", they are also making
themselves vulnerable to overdose as they are less likely to be noticed and hence
intervention is less likely to be initiated prior to death.
Various studies have reported on the circumstances leading up to a heroin death and note
that the deceased was in the company of others in 58%95, 61% 120 and 79% 121 of cases
studied. These studies do not specify, however, whether the deceased was merely within
the locus with other people or whether drug misuse had actually been witnessed. This
study revealed that the deceased was definitely or most probably on their own at the time
of death in 49% of cases as one cannot preclude the possibility that a third party was
present and evaded the scene. Hence, a witness was present within the locus in the
remaining 51% of cases of which there were basically three scenarios. Either the deceased
was seen to be intoxicated prior to a period of sleep (34%); the deceased was physically
segregated from the witness, the body being discovered when the witness went to check on
the deceased some time later (31%), or drug consumption/physical collapse was witnessed
(31% and 4% respectively). Of the cases where drug consumption was witnessed the toxic
effects of the drugs were noticed by the witness in two-thirds of cases and in the
remainder, the witness was under the influence of drugs and discovered the deceased once
they themselves had "come round". In the cases where intoxication was witnessed prior to
a period of sleep, the witness would probably think that allowing the deceased to "sleep
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off' the effects of the drug was the right thing to do. However, it is feasible to suggest that
some of these deaths may have been preventable had medical assistance been sought on the
first signs of intoxication.
Evidence of drug paraphernalia was noted at the locus in three-quarters of all deaths. The
location of a syringe and needle was indicative of a sudden death in 20% of all heroin
deaths where paraphernalia was found. This consisted of a needle and syringe being found
either in situ in the majority of these cases, suggesting that death was almost instantaneous
(particularly since the syringe was noted to contain blood in most cases) or the needle and
syringe being located under the body. In these cases it is possible that the deceased
collapsed immediately after withdrawing the needle and hence landing on it or the needle
and syringe were still in situ when the deceased collapsed, the fall causing them to
dislodge. Nevertheless the finding that the majority of deaths did not appear to be instant
following heroin administration is consistent with other studies".
Attempts to revive the deceased were made prior to the arrival of paramedics in only one
fifth of cases where this information was available. However, this is still slightly higher
than what was reported by Zador et al where resuscitation was attempted by an onlooker in
only 11% of cases. The majority of instances were void of any efforts to revive the
deceased by the witnesses own accord and this was despite a witness being present at the
locus in just under one half of these cases. This is in agreement with findings of another
study where no intervention occurred prior to death in similar circumstances 122. As one
might expect, intervention prior to the arrival of an ambulance was more likely to occur if
witnesses were within the locus, particularly if drug consumption/collapse had been
witnessed. This again highlights the risks of solitary heroin use.
In contrast to previous studies where witnesses appeared reluctant to seek assistance'?" 122
an ambulance was summoned in approximately three-quarters of all cases where this
information was available. However, the deceased was obviously already dead in just over
one half of these cases and no intervention occurred. In these cases the deceased was more
likely to have been at the locus alone and found by a witness some time later. In the
remaining cases, resuscitation attempts were initiated, but only a small proportion of these
cases were revived and transferred to intensive care. It would appear, from the police
sudden death report, that an ambulance was summoned shortly after the discovery of the
body, however, as resuscitation attempts were initiated in less than one half of cases where
an ambulance was called, this may not be entirely true. Resuscitation attempts were more
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likely to be initiated by paramedics if the deceased had been in the locus with witnesses
which suggests that intervention is perhaps sought more promptly when witnesses are
present.
A period of abstinence was known to have occurred preceding death in one fifth of cases,
the majority of which related to a period of incarceration. There were a few cases where
the deceased had been involved with a residential rehabilitation programme. Over one half
of these individuals overdosed within five days of leaving, two-fifths of whom had
discharged themselves early. These findings that an individual is at risk of overdose
following a rehabilitation programme is supported by Strang et al who followed up 137
opiate addicts who had been receiving opiate detoxification as part of a 28 day inpatient
treatment programme. This study showed that patients who had "successfully" completed
the programme were more likely to have died within the year following completion. In
contrast there were no deaths amongst patients who failed to complete detoxification 123.
Of the cases involving a recently released prisoner, over one-half of overdoses occurred
within one week of release, the vast majority of whom died within the first two days of
liberation. In fact, of those dying within the first two days, one fifth overdosed on the day
of release itself. The risk of resuming drug consumption following a period of abstinence
in the Strathclyde area has been previously reported 124 where it was also highlighted that a
breakdown in communication between prison doctors and general practitioners often
resulted in methadone prescribing being discontinued upon imprisonment. Other studies of
similar cases throughout Scotland showed that the risk of death from overdose was up to
eight times higher in the two weeks after release than at other times at liberty 125. 126. It has
been noted by Glasgow GPs that the adverse consequences of imprisonment include
resumption of heroin injecting and chaotic drug use both in prison and upon release 127.
Presently, the Scottish Prison Service (SPS) conduct "voluntary" drug testing and offer
advice about the risks of overdose as a result of decreased tolerance. However, this study
suggests that a large proportion of recently released prisoners resort back to quantities of
drugs that they were previously accustomed to. Drug misuse within the prison system is
clearly a problem. It's estimated that approximately 3 out of 4 people entering prison in
Scotland test positive for drug misuse at the point of entry 128. With nearly £8 million
being spent on treatment and prevention initiatives, it was estimated that approximately
5,000 prisoners accessed treatment services in 2000, which is a 203% increase from 1997-
98. The SPS has revised their drugs strategy which now has a prinicipal emphasis on harm
reduction within prisons, an objective being to encourage drug misusing prisoners to
present themselves for treatment and enter prison based drug interventions. A key
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objective is also based on the continuity of care with the implementation of through care
regimes 128. However, whilst access to treatment services are scheduled for the individual,
it has been shown that a large proportion fail to keep their appointments 129. There are
issues regarding the joint working between community and prison based services with
respect to continuity and transfer of community based treatment plans on admission and
similarly with consistency of pre and immediate post release services. Initiatives
elsewhere in the UK have proved successful. For example, The Tower Project is a crime
reduction initiative that has been operating in Blackpool and the Fylde since l" January
2002. Its main aim is to target local persistent offenders either in prison or in the
community and offer them immediate access to drug treatment and support with
accommodation, benefits and employment. The project has been independently evaluated
and has been shown to meet its 30% crime reduction targets. In addition, and most
importantly, there have been no drug-related deaths amongst the client group 130. This is an
area which is in need of address and could begin with the evaluation of current strategies
which are in place and identification of failings of these to meet specified targets.
In cases where a medical history was available, less than 10% of individuals had been
enrolled on an MMP at the time of their death. It is possible to speculate that had more
individuals been enrolled on an MMP, there may have been fewer deaths as a result of
heroin overdose as methadone treatment is known to have a positive impact on reducing
mortality amongst heroin-dependent individuals 131, 132. This study also showed that there
were a number of individuals who had had several previous attempts on an MMP, however
were unsuccessful at completing them for one reason or another and that some individuals
simply defaulted or failed to keep appointments. Another study reported that individuals
who left treatment early had a higher risk of overdose than those still in treatment where an
odds ratio of 3.55 (95%CI 1.82 to 6.90) was noted 133. Of those who had been enrolled on
an MMP at the time of their death, just over one-half were found to have methadone
detected following toxicology. This finding together with a positive heroin result suggests
that they were either selling their prescription in order to finance their heroin habit or
"topping up" as a result of being prescribed too Iowa dose. To support the former, whilst
much of the methadone prescribed by drug treatment services is supervised, some
individuals may be prescribed methadone by a GP who is not involved in the shared care
scheme, hence supervision of consumption would not be mandatory. In Glasgow, for
example, over 50% of GPs participate in the shared care scheme and a main obstacle to GP
involvement is lack of confidence and available training 134. A possible explanation as to
why an individual may have to "top-up" their dose may be due to genetic polymorphism
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that results in varying degrees of methadone metabolism. For example, a study of 256
MMP patients showed that 89% were extensive metabolisers, 4% were ultrarapid
metabolisers and 7% were poor metabolisers 135. Drug clearance has also been noted to be
significantly greater during pregnancy 136. Due to a wide inter-individual variation of drug
clearance, new research suggests that doses ranging from l20mg per day to more than
700mg per day may be optimal for many patients 137. Interviews with drug addicts indicate
that methadone is not a solution to their habit as some say that all it does is give them a
kick start in the morning before going to get other "stuff' or that it made them feel
lethargic, didn't give them a "buzz", was more addictive than heroin and was therefore
harder to get off 138.
An important aim of any maintenance programme is to retain patients under medical
supervision in order to reduce the health hazards associated with illicit drug consumption.
Whilst methadone is the most frequently prescribed drug for opiate maintenance, concerns
have been raised that GPs who prescribe the drug are not confident about doing so 139. A
possible explanation for this could be that the quality of treatment suffers because of a lack
of training of the doctors 140. There is scope for other treatments for heroin dependence
such as buprenorphine. France was the first European country to legalize buprenorphine
tablets for maintenance therapy and in the year 2000, there was estimated to be between
67,377 and 89,836 drug users being treated with this drug 141. Kakko et al concluded that
buprenorphine and intensive psychosocial treatment is a safe and highly efficacious
treatment option for heroin dependent individuals 140.
As would be expected the median morphine concentrations in heroin only deaths was
significantly higher than those where other drugs were considered to be a contributory
factor in death. However, unlike other studies 95, 96, a significantly lower blood morphine
level was not detected in those who were also found to be positive for alcohol.
Nevertheless, the depressant effects of alcohol in combination with heroin has been
reported to be synergistic in causing death, i.e. greater than if just additive 142.
Females were shown to have a significantly higher median blood morphine concentration
compared to that of males. It is known that sex differences exist in drug pharmacokinetics
and pharmacodynamics and it has been suggested that female-specific issues such as
pregnancy, menopause and menstruation may also have profound effects on drug
metabolism 143 This could be one explanation for the difference in median blood
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concentration but it is also probable that this difference was observed due to a larger
distribution volume and hence faster clearance in men compared to women 144.
There is also scope for future work regarding the role of morphine metabolites in
mediating respiratory depression of heroin. For example, the role of morphine-S-
glucuronide needs to be further investigated as it is possible that there may be significant
levels of this metabolite, which is known to be pharmacologically active, in cases where
there are relatively low concentrations of morphine detected in the blood.
Certain theories exist as to why overdoses occur such as that the individual has taken a
quantity of a drug which is in excess of their current tolerance. Another is that an increase
in the purity of street heroin is conducive to an increase in heroin deaths. This theory,
however, has not been supported by recent studies that showed either a moderate
association between heroin purity and overdose fatalities 145 or no statistically significant
relationship between the two 146. In both these studies, other central nervous system
depressants such as alcohol and benzodiazepines were detected in the samples in addition
to morphine. A prominent finding of this study and one that is reported by various authors
elsewhere 77, 95, 147, 148, 149 was that there was a very low number where solely morphine had
been detected. In France, for instance, it has been reported that overdoses due to heroin
alone have become "exceptional"!". In this study, a combination of either two or three
drugs accounted for approximately three-quarters of all polydrug cases and
benzodiazepines and alcohol were the most frequently detected drugs to have been taken
concurrently with heroin which is similar to heroin deaths in Australia'". This drug
combination has been reported to be a common practice among heroin users 107 and has
been a favoured cocktail amongst Scottish drug users for many years 45, 46, 79. A legislation
change in temazepam prescribing was shown to have an impact on the availability of this
drug and hence there was a trend change regarding the benzodiazepine of choice.
However, regardless of what benzodiazepine was being taken concurrently with heroin,
this mixture is potentially lethal. Heroin itself depresses the part of the brain that controls
breathing, causing it to work at such a low level that it stops sending signals to the lungs to
breathe. Benzodiazepines are also CNS depressants and the simultaneous administration
of these drugs has a potentiating effect and can enhance and prolong the depressant effects
of heroin. Despite polydrug use being prevalent, heroin was the only drug cited in the
cause of death in 45% of all heroin deaths. In the remaining 55%, heroin was cited in the
cause of death with other drugs. This was primarily with alcohol (107 cases),
benzodiazepines (204 cases) or a cocktail of all three drugs (31 cases). It has been
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suggested that concurrent intoxication may also make the heroin user more prone to risky
behaviour and overdosing 150.
The concurrent use of heroin with any opiate is potentially fatal as both are respiratory
depressants. Whenever methadone and dihydrocodeine had been detected, it was evident
they had been obtained by the diversion of legitimate supplies in approximately two-thirds
of each of the cases. These drugs are both prescribed for the management of opioid
dependence, although DHC is not licensed for this purpose; it's main medical use is as an
opioid analgesic. Therefore, there is a great concern as to why patients being prescribed
these drugs are continuing to use heroin or indeed why prescription only drugs such as
these are being abused by people who are obtaining them illicitly. Deaths involving these
drugs will be discussed later in this chapter.
Cocaine was found to be present in 24 cases and these involved primarily males. There is
a slow but increasing trend for cocaine as a drug of misuse in Scotland and it has only been
in recent years that this drug has emerged in drug related overdoses. The combination of
heroin and cocaine, usually by simultaneous injection, is a recognized phenomenon and
referred to as "snowballing" or "speedballing", a practice which dates back to the 1930s.
However, it became more well known as the cocktail that killed John Belushi in 1982 and
River Pheonix in 1993. Whilst this combination was primarily used amongst heroin
injectors who would add cocaine when they could afford it, there is evidence that it is now
being used by those who snort cocaine. In these cases, whilst the heroin is snorted to bring
them down, they still consider cocaine to be their main drug of use 151.
5.4.9 Conclusion
Heroin addiction remains a disturbing cause of premature death in Scotland. The
demographical profile of such deaths has not changed dramatically over the study period,
with the exception of a slight increase in mean age in the latter years of the study. Also,
within the Strathclyde police region, the prevalence of heroin as a cause of death was
shown to disseminate out to other health board regions. The availability of heroin, despite
increased seizures over the years remains problematic to society. Various Government
stratagems regarding drug use has varied from zero tolerance approaches to more
educational based initiatives (e.g. Know the Score). However, drug misuse continues to
increase regardless.
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In an ideal world, the solution would be to restrict the supply of heroin on the streets and
inhibit the initiation into drug misuse. This unfortunately is not feasible. As people will
always abuse substances, it is better to concentrate on ways of preventing the outcome that
is often a fatal overdose. This study has shown that in many cases, there is a possibility
that death could have been prevented and has highlighted some potential risk factors which
could form the basis of an educational campaign targeted at all drug users and their
family/acquaintances. The misuse of drugs in isolation for example, is a precarious
practice rendering any intervention almost impossible. Witnesses should be alerted to the
possibility of respiratory failure in individuals that they witness to be obviously intoxicated
prior to a period of sleep. They should be encouraged to be proactive in attempting to
avoid overdose in these types of cases by promptly seeking medical attention. The issue of
increased risk of overdose following a period of abstinence has substantial implications for
public health prevention efforts. It is clear that current efforts with through care regimes
are inadequate and need to be enhanced.
Another matter in need of address via education campaigns is the increased likelihood of
overdose when drugs are taken concurrently, particularly multiple eNS depressants such as
opiates, alcohol and benzodiazepines. It is clear that this is common practice amongst drug
users in the Strathclyde Police region.
A lack of confidence by GPs prescribing maintenance therapy treatment due to a possible
lack of training was mentioned earlier. Initiatives which aim to assess the medical care and
patient management provided by GPs could be offered in an effort to maintain a level of
clinical care which is considered adequate at retaining patients in treatment.
Perhaps by more education campaigns and encouragement aimed at the clinicians involved
in drug misuse, heroin deaths will, one day, show signs of decreasing.
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5.5 Methadone
Street Names: Meth, Phy, fairy Liquid, Green Death, Jungle Juice, Green Turtle
Methadone is a synthetic opioid agonist that was first synthesized in Germany during
World War II. It was first used in opiate maintenance treatment by Vincent Dole and
Marie Nyswander in the 1960s following failed attempts to maintain addicts on short-
acting opiates. Despite being chemically different from morphine, it has clinically similar
actions and analgesic effects!". Due to this it is used successfully for the treatment of
heroin addiction. It has a slow onset (approx. 4 hours) and long duration of action (half-
life 15 - 72 hours) thereby preventing the onset of withdrawal symptoms.
One of the first studies highlighting the benefits of methadone amongst heroin dependent
individuals was carried out by Dole and Nyswander in the 1960's 153. They showed that
stabilization was possible with methadone and of22 males aged between 19 - 37 years, all
with several years drug history, only two individuals had been discharged from their study
(the authors referring to them as "uncooperative and disruptive psychopaths"). It was
concluded that methadone had contributed in a favourable way to this stabilization in that it
relieved narcotic hunger and protected the individual against re-addiction to heroin by
establishing a pharmacological block so as to induce sufficient tolerance to block the
euphoric effects of an average dose of heroin. The authors supported the need for both the
medication in addition to a supporting program as being key factors in succeeding to
stabilize heroin dependent individuals.
Another study conducted by Dole and Nyswander reported on the success of methadone
whereby the procedure was separated into three phases. The first phase begins with a six-
week period of hospitalisation where the subjects receive a medical examination and are
started on low levels of methadone (10 - 20mg daily) which are gradually increased to a
blocking level (80 - 120mg daily). Phase two involved the subjects being transferred to an
out patient clinic where they are in receipt of financial support.
"Maintenance of patients with methadone is no more difficult than maintaining
diabetics with oral hypoglycaemic agents and in both cases the patient should be able
to live a normal life"
Dole and Nyswander
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The final phase is when they are able to live a self-supporting lifestyle where no or little
social assistance is required. The results revealed that of 120 patients admitted, only 13
failed to complete treatment. Of the remaining 107 patients, heroin use had stopped, drug-
related crime had been eliminated and a substantial number were employed in a steady job
154. Another study in Sweden showed a high rehabilitation rate of individuals who were
enrolled on an MMP of 76% compared to 6% in a control group 155. That said though,
Dole reports that despite some patients doing well once treatment is terminated, the
majority experience a return of symptoms after maintenance has stopped. Therefore,
methadone as a treatment is "corrective but not curative for severely addicted persons" 156.
5.5.1 Legal Status
Like heroin methadone is a Class A drug under the Misuse of Drugs Act 1971. It is
controlled under schedule 2 hence is considered to have medical therapeutic use and is
legal to possess only if prescribed by a doctor, and then only if taken in accordance with
the doctor's instructions. Presently, in the United Kingdom, any medical practitioner can
prescribe methadone for the management of opiate dependence.
5.5.2 Prescribing
Methadone is presently the drug of choice in the United Kingdom for substitute prescribing
in the treatment of heroin addiction 157. 1S8. It has been estimated that there are presently
26,000 opiate addicts in methadone maintenance programmes in the United Kingdom,
which is equivalent to 17% of the known opiate addict population'". The benefits of this
drug are well documented and include a reduction in illicit drug use 159. 160, reduction in
mortality rates 159 and a reduction in the level of criminal activity amongst opiate drug users
127. 160. In addition this substitute drug appears to be more effective at keeping drug users in
contact with health services compared to other interventions 161. However, an increasing
trend in the prescribing of this drug has also received concern with respect to the
contribution it may have in drug related deaths both nationally 97. 162. 163 and internationally
164.165. In Scotland, a study investigating the views and experiences of drug users supported
the notion that methadone is a useful, but controversial substitute drug. Whilst the drug
users agreed that it had multiple advantages but simultaneously caused many problems for
drug users, it was concluded that on the whole the respondents' comments were consistent
with the views expressed by professionals in relation to reducing illicit drug use,
decreasing drug-related harm and preventing drug-related crime 166.
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5.5.2.1 Methadone prescribing in the Strathclyde area
In response to the increasing heroin epidemic in Strathclyde, various stratagems were
devised to reduce the damage caused to opiate users and included the introduction of
needle exchanges and substitute prescribing in communities. In the early nineties, it
became evident to the small group of Glasgow general practitioners (GPs) who were
prescribing methadone that it would be beneficial for drug misusers to attend clinics
specifically designed for their care". As a result, in 1994 both the Glasgow Drug Problem
Service (GDPS) and a GP Drug Misuse Clinic Scheme were created to reduce drug related
harm to health and ''promote better management of drug injectors in general practice
through a system of shared care?", In addition to the shared care by staff in the GDPS and
in general practice, community pharmacists were recruited to supervise the consumption of
daily doses of methadone. In early 1994, approximately one fifth of all Glasgow
community pharmacies had become involved 60 which increased to approximately two-
thirds by 1999 61. In 1996, 99% of all methadone that had been prescribed by the GDPS
involved supervised daily dispensing 58, a figure that remains unchanged 59.
Figure 21 shows that the number of methadone prescriptions dispensed in the Strathclyde
police region increased approximately ll-fold over the ten-year period 1992 to 2001 167
with the majority of this methadone being dispensed in the Greater Glasgow Health board
area. The proportion of methadone dispensed in the Greater Glasgow area compared to the
whole of Strathclyde ranged from 63% in 1992 to 77% in 1995 and then decreased from
69% in 1996 to 54% in 2001. These figures suggest that although initially confined to the
Greater Glasgow area, the establishment of methadone maintenance in the rest of the
Strathclyde area has increased over the latter years.
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Figure 21: Number of prescriptions dispensed in Strathclyde, 1992 - 2001.
is
Cl 200Cl...,
><
'-'
til
C
0;: ISO
Co
'c
(,j
til
c:;...~ 100...
0...
c:;
..c
E SO=Z
0
1992 1993 1994 1995 1996 1997 1998 1999 2000 2001
..... GG -Rest of Strathclyde ..... Whole of Strathclyde
Whilst it is not possible to decipher whether these prescriptions relate to those which are
prescribed daily or monthly, an increasing trend for the quantity of methadone dispensed is
shown in Figure 22. This shows that the quantity of methadone dispensed in the Greater
Glasgow area compared to the whole of Strathclyde ranged from 47% in 1992 to 79% in
1995 and then decreased from 76% in 1996 to 63% in 2001, a trend which is similar to the
one described above for prescriptions.
Figure 22: Quantity of Methadone Dispensed (g)
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5.5.3 Identification of drugs in samples
Methadone is absorbed following oral administration (approximately 4 hours to achieve
peak:plasma levels) and is converted to EDDP. Exposure to methadone can be determined
by the presence of the parent drug alone or in combination with its inactive metabolite.
5.5.4 Toxicity
The optimal daily dose of methadone for maintenance is the quantity that will hold the
blood level between 0.15 - 0.6mgllitre. For this, and as a general rule, 60 - 80mg of oral
methadone a day has been reported as being an adequate dose 168 which is in agreement
with other authors who suggest a therapeutic window for dosage ranging from 50mg -
120mgl60• However, it has been noted that the dose of methadone necessary for effective
treatment of opiate addiction has wider inter-individual variability than has been
previously acknowledged and that inadequate doses of methadone will result in patients
supplementing their dose with illicit opiates, benzodiazepines and alcohol 169. 170.
The concentrations of methadone in maintenance patients are known to overlap those
experienced in fatality cases. For example, a mean plasma methadone concentration of
0.45mgll was noted in a study of 104living addicts (range 0.02 - 1.3mgll) 171. This equates
to approximately a mean blood methadone concentration of 0.34mgll (average
blood/plasma ratio for methadone is given as 0.75 172). However, mean blood methadone
concentrations in drug fatalities have ranged from 0.28mgllitre amongst a study of 59
victims 173 to 0.56 in a study involving 18 victims 174. And various studies have shown fatal
concentrations to range from 0.1 - 4.5mgllitre 175. Obviously tolerance is a major factor to
be considered when interpreting methadone concentrations and therefore knowing whether
an individual was enrolled on a methadone programme at the time of death is
advantageous. There are other variables that can have an effect on determining a toxic
blood methadone concentration. Polydrug use is a common phenomenon in drug overdose
deaths, particularly the concurrent use of opiates, alcohol and benzodiazepines. These
latter two drugs may augment the sedation and respiratory depression caused by
methadone'". Another factor to be considered when interpreting a methadone level is the
possibility that the liver is capable of releasing substantial amounts of methadone into the
bloodstream long after ingestion 177. Also methadone may exhibit post-mortem
redistribution to some degree in that blood concentrations can be significantly higher at
post-mortem than they were at the time of death, hence a degree of caution must be
exercised with interpretation. This has been illustrated by Prouty and Anderson who found
that heart/femoral blood concentrations averaged 1.1 (range 0.8 - 1.4), hence highlighting
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the importance of analysing peripheral blood before a definitive interpretation of post-
mortem toxicological analyses is possible 178. Therefore, obtaining as much information as
to the background of the case being investigated is of utmost importance as post-mortem
measurements of methadone cannot be used in isolation to determine toxicity 179.
5.5.5 The Incidence of Methadone in Drug Related Deaths in the
Strathclyde Police Region of Scotland.
Methadone was first detected in a drug-related death in 1986, however, it appeared to play
no part in the death as the pathologist certified the cause of death as being attributable to a
heroin overdose. The next methadone positive case was recorded in 1991 after which its
presence in drug related deaths investigated by Forensic Medicine and Science, increased
dramatically up until 1997 (Figure 23). In 1994, the year the MMP was introduced into
Glasgow, there was a 150% increase in methadone positive cases compared with the
previous year. A continued increase resulted in media attention that called into question
the efficacy of methadone as an opiate substitute 180. 181. Consequently, in 1996, the GDPS
co-ordinated a confidential enquiry into methadone-related deaths in Glasgow with a view
to assessing the medical care provided by the clinicians who prescribed methadone 182. It
reported in 1999 and showed that medical services might have been deficient in 56% of the
methadone deaths. Possible failures in clinical care were identified in 69% of cases and
included, for example, prescribing too low or too high a dose of methadone or failing to
examine a patient for continuing drug misuse. The response from the prescribing doctors
was very positive with 93% "definitely" intending to change their future management of
drug misusers. In order to disseminate the findings of this enquiry a booklet outlining the
guidelines for safe methadone prescribing was distributed to all GPs in the Greater
Glasgow area 183.
There was a 49% decrease in the number of methadone positive cases in 1997 which can
possibly be explained by both the combination of increased supervision that was occurring
at that time and also as a result of the ongoing confidential enquiry.
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Figure 23: Number of methadone positive cases detected in drug related deaths
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Over the 12-year study period, methadone was detected in 352 sudden, unexpected deaths
in the West of Scotland. Of these, 271 cases (77%) were considered to be directly
associated with the toxic effects of drugs either alone or in combination with alcohol. In
the majority of cases, the deceased was male (79%, n = 213) and the average age was 27
years (range 15 - 58 years). A history of drug abuse was noted in 262 cases (97%), of
which approximately two-thirds were known intravenous drug users (68%, n = 178).
5.5.5.1 The Role of Methadone in Drug Related Deaths
All drug related methadone positive cases (n = 271) were classified as "methadone only"
deaths (e.g. methadone intoxication), "methadone-related" deaths (e.g. methadone and
heroin intoxication) or "not methadone-related" deaths (e.g. heroin intoxication) in
accordance with a previous study 97 and depending on the primary cause of death.
Methadone in combination with other drugs accounted for 140 deaths (52%). Fifty-six or
approximately one fifth of deaths (21%) resulted from the effects of methadone alone. In a
further 75 deaths (27%) although methadone was found to be present, it was not
considered to be at a high enough concentration to have caused or contributed to the death.
In these 75 cases the interpretation of toxicological findings and the conclusion that
methadone was not implicated in the death was stated by the pathologist on completion of
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all post mortem investigations and having taken due notice of previous medical history. It
is recognised that there is an overlap between therapeutic and fatal methadone
concentrations!", however, interpretation of levels is also based on circumstantial
evidence, such as witness statements, provided in the police sudden death report.
Table 10: Drug related methadone positive cases according to primary cause of
death.
Year Methadone Only Methadone Related Not Methadone Related Total
1986 0 0 1 1
1991 1 0 1 2
1992 2 2 3 7
1993 1 9 2 12
1994 9 11 10 30
1995 10 23 9 42
1996 9 24 10 43
1997 9 8 5 22
1998 4 13 7 24
1999 6 21 7 34
2000 1 13 9 23
2001 4 16 11 31
Total 56 140 75 271
Methadone Deaths = 196
5.5.5.2 Methadone as a Cause of Death in Drug Related Deaths
In order to study deaths where methadone was considered the cause of death either alone
or as a contributory factor in combination with other drugs, all deaths classed as
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"methadone alone" or "methadone related" will be the focus of the remainder of this
section. Collectively these two subgroups will be referred to as "methadone deaths".
From Table 10, it can be seen that over the 12-year study period, there were 196
methadone deaths. The majority were male (80%) and the average age for both males and
females was 26 years (range 15 - 38 years for females and 15 - 46 years for males).
Figure 24 illustrates that of all illicit overdose cases throughout the years, the presence of
methadone increased from 5% of all cases in 1991 up to 42% in 1996. From 1997 onwards
the number of methadone cases as a percentage of all illicit overdose cases has continued
to decrease. Whilst approximately two fifths of all illicit overdose cases involved
methadone in 1996, only one third were due to the effects of methadone alone or in
combination with other drugs.
Figure 24: Methadone positive cases and methadone death cases as a percentage of all
illicit drug overdoses over the years 1991 - 2001
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5.5.5.3 Methadone Deaths by Health Board Area
Just over one half of all methadone deaths occurred within the Greater Glasgow Health
Board Area (55%, n = 108). The corresponding figures for Ayrshire and Arran, Argyll and
Clyde as well as Lanarkshire were 21% (n = 41), 16% (n = 32) and 8% (n = 15) of
methadone deaths respectively. Between 1991 - 1995, 62% of methadone deaths over that
5-year period occurred in the GG health board area, this decreased between 1997 - 2001,
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when less than one-half of all methadone deaths in this 5-year period occurred in the GG
health board area. This difference was shown to be statistically significant (p = 0.02, -; =
5.8). This shows that as well as methadone prescribing disseminating throughout the rest
of Strathclyde, so too were methadone deaths.
Table 11: Methadone deaths defined by health board region
GGHB A&A A&C L Total
1991 1 0 0 0 1
1992 3
I
1 0 0 4
1993 6 2 0 2 10
1994 14 4 0 2 20
1995 18 6 8 1 33
1996 23 5 5 0 33
1997 7 3 5 2 17
1998 8 2 4 3 17
1999 13 11 1 2 27
2000 9 0 5 0 14
2001 6 7 4 3 20
Total 108 41 32 15 196
5.5.5.4 Source of Methadone
It was possible to ascertain whether the deceased had been enrolled on an MMP from
information provided in the medical history section of the police sudden death report. This
was omitted in 14 cases either because there was no police report available or the GP was
unobtainable at the time the police report was compiled. Therefore, it was only possible to
comment on the remaining 182 cases. Of these, the deceased had been in receipt of a
methadone prescription in just under one half of cases (43%, n = 79), the majority of these
cases were classed as a methadone related death (68%, n = 54). Therefore, methadone had
been obtained by the diversion oflegitimate supplies in 103 cases (57%).
The exact number of patients enrolled on a MMP within each health board area at anyone
time was unobtainable, but the following estimate was made in order to calculate the death
rate. On the assumption that the average prescription for methadone is 50mg per day, a
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patient will receive 18,250mg per annum (50mg x 365 days). Consequently, from the
knowledge of the quantity of methadone prescribed in each health board area!", it is
possible to attain an indication of the number of patients in receipt of a methadone
prescription.
Table 12 shows that, for individuals on an MMP, the methadone death rate fe1l sharply
after 1996 and remained low thereafter. Following the distribution of the guidelines and
changes in methadone dispensing there was a 0.38% absolute reduction in summary death
rates from 0.53% per person year to 0.15% per person year. The numbers of methadone
deaths for individuals not on an MMP decreased slightly from 54 deaths during the period
1991 - 1996 to 49 deaths during the years 1997 - 2001. This was despite a threefold
increase in the amount of methadone being made available via the MMP. For 2001,
Glasgow had a lower methadone death rate among individuals on an MMP than the three
other health board areas (0.07% compared to 0.13%, 0.1% and 0.13%). In general, rates
were low, indicating a good safety profile of the MMPs. A similar pattern was seen for
those not on an MMP where Greater Glasgow had three deaths compared with a total of 11
from the three other health board areas (Lanarkshire: two deaths, Argyll & Clyde: three
deaths, Ayrshire & Arran: six deaths). This was despite nearly twice as much methadone
being prescribed in Glasgow via the MMP.
Table 12: Methadone Death Rates for Individuals on an MMP, 1991 - 2001
Year Estimated number of Number of MMPdeath
MMP patients MMP deaths rate
1991 Unknown: 1 unknown
1992 304 0 0.00%
1993 676 4 0.59%
1994 1512 9 0.60%
1995 2246 14 0.62%
1996 2815 13 0.46%
1997 3645 4 0.11%
1998 4252 10 0.24%
1999 4714 11 0.23%
2000 5519 7 0.13%
2001 6896 6 0.09%
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Of the 79 cases involving prescribed methadone, it was noted that multiple doses had been
prescribed in 21 of these cases (27%). This ranged from a single dose to one month's
supply although the majority of cases were due to a forthcoming Sunday and/or bank
holiday/long weekend closure of the pharmacy (52%, n = 11). In the remaining cases, the
dispensing of multiple doses had been the decision of the GP. The reasons for multiple
prescribing is shown in Table 13 below.
Table 13: Reasons why multiple doses were prescribed to the deceased
Number of Doses Reason Number of cases
1 day Sunday Closure 6
2 days Forthcoming Pharmacy Holiday 1
3 days Forthcoming Pharmacy Holiday 3
5 days Holiday Weekend Closure 1
Total No. of Cases due to a Pharmacy Holiday 11
4 days Apparent holiday of patient 2
1 week Decided by GP 3
1 week Apparent holiday of patient 1
2 weeks Decided by GP 2
1 months supply Apparent holiday by patient 1
1 months supply Decided by GP 1
Total No. of Cases due to Discretion of GP 10
In a further two cases involving prescribed methadone, while there was no mention of
multiple prescriptions in the police report, the deceased was found to be in possession of
two bottles of methadone prior to death in one case and an empty 200ml bottle was found
at the locus in the other case.
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5.5.5.5 Day of Death
Over half of the cases (n = 107, 55%) occurred over a weekend, Friday - Sunday with 80
deaths occurring on Saturday or Sunday (Table 14). Of these 107 cases, 46% (n = 49)
were enrolled on an MMP which compares to 34% (n = 30) of deaths that occurred on a
weekday. Despite this, there was no significant evidence of an association between the
timing of the death (weekend or weekday) and MMP status (x- = 2.411, P = 0.12; 14
individuals whose MMP status was unknown were excluded).
Table 14: Time of Week When Death Occurred and MMP Status of Deceased
MMP Status Weekend Death Weekday Death
Yes 49 30
No 52 51
Unknown 6 8
Total 107 89
5.5.5.6 Circumstances of Death
Each case was classified according to when the death occurred in relation to drug
consumption. In 13 cases (7%) involving heroin, death was immediate as a needle and
syringe were found still inserted into the injection site. In 36 cases (18%) the mode of
death was undetermined as the deceased had been found dead at the locus and had not been
seen for a prolonged period, hence circumstances directly prior to death could not be
ascertained. The sequence of events prior to death in most cases (74%, n = 146) involved
the deceased being seen to be intoxicated prior to falling asleep. Witnesses often reported
heavy uncharacteristic snoring in these cases such as "gurgling" noises. In the final case,
the deceased attended an Accident and Emergency department. Having been attended to,
he was asked to sit in the waiting area. He was found dead in the toilet area approximately
two hours later.
5.5.5.7 Recent Prison Release
Of all 196 methadone deaths, it was noted from the police sudden death report that 21
individuals (11%) had died with 2 weeks of release from prison, the majority of whom
were male (76%, n = 16). Methadone had been prescribed in only 43% (n = 9) of these
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cases. In these cases, methadone had been prescribed to the deceased between one and
five days prior to death and dosages varied from 35ml daily to 90ml daily. Multiple doses
had been prescribed in three cases, in one case a weeks supply was issued, in another case
4 days supply was dispensed and in a final case an extra dose for a Sunday pharmacy
closure was given to the deceased. The majority of cases involving prescribed methadone
were classed as methadone related (89%, n = 8) and in just over three fifths of these cases,
heroin had been taken concurrently with the prescribed methadone (62%, = 5). In these
five cases, a used syringe was found either next to or underneath the body (n = 4) or in one
case, protruding from the groin. This shows that the guidelines of the methadone
maintenance programme had been contravened.
The remaining 12 cases involved methadone which had been obtained by the diversion of
legitimate supplies. Half of these cases were classed as methadone related with two thirds
of these cases (67%, n = 4) testing positive for heroin.
5.5.6 Results of Toxicological Analyses
A blood sample was unobtainable in five cases because of decomposition, however, urine,
liver and liver blood were used as alternative matrices. In an additional 4 instances, it was
noted that the blood had been taken from a source other than the periphery. Of the
remaining 187 cases, the post mortem blood methadone concentrations ranged from 0.01 -
3.84 mg/litre. Table 15 lists the mean, median and range of concentrations detected for
each cause of death group and whether or not the deceased was enrolled on a MMP at the
time of death. The mean concentrations for methadone only deaths were significantly
higher than those for methadone related deaths (all deaths, two-sample Hest
p<O.OOO1;methadone prescribed, p=O.OOO1; methadone not prescribed, p<O.OOO1).
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Table 15: Methadone Concentrations, Cause of Death and MMP Status.
Methadone Only Methadone Related
n 52 135
All Cases (n = 187*} Mean 0.8 0.4
Median 0.7 0.3
Range 0.08 - 2.63 0.01 - 3.84
n 21 49
Prescribed Mean 0.9 0.5
Median 0.7 0.4
Range 0.28 - 2.2 0.067 - 1.8
n 25 78
Not Prescribed Mean 0.7 0.3
Median 0.5 0.2
Range 0.08 - 2.63 0.01 - 3.84
n 6 8
No Record Mean 0.7 0.3
Median 0.6 0.3
Range 0.26 -1.3 0.038 - 0.8
*In total the study period involved 196 MO and MR deaths, however, toxicology was carried out on the liver
in 1 case, liver blood in 2 cases, urine in 2 cases. In a further 4 cases, the blood had been taken from a site
which was other than the periphery.
Multiple drug use was prevalent with two or more drugs being detected in 163 cases (85%
of blood drug positive cases). The most frequently detected additional drug group was the
benzodiazepines with diazepam and temazepam being present in 65% (n = 106) and 31%
(N = 50) of polydrug cases respectively. Heroin was found to be positive in 55 multiple
drug cases (34%). In 16 of these cases (29%) the deceased was in receipt of a methadone
prescription. Effectively, of all methadone patients in this study, one fifth (20%) were
found to be non-compliant with the methadone programme guidelines in that they
continued to use illicit drugs. The other drugs detected are shown in Figure 25.
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Figure 25: Frequency of Drugs Detected
1991 - 1996 .1997 - 2001
This graph also shows trends of drug misuse over the two-year blocks such as the decrease
in temazepam following its legislation change and an emergence of dihydrocodeine. Of
the 106 diazepam positive cases, prescribed diazepam accounted for only 28% (n = 27) of
cases (NB no medical history was available in eight cases).
The cocktails of drugs consumed by the subjects of this study reflect the present pattern of
drug misuse in Strathclyde which primarily involves the concurrent use of opiates and
benzodiazepines". All drug combinations in methadone deaths are summarised in Table
16 below. Methadone had been administered together with heroin (evident by the presence
of morphine at toxicology) alone, or in combination with other drugs in seven (4%) and 48
(25%) of blood drug positive cases respectively. The other drugs involved were primarily
benzodiazepines (85%, n = 41). Methadone in combination with benzodiazepines alone or
together with other drugs other than heroin accounted for 60 (31%) and 29 cases (20%)
respectively.
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Table 16: Summary of Drug Combinations in Blood Samples (n = 191)
Drug Combination Number of Cases
Methadone Alone 28
Methadone + heroin 7
Methadone + heroin + "other drugs" 7
Methadone + heroin + benzodiazepines 27
Methadone + heroin + benzodiazepines + "other drugs" 14
Methadone + benzodiazepines 60
Methadone + benzodiazepines + "other drugs" 29
Methadone plus "other drugs'" 19
Total 191
r " ".other drugs . any drug with the exception of herom and benzodiazpines, for
example anti-depressants
Alcohol was detected in the blood in 59 cases (31%). The mean blood alcohol
concentration (BAC) measured was 85mg/lOOml (median 44mg/100ml), with
concentrations ranging from 4 - 462mg/100ml. A BAC of greater than 200mg/100ml (a
level associated with probable coma in intolerant individuals) was noted in five
individuals, and a history of chronic alcohol abuse was evident in all but one of these
cases. Despite a level of tolerance in these four cases, the alcohol would have a possible
potentiating effect on other respiratory depressants such as opiates leading to fatal
respiratory depression.
85
Drug Related Deaths - Methadone
5.5.7 Discussion
The proliferation of the methadone maintenance programme (MMP) throughout the
Strathclyde area is evident from the annual increase in methadone prescriptions dispensed.
Over the study period, 1986 - 2001, only 21% (n = 56) of drug related deaths where
methadone was detected post-mortem were judged to be due to methadone alone.
This study revealed that fatalities from polydrug use involving other opiates and
benzodiazepines were much more cornmon than from methadone alone. This combination
of drugs has previously been documented previously, not only in drug users in the West of
Scotland?' 46, 79 but also in Europe'?" 146and Australia!". As both groups of drugs are
respiratory depressants, at least an additive effect may result when taken in combination.
Other illicit drugs (e.g. amphetamine, cocaine, ecstasy) and commonly abused medicinal
drugs such as dihydrocodeine and chloral hydrate were also detected.
From the 182 cases where MMP status could be ascertained, less than one half of cases
involved legitimately supplied methadone. This demonstrates the risk of diversion of
legitimate supplies of methadone. Multiple "take home" doses was noted in 21 cases.
Whilst permitting a patient to uplift multiple doses may be perceived as a "step forward",
this practice should not be encouraged unless the patient has been on a stable dose for
some significant period and tested negative for other drugs of abuse by urinalysis on
several occasions. The prevalence of illicit methadone was also shown to be significant in
a study of non-fatal overdoses in Glasgow and Dundee and was found to be particularly
common amongst drug users already enrolled on an MMP 185.
There is concern that some MMP patients continue to use illicit opiates and there were a
number of MMP patients who tested positive for continued heroin abuse. This was
confirmed by the presence of morphine and either codeine from the breakdown of
monoacetylcodeine, an impurity in street heroin andlor 6-monoacetylmorphine, the first
metabolic product of heroin. A possible reason for this continued usage may be that the
patient has to "top-up" as a result of being prescribed too low a dose of methadone. As
discussed earlier, a therapeutic window ranging from 60mg - 120mg has been suggested 186
and in Glasgow, an average dose of 48mg was recorded, a dose regarded as being sub-
optimal!". In difficult cases, bloodlserum monitoring would be beneficial in achieving the
optimal dose. This has been supported by work carried out in Austria where it was
concluded that therapeutic drug monitoring should become routine amongst MMP patients
in order to achieve optimal results by preventing relapse and intravenous drug use'",
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Another possible explanation for the concurrent use of heroin with prescribed methadone is
that the latter was prescribed as part of a low-threshold programme. In these programmes,
methadone is prescribed while continued drug use is tolerated, the aim being that drug
users are retained in treatment with a main focus being harm reduction. They are targeted
at disorganized clients, who are not reached by regular programmes or who are unable to
sufficiently control their consumption, to follow regular treatment 188. These programmes
have shown benefits such as reaching a marginalized clientele exposed to the HIV virus
through unsafe injecting practices. Or to those who would not have access to regular
programmes that are characterised by restrictive selection criteria and limited availability
189. Van Ameijden et al also showed that whilst methadone-assisted detoxification and
high-dose methadone programmes are shown to reduce mortality, low-threshold
programmes also reduce overdose mortality 190. Torrens et al report on a study in
Barcelona where of370 opioid-dependent patients, the retention rate after 2 years was 72%
which supports the efficacy of the low-threshold methadone program 191. In Switzerland, a
pilot project in Zurich in 1992 showed that of 800 clients, 450 were retained in treatment
with many entering high-threshold programmes 192. This "promotion" to high-threshold
programmes has also been described in Amsterdam. Here, the offering of more favourable
dispensing conditions and linking the low- and high-threshold programmes, is expected to
stimulate the addict into regulating their own addiction and organize their life in a better
way as a step towards rejecting the addiction on their own initiative 193.
From the circumstances of death it was ascertained that approximately three-quarters of
deaths (74%, n = 146) occurred whilst the deceased was presumed to be sleeping,
following a period of observed intoxication. Permitting a "sleep it off' period was
considered to be beneficial by witnesses, presumably in order to allow the effects of the
drugs to wear off. However, as reported in a previous study", had medical attention been
summoned on the first indication of overdose, some of these deaths may have been
preventable, a conclusion supported by Clark et al who found that the toxic effects of
methadone are often delayed'?'.
The source of methadone could not be ascertained in the majority of recently released
prisoners in this study sample. A period of abstinence can result in a loss of tolerance for a
drug and prisoners are made aware of these dangers prior to their release. Despite this,
some individuals choose to revert back to quantities of drugs they were previously
accustomed, hence increasing their risk of overdose. Whilst some of the recently released
prisoners were enrolled on an MMP at the time of their death, their MMP status was
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unobtainable prior to their term of imprisonment. The possibility of having been recently
liberated should always be investigated by a GP when a patient is being prescribed
methadone either for the first time or as an apparent "continuing" patient. If the latter case
is applicable then the patient should be started on a dose lower than that previously
prescribed. In addition, permitting multiple doses to be prescribed at the one time should
be discouraged due to the obvious risks of overdose and/or leakage onto the black market.
Post 1996, deaths involving methadone have decreased despite both an increasing number
of people being prescribed methadone and an overall increase in drug related deaths. This
suggests a positive impact of both improved medical practice following 1996 and the
dissemination of methadone programmes from Glasgow to Strathclyde. Supervision
programmes did not become common practice in the rest of Strathclyde until 1997
onwards and presently the supervision scheme in the other three health board areas remains
incomplete'. The death rates for 2001 in Glasgow are particularly encouraging, showing
lower rates compared with the other health board areas despite this area having nearly
double the amount of MMP patients than the other three health board areas combined. The
figures presented in this paper reflect the success of the supervised programme in Glasgow.
As the rest of Strathclyde becomes increasingly involved in the MMP it is essential that
pharmacies are recruited to supervise daily doses of methadone. There are, however
continuing concerns. For example, in all areas, a small proportion of patients continue to
be issued either daily or weekly unsupervised scripts. Whilst this may be seen by GPs and
other agencies as progress in building trust between the patient and GP, the potential for
diversion should not be overlooked. In addition the Advisory Council on the Misuse of
Drugs suggests that lax prescribing is responsible for a significant proportion of drug-
deaths 5 and supports recent national guidelines on the management of drug misuse with an
emphasis on the supervised consumption of controlled drugs 194.
Possible initiatives could target clinicians in an attempt to increase the participation and
confidence of GPs involved in the methadone programme by continuous training and
support in prescribing and supervision to avoid difficulties encountered with methadone
dose assessment.
There may be other confounding factors aside from the introduction of the guidelines for
improved patient management and clinical care together with increased supervision of
consumption that resulted in a fall in the death rate. However, this observational study
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showed that the death rate reduction did coincide with these changes in practice which
indicates a possible positive effect on overall reduction of methadone deaths.
5.5.8 Conclusion
The use and effectiveness of methadone as a treatment for opiate addiction initially
received much criticism. However, the findings of the confidential enquiry in addition to
increased and widespread supervision implemented by pharmacists have been major
factors in reducing deaths involving methadone. The argument that methadone is an
unsafe alternative therapy for opiate addiction is not supported by the results of this study.
What has been demonstrated in the West of Scotland is that methadone, if not sufficiently
supervised can lead to otherwise preventable deaths by diversion of supply. In addition,
regular monitoring should be adhered to as per the guidelines to ascertain the stability of
the patient in order to establish the correct dosage is being prescribed. With efficient
patient management to establish the compliance with the guidelines of the programme,
methadone can be a safe drug for substitution therapy.
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5.6 Dihydrocodeine (DHC)
Street Names: Diffs, DFs
Dihydrocodeine is a semi-synthetic opioid agonist derived from codeine. It's
pharmacological action is almost purely analgesic and it is primarily prescribed for the
relief of moderate pain, especially for terminal cancer patients. Other indications include
that of an anti-tussive drug, being effective at doses lower than those employed for
analgesia and as an anti-diaorrheal (DHC is the most constipating of all the opiates).
5.6.1 Legal Status
Dihydrocodeine is a Class B drug under the Misuse of Drugs Act 1971. Possession and
supply of this drug carries a maximum penalty of 5 years andlor an unlimited fine and 14
years andlor an unlimited fine respectively.
5.6.2 Prescribing
DHC is available in the United Kingdom in oral and parenteral (50mglml injection)
formulations. The oral preparations include an elixir syrup (lOmg/5ml) and tablets of
varying strengths (30mg, 4Omg, 60mg, 90mg and 120mg). The 60mg - 120mg tablets are
controlled release formulations allowing one tablet to be swallowed every twelve hours. In
Strathclyde, the preferred formulation is the 30mg tablet which accounted for 75% of all
DHC formulations prescribed over a five-year period". For analgesia, the usual dose by
mouth is 30mg or for severe pain up to 240mg daily whereas when prescribed as a cough
suppressant, 10-30mg up to three times daily would suffice 195.
In the United Kingdom, DHC was first used in the treatment of narcotic addiction in the
early 1970s. More recently there is evidence to suggest that it is emerging as an alternative
to methadone in the management of drug misuse by some GPs 196. 197, even although DHC
is unlicensed for the management of drug dependence 198. This means that, unlike
methadone, no rigorous research has been carried out into the effectiveness of this drug as
a substitute for opiate addiction. In Scotland, for example, Matheson et al revealed that
DHC was being dispensed for the management of drug misuse by 26% of pharmacists who
participated in their study lS7. The prevalence of this drug in DRDs has been previously
reported so and it's potential for abuse and caution on repeat prescriptions has been
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publicised 199. For those receiving DRC as an opiate substitute, the oral solution or
controlled-release preparation is given in daily doses of up to 3000mg 200. There are a few
reasons as to why DRC prescribing is preferred by some GPs over methadone in the
management of harm-reduction which include:
Q It is perceived to be less addictive than methadone 201 with the manufacturers
reporting that it has a "low addiction potential" 202.
Q Itmay seem more favourable to GPs in that several days supply can be dispensed at
the one time. (This can however, be perceived as problematic. The short half-life
of this drug means that patients often have to consume very large numbers of
tablets daily. This, in turn, may lead to diversion oflegitimate supplies.)
Q There is no need for patient follow up care or the administrative measures that are
associated with methadone programmes.
Q It is relatively insoluble and hence less likely to be injected.
Cl The supervision of DRC is not considered to be necessary (in any case, it would be
a near impossible task to implement due to multiple doses having to be consumed
daily owing to its short half-life).
DRC has been subject to virtually no media interest as a drug of misuse, despite, its abuse
by drug addicts being widely reported 196.202.203.204. Due to this potential for misuse, it has
been noted that a DRC detoxification programme should be managed just as carefully as
that of methadone!", The presence of this drug as a contributory factor in deaths from
narcotic overdoses has also been reported in Germany 205.206.
5.6.3 Identification in biological samples
Dihydrocodeine is identified in biological samples by the presence of the parent drug itself.
Metabolites such as dihydromorphine and nordihydrocodeine are not included as part of
the routine analyses in the laboratory.
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5.6.4 Toxicity
An overlap between levels ofDRC detected in fatal and non-fatal cases have been reported
in the literature. The blood concentration of DRC detected in a study of 36 fatalities ranged
from 0.6 - 25.3 mg/litre 206 and in another study involving 4 self-poisoning cases ranged
from 7.2 - 12.0 mg/litre 207. In contrast, cases involving drivers suspected of driving whilst
impaired have ranged from 0.1 - 3.3 mg/litre serum in one study 208 and 0.01 - 5.98mg/litre
blood in another 209. Efforts have been made to tabulate therapeutic, toxic and fatal levels,
for example, Repetto and Repetto suggest a therapeutic window of 0.03 - 0.25 mg/litre in
serum plasma and a fatal concentration of 0.8 mg/litre in blood 210. These concentrations
are in general agreement with Osselton who gives a therapeutic window of 0.07 - 0.13
mg/litre in serum plasma and a fatal range in blood of 0.8 - 1.7 mg/litre 211. These are only
guidelines for interpreting whether the drug has been conducive to death, however, and
other information available must be considered such as the circumstances of death, other
drugs detected and the tolerance of the individual.
5.6.5 The Incidence of Dihydrocodeine in Drug Related Deaths in the
Strathclyde Police Region of Scotland.
The presence of dihydrocodeine was confirmed in 99 accidental drug related overdose
deaths in the Strathclyde Police region over the years 1985 - 2001. The incidence of this
drug increased from one case in 1986 to 25 cases in 1999 and decreased slightly to 18
cases by 2001 and accounted for between 1% and 15% of all accidental illicit drug
overdoses throughout the study region over the study period. Figure 26 shows an
emerging trend for this drug over the latter four years of the study which accounted for
almost four fifths of all DRC positive drug death cases (79%, n = 78).
In the majority of cases, the deceased was male (84%, n = 83) with an average age of 28
years (ranging from 14 - 43 years, std dev. = 6.96), Females had an average age of 30
years (15 - 49 years, std dev. = 8.58). This difference of 2 years was shown not to be
statistically significant (p = 0.28, 95% Cl -6.09 to 1.76). The deceased was known to have
a history of drug abuse in 95% (n = 94) of cases and in just under three-quarters of these
cases, the deceased was known to be an intravenous drug user (73%, n = 69).
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Figure 26: Number of dihydrocodeine positive illicit drug overdoses
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5.6.5.1 The role of dihydrocodeine in causing death
All cases were classified into one of three groups depending on the cause of death assigned
by the investigating pathologist and in a similar fashion to the way the methadone positive
cases were classed. Table 17 shows that 18% (n = 17) of cases were certified to be due
solely to the effects of dihydrocodeine, 41% (n = 41) were due to dihydrocodeine in
combination with another drug and a further 41% (n = 41) were due to the effects of a drug
other than DHC despite its presence in the biological sample.
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Table 17: Dihydrocodeine cases classified according to cause of death as certified by
the investigating pathologist
Year DHC Only DHC Related Not DHC Related Total
1986 0 I 0 1
1990 0 I 0 1
1991 I 2 0 3
1992 2 0 0 2
1993 0 1 0 1
1994 I 2 1 4
1995 1 2 2 5
1996 0 1 0 1
1997 1 1 1 3
1998 1 4 10 15
1999 10 7 8 25
2000 0 10 7 17
2001 0 9 12 21
Total 17 41 41 99
DHC Deaths = 58
5.6.5.2 Dihydrocodeine as a cause of death
In order to study deaths where dihydrocodeine was considered the cause of death either
alone or as a contributory factor in combination with other drugs, all deaths classed as
"DHC alone" or "DHe related" will collectively be referred to as "DRC deaths". More
than half of all ORe positive drug related accidental overdose cases were found to be due
wholly or partially to the effects ofDRC (59%, n = 58). Males outnumbered females by a
ratio of5:1. Of this group, the mean male age was 26 years (14 - 39 years, std. dev. 6.71)
and the mean female age was 28 years (15 - 42 years, std. dev. 7.50). There was no
significant differences in age between males and females where a mean difference of 2
years was observed (p = 004, 95%eI -6.6 to 2.9). The number of ORe positive cases and
ORe deaths as a proportion of all accidental drug overdoses is shown in Figure 27 with the
exception of 1986. This shows that ORe was considered to playa role in causing death in
all ORe positive cases between 1990 and 1993 only (as well as in 1986). From 1997 there
was an emerging trend for ORe in overdose deaths and by 1999 it was found to be positive
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in up to 16% of all accidental drug overdoses. Despite this increase in positivity between
1997 - 2001, it was considered attributable to the death in between 33% - 68% of cases.
Figure27: DHC positive cases and DHC deaths as a percentage of all accidental illicit
overdoses
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It is interesting to note the changes in trends between methadone and DHC when the
number of methadone positive cases and methadone deaths as a percentage of all
accidental drug overdoses are compared with the number of DHC positive cases and DHC
deaths. Figure 28 shows this trend from 1994 onwards. When methadone positive cases
started decreasing in 1996, the number of DHC positive cases detected in the laboratory
were seen to increase. This could possibly be explained by the preference of some GPs to
prescribed DHC in favour of methadone which at the time was being more strictly
supervised. The defined daily dose (the typical adult daily maintenance dose of a drug) of
DHC increased by 80% between 1992 and 200l. An increase in DHC prescribed could
potentially result in an increase in DHC on the black market.
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Figure 28: Prevalence of Dihydrocodeine and Methadone Amongst Drug-Related
5.6.5.3 SourceofDihydrocodeine
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prescribed DHC from information provided in the medical history section of the police
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the remaining 52 cases, approximately two-thirds involved DHC which had been obtained
by the diversion of legitimate supplies (69%, n = 36) with the deceased having been in
receipt of a DHC prescription at the time of their death in just over under one-third of cases
(31%, n = 16).
5.6.5.4 Prescribed DHC
Information as to the strength and quantity of medication that the deceased was prescribed
was available in 15 cases. Of these, there were four cases where it was known that the
deceased was prescribed multiple tablets a day ranging from 2 - 13 tablets, but no dosage
was given in the police report. However, all information was available in the remaining 11
cases and these are summarised in Table 18 below. The daily doses ranged from 60mg -
600mg daily. In two of these cases, the dose was in excess of that recommended for severe
pain, suggesting that in the remaining cases, the DHC had been prescribed for the
management of analgesia.
Table 18: Doses and quantities of dihydrocodeine prescribed
Dose Daily Dose N Dose Daily Dose N
30mg 2 1 60mg 4 1
30mg 6 1 60mg 10 1
30mg 17 1 60mg Daily 1
60mg 2 1 90mg 2 1
60mg 3 2 120mg Daily 1
There was also note that in excess of the prescribed amount of medication had been
consumed in three cases involving prescribed DHC. Details of these are summarised in
Table 19.
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Table 19: Details of cases where in excess of the prescribed dosage had been
consumed.
Date Amount Date of Evidence to indicate DHC
Prescribed Prescribed Death an excess had been Involvement
consumed
1 27/11102 36 28/11/02 34 tablets missing from DHC Only
bottle
2 9/3/02 ? 1013/02 34 tablets missing from DHC related
bottle
3 7/1/00 56 tablets 10/1/00 Empty bottle at locus DHC related
Information that the deceased had been on an MMP in the past but did not complete the
programme for one reason or another was applicable to three cases where DHC had been
prescribed (19% of prescribed cases). This involved one DHC only death and two DHC
related deaths. In these instances it is probable that due to a failure to comply with an
MMP, the GP decided to prescribe DHC as an alternative opiate substitute therapy.
5.6.5.5 Circumstances of Death
From the police sudden death report, it was possible to ascertain the deceased's last
movements prior to death. From this all deaths were categorised according to the
categories outlined in Table 20 and summarised in Figure 29:
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Table 20: Categories of Activities Prior to Death
A Not seen for a while (long enough for relative/friend to become concerned) and
found dead at locus
B Gone elsewhere within locus, witness becomes concerned and checks on deceased
C Witnessed to be intoxicated prior to following asleep and never wakes up
D Witnessed to take drugs prior to lapsing into unconsciousness
E Anonymous phone call made to ambulance control and exact details unknown
F Found dead at locus which was not a dwelling abode
G Hostel Death - found dead whilst staff were carrying out routine checks
H Death in Custody
I No intoxication / drug consumption witnessed. Found dead in other part of locus
to where witnesses were
J Died in hospital having been admitted for suspected drugs overdose
K Feeling unwell! took a funny tum although no drug consumption witnessed
L Exact details not known
Approximately one-third (36%, n = 21) of all DHC deaths fell into category C where
intoxication was witnessed prior to a period of sleep (13 DHC related: 8 DHC only). In
two-fifths of cases, (40%, n = 23), no intoxication or drug consumption had been
witnessed. The circumstances surrounding these 23 cases included the deceased being
found by a witness who:
o was within the same locus although physically segregated (categories B and I, n
=9),
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o had not seen the deceased for a while and found them dead within their own
abode (category A, n = 8),
o was passing by the locus and found deceased (category F, n = 4)
o were hostel staff employees carrying out routine bed checks (category G, n =
2).
In the remaining 14 cases, drug use and/or collapse was witnessed in 7 cases (categories D
and K); the exact details of overdose and witness accounts were unknown in 4 cases
(categories E and L) and finally death occurred either within hospital or police custody in
the remaing three cases (categories H and I).
In 13 cases (22%) a syringe and needle was found at the locus either in situ (n =5) or
adjacent to the deceased (n = 8). These were all DHC related deaths and morphine,
indicative of heroin misuse, was confirmed as being a contributory factor to death in all of
these cases.
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5.6.6 Results of Toxicological Analyses
A blood sample was not obtained in six cases. However, urine and a liver sample were
used as alternative matrices. Of the remaining 52 cases, the post mortem blood DHC
concentrations ranged from 0.03 - 19.9 mg/litre. Table 21 lists the mean, median and
range of DHC concentrations detected for each cause of death group and whether or not
the DHC had been prescribed. The mean concentrations for DHC only deaths were
significantly higher than those for DHC related deaths (p=O.Ol, 95% Cl: 1.9 to 6.9) and a
mean difference of 4.5mgllitre was observed.
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Table 21: Mean concentrations of post-mortem DHC concentrations detected
depending on cause of death
DHC Only DHC Related
n 16 36
All Cases {n = 52*} Mean 6.2 1.7
Median 3.8 0.9
Range 0.9 -19.9 0.03 - 17.5
n 4 10
Prescribed Mean 4.01 lA
Median 3.8 0.6
Range 2.3 -6.14 0.17-7.18
n 10 23
Not Prescribed Mean 6.2 1.8
Median 3.8 1.0
Range 0.9 -17.6 0.03 - 17.5
n 2 3
No Record Mean 10.6 2.2
Median 10.6 2.9
Range 1.4 - 19.86 0.23 - 2.9
NotDHC
related
41
0.3
0.05
0.01 - 1.6
10
0.5
0.3
0.01 - 1.3
27
0.2
0.04
0.01 - 1.6
1
N/A
N/A
0.06
* In 6 cases it was not possible to collect a peripheral blood sample, however, liver
blood or urine was available in 6 cases (5 DHC related, 1 DHC only)
Polydrug usage was evident in all 58 cases. DHC had been taken concurrently with
another one drug in just over one-quarter of cases (28%, n = 16), together with another two
drugs in 45% of cases (n = 26) and with another three drugs in 22% of cases (n = 13). As
many as an additional four drugs had been detected three cases (5%). Diazepam was the
most frequently detected additional drug closely followed by morphine which were found
to be present in 42 (72%) and 28 (48%) of cases respectively. These two drugs had been
consumed concurrently in 20 cases (48% of diazepam positive cases and 71% of morphine
positive cases), 3 were DHC only deaths, 17 were DHC related deaths. In just over one-
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third (39%, n = 11) of all morphine positive cases, the deceased had been prescribed DHC
and indicates non-compliance with an opiate substitute programme in approximately two-
thirds of all patients known to have been prescribed DHC throughout the study period
(69%). Even if these individuals were not prescribed DHC as part of an opiate substitute
programme, the dangers of polydrug use should have been highlighted by their GP. The
other drugs detected are shown in Figure 30.
Figure 30: Other drugs detected in DHC positive cases
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* Other (one case each) Amitriptyline, Chloral Hydrate, Diconal, Phenytoin,
Chlorpromazine, Ibuprofen, Co-proxamol, Warfarin, Chlordiazepoxide, Diphenhydramine,
Citaolpram, Venlafaxine
The frequency and types of drugs detected are consistent with the overall drug scene in the
West of Scotland in that the opiateibenzodiazepine cocktail is preferred. This study shows
that the type of opiate used may change or be taken concurrently with other opiates,
therefore increasing the risk of overdose in an individual.
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Alcohol was found to be positive in 24 (41%) cases (23 blood and 1 urine sample). An
average BAC of 87mg/1OOmlwas observed (3 - 364mg/100ml). Morphine was found to
be positive in just over one-half of these cases (57%, n = 13). A median BAC of
74mg/100ml was observed in these cases compared to 28mg/100ml in cases where no
morphine was detected, however there appeared to be no statistically significant
association between BAC and presence of morphine (p = 0.06, Mann Whitney).
5.6. 7 Discussion
In addition to heroin and benzodiazepines, the role of DHC as a significant drug of misuse
has been detected in the West of Scotland. An increasing amount of DHC is being
prescribed in this region. The reasons for its use as an opioid substitute include prescribing
it to allow more flexibility for the GP and their patients in instances where methadone was
not a suitable alternative. Over the latter four years of this study, there was a significant
increase in the number of drug related deaths testing positive for this drug. Over the past
decade patterns of drug taking as seen in drug deaths have varied depending on drug
availability, changes in legislation and the quality of the drug. For example, the
rescheduling of temazepam in 1996 from schedule 4 of the Misuse of Drugs Regulations
1985 to schedule 3 resulted in diminished availability of this drug and consequently
diazepam emerged as its substitute in the heroin-benzodiazepine cocktail favoured by the
Strathclyde drug misuser. It has been speculated that dihydrodocodeine is used during
periods of heroin deficit either due to personal circumstances or a lack of availability of
street heroin?", However, this study revealed that DHC had been taken in combination
with heroin in one half of all cases.
Similar to all drug related deaths in the West of Scotland, the presence of a cocktail of
drugs presents a problem. DHC, like other narcotics, interacts with other drugs to depress
the central nervous system and consequently leads to acute respiratory depression and
respiratory failure. This is recognised at post mortem by the presence of pulmonary
congestion and oedema which is often the only significant autopsy finding in a drug related
death. It should also be noted that the depressant effects of alcohol are enhanced by DRC.
The majority of DHC in this study had been obtained by the diversion of legitimate
supplies. This is similar to findings of a study investigating methadone deaths in the same
region where black market methadone accounted for the majority of the methadone
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involved 97. It is possible that the increased quantities of DHC prescribed over the study
period have resulted in increased availability on the streets. This in turn makes DHC a low
cost analgesic, which presently can be bought, on the streets of Glasgow for between 50
pence and £1.00 212. The pharmacokinetics of the most frequently prescribed 30mg DHC
tablet render a supervised programme almost impossible to implement as the half-life is
significantly shorter than that of methadone. This in combination with the fast acting
properties of DHC means that often several doses have to be taken throughout the day.
Seizures of DHC on the streets are relatively low and police tend not to consider this as a
problematic drug'",
From the circumstances of death, it was noted that of all DHC only and DHC related
deaths, approximately one third of all cases involved the deceased falling asleep having
been witnessed to being intoxicated. This is a similar scenario to that of methadone deaths
and raises the point that some deaths may have been preventable had medical intervention
been sought on initial contact as opposed to the witness allowing a period of sleep and
ultimately unconsciousness.
The decreasing prevalence of methadone deaths with respect to the total number of
accidental drug related deaths per annum reflects the positive impact of increased
supervision of its consumption. What is of some concern is the fact that as the figures for
methadone decrease, those for DHC are increasing, suggesting the possibility that as the
supply for one opiate substitute on the streets decreases, the demand for another emerges.
5.6.8 Conclusion
DHC as a suitable, safer alternative to methadone prescribing is questionable. The
increasing prevalence of DHC detected amongst drug related deaths and the consequent
conclusion that it has attributed to death, particularly over the past two years of the study
has been highlighted. The present situation reveals that the initial problems encountered
with methadone dispensing, such as diverted methadone, have been resolved and is
reflected in the decreasing numbers of methadone deaths per annum. However, an
increase in DHC prescribing has resulted in an increase in DHC related deaths possibly due
to this drug being more readily available and inexpensive to buy on the streets. Whilst in
some aspects, DHC may appear to be a good alternative to that of methadone, its abuse
potential should not be overlooked. The incidence of DHC detected in cases is a matter of
concern and requires monitoring to establish if this is a "real trend" or "fashionable phase".
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5.7 Cocaine
Street Names: Coke, Charlie, Snow, Base, Rock
Evidence of South American Indians chewing the leaves of the coca plant became apparent
as early as AD500 where its ability to decrease fatigue, elevate mood and heighten
alertness was known and was a practice they had been accustomed to for thousands of
years 213. It was in the mid 1800s that cocaine, an alkaloid substance present in the coca
leaf was extracted by Albert Niemann who subsequently published his Ph.D thesis, "On a
New Organic Base in the Coca Leaves" in 1860214• However it was not until 1880 that the
drug's effects were recognized by the medical fraternity and in 1884 Sigmund Freud
published "Uber Coca?" which documented his experiences of cocaine advocating that it
was a tonic that could cure hunger, melancholy, asthma and morphine addiction'". Since
this date, it's use in a number of products throughout the centuries have been well
documented", for example, the psycho stimulant has been used as a component in drinks
(Coca-Cola'"), patent medicines (e.g. Dr Tucker's Asthma Specific) and ophthalmic and
dental procedures. However, like other psychotropic drugs it's abuse potentia1 carne to
light and today the misuse of cocaine is dominant in the United States 217. 218 and conducive
to a large proportion of drug related deaths 219.220. That said, the prevalence of cocaine in
other countries is becoming evident 221.222.
Cocaine is available in two illicit forms, the water-soluble white crystalline salt form
cocaine hydrochloride ("snow") and a free base form referred to as "crack", so named due
to the sound it makes when heated. The most common route of administration of cocaine
is snorting, using the hydrochloride form where absorption occurs mainly through the nasal
mucosa and euphoriant effects can last between 60 - 90 minutes due to slow and prolonged
Extract from Sigmund Freuds ''Uber Coca" where he writes of cocaine
inducing ...
"...exhilaration and lasting euphoria, which in no way differs from the
normal euphoria of the healthy person ...You perceive an increase of self-
control and possess more vitality and capacity for work....In other words,
you are simply normal, and it is soon hard to believe you are under the
influence of any drug....Long intensive physical work is performed without
any fatigue ...This result is enjoyed without any of the unpleasant after-
effects that follow exhilaration brought about by alcohol....Absolutely no
craving for the further use of cocaine appears after the first, or even after
repeated taking of the drug... "
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absorption. Inhaling the vapours produced when the rock form (crack) is heated produces
a much more intense "high" compared to that of cocaine hydrochloride, however, in order
to maintain the euphoriant effects, the process has to be repeated as frequently as every 20
minutes. Injection of cocaine hydrochloride has also been reported particularly when taken
concurrently with heroin. The use of this bolus termed as a "speedball" has been reported
in the literature 223.224.
In the mid eighties cocaine use tended to be restricted to small groups of upper class
executives with disposable incomes residing mostly in the London area when it was used
recreationally to enhance their party mood. In the past, due to it's relatively high price
which acted as a natural deterrent, cocaine was not widely abused and was known on the
streets as the "champagne of drugs'?". However, the prevalence of abuse and cocaine
related deaths have risen over the past decade in Britain and this has been speculated to be
due to a wider availability of the drug as a result of a depreciation in price 226. It's
availability in the United Kingdom is no longer limited to adults as a recent survey
reported that of every 1000 children in the 10-12 year age group, 17 will have been offered
cocaine 227. National statistics relating to police seizures also suggest that cocaine is
becoming problematic since the number of seizures in Scotland has increased over the
years 1985 - 1998. In terms of quantity seized, O.4kg was retrieved in 1985 compared
with 22.8kg in 2001228• Whilst these figures do not differentiate between cocaine
hydrochloride and "crack", anecdotal information suggests that the majority of cocaine
circulating around the Strathclyde area is cocaine hydorchloride owing to a dearth in
"cocaine houses" being identified. It is assumed that users attempt to produce their own
crack in situ for their personal use. Cocaine use has not reached epidemic proportions
compared to that of heroin, however, it is emerging as a drug of misuse with an increasing
number of new clients presenting at drug agencies claiming to use the drug. In fact,
between 1997 and 2001 there was a 307% increase in reported cocaine use amongst this
population, the majority of whom resided in the Greater Glasgow area (64% of all reported
cases in 2001)229. This together with the high number of recent seizures, are indicative of a
higher demand and use of this drug in the West of Scotland.
5. 7.1 Legal Status
Owing to the abuse and addiction potential of cocaine, possession and/or supply of this
drug incur heavy penalties since it is controlled as a Class A drug under the Misuse of
Drugs Act 1971.
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5.7.2 Identification in Biological Samples
Cocaine has a relatively short half-life of approximately 40 - 60 minutes 230. 231. The major
metabolites in the blood are benzoylecgonine (BE) and methyl ecgonine (ME), the former
having a much longer half-life to that of cocaine (5 - 7 hours). In addition nearly a dozen
other metabolites have been identified such as cocaethylene 232, produced in the presence of
alcohol and by-products such as anhydroecgonine methyl ester (also known as
methylecgonidine) which is produced following the pyrolysis of cocaine as a result of
heating in the smoking process and hence is indicative of the use of crack cocaine 233. 234.
For the purposes of this study, however, evidence that cocaine had been taken was
determined by the identification of the parent drug, BE and/or ME.
5. 7.3 Toxicity
The ability to define a toxic level following the administration of cocaine is not so clear
cut. For most other drugs the concentration of a drug detected in blood can be used to
assess toxicity and lethality, however, cocaine would appear to be an exception to this rule
235. Cocaine concentrations amongst deceased persons who have succumbed to the drug
are known to vary greatly depending on the dosage, route of administration and period of
survival. Excited delirium is a known syndrome related to cocaine use which is
characterized by hyperthermia, delirium with agitation and respiratory arrest. A study of
seven deaths whereby the deceased exhibited "excited delirium", prior to sudden collapse
showed a mean PM blood cocaine concentration of 0.6mgll (range, 0.1 - 0.9)236. Another
study involving 2 patients who presented to the emergency department had cocaine
concentrations that averaged 0.33mgll 237. These levels were significantly lower when
compared to a study where the mean blood cocaine concentration measured in 48 males
who died due to cocaine toxicity was 1.12mgll (range, 0.001 - 18.1)219. Extremely high
levels of cocaine and it's metabolites have been reported in cases, for example, a PM blood
cocaine level of 51.7mgll was recorded in a female who had reportedly ingested a large
quantity of cocaine prior to suffering from a seizure'", The highest PM blood cocaine
level recorded occurred in a female who died as a result of acute cocaine intoxication, a
level of 330mgllitre was recorded even although the history suggested a series of
recreational uses'". Also, Howell and Ezell report a case where a PM blood concentration
of 30mgll was recorded in a known chronic cocaine abuser, however, the presence of
cocaine was merely incidental to death as the male died from a fatal gunshot wound 240.
Indeed the authors of this study report that "a relationship between PM cocaine blood
levels and toxicity has yet to be established and remains a matter of considerable debate".
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5.7.4 The Incidence of Cocaine in Drug Related Deaths in the Strathclyde
Police Region of Scotland
Cocaine was first detected in a DRD in the Strathclyde Police region of Scotland in 1993
and since this date, evidence of its consumption in post-mortem samples has increased on a
year to year basis. Over the study period, 66 cases showing exposure to cocaine were
investigated in the Strathclyde region. For the purposes of this study, in order to show
trends in drug misuse, the term "cocaine positive case" refers to a case where cocaine
and/or metabolites were detected which would indicate consumption of the drug. In 1999
there was a 233% increase in cocaine positive cases compared with the previous year and
by 2001 the number of cocaine positive cases had almost doubled compared to 1999. For
all 66 cases, males outnumbered females by a ratio of 7: 1. The mean age for both males
and females was 30 years, ranging from 18- 46 years for males and 18 - 49 years for
females. Figure 31 shows that just over one half of all cocaine positive cases were due to a
drugs overdose (56%, n = 37) with the presence of the drug being considered as incidental
to death in the remaining 29 cases. The mean age of males whose death was attributable to
a drugs overdose was exactly the same as males where cocaine was regarded as being
incidental to death (30years, S.D. 7.98 and 8.43 respectively). For females, the mean age
of those who died of a DRD was 32 years (S.D. 11.28) and where cocaine was incidental to
death, 30 years (S.D. 6.65). Of the 37 drug overdose deaths, the deceased was known to
have a history of drug abuse in 33 cases (89%), 15 cases of which the deceased was known
to abuse drugs intravenously. A history of cocaine abuse was noted on the police sudden
death report in 10 cases, this being the only drug reported to be abused in 6 cases, misused
in combination with other recreational drugs in two cases and misused by IVDA's in a
further two cases.
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Figure 31: Number of Cocaine Positive Cases Detected
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5.7.4.1 The Role of Cocaine in Causing Death
From the causes of death certified by the investigating pathologist it was possible to
ascertain the role of cocaine in the 37 overdose deaths and this is shown in Table 22 below.
Just over one half were certified as being due to the effects of cocaine either alone (24%, n
= 9) or in combination with other drugs (27%, n = 10). Just under one half were due to a
drug other than cocaine (49%, n = 18). In these 18 deaths, heroin was certified as the
cause of death in 12 cases either alone (9 cases) or in combination with other drugs
(temazepam in 2 cases and diazepam in one case). The remaining six cases had a non-
specific cause of death (e.g. inhalation of gastric contents, multiple drug intoxication),
however, toxicology and circumstantial evidence indicated these were opiate related
deaths, with heroin being positive in every case. This shows that the practice of
concurrently injecting heroin and cocaine was prevalent amongst these cases.
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Table 22: Cocaine cases classified according to cause of death certified by
investigating pathologist
Year Cocaine Only Cocaine Related Not Cocaine Related Total
1993 1 2 0 3
1994 1 0 0 1
1995 1
I
1 0 2
1996 1
I
1 2 4
1997 1 1 1 3
1998 0 0 2 2
1999 2 1 3 6
2000 0 2 4 6
2001 2 2 6 10
Total 9 10 18 37
Cocaine Deaths = 19
5.7.4.2 Cocaine as a Cause of Death
In order to study deaths where cocaine was considered the cause of death either alone or as
a contributory factor in combination with other drugs, all deaths classed as "Cocaine
alone" or "Cocaine related" will collectively be referred to as "Cocaine deaths". Males
accounted for all cocaine deaths with the exception of one case involving a 32 year old
female, the mean male age was 30 years (19 - 44 years). Despite there being an increase
in the number of cocaine positive cases reported in the laboratory, cocaine as a
contributory factor to death in the West of Scotland remains negligible. (Figure 32). In
fact in 1993, cocaine was attributable to death in 75% of all cocaine positive cases but by
2001, this fell to just over one fifth of all cocaine positive cases (22%, 4 cocaine deaths of
a possible 18 cocaine positive cases). In relation to all accidental illicit overdoses over the
study period and on an annual basis, cocaine was found to be positive, on average, in 4%
of all cases between 1993 - 1999 and as a contributing factor to death in 2% of all
overdoses. In 2000 and 2001, cocaine was found to be positive in 12% of all illicit
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annum.
overdoses, however was considered to be contributory to death in only 2% of cases per
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5.7.4.3 Circumstances of Death
From the police sudden death report, it was possible to ascertain the deceased's last
movements prior to death and all deaths were grouped according to the categories outlined
in Table 23 and these are summarised in Figure 33.
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Table 23: Categories of Activities Prior to Death
A Not seen for a while (long enough for relative/friend to become concerned) and
found dead at locus
B Gone elsewhere within locus, witness becomes concerned and checks on
deceased
C Witnessed to be intoxicated prior to following asleep and never wakes up
D Witnessed to take drugs prior to suffering from a fit, foaming at mouth
E Found dead at locus which was not a dwelling abode
F No intoxication / drug consumption witnessed but collapse / reaction was
witnessed
G Swallowed drugs package in front of police
H In another room in locus from witnesses. No intoxication / consumption
witnessed. Found dead when checked on by witnesses
Figure 33: Number of cases classified by type of death and category of circumstance
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5.7.4.3.1 Circumstances of Cocaine Only Deaths
In two cocaine only cases, death was intentional and this was ascertained by the presence
of suicide notes at the locus. In the first case the deceased was a known drug user who
took drugs both orally and nasally. He had been with friends earlier and was witnessed to
smoke cannabis, prior to falling asleep, no indication of cocaine was evident from the
police sudden death report apart from some empty paper folds with remnants of white
powder (Category C). The second case involved a male who had no known drug history of
note and was found in his works van along with a bag containing white powder. Despite
paramedics conveying the deceased to hospital, he was pronounced dead on arrival
(Category E).
In another two cocaine only cases, the deceased had swallowed or attempted to swallow a
package containing cocaine respectively. In the former case, the deceased had not been
seen for a while (Category A), however at post-mortem, a plastic bag containing white
powder was found within the stomach and this showed evidence of having ruptured. A
blood PM cocaine concentration of 8.4mgllitre was measured, a level consistent with levels
found in similar cases 241. In the second case, the deceased attempted to swallow a drug
package when confronted by police (Category G). He refused to open his mouth which
was firmly clenched shut and the package was retained within. At hospital diazepam was
administered as a muscle relaxant in an attempt to open the mouth. On retrieval it was
noted that the package, which weighed 12.93 grams, had been punctured. Shortly after this
the deceased suffered from a seizure and despite efforts to resuscitate him, died.
In a further two cases, the deceased was witnessed to consume cocaine, either alone where
approximately 10 lines were snorted and some "eaten" (possibly by rubbing on gums) or in
combination with a cocktail of drugs (heroin, dihydrocodeine, cannabis and alcohol). In
both of these cases, the deceased was witnessed to suffer from a seizure, where the
witnesses reported the deceased to be sweating profusely, foam was also seen to emanate
from the mouth (Category D). These cases are classical of the typical cocaine overdose
which results in sudden collapse and frequently involves a pre-terminal seizure'".
The circumstances surrounding the remammg three cocame only deaths are a little
ambiguous. The first case was classed as Category A. He had been snorting cocaine with
friends who left the deceased alone for a period of time. When they returned to his house
some hours later he was found to be dead. Despite being conveyed to hospital, he was
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pronounced dead on arrival. The second case (Category F) involved a male who was
working although feeling unwell and complaining of a sore head. Whilst in a car being
driven by a witness, he vomited, got out the car, stumbled and fell over banging his head.
The witness also reported foam emanating from the deceased's mouth. He too was
pronounced dead on arrival at hospital. In the third case, the deceased (who was witnessed
to be intoxicated) admitted to having snorted a couple of lines of cocaine. He was later
seen apparently sleeping on his bed, but was later unrousable (category C). Paramedics
efforts to revive the deceased at the locus were fruitless.
5.7.4.3.2 Circumstances of Cocaine Related Deaths
Heroin was a contributing factor to death in 80% (n = 8) of the cocaine related deaths. In
five of these eight cases, the deceased was witnessed to be intoxicated prior to falling
asleep (Category C). In another two cases involving heroin as a cause of death, the
deceased was found dead at the locus (public toilet and common landing) and a syringe
and needle was found close to the body (Category E). In the final case involving heroin,
no intoxication or consumption of drugs had been witnessed, the deceased was in another
room at the locus from witnesses, however was found to be dead when witnesses looked
in. Syringes and pieces of foil were adjacent to the deceased (Category H).
One CR death was classed as Category B, the deceased was found with a syringe inserted
into the groin area. Temazepam was a contributing factor in death in this instance. In the
death classed as Category F the deceased had been talking to friends when he fell over,
banging his head. Initially friends thought he was fooling around but they noticed his lips
turned blue. Methadone was a contributing factor in the cause of death and this had been
prescribed to the deceased.
5.7.5 Results of Toxicological Investigation
A blood sample was obtained in all but two of the 19 cases, in these two cocaine-related
cases a urine sample was analysed due to an insufficient blood sample being provided for a
full toxicological examination. Despite cocaine being mentioned in the cause of death in
all these cases, the presence of cocaine itself was identified in 14 cases as shown in Table
24 (8 cocaine only deaths, 6 cocaine-related deaths). The mean, median and range of
cocaine concentrations are summarised in Table 25.
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Cocaine and metabolites detected in cocaine deaths
N Cocaine BE ME
Cocaine Only 9 8 9 6
Cocaine Related 10 5 (+ 1 urine) 6 (+ 2 urine) 5 (+ 2 urine)
Table 25: Blood Concentrations of cocaine and metabolites detected in cocaine
positive cases
Cocaine Cocaine
Only Related
Cocaine
n 8 5 (+ 1 urine)
All Cases (n = 19) Mean 6.52 0.33
Median 5.23 0.17
Range 0.005 - 16.8 0.01 - 0.8
Benzoylecgonine
n 9 6 (+2 urine)
Mean 10.4 1.6
Median 9.64 0.46
Range 0.03 - 30.3 0.31 -7.1
Metbylecgonine
n 6 5 (+ 2 urine)
Mean 5.5 0.14
Median 4.2 0.12
Range 0.007 - 14.3 0.006 - 0.31
Not Cocaine
related
8
0.04
0.03
0.007 - 0.09
15 (+3urine)
0.4
0.14
0.016 -1.26
J 3 (+2 urine)
0.09
0.04
0.005 - 0.45
The mean cocaine blood concentration for cocaine only deaths was significantly higher
than those found in cocaine related deaths (p = 0.03) where a mean difference of
6.2mg/litre was observed (95% Cl: 0.7 to 11.7).
Cocaine was the only drug detected in three cases (16% of all cocaine deaths). Polydrug
use was evident in 67% (n = 6) and 100% (n = 10) of cocaine only and cocaine related
deaths respectively. For the blood samples, this varied from one additional drug (5 CO
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deaths,2 CR deaths) up to three additional drugs (1 CO death), but in the majority of cases
cocaine in combination with two other drugs were detected (6 CR deaths). Polydrug use
involving two and six additional drugs was evident in the urine samples. The drugs
detected for both blood and urine are shown in Figure 34. Opiates were detected in only
two CO deaths, morphine in one instance and unprescribed methadone in the other.
Figure 34: Other drugs detected in cocaine deaths
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Heroin identified by the presence of morphine was the most frequently detected drug taken
in combination with cocaine, this pattern of drug taking is referred to as "snowballing" or
"speedballing", a cocktail used by drug users for many years. The drugs are taken in
conjunction to allow the user to achieve the brief exhilarating high from the cocame
combined with the longer lasting effects of heroin which dissipate the crash'".
Alcohol was found to be present in only 5 cases (4 x CO, 1 x CR) and in every case the
BAC was below the legal limit as stipulated in the Road Traffic Act 1988. The mean BAC
was 40mg/l00ml ranging from 16 -70mg/100ml (median 41mg/l00ml).
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5.7.5.1 Should Cocaine be mentioned in the cause of Death?
When ascertaining whether cocaine has attributed either wholly or partly to a death, it is
vital to know the circumstances surrounding the case as well as whether the individual had
a history of cocaine abuse. Karch and Stephens report that the quantitation of cocaine
blood levels is not required for actual decision making when determining a cause of death.
They highlight that "if there is a strong history of cocaine abuse and typical myocardial
pathology is observed, the case should be certified as cocaine induced sudden death, even
in the face of negative toxicology testing"243. Indeed cocaine levels cannot be used to
explain the cause of death as cocaine-associated sudden death is not dose-related and some
chronic users may have alterations in their hearts 243 and possibly their brains'".
When the two suicide, two body packer and two cases involving sudden collapse
subsequent to a seizure are excluded, the circumstances surrounding the remaining 13
cases (3 CO deaths and 10 CR deaths) are not characteristic ofa stimulant type death. The
CO death classed as Category F had a cocaine level of 1.7mgllitre, a concentration reported
to be linked to cocaine toxicity 219 and in the absence of any other drugs would strongly
indicate a cocaine death. Whilst collapse was witnessed, it could be that the deceased did
in fact suffer a pre-terminal seizure (foam was seen emanating from the mouth as had been
seen in one of the other "seizure" type deaths), but this was not conveyed as such in the
police sudden death report. In the Category A case, the deceased had been snorting
cocaine with friends prior to being left alone. Cocaine itself was not detected, possibly
owing to the fact that a number of hours had elapsed allowing for this to be fully
metabolised, however a high level of benzoylecgonine was quantitated. Again in the
absence of any other drugs, this would strongly suggest cocaine as the main drug in
causing death. In addition, Coronary Artery Atheroma was noted as being an underlying
cause of death, a risk factor associated with cocaine misuse'": 246. However, for the final
CO death, the circumstances and toxicology do not fully support the cause of death as
certified by the pathologist. Despite a very low level of cocaine and metabolites being
quantitated, this Category C death may have been due to an overdose of methadone which
would appear to have been obtained illegitimately. The level of 0.13mgllitre of methadone
detected falls into the lower end of the range detected in methadone only deaths amongst
illicit users 98.
The circumstances surrounding five of the CR deaths are not characteristic of a stimulant
death as the deceased was seen to fall asleep whilst clearly intoxicated (category C). In
two of these cases the deceased was seen to either snort (in addition to consuming
'jellies") or smoke cocaine. Cocaine itself was detected in the blood in one instance and
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urine in another case. In all five instances, heroin was a contributing factor to death, either
alone or in combination with an additional respiratory depressant. In four other CR deaths
where neither drug consumption nor intoxication had been witnessed (2 x category E, 1 x
category B, I x category H), a syringe was found adjacent to the deceased's body. Heroin
was a contributing factor to death in three of these cases and in the remaining case, death
was due to cocaine and temazepam, it is possible the cocaine had been administered
intravenously in this case. In the final CR case, no drug consumption or intoxication was
apparently witnessed although the deceased was seen to fall over. Cocaine was detected at
autopsy at the highest cocaine concentration amongst all CR deaths in this study
(O.8mg/litre) and is consistent with a study where cocaine was purported to precipitate
sudden death in individuals with undiagnosed cardiovascular disease 247. It cannot be
precluded that the deceased died of a sudden death due to cocaine consumption which the
witnesses failed to divulge. Methadone was also a contributory factor, however, this
methadone had been prescribed and was not an excessive amount for the dosage he was
receiving, hence it's role in causing this death could in fact be subsidiary.
5. 7.6 Discussion
The increase in recent seizures of cocaine, drug users admitting to using this drug when
presenting themselves to drug clinics and the increase in cocaine positive cases amongst
deceased persons investigated by FMS are evidence that cocaine is emerging as a drug of
misuse in the West of Scotland. The wider availability of this drug owes itself to the
decreased price where, today, a gram of cocaine hydrochloride and a rock of crack can be
purchased in the Strathclyde region for approximately £50 and £20 - £50 respectively.
This compares to 10 years ago where a gram of cocaine hydrochloride would cost in the
region of £100 212. In addition recent research indicates that the dramatic increase in the
use of cocaine in Scotland could be related to the methadone programme. With an
increasing number of people being initiated on a methadone maintenance programme and
the demand for heroin diminishing, the article reported that drug dealers were merely
diversifying their product line by targeting patients on a methadone programme. The study
group suggested that as many as one quarter of addicts coming forward for treatment have
used cocaine in the last three months and not only were most using heroin in combination
with cocaine, around one-third were also using methadone'".
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Although there has been a substantial increase in cocaine positive cases investigated by
FMS, it should be noted that the majority of cases were not as a result of a drugs overdose
and the presence of cocaine was merely incidental. In the majority of CO deaths, the
decision of the pathologist to certify death as cocaine only was aided by the circumstances
surrounding the death, namely intentional overdosage, sudden collapse subsequent to a
pre-terminal seizure or death due to concealing drug packages, the dangers of which have
been well documented 249. 250. 251. Of those, where cocaine was a contributory factor in
causing death, some ambiguity exists as to the actual role of cocaine in causing death,
especially since the circumstances surrounding the majority of deaths together with the
presence of an opiate would be indicative of an opiate induced death. Indeed, it may be
that the presence of cocaine in some of these CR deaths may have been incidental and the
fact that they were mentioned in the cause of death due solely to the discretion of the
investigating pathologist. There was one CR death whereby respiratory depression
subsequent to a collapse, and with no other information available, led the pathologist to
certify the death as due to the intoxicating effects of cocaine and methadone, despite the
methadone having been prescribed. It is not impossible to suggest that had more
information been available, this may have been a CO death.
Due to the usually brief "rush" that is experienced with cocaine which is often followed by
a dysphoric "crash", the use of longer-acting drugs and alcohol is common!". Alcohol in
combination with cocaine, despite being the most frequent cause for drug-related
emergency room visits in the United States 253 was more the exception than the norm in this
study. This outcome is similar to findings of a study that concluded that the concomitant
use of ethanol and cocaine does not appear to be nearly as common as suggested by
epidemiological studies'",
Variables exist which can hinder the interpretation of PM blood cocaine and metabolite
findings when trying to extrapolate levels back to perimortem drug concentrations. Firstly,
cocaine continues to deteriorate in the post-mortem state if specimens are not properly
preserved 255. This in vitro instability must be taken into consideration when interpreting
PM blood cocaine concentrations especially in unpreserved blood that has been maintained
at room temperature for any length of time 256.
All samples investigated by FMS are stored at optimal temperatures whilst awaiting
analyses. Blood concentrations of cocaine have also reported to be site-dependent in a
study where cocaine concentration in subclavian vein blood was shown to decrease whilst
120
Drug Related Deaths - Cocaine
that from heart, aorta and femoral vein blood increased during the interval between death
and autopsy'". A further study noted that there were no consistent patterns of site-specific
differences for cocaine, benzoylecgonine or cocaethylene and that the central compartment
showed both higher and lower concentrations than the peripherali". This illustrates the
difficulties encountered by a toxicologist when interpreting a PM blood cocaine level and
highlights that caution should prevail when determining whether cocaine has been
conducive to death.
5.7.7 Conclusion
Over the past decade, cocaine use in the West of Scotland has increased and is receiving a
lot of attention from the media, law enforcement and harm reduction agencies. It's
occurrence in deaths in the Strathclyde Police region is relatively new but is now
increasing. Itmay be somewhat premature to start comparing local experiences of cocaine
related deaths to other studies due to the relatively small incidence of cases and lack of
deaths where only cocaine was detected, an issue raised by Karch et al 219. From the
experience in the West of Scotland, it was noted that there are some cases where the role of
cocaine in deaths is somewhat ambiguous. It is accepted that the concentration of cocaine
andlor metabolites, in isolation, is not sufficient enough to determine a cause of death but
that other sources of evidence must be taken into consideration, for example, results of the
autopsy and in particular the circumstances surrounding the death. Hence, the pathologist
can only certify a death on the information available to them. In the absence of significant
PM findings, a trivial toxicology level and lack of circumstantial evidence, an accurate
determination of cocaine as a causative factor may not be possible.
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5.8 Chapter Conclusions
It is clear from this chapter that drug related deaths remain a problem in the Strathclyde
Police region of Scotland and one that is shared internationally. The main drug groups
involved in deaths within this study has been the opioids, heroin in particular. Similar
scenarios were prevalent throughout this chapter. For example, in a substantial number of
cases, the deceased was witnessed to be intoxicated prior to falling asleep. Education
initiatives to target drug users and acquaintances into recognizing signs and symptoms of
overdose as well as simple cardiopulmonary resuscitation skills may have a positive impact
on reducing some of these otherwise preventable deaths. However, an obvious obstacle
with this is obtaining funding to implement it. In the early nineties, safety campaigns to
discourage drug users from sharing needles together with the implementation of needle
exchange schemes all had an encouraging outcome in that the prevalence of HIV in the
West of Scotland remained low. This method of campaigning would have incurred a
substantial sum. However, it may be viewed that the necessity to finance this particular
health promotion was justified due to the potential risk of infection to the community at
large and not just drug users as is the case for education to prevent fatal overdoses.
Other strategies for prevention of fatal overdoses may be the implementation of trials to
assess the efficacy of naloxone and naltrexone amongst the drug using fraternity in the
Strathclyde Police district. These are opioid antagonists that in the absence of opioids have
no pharmacological activity and when used therapeutically have no impairing effect on
respiration. The only adverse effect may be the rapid onset of opioid withdrawal
symptoms in opioid-tolerant individuals. This may be seen as a positive aspect, however,
in that it may allay fears that heroin users would be likely to inject more heroin if naloxone
was available in the knowledge that an overdose could be reversed 259. This view has also
been reported elsewhere where it was noted that an "addict's extreme distaste for the
withdrawal caused by naloxone may make them reluctant to use it even if it is available"
260. Despite the positive aspects of these antagonistic drugs, there are possible limitations
of their use. For example, naloxone has a relatively short half-life and hence may be
ineffective if administered in cases of methadone overdose, an opioid agonist with a longer
half-life, in that the effects of the full agonist may return after the naloxone has been
cleared. That said, the advantage of administering naloxone in methadone related cases is
that the reverse effects will permit a sufficient period of time to summon an ambulance and
convey the individual to hospital where medical intervention can commence. Naltrexone
has a longer half-life and may precipitate a longer lasting withdrawal syndrome in opioid-
dependent individuals 261. Further it should be noted that specific opioid antagonists will
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only block the respiratory depressant effects of an opioid and hence has no effect on
respiratory depression which is caused by the concurrent use of alcohol and
benzodiazepines?", A pre-launch study into the acceptability of these drugs as possible
intervention strategies concluded that it is appropriate to proceed to a carefully constructed
trial of naloxone distribution as it was estimated that at least two-thirds of witnessed fatal
overdoses could have been prevented had naloxone been available by witnesses'". An
early report on the provision of naloxone to drug users revealed that 10% of distributed
naloxone had saved lives 263. Despite lives having been saved, this study raised concerns as
to the amount of naloxone which remained unaccounted for. This highlights the need to
fully assess the extent of possible harm caused by this manner of intervention 21>4. There
may be scope for the use of these antagonists but only in cases where overdose has been
obviously witnessed, the opioid used is known and polydrug use is absent (e.g. they will
not be effective in cases where opiates have been taken concurrently with alcohol and/or
benzodiazepines).
Another strategy, which is not new to the United Kingdom, is that of heroin prescribing.
Prior to 1968 any doctor was able to prescribe pharmaceutical diamorphine to opioid-
dependent individuals. Concern as to the diversion of prescribed drugs to the black market
due to prescriptions of these drugs remaining freely available coincided with a change in
the sub-culture associated with drug misuse which saw the number of heroin and cocaine
addicts increasing sharply 265. In London, an illicit market in pharmaceutical cocaine and
heroin was thought to originate from the prescribing procedures of Lady Isabella Frankau
who was reported to be the mainstay of the flourishing illicit heroin market 266. However,
today heroin and cocaine prescribing is strictly controlled. There are approximately 100
doctors, mainly specialist psychiatrists, who have a Home Office licence to permit this
practice and encompass prescriptions for about 500 patients, most of whom are in receipt
of diamorphine 267. A study to determine the scale and practice of diamorphine prescribing
showed that the majority of doctors who were prescribing had not initiated a prescription
but rather inherited patients who were already receiving a prescription. However, they
reported that prescribed heroin provided an opportunity for clinical improvement and a few
reported their reasons for prescribing it as being to help them attract and retain hard-to-
reach drug users. Reasons for not prescribing heroin, despite holding a licence ranged
from the doctors concern regarding diversion of supplies, lack of evidence for it superiority
over oral methadone to the high costs compared to methadone and also that it was
considered not to be good clinical practice. In addition there was a great variation in the
doses prescribed (ranging from 5 - lS00mg/day) and an agreement regarding the daily
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dose-equivalent of 100mg of methadone (ranging from 50 - 900mg) 268. In 1994, a heroin
prescribing project was initiated in Zurich, Switzerland, however this was accompanied by
medical, psychiatric and social assessments. Between 1994 and 1996, a total of 1000
patients were treated, 800 of whom had asked for heroin prescription. The results were
promising and showed that the physical health state of the individual improved, as did their
mental health state which showed a clear regression in co-morbidity related issues linked
to drug misuse such as depression and anxiety. Concurrent use of benzodiazepines also
decreased, as did drug-related criminal behaviour. Social integration greatly improved and
permanent employment was more than doubled. A conclusion from this study was that
heroin prescription can be recommended for a designated target group, i.e. heavily
addicted persons who have failed attempts in other treatments. In addition, a vital element
of treatment was the health and social support made available. That said, the United
Nations remain concerned about the treatment and were reported to state that they were not
convinced that the limited positive effects were solely due to the heroin prescribing but that
other factors such as the support made available could have been involved'". This
highlights the varying views of doctors who are able to prescribe heroin as well as the
inconsistencies of treatment protocols and prescribing practices throughout the UK. A
limitation of this treatment is the cost incurred which is estimated to be approximately
£3000 - 6000 per patient-year 268. The success of the Swiss trials could well be down to
the simultaneous assistance offered both on a health! counselling and welfare basis which
together with prescribing may assist in retaining individuals in treatment.
A risk factor associated with fatal overdoses is injecting alone which denies the individual
of imminent medial intervention. Over the past few years, injecting rooms have been
established in several European cities in Holland, Germany and Switzerland. Australia has
experimented with a "medically supervised injecting centre" (MSIC) which aims to reduce
the risk of morbidity and mortality associated with drug use. In addition to reducing the
spread of blood borne viruses, another aim of the MSIC is to provide access for drug users
to drug treatment, health welfare and social services. As well as providing sterile injecting
equipment, staff are on site to advise on safe injecting practices and observe the "clients"
until they are ready to leave. While this would seem a likely alternative initiative in
preventing fatal drug overdoses, their place in Scottish society is improbable at present.
These facilities need to be legally sanctioned, and even though Scottish legislation would
allow this, the Government seems unwilling to embrace the idea as a possible solution.
However, this may change as did the legislation governing the supply of specific items
such as swabs, citric acid, filters, sterile water ampoules for safe injecting practice. In
124
Drug Related Deaths - Chapter Conclusion
August 2003 there was an amendment to Section 9(a) of the Misuse of Drugs Act (MDA)
1971 to allow the supply of the aforementioned items to drug users by medical
practitioners, pharmacists and drug treatment service providers. Prior to this date, this
section created an offence ''for any person who supplies, or offers to supply, any article,
which may be used to prepare a controlled drug for administration, by any person, to
himself or another, believing that the article is to be used in circumstances where the
administration is unlawful". This section was inserted into the MDA (1971) in 1986 and
excluded the supply of a hypodermic syringe and needle in order to reduce the spread of
blood borne viruses such as HIV. However, this section was regarded by Drug Action
Teams to obstruct harm reduction activities and hinder service provision via the needle
exchanges and was highlighted to the Scottish Executive. In response the Scottish
Executive advised that a Letter of Comfort be issued by regional Procurators Fiscal stating
that prosecution would not be contemplated for the supply of drug paraphernalia as
mentioned above. In any case, it was considered that prosecution in such cases would not
be in the public interest 270. So, amendments to drug legislation have occurred over the
years in response to the magnitude of the problem and has resulted in a decrease in supply
of some drugs and the lawful provision of drug paraphernalia to permit safe injecting and
promote harm reduction. Government attitudes to the provision of a "safe haven" for drug
misusers to inject may change in the future particularly if positive research findings
regarding this issue continue to be promoted from areas where these are already
operational.
As well as education initiatives for drug users and acquaintances, there is a need for
training of GPs in the management of narcotic addiction. A study involving inner city
London GPs revealed that they were not taking on an active role in drug misuse treatment
that was being encouraged by the Department of Health. Less than one-half of GPs
responded to a questionnaire which was sent in order to assess the proportion of GPs who
were seeing narcotic users and what methods of treatment were being employed.
Inadequate training in the management of narcotic addiction was noted amongst the GPs
although they were interested in partaking in small group training to improve their skills
271. Although drug misuse management has come a long way in the West of Scotland
particularly with the initiation of the Glasgow Drug Problem Service and methadone
prescribing, there is still scope to assess GPs views on this issue, similar to the study
carried out in London. This would identify if there is a need for further training for GPs
which may even increase the participation from GPs who have opted out of shared care
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schemes already in practice. This may even increase the accessibility for drug users to
enter into drug treatment services.
Another theory regarding drug overdoses is that there may be a greater number of cases
whereby the deceased overdosed intentionally. Usually, the manner of death is ascertained
as suicidal in the presence of a note or if the deceased was exhibiting strong suicidal intent
shortly prior to death. A connection between suicide and overdose amongst drug users has
been identified elsewhere in the literature?" 273. Neale reports on a study involving 76 drug
users who had recently experienced a non-fatal overdose!". Interviews took place within
the hospital setting which meant that the respondents accounts were not clouded by time or
subsequent events and also allowed for a higher level of reliability and a greater degree of
insight into the event. It was concluded that non-fatal overdoses are often motivated by
suicidal intent especially since approximately one-half of interviewees reported suicidal
thoughts or feelings prior to the overdose they had just experienced. Initiatives to offer
counselling and support for drug users, via both primary and secondary care may help to
reduce these suicidal tendencies experienced by drug users and hence potentially safe lives.
Despite efforts at reducing the supply of illegal drugs, their misuse will always be
prevalent in society be it because of their abundance and/or because peoples attitudes will
not change. The major task for government and health care providers, therefore, is to
prevent fatal overdoses occurring. This can be done by encouraging drug users to access
treatment by making this readily available as well as providing support and counselling as
part of the package. Continued monitoring of patients to ensure cessation of illegal drug
use and compliance with the treatment is also required and hence clinicians may have to
undergo training to ensure they are competent in this. Education programmes to
encompass drug users and those close to them would help by encouraging safe injecting
practice and highlight the dangers of concurrent consumption of drugs.
There is no shortage of strategies that can be implemented in order to reduce drug-related
deaths. However, additional research is required into the efficacy of some that were
mentioned earlier particularly in the West of Scotland society. The need for medical
treatment, counselling, social welfare support and continued education is the vital equation
in the fight against drug misuse. A multi-disciplinary approach is required in an effort to
reduce drug-related deaths in Scotland.
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6 Drugs and Driving
Driving is a multi-factorial task requiring precision and alertness where the driver is
continuously receiving information (visual), processing and analysing it (decision making)
and consequently reacting accordingly to it (possible risk taking). All of these tasks are
controlled by the cognitive and psychomotor functions of the central nervous system
(CNS) which when working unimpeded will allow the driver to react efficiently.
Therefore, any substance, which affects the CNS in such a way as to cause significant
alterations to these functions, has a potentially impairing effect on the ability to drive
safely.
In 2001, there were approximately 33 million persons holding a full driver's license in the
United Kingdom 274, 63% of whom are aged between 17 - 50 years of age, a range deemed
sufficiently large enough to include distributions of both recreational and dependent drug
users 275. With an increase in drug misuse throughout society in general, it is of no surprise
that drug misuse amongst the driving population is also an issue in need of address. In a
study of samples obtained from suspected drugged drivers received by the Forensic
Science Service in 1997, drugs were detected in 89% of cases. The drugs detected were
primarily drugs of abuse and polydrug use accounted for over one half of the samples
received 276. In addition, the experience in the West of Scotland shows that driving under
the influence of drugs rarely involves individuals who are taking prescription medicines.
In reality, those who are suspected of contravening section 4 of the Road Traffic Act 1988
are using drugs of abuse including commonly abused prescription drugs that have been
obtained illegally (e.g. benzodiazepines, opioid analgesics) or, particularly in the West of
Scotland, a combination of both'?" 277
The Driver and Vehicle Licensing Agency (DVLA) treat drug addiction in the same as any
other medical condition. If a driver is deemed unfit to drive due to a medical condition,
which they are obliged to notify to the DVLA, the Secretary of State for Transport has the
power to revoke their license. In reality, however, the likelihood that a person will divulge
this "medical condition" is remote. Recently, the British Medical Association
recommended that the Government develop a campaign to highlight that taking drugs (licit
or illicit) can have an impairing effect on driving ability similar to that of alcohol 278. The
proposed initiative would be aimed at educating the public to the dangers of driving whilst
under the influence of drugs.
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6.1 DUID: A world-wide problem
The problem of driving under the influence of drugs (DUID) is by no means restricted to
the United Kingdom. Studies have shown that driving whilst impaired through drugs is
increasing in epidemic proportions all over the world. Smink et al reported that 80% of
their study group of impaired drivers in the Netherlands tested positive for drugs, 42% of
whom were polydrug users 279. A study in Austria revealed that over a three-year study
period, 94% of urine samples obtained from drivers suspected of DUID tested positive for
drugs thereby confirming the police officers suspicions. Cannabis was the most commonly
abused drug followed by morphine 280. An indication of widespread consumption of
alcohol and drugs was reported by Alvarez et al in Spain, following the distribution of
questionnaires to drivers who were due to undergo a medical examination prior to
obtaining or renewing their driving licence 281. In addition, Lillsunde et al showed that the
number of positive drug findings and drug abuse has steadily increased among drivers
suspected of DUm in Finland. These results followed the comparison of two one-week
study periods, one in 1979 and one in 1993. Drugs classed as hazardous to traffic safety
were detected in 7% of the samples in 1979 compared to 26.8% of those in 1993. In both
years, benzodiazepines were the most commonly detected drug group and illegal drugs
were found in 4% of cases in 1993, primarily cannabis and amphetamine. Polydrug use
was also a common finding in the samples 282. Polydrug use was also a finding of a study
conducted by Augsburger and Rivier. Their retrospective study of suspected DUID drivers
in Canton de Vaud (Switzerland) showed a very high correlation between police suspicion
and positive results for drug analyses where one or more psychoactive drug was found to
be present in 92.8% of samples over a 13-year period. The most commonly detected drug
group was the cannabinoids followed by opiates, benzodiazepines, cocaine, methadone and
amphetamines 283. Findings from other European studies are outlined in Table 26 below.
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Table 26: Abstract Findings of European Studies into Drivers suspected of OVID.
Author(s) Country Study Period Major drug Other notes
of Study group detected
Christensen et al 284 Denmark 1981 - 1985 Benzodiazepines Polydrug use
prevalent
--Gjerde and Kinn 285 Norway June 1989 - June THC Polydrug was
1990 prevalent
--
Cosbey S.H. 286 Northern 1982 - 1985 Benzodiazepines
Ireland
Bjemeboe et al 287 Norway 1978 and 1983 1978: Benzodiazepines
1983: THC
Alarmingly, a study investigating the perceptions and behaviours of drivers who use illicit
substances revealed that the participants were aware of many drug effects which may lead
to impairment. However, they believed the risk of accidents whilst drug-driving were
smaller than the risk of being caught for a traffic offence or in possession of drugs. This
was despite reports of "alarming attitudes and behaviour" amongst the amphetamine users
and "drug-induced tiredness" amongst the heroin users in the study group 288.
6.2 DUID: The Procedure in the UK
In 1997, the Transport Research Laboratory (TRL) carried out research for the Department
of Transport, Local Government and the Regions (DTLR) and reported that illicit drug
consumption by fatally injured drivers showed a six-fold increase compared with a
comparable study carried out 10 years previously 289. Drugs and driving is, without a
doubt, an increasing crime in the United Kingdom.
Alcohol as an impairing agent in relation to driving was first addressed in the Criminal
Justice Act 1925 which made it an offence to be a person "drunk while in charge on any
highway or any public of any mechanically propelled vehicle". Over the next few years
the Road Traffic Act 1930 made it an offence to drive, attempt to drive or to be in charge
of a vehicle on a road or other public place when "under the influence of drink or drug to
such an extent as to be incapable of having proper control of the vehicle".
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The 1962 Road Traffic Act allowed a police constable to request a blood or urine sample
from an individual and required the Courts to have regard for the proportion of alcohol or
drugs in the body as evidenced by blood or urine levels. With regards driving under the
influence of alcohol, a statutory limit did not come into effect until the 1967 Road Safety
Act was passed. In addition, this Act introduced the Breathalyser as a screening test, and if
a positive result was obtained from this, it had to be followed up by an evidential blood or
urine test. This made it an offence to drive a vehicle on a road or public place whilst the
proportion of alcohol in the blood, ascertained by laboratory procedures, exceeded a
prescribed limit (which in the UK is 80mgll00ml). Prior to this, an individual suspected of
driving whilst intoxicated was liable to be charged under the Criminal Justice Act 1925.
The definition of "drunk" was however open to interpretation and only those who were
obviously drunk were prosecuted. The Road Transport Act 1981, introduced a fixed limit
for alcohol in breath which facilitated the police officer with a rapid means of dealing with
suspected drink driving cases through the introduction of the evidential breath testing
device. The existence of statutory limits is advantageous for the purposes of prosecution
which in the United Kingdom can be enforced if the person is above the following defined
alcohol limits:
Blood 80mgll00m1
Urine 107mgll OOmI
Breath 35IJglml
To date, there are no defined limits with respect to drugs, despite it being an offence to
drive whilst under the influence of drugs. In the United Kingdom, the statutory offence
relating to drugs and driving is contained under Section 3A and 4 of the Road Traffic Act
1988 (as amended by S4 of the Road Traffic Act 1991).
Section 3A RTA 1988 as amended states:
"If a person causes death of another person by driving a mechanically propelled vehicle
on a road or other public place without due care and attention, or without reasonable
consideration for other persons using the road or place, and -
(a) He is, at the time when he is driving, unfit to drive through drink or drugs ...... he is
guilty of an offence. "
Section 4(1) RTA 1988 as amended states that:
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"A person who, when driving or attempting to drive a motor vehicle on a road or other
public place, is unfit to drive through drink or drugs shall be guilty of an offence".
The problem with this existing legislation is the ability to prove that a person is unfit to
drive. The Appeal court has said that, "For the purposes of this section, a person shall be
taken to be unfit to drive if his ability to drive properly is for the time being impaired".
Presently, there is no categorical definition of "impairment" in the Road Traffic Act.
A police officer must have due cause to arrest a person on suspicion of driving whilst
impaired. In the majority of cases, if a positive breath test is obtained, the person will be
charged under Section 5 of the RTA 1988, the fixed level alcohol offence. However, if the
police officer still suspects the person to be impaired after providing a negative breath test,
the person should be charged under Section 4. In such instances, the person is taken to a
police office where they are required to undergo a medical examination. If the police
surgeon agrees that the person's condition may be due to the effects of drug(s), a
blood/urine sample is obtained and submitted to a laboratory for analyses. It is an offence,
at this stage for the person to refuse to provide a sample. If the police surgeon disagrees
that the person's condition may be due to the effects of drug(s) further prosecution is at the
discretion of the reporting police officer (Figure 35).
The objective of the Police Surgeon's examination is to establish that the individual is fit to
be detained in the police station and to exclude any conditions, illnesses or injury which
may mimic intoxication. They are then required to determine whether there is a condition
that might be due to a drug. The police surgeon therefore carries out their own series of
tests, within which are tests equivalent to those used in the field impairment tests (e.g.
finger to nose, walk in a straight line). For this purpose a Pro Forma (F97) is used. There
is no obligation for the driver to undertake these tests and the tests themselves are not
exhaustive. In order for a specimen to be obtained, the Police Surgeon has to advise the
police officer that the condition of the person might be due to a drug.
The decision as to whether a person is impaired must be reached by a Court following
evidence received from police officers involved, witnesses, the Police surgeon and the
forensic analyst. A conviction is not weighted solely towards the evidence of the police
surgeon. Convictions have been successful going on evidence obtained from only the
police officer and the forensic analyst 290.
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The problem of proving impairment has led some countries to introduce a per se type law.
For example, Germany introduced a new law in 1998 which sanctioned drivers suspected
of being under the influence of any of the following banned drugs: amphetamine, MDMA,
MDE, cannabis, cocaine, heroin and morphine 291. If any of these analytes are identified in
a blood sample, this, according to the law, is prima facie evidence of impairment. In such
cases where there has been a violation of the analytical zero-tolerance limit, the individual
is subject to an "administrative sanction" whereby they are fined. However a violation of
the impairment "limit" is a "criminal sanction" 292. In addition following a multi-
disciplinary approach, a similar per se law was made applicable in April 1999 in Belgium
and is being enforced at police check points and areas where drug driving may be common,
e.g. roads to and from nightclubs 293.
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Simplified Diagram of the current procedure for dealing with a driver
suspected of DUID in the United Kingdom
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used
~r
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6.3 Improvements to the Present Procedure
In Scotland, over the years 1995 - 2001, the police prosecuted 52,592 persons under
Section 5 compared to only 5,963 persons under Section 4 of the RTA (Tables 27 and 28)
294. A possible explanation for this vast difference may be that a significant number of
drugged drivers go undetected as a consequence of two factors. Firstly, police officers are
not trained in relation to drug recognition. It has been suggested that due to the success of
the roadside breath screening and evidential breath testing devices, observational skills of
police officers in identifying otherwise impaired drivers have been lost 295. Secondly, there
is no readily available roadside screening devices similar in principal to the breathalyser.
Table 27: Number of Crimes Recorded under Section 4 of the Road Traffic Act
1988 in Scotland and the Strathclyde Region.
Driving In Charge of Vehicle
Year Scotland Strathclyde (%) Scotland Strathclyde (%)
1995 597 359 (60%) 113 55 (49%)
1996 921 485 (53%) 112 70 (63%)
1997 899 561 (62%) 225 137 (61%)
1998 987 658 (67%) 131 70 (53%)
1999 825 479 (58%) III 46 (41%)
2000 793 429 (54%) 125 40 (32%)
2001 941 498 (53%) 119 39 (33%)
Total 5,963 3,469 (58%) 936 457 (49%)
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Table 28: Number of Crimes Recorded under Section 5 of the Road Traffic Act
1988 in Scotland and the Strathclyde Region.
Driving In Charge of Vehicle
Year Scotland Strathclyde (%) Scotland Strathclyde (%)
1995 7,450 3,042 (41%) 248 96 (39%)
1996 7,987 3,238 (41%) 277 99 (36%)
1997 7,686 2,989 (39%) 274 75 (27%)
1998 7,246 2,772 (38%) 265 59 (22%)
1999 7,397 3,078 (42%) 277 98 (35%)
2000 7,139 2,955 (41%) 349 146 (42%)
2001 7,687 3,187 (41%) 411 124 (30%)
Total 52,592 21,261 (40%) 2,101 697(33%)
This deficiency in training of police officers in addition to growing concerns surrounding
an increased prevalence of DUID inspired two Strathclyde police officers (Inspector Paul
Fleming and Chief Inspector Davey Stewart) to pursue a study of existing drug recognition
procedures utilised by police. Following a visit to the United States in 1997, they made a
recommendation that a new procedure be initiated in the United Kingdom based on the
standardised Drug Evaluation and Classification (DEC) programme being utilised in
California. Previous adaptations of the DEC programme are being successfully put into
practice in other countries. Saarland in Germany, for example, has had a training
programme available to police officers since 1997, which is practised by police officers in
10 of the 16 German states 291.
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6.3.1 The DEC programme
In response to the increase in substance misuse in the 1970s and the lack of experience of
drug-driving recognition together with a necessity to legally document DUID cases, the
Drug Evaluation and Classification (DEC) program was developed by the Los Angeles
Police Department and introduced in 1979. The development was aided by other experts
in the drug field, such as scientists and physicians 296. The programme enables specially
trained police officers (Drug Recognition Experts, DRE) to evaluate the situation and
conclude (a) whether a subject is impaired, (b) if impaired, that impairment is or is not due
to a drug and (c) if due to a drug, identify the specific drug category involved. The
programme comprises a systematic and standardized series of events starting with
examination of the subject through to evaluating the subject's performance in a number of
field sobriety tests. The DRE works through 12 steps which are outlined in Table 29
below. It should be noted that at no point is there a requirement for a medically qualified
person to examine the subject.
Laboratory validation of this procedure was initially conducted in 1984 co-operatively by
the National Highway Traffic Safety Administration (NHTSA) and the National Institute
on Drug Abuse (NIDA). Results were very encouraging showing that the DRE's were able
to identify correctly 95% of drug-free subjects as "unimpaired" and classify 98.7% of high-
dose subjects as "impaired". In addition they were able to identify the category of drug for
approximately 92% of high-dose subjects 297. Following this controlled laboratory study,
NHTSA proceeded with a field validation of the DRE procedure. Again results were
promising and revealed that when a DRE claimed drugs other than alcohol were present,
this was the case in 94% of cases 298. Over the years a highly standardized training and
certification programme evolved with the co-operation of NHTSA and the International
Association of Chiefs of Police (IACP). This DEC program is now operational in 40 states
and the District of Colombia 299.
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Table 29: The 12 components of the DRE procedure.
Test Purpose of test
1 Breath alcohol test Precedes involvement ofDRE
2 Consultation with arresting officer DRE discusses circurnstances of arrest
with arresting officer
3 Preliminary examination and first Purpose IS to determine that there IS
pulse sufficient reason to suspect drug influence
4 Eye examinations Conducts 3 separate eye movement
examinations *
5 Divided attention tests The Romberg Test
The Walk and Turn test
The One-Leg Stand Test
The Finger to Nose Test
6 Vital signs and second pulse DRE takes blood pressure, body
temperature and pulse
7 Dark room examination and Responsiveness of eye pupils to light and
ingestion examination dark conditions
8 Muscle tone check Certain drugs cause muscle rigidity and
some cause muscle flaccidity
9 Injection site search and third pulse To ascertain IV usage
10 Further interview and observations DRE conducts a structured interview with
arrestee and asks questions about drug use
11 Expert opinion of evaluator Based on totality of all tests outlined above
and is in their opinion to a "reasonable
degree of certainty"
12 Toxicological sample To allow corroboration which is required
for a successful prosecution
* Honzontal gaze nystagmus, vertical gaze nystagmus and eye convergence
examination
In the United States, the DRE is only called to conduct a thorough examination as outlined
above if the arresting officer suspects impairment through drugs. At the roadside, the
arresting officer carries out the Standardised Field Sobriety Tests (SFST) which are used
irrespective of whether drugs or alcohol are suspected. These consist of psychomotor and
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divided attention tests which have been validated using scientific techniques 300. The
SFSTs consist of
Q The Walk and Turn Test
Administered to detect for alcohol
Q The One Leg Stand
Q Horizontal Gaze Nystagmus
Q The Romberg Test } Administered to detect for drugs
Some of these tests are repeated by the DRE once in the controlled environment of the
police station, however in a slightly different order as outlined in Step 5 of Table 4.
The general principles and techniques utilised in America formed the basis for the
development of a programme adapted for use in the United Kingdom. The SFST battery
used by the arresting officer at the roadside was the initial starting point for a suitable
procedure to be adopted in the United Kingdom. However, it was felt that the horizontal
gaze nystagmus may be construed as being too medical and it was decided to include an
alternative eye test which would be easier to conduct and possibly more informative in
terms of drug symptom recognition, i.e. the examination of the pupil size. In addition, the
Finger to nose test utilised by the DRE would be included as an additional test to be
conducted at the roadside.
Essentially the training package for use in the UK is comprised of the Drug Influence
Recognition Training (DIRT) and the Field Impairment Testing (FIT). Having trained 209
selected police officers from across 6 police forces throughout the United Kingdom, an
evaluation of the adapted programme was carried out in 1999 which was commissioned by
both DETR and TRL. This showed that the correlation between the drug suspected by the
police officer and the drug identified following toxicological analyses was generally very
good. It transpired that the presence of a drug was confirmed in 92% of cases. In addition,
police officers considered the training very worthwhile and enhanced their ability to
recognise drug impairment and the drug that may be causing it 301.
The proposed FIT procedure has, however, received criticism from some members of the
medical profession. Results of a questionnaire distributed to police surgeons following a
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full day training programme in respect to "Drugs and Driving" showed that whilst 54%
were happy to accept the tests, concerns did exist with the Walk and Tum Test and the One
Leg Stand Test 302. In addition, a female police surgeon has publicly expressed her
concerns with the tests rating them as "totally hopeless" and marking them "0 out of 10"
303
Fleming and Stewart showed that there seems to be no compulsory rigorous training
available for police surgeons with regards impairment testing or symptom recognition in
relation to drug driving 300. Whilst some police forces do offer courses, others are reliant
on the police surgeons experience and professionalism. Further, they distributed a
questionnaire to 250 police surgeons asking them about training issues regarding drug
impairment. Only 61 forms were returned, however showed that 87% of police surgeons
thought it would be beneficial for them to receive specific training to assist in identifying
symptoms of drug usage in drivers, 89% felt this type of training would be beneficial for
police officers also. The majority also thought that the reason for disagreement between
the police officer and police surgeon with respect to whether a person was impaired was
not down to lack of knowledge or training but due to the effects of a drug having worn off
(58%). Rogers and Stark noted that there was uncertainty amongst some forensic medical
examiners as to whether a blood sample can be lawfully requested in the absence of
evidence of impairment at the time of their examination 304. This resulted in
correspondence from two eminent lawyers who stated that "the effect that the condition (of
impairment) referred to in the road Traffic Act 1988 related to when the offence was
allegedly being committed, i.e. when the person was driving, attempting to drive or in
charge of a vehicle". Hence, if sufficient evidence was available from police officers at
the time of the offence despite an absence of evidence at the time of medical examination,
it is lawful that a blood sample be obtained for drug analysis 305.
The proposed FIT procedure in the United Kingdom is not regarded as a duplicate of the
American system. In order for that to happen there would need to be a change in the
legislation, as under current UK law the driver must be examined by a police surgeon, who
is regarded as an impartial witness. The FIT is being proposed as an extra "diagnostic
tool" for the police officer which will increase their confidence in dealing with the
suspected drugged driver. The results of Fleming and Stewart's questionnaire highlights
that a high proportion of police surgeons felt that training would be beneficial to both
parties whose corroboration is vital in requesting a biological sample and ultimately the
fight against drugs and driving in society.
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6.4 The FIT Procedure in the United Kingdom
If a subject provides a negative breath test but the police officer still suspects impairment
then the subject is obviously exhibiting signs and/or symptoms indicative of recent drug
misuse. For example, reddened eyes, loss of co-ordination, slurred speech or drowsiness.
As part of the new FIT procedure, the police officer is trained to identify these various
signs and/or symptoms and is implementing his/her drug recognition skills. At this point,
the subject is asked to participate, on a voluntary basis, in a series of four divided attention
tests (Field Impairment Tests, FIT). If the individual declines to participate in the FIT, the
normal procedures for a Section 4 offence are applied in that they are arrested and
accompanied back to the police office. In Scotland, FIT is, presently, regarded as part of
the investigation process. If the subject agrees and carries out the tests to the satisfaction
of the police officer, they will be permitted to carry on their way and no further
proceedings will ensue. If, however, the police officer is not satisfied with the way in
which they have been carried out, the subject is arrested and the normal procedures for a
Section 4 offence proceed from this point forward (Figure 36).
6.4.1 Symptoms of Recent Drug Misuse (Drug Recognition Phase)
The police officers are trained to identify signs and symptoms of six drug groups:
• Opiates
• CNS Stimulants
• CNS Depressants
• Cannabis
• Hallucinogens
• Solvents
Table 30 shows some of the clues and symptoms which can be exhibited by a user of a
specific drug group. As part of their training, the police officers are trained to recognise
these clues when in contact with a suspected drugged driver.
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Figure 36: The current procedure for dealing with a driver suspected ofDUID in
the United Kingdom implementing the voluntary FIT
SUbject suspected to be
unfit to drive through
drink and/or drugs
Subject arrested for the
purposes of Section 5 of
the RTA 1988
PositiveBreathalyzer
used ....
Negative ~,
NoImpairment still
suspected by Police
Officer?
Subject released
End of Proceedings....
Yes
."
FIT carried
out
Asked to participate in FIT in
order to prove impairment
Any further
proceedings at the
discretion of the
reporting police officer
Disagrees ~,
Impaired .... Arrested and conveyed1-------1.... to police office
Examined by Police
SurgeonNot
Impaired ......
NoImpairment still
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."
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Table 30: Signs and symptoms which are indicative of drug use
Probable sign/symptom Possible sign/symptom:
Cannabis Opiates CNS CNS Hallucinogens Inhalants
Stimulants Depressants
Constricted .I
Pupils
Dilated .I J .1-
Pupils
Reddened .I J J .r:
Eyes
Watery Eyes J 7 "
Slurred .t .t
Speech
Dry Mouth .I .I
Euphoria .I .I .I -;,t .1-
Relaxation .I .I
Drowsiness .I ;,,-
Increased .I
confidence
Sweating / .t
Itching
Sedation .I ;(
Synesthesia ;(
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6.4.2 The Field Impairment Tests
If the subject agrees to participate in FIT, the police officer initially notes the condition of
the eyes (glazed, watery, reddened) and also estimates the size of the pupil by using a chart
which is held adjacent to the eye. The police officer then reads out the instructions for
each test and demonstrates where necessary. The four divided attention tests consist of:
o The Romberg Test: The subject is asked to stand with his/her heels and toes
together and arms by their sides. They are asked to tilt their head back, close their eyes
and maintain that position whilst estimating the passage of 30 seconds. Once they
suspect the passage of 30 seconds they raise their head and say "Stop". The subjects
ability to balance during the instruction phase, maintain the required stance and also
estimate the passage of 30 seconds is assessed.
o The One Leg Stand: The subject is asked to stand with his/her heels and toes
together and arms by their sides. When instructed they have to raise their right foot
approximately six inches off the ground, keep their leg straight and toes pointing
forward and count in the fashion "1001, 1002, 1003" etc until told to stop. This is
repeated for the left leg. The subjects ability to balance during the instruction phase,
carry out instructions and count correctly are assessed.
I:l The Walk and Turn Test: The subject is asked to walk along a line making sure
their feet touch heel to toe on every step. Having walked nine steps they leave their
front foot on the line and use a series of small steps to turn thereby facing the opposite
direction. They then walk a further nine steps. At all times, their arms are required to
stay by their side. The subjects ability to balance during the instruction phase, carry
out the required instructions and count correctly are assessed.
o The Finger to Nose Test: The subject is asked to stand with his/her heels and
toes together and arms by their sides. They are instructed to extend both arms, palm
side up, make fists and extend both index fingers. They are then required to touch the
tip of their nose with the tip of their index finger as instructed. The ability of the
subject to balance during the instruction phase, stand as instructed, count and carry out
required instructions are assessed.
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Throughout the series of tests, the ability to understand and follow each instruction are
observed and any mistakes, excessive body sway and loss of balance noted. The outcome
is not regarded as a "pass" or a "fail". These tests are regarded as an extra implement for
the police as an evidence-gathering tool and the suspicion that the subject is impaired is
reached on the totality of all observations, i.e. the reason for stopping the subject, the
behaviour of the subject and the performance in FIT. At no point can these tests be used as
the sole reason for arresting a subject and likewise the subject is not noted as "failing" any
one particular test.
6.4.3 The Public Reaction to FIT and Drugs and Driving
During the summer of 2002, a drug driving advert was developed by Faulds Advertising on
behalf of the Scottish Road Safety Campaign's Drug Drive Working Group. This
consisted of American police video footage of intoxicated individuals participating in the
various tests and came across to the public as amusing. However, the advert then shows a
man at a police check point in Scotland failing a test. A message that these tests are being
carried out in Scotland flashes on the screen and leaves the viewer with the hard hitting
slogan "Who's laughing now?" The Scottish Executive and the Scottish Road Safety
Campaign commissioned NFO Social Research to evaluate this advert and there was a
particular focus on its impact on young drivers aged 17 - 24 years. In general, young
people did not consider drug driving to be as dangerous or likely to lead to a prosecution
than drink driving. That said, the key messages of the advert were well understood and
general awareness of advertising and publicity on drugs and driving was high following the
advert. However, there was some criticism as to the lack of actual legal consequences of
drug driving and NFO Social Research felt that including confirmed high-profile successes
may strengthen the credibility of the enforcement message 306.
In order that the FIT can be used in evidence in a court of law, it has to be validated to
show that it is a reliable evidence gathering tool which can be utilised by the police officer.
The results of a national study commissioned by the Department for Transport in
collaboration with the University of Glasgow aiming to do just that will be discussed later
in this chapter and following an evaluation of the prevalence of DUID in the Strathclyde
Police district of Scotland.
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6.5 Methodology for Drugs and Driving
6.5.1 Drivers Suspected ofDUID
Forensic Medicine and Science receive biological samples from drivers suspected of DUID
from all Police Forces throughout Scotland with the exception of Lothian and Borders. All
biological samples obtained from subjects who are charged under Section 5 of the RTA
1988 are conveyed to the relevant regional Police Laboratories. The results of
toxicological analyses from samples obtained from drivers suspected of DUID were
retrieved from archive records retrospectively and from the department database
prospectively and were reviewed to determine the number which were found to be drug
positive and of those, the drugs which were detected. Unfortunately, there was no
information available relating to any prescribed medication that the individual may have
been in receipt of at the time the sample was obtained. It was therefore not possible, to
ascertain if, for example, methadone had been prescribed or obtained illicitly.
The same analytical procedures applied as per the drug-related death cases in that all
samples were routinely screened for all illicit and prescription-type drugs and any tentative
positive drugs / drug groups were confirmed. There was no significant changes to these
procedures which would affect the sensitivity or specificity over the study period.
6.5.2 Field Impairment Test
Nation-wide, some police officers had been trained on the use of FIT to detect the drug
impaired driver. As a result, Forensic Medicine and Science was commissioned by the
Department for Transport to evaluate the use of FIT. Whilst having no control over the
design of the incorporation of FIT into present police procedures, a protocol was developed
to ensure delivery of all toxicological results and the voluntary provision of a saliva
sample. That is, in addition to obtaining blood/urine samples from individuals who were
judged to be impaired at the roadside, those who were judged to be unimpaired were asked
to donate a specimen of saliva to detect any "missed" drugs and to confirm drug free
drivers. The use of saliva over other alternative matrices has been shown to be preferable
due to it's collection being rapid, non-invasive and relatively easy to obtain 301, i.e. it does
not require special facilities and close supervision of private functions of the subject 308. A
project known as the Roadside Testing Assessment (ROSITA) was set up in 1999, part of
which was to investigate the use of oral fluid in road-side testing. This demonstrated that
driver response to providing saliva specimens has been favourable and also that, in the
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absence of blood, saliva provides the best indicator for the drugs in circulation in the body
309. Saliva is an ultrafiltrate of interstitial fluid and contains the free component of drugs
(i.e. the physiologically active fraction). Therefore, measurement of drug concentrations in
saliva provides an estimate of the actual amount of drug in circulation and the results can
therefore be used to indicate possible drug impairment 308.
A liaison officer was appointed for each police force in Scotland who would be the main
point of contact between the department and their operational officers. In order to
document results of the field impairment test (FIT), a five-page form was devised in order
that mistakes and/or clues of impairment could be easily recorded by the police officer for
each element of the test (Form I). Forensic Medicine and Science were involved with the
design and layout of these forms. In addition an extra form was included in order that the
police officers drug recognition skills may be monitored (Form 2).
Prior to an individual agreeing to carry out the test, they were informed by the police
officer that participation was on a voluntary basis and if found to be not impaired and a
saliva sample obtained, that anonymity would prevail at all times. This was read from the
reverse side of the information sheet (Form 3) that was within the saliva kit and given to
individuals for their information. A phone number was provided should the individual have
any questions or concerns regarding their participation.
In cases where the individual was presumed to be impaired, they were taken back to the
police station for a medical examination by a police surgeon and the usual procedures for a
Section 4 offence carried out. All samples taken by police surgeons from accused persons
suspected of contravening Section 4 of the Road Traffic Act 1988 are submitted to the
laboratory of Forensic Medicine and Science for toxicological investigation. This is the
case for all police forces throughout Scotland with the exception of Lothian and Borders
who have their own Forensic Laboratory. The samples are subjected to the same analytical
procedures as the post-mortem samples. In order for a full investigation to be carried out
and in duplicate, it is a requirement that a quantity of 10ml of blood be submitted. In some
cases, confirmation of drugs which screened positive is not possible due to an insufficient
blood sample being obtained by the police surgeon. All toxicological results from these
cases are held on the department database allowing for retrospective and prospective
analyses. This study did not impinge on the normal Police - Forensic Laboratory
arrangements for the analysis of blood or urine samples taken for the purposes of Section 4
of the Road Traffic Act.
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For the purpose of this study, a saliva kit was produced and batches sent to each of the
eight police forces. The kit contained the following:
• Information sheet
• Labelled universal container
• Stamped, addressed jiffy bag
• Disposable gloves
• Extra label corresponding to that on universal which was attached to DRE form
The driver was requested to expectorate into the plastic universal enough to cover the
convex bottom (as illustrated below). Disposable gloves are supplied with the kit if
required. The universal was then placed in the stamped addressed envelope and posted by
the police officer or if necessary, the individual.
} Recommended quantity of saliva (-2ml)
....._~___.
The following protocols were put into place:
In EVERY case, the paperwork was received as follows:
The police officer was required to complete a FIT form for EVERY person who
participated to take part. In addition a DRE form was also completed
• Both forms were forwarded to the appointed force liaison officer
• Both forms were photocopied, the FIT form was made anonymous and they were
attached together and forwarded to the department
For impaired drivers where sample was obtained
• Completion of forms as above
• The liaison officer noted on the FIT form whether a blood or urine sample was
obtained
147
Methodology for Drugs and Driving
• The department database was searched in order to find a sample that had been obtained
by the specific police force round about the date the FIT was carried out. The match
was verified by checking the arresting police officer noted on the FIT form matched
that on the database
• For cases from Lothian and Borders, it was necessary to contact the liaison officer who
in turn received the results from their laboratory
For impaired driver where no sample was obtained
• Completion of forms as above
• Reason why sample not obtained noted accordingly on the DRE form
For drivers found to be not impaired who agreed to provide a saliva sample
• Completion of forms as above
• Driver asked to provide saliva sample
• This was placed in the envelope provided and posted as soon as possible (N.B. No
paperwork accompanied the sample)
6.5.2.1 Measuring Impairment
FIT was used to identify drug-induced impairment. A key concept in the design of this
study was the use of an available objective indicator of probable drug-related impairment,
which was drug analyses of biological specimens. There is at present, no other recognised
reference or standard method for measuring impairment or indeed an absolute definition of
impairment. Hence whilst it is recognised that the mere presence of a drug in blood or
saliva does not indicate impairment per se. However, in the absence of any other objective
indicator, the occurrence of toxicologically significant concentrations of drugs supports the
presumption of impairment.
6.5.3 Statistics
In order to assess the ability of the FIT to diagnose impairment the sensitivity, specificity
and accuracy of each test was calculated.
The sensitivity is defined as the proportion of drug positive cases that are correctly
identified by the test (i.e. the probability that a driver with drugs in their system was
identified as impaired) and is calculated as:
TPxl OO/(TP+FN)
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The specificity is defined as the proportion of drug negative cases that are correctly
identified by the test (i.e. the probability that a driver with no drugs in their system was
identified as not impaired)and is calculated as:
TNxlOO/(TN+FP)
The accuracy can be defined as the proportion of cases that were correctly diagnosed in the
study sample and is calculated as:
(TP+TN)xlOO/(TP+TN+FP+FN)
The positive and negative predictive values were also calculated. The Positive Predictive
Value (PPV) is defined as the proportion of drivers with positive test results (i.e who are
suspected to be impaired) that are correctly diagnosed and is calculated as:
TPxlOO/(TP+FP)
The Negative Predictive Value (NPV) is defined as the proportion of drivers with negative
test results (i.e who are suspected to be not impaired) that are correctly diagnosed and is
calculated as:
TNxlOO/(FN+TN)
Where TP. FP. TN and FN are defined as follows:
TP (True Positive) the number of drivers who were suspected to be impaired /
displayed clues and who tested positive for drugs (drug positive blood samples)
FP (False Positives) the number of drivers who were suspected to be impaired /
displayed clues but were drug free (drug negative blood samples)
TN (True Negatives) the number of drivers who were not suspected to be impaired
/ did not display clues and were drug free (in saliva)
FN (False Negatives) the number of drivers who were not suspected to be impaired
/ did not display clues but drugs were detected (in saliva)
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Form 1: The FIT form
IMPAIRMENT ASSESSMENT
Section 3AJ4 RTA 1988
INTRODUCTION AND GENERAL CIUIDANCI
NolI: TII.tonnlllDr ~ ~ 8UIIcIfIIed poIIae cUIng "1PPIIDIIon 01AIId IIIIpIInnn ,... Oft a ..tIo NI
-.arty..,..cl to patIaIpIII. WtIn a lilt 11 __ ............. be..aordlclln 1IIcIIonII If ..
queIIcn ... raad from alMllnllld 0IUd, .. WOIdng .... beldlnllaal to ._ In .. tDmI and .. oard IIIUIt .....
....... 101oourt IUJIQMa.
RIQUIST ANDCAUTION
..., orr»r to_1IIIItetMr)'DU'''''' to dtIw. ~ I wtUd")QI eD,..",. til ..... The'_
.,.,.,. Md.. .,.. me to"..,. ./IJdIIMrWI- eD your..." to ctM I"..,'**'
)QI""")QI" nDt fWIUIted eD~; 1I)Q1. ,. til1M.... ~". &-.d In PM til".
.. MIfbt.".. 0tI)'DU'..." to A*wmy ~ ')QIdtJnot ",..,.,tdMY til". ~
..... me .0 "., ICM DIIIIIIy ".",.
'00,., """.,..,. VIII NO
'Oo,.,.",....,,..,rtc., rtf In .". ..... VIII NO
,RlLEVANT DlTAILI
. . .
..
HAIlE I I D·0.8·1 lID:IIALI 0 PllIlALI 0
ADDRIII L J
TIMISTAImD I IDAYIDATE I J
LOCATIONL I
WEATHER FINE 0 RAIN 0 SNOW 0 WIND 0
LIGHTING CONDITION DAYUGHT 0 lWIllGHT 0 DARKNESS 0
STREET LIGHTING UT 0 UNlIT 0 NI.. 0
ROADSURMCI! WET 0 DAY 0
FOOTWEAR SUITABlE 0 UNSUITABlE 0 REMOIED 0
• ...,... "'rMIOI\: ..
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PUPILLARY EXAMINATION
, I vn QOIrig to .."",. the .. 01your pupIIa, oompIJIing them to thI. gaige, which I wII hold up ., the lit» 01your
faoI,AI I requlnt you to do II IooIc 6Ir8J(Jht ahMd WIdkMp your e)W open'.
'Do you ~mnd?'
'AN you .,..,."" contact ...... ?'
YES I NO
YES I NO
PUPIL SIZE LEFT: CONSTRICTED I NORMAL I DIl~TED Appro( SID: 1 __ 1
AppIOlC SIze: I __ 1PUPIL SIZE RIGHT CONSTRICTED I NORMAL I DILATED
NOTE CONDITION OF EYES: WATERY YES I NO
Addltlorial ComrnInIa
REDDENING YES/NO
· . . . . . . . . . . , . . , . . . . . . . . ~. . . . . . . . . . . . . . . . . . . ' . . . . . . . . . . . . . . . . . .
· . . . . . . . . . ~. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . , . . . . . . . . . . . . . . . .
· .
ROMBERG TEST
'PIeutI.r.nd with your IwII WId toM ~ with your .,.".. doWn by your .... {DemoMInIIM). AIaIntaJn '"'"
pt»II/otI while I (live you the tetrtatitrg IMtnJt;tIona Do not begin untJ I ,., you. WhIn I "')"DU, ,. your Iwd bade
"gIrIIy. dOH yout ItW (DemoMIrIIIe - do not ... 10'" .,..). WhIn you IhInk that 30 -=cndI1NIW MpNd.
bring your lINd forward, open your eyN .-Id.. 'Wfop.,'
'Do you~?' YES/NO
'00 you ,.... dIubIJIty or ~ condition "., ",..,.,.,. you frDm pMIoIpIfIItt, In". lINt" YEll NO
'TIIt)"DU lINd bIIdc. doea your e)W •bf9n'
ARLETO BALANCE DURINQ INSTRUCTION.., YES I NO
FNO STEPS 0 fNJAYS 0 RAISE ARMS 0
YES/NO
HEAD RAIseD
COIIPUED wrTH INSTRUCTIONS?
51EVESOPENI STEPS fNJAYS
ESTIMATION OF 30 BECS. I I
• • , • , ••••••••••••••••••••••••••••••••••••••••••••• I ••• I ••••• , •
· .
· .
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WALK AND TURN TEST
'Please put your left foot on the line. place your tIQht loot llliront of your It1ft foot, toud'IIng ~ to It» with your anna
cbm by your tilde. ~). MaIntain that poeIrion wH» I give you the I1JIrIaItlkIg 1MttuctIona. Do not /»gIn
urd I tell you .•
"When I tell you. ,... riIne /wi to toe.,.". along the II"., on NdI ".", the heel of the #oat nut I» I*»d agttIIvt
the It» of the othtIr foot (DMton."",.j. On the ninth atep, .... the front foot on the line WJd tum round uMnQ • .
.... oflll'Ml _". with the attr.r foot (Dwnon."",.). ~r tumIng. ,... another ,.". heel to toe ".". MJng the
IInA, Durfng the INt. kaep your atmII by your .... wH:h your .... OOCXIIthe .,.".·out /cud and don't IItOp waJIdng
untH the INt la complete',
'Do you ~1' YESI NO
Do you "..,. • dlubillty orm«Ik:tIl oondltJon thIIt ",..,.,.ta you from /MfflCIpIItJng In tlt/ ... 1 YES I NO
ABLE TO BALANCE DURING INSTRUCTION? YES I NO
IF NO STEP~ 0 SWAYS 0 RAISE ARMS 0 STARTS TOO SOON 0
ABLE TO BALANCE DURING INSTRUCTION? YES I NO
COMPUED WITH INSTRUCTIONS? ~S/NO IF NO:
« • E •••••• '-)
...-t • • ... • • • • ,R
STOPS WALKING DJ RAISEARMS mMISS HEElJTOE [!J STEP OFF LINE GJ
CORRECT TURN? YES I NO IF NO STATE REASON:
COUNTS OUT LOUD YES I NO
CORRECT STEP COUNT? YES I NO
If no: TO TURN I FROM TURN I........_ ...
Additional Comrnen18
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ONE LEG STAND
'PIeaII BflItId wtth your heellJlItId toes together with your."". down l¥ your __ ~).
AA..." that podon while I give you the remaining IfI8tNct/ons. Do not begin until tel you',
When I telyou, rUe your ttght foot ~teIy _lnohIM 011",. gtOUnd, kMpIn(1 your • .u.JQtt IItId your tOM
poIntinQ fornrrJ (demOMtl'la). KHp your .",. by your •• , look at your elevated loot IItId count out lOud
·1001,1002,1txrr IIIId 80 on untJJ I tell you to 8IOp.'
Do )lDU undetsmntl?· YESI NO
Do )'DU ,...,. • dlubUIty or medical condition thItt ptWWa you IrDm ".nJcIpdng In III,. tNt?' vs:.s I NO
(1'1me 30 .econt»)
REPEAT FOR OTHER FOOT.
ABLETO BALANCE DURING INSTRUCTION? YESINO
RAISE ARMS 0ST~PS 0 SWAYS 0.IFNO:
COIIPUED WITH INSTRUCTIONS? YES I NO
SWAY FOOT DOWN RAISE ARMSlEFT LEG
TIME(uca)
HOP
SWAY HOPRIGHT LEG
TIME(aecs)
FOOT DOWN RAISE ARMS
COUNTED CORRECTLY? YEll NO
AddItional Comments
... '.' , .
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FINGER TO NOSE TEST
PIeaN mild with your IWIB and tOM togetMr with your ."". dow! by your __ . (Demon""""). Extend both
anM· bwant, palm side up. mM1J ".,. and IItIfIIId both IntJ.c fIngeta. Low8r your ."". 10 tM __ . 1b/tD/n",.,
~ while I give you the remaining IMtIUCliona. Do not t»gIn urtlll t8II you. When I tel you, till your hMd ba:Ic
a/IffItIy. dOMl your -r- BIId 1111your ."". MlVJI1YIn '1M of you (Dem0Mtrllle). I will ay e/tIW ,." or right, ., which
time1ft the reI#MII'It hand dirrJctiy In front WId touch tM ,., 01your lION with IN tipd the Indet .r. Alter touching
the lION lower the hand until I teO you the MlItt hand to UN (Demon.".",.).
Do )IOu under8tllntl' YES/NO
I
ABLE TO BALANCE DURING INSTRUCTION?
IF NO: SWAYS0 STEPS0
YES/NO
RAISESARM 0
I
TIlt your fINd bIIcIc, oIoN your .,... and bI1ng your hIInt» .nghtJy fDrwMJ
call out the IWIda In the following arder: left, right, Wt, right, right, left.
TOUCH CORRECT WAONGHAND MISSED NOSE
[i) G)
2 ~Jr'3 m (i).. IJ~\I
5 III ,.-.." (!)
8
CO'-PLIED WITH INSTRUCTIONS? YES/NO
IF NO SWAYS D STEPS D RAISESARM 0
ADDn1ONALtOMMENTS
TlMETEST COMPLETED 1'- ....1
TEST RESULTS: SUSPECT IMPAlREOJNOT IMPAIRED
OF~CERCONDUcnNGTEST
(Print ~ and a9J)
OF~CER CORROBORATING TEST l I
(Prtntnameandslgn) .......--------------------1
I
I
ARRESTING OFFICERS I
I
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Form 2: The Drug Recognition Form
Drug Recognition Form
[please tick"'; as appropriate I
Please use this form for ALL F.LT. participants - ALL sections to be completed
Section A - Initial Stage
Reason For Stopping: Suspicion of Impairment 0
Moving Traffic Offence 0 Specify: _
Other 0 Specify: _
Involvement in RTA 0
Results of Roadside
Breath Alcohol Test:
Not requested 0Positive 0
Negative 0
Alcohol Present 0
Refused 0
Reasons for
suspicion of drug
consumption:
Constricted pupils 0Dilated pupils 0
Slurred speech 0 Drowsiness 0
Reddening of eyes 0 Slumped position at wheel 0
Poor co-ordination/balance 0 Nervous/agitated demeanour 0
Sweating 0 Other: _
Section B - Field Impairment Test
Build: o
Obese
o oo
Underweight
o
Slim Normal Overweight
F.I.T. Result
Not impaired
Was a sallva sample
obtained?
Yes 0
No 0
Impaired
Does police surgeon
bel ieve condition is due
to the effects of a
drug(s)?
Yes 0
No 0
Iryes. saliva kit reference number:
Stick label here
If ye5, sample obtained: Blood 0
Urine 0
Sample Refused 0
Other: _
If lUI, saliva sample
obtained:
Yes 0 Sample forwarded to Police 0
0
University by:
Subject 0No
Cannabis 0 eNS Depressants 0 CNS Stimulants 0
Inhalants 0 Polydrug Use 0 Unknown 0
Drug groups suspected:
Opiates 0
Hallucinogens 0
This form to be forwarded with impairment assessment form to force liaison officer
Label provided in saliva kit [ SOl - 0001 ]---'
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Form 3: Information sheet supplied to individuals who agreed to provide an
anonymous saliva sample
(a) Front of sheet
University of Glasgow
Road Safety Project
(1) You have been tested to ascertain if your ability to drive is impaired. It has
been concluded that you are NOT UNFIT to drive and no PROCEEDINGS
WILL BE TAKEN in respect of offences under the Road Traffic Act 1988, Section 3A
or4.
(2) The project you have agreed to participate in is designed to ascertain the
TRUE USAGE OF DRUGS (illicit and prescribed) by drivers.
(3) Your participation in this project is strictly VOLUNTARY and
ANONYMOUS.
(4) Consequently, at no time can your identification be linked to the saliva sample
that has been taken for RESEARCH PURPOSES ONLY.
(5) Should you have any QUESTIONS regarding this research you can contact
the University of Glasgow, Tel: 0141-330-2464
Thank you for your co-operation
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(b) Reverse side of sheet
Statement by police to subject
I have to advise you that the tests that you have been subjected to have been concluded and
I can advise that there were no signs of impairment and consequently no prosecution will
follow in respect of the offences under the Road Traffic Act 1988, Section 3A or 4.
I would now ask whether you would agree to participate in a research project, which is
being conducted by an independent body. The purpose of this research is to ascertain the
true usage of drugs in drivers. Your participation in the research is on a strictly voluntary
and anonymous basis.
Your name and address will not be disclosed to the researchers and any samples obtained
will be used for research purposes only. You are under no obligation to participate in the
research and may withdraw at any time.
The research consists of taking a saliva sample and will take no more than a few minutes.
The samples will be collected using sterile equipment (show kit) and once obtained, will be
sealed in this tamper proof envelope. The Police will thereafter post the envelope to the
researchers unless you specifically request to do this yourself.
Do you agree to participate in this research?
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6.5.4 Storage of Data
On receipt of a FIT form, information was extracted and entered onto a database that had
been devised specifically using the Microsoft Access 2000 package. This consisted of an
eight page tabbed form with each tab representing a different test or stage of the process:
• General Information
Pupillary Examination
Romberg Test
Walk and Turn Test
• One Leg Stand
Finger to Nose Test
DR Form
Toxicology Results
• •
• •
• •
Each tabbed page was designed using the outline of the FIT form.
6.5.5 Analysing Data in Access
Manipulation of data was achieved using the system query function in Access that enables
data corresponding to specific criteria to be retrieved.
An example of each page of the form are shown in Figures 37 - 44.
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Figure 37: General Information Screen
I I
.!.
BRITE Project Reference j502/S • ..,,,
GenettlJ Inlo.\ Puplll~Exam IRor:!!!lerg Test IWe1~.TurnTestl One Le9Stand IFinger· NOGa Test IORE Form ITOXIcology I
I Reference 1-_If"E' I Agree to Po.rtJcipo.te in Tests? J;1
Cender IMoie OJ Ago ~ 0.,.j23/07/2002
Time Started I 08:20·00 Time Finjshed ~ LlllngthofTB'I~
Locenon IPo.lsley Reed West oil! Dembreck Road
Weather IFine OJ Other
ughbng IOaylight OJ
Streetughtlng IUnlit OJ
RcadSurto.ce twa! OJ
FOOtweOf ISulte.ble OJ
-
Add Reaml I Find Record I ~
.'
.z,
.,
Record: I<J, Ir-ill • 1.11.*1of SS>
>(/'>/' ......·~;~·;:W#o\,;:;·;;itJl[~lll:1j~~~;~:;J) .' ,t.', I ..' " "
'.'
~'1"r"~"11 At, ... ~
Ella Edit ~iew Visert FQrmat 8.ecords 1001& Wi"dow !::ielp
III - " § CA". :J, 'Ii>" " . @'. tl II Vj YI !Mo •• It< ci' II:> 011 - Il)_
.. MSSdlnsS8rlf ... 8 .. B I:U II!.=-~ . .t.,,-.l.. ·r-
Figure 38: Pupillary Examination Screen
Elle ~:ht y'iew IfI$er"t ~mat B.eccrds Ioola ltiin:low t:te_'
III-I iii' e ~ "'I :I. ~" 'I- I"· tl II "<f YI !Mo •• If( ci' II:> 011- (J)_j
II'.'II~·A.·~-r-.. MS Sana Serif .. 8 .. II .I 11
BRITE Project Reference IS02/Strcthllo
GeniltClllnfo. PupiliaryExam 1Ro_pbe!9 Te., IWolk..Turn T,., I On. leg StClfldI Flng.r· No .. TIt! lORE Form I TOXICOIOIjDII
Refarenca _
Understondlnltrucllonl? fl'n ::::J COnIOClUtnl.,Wom? INO
Test ~mpletild? po
Right Pupil ~
Eyes watery? tyes Eyel Reddened? INO OJOJ
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Figure 39: Romberg Test Screen
Ei!e ~cht <t- Insert Fg-mat Becords 10015 ~ildow !::;!a~
""1iI8[}::<~1iIo"'~ ,~.tlU'i;jYl
• MS Sans serif
BRITE Project
Eile !;dit ~I8W tnsert FQrmat B.ecord6 10011 wrd:Jw I::talp
",·ilil 8[}::< l' IQI'\ '. I@', till '<,111 " ,.00< 'Ii! i!:l ... Ill.'
., ... 'i~' 01:,. r·
BRITE Project Reference
Reference
GenaralJ!lfo. ~pllla.ryExom_ RombergTesl
I Reference 1-
'-:'U:"d:':''':'''':d~'":"ru~'''=O":'?:-;fi;''~'~~~-::oJ:-J· Dlse.bihty/MedcondJtion "IN""o-----::oJ' Details of Dllabllrry/Mlld Condroon ,-------
Belenca during mstrurnons? r Stepsr SwIl)'S P Raises Arms W
Teat rompletad? IYBS
Eyes open J;J
HeodR~8eo r:
Eyesopenat_llIconds ~
Head rat.edat_,econd. r-
Stepsct_slicxlndl r-
SwaysllIt_sBconds ~
ClUBS displayed?
Step r
Swoy r>
ROlles armso.t_18conds ~
30lecscu~ O~err-----------------------------
-J
Raccrd:
Figure 40: Walk and Turn Test Screen
D"I",,,~..ttA., .....
... I MS Sans ser If
General Info. I PlJpilloryExam I Romberg Test Walk..TurnTut IOne Leg Stand IFinger-NossTestl ORE Form ITmoeologyl
B~IOIlCQ dunng InstruCbons7 r $tapa r Rai,.SOIms P
TesicompililtBd7 f"ss
StopsweJking F1 Stopswe.lkinge.t_sacs ~ Millh •• lt\oe r Mlllh .. lllo.e.t_I.CI r-
Re.ISillirms 1'7 Re.lsese.rrnsOi secs 11(1).9(1~1(2)· Slep off lin. ~t_ ••CI 15(1). 9(1~ 6(2)
Correct tum? INo ::oJ '"0' ITum" whol.bOdy ..... ""'000 off 1008
Count. out loud? pa, ::oJ
Correct step count? INO ::oJ 0".. r
~no,10Ium ~
11no. trom tum ~
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Figure 41: One Leg Stand Test Screen
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Figure 43: DR Form Screen
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6.6 An Evaluation of Drug Consumption amongst Suspected
Drugged Drivers in the Strathclyde Police District of
Scotland, 1995 - 2001
6.6.1 Number 0/ Biological Samples Received/or Analysis
Over the 7-year study period, a total of2110 samples were received from 7 Scottish Police
Forces, 63% of which were samples which had been submitted by Strathclyde Police.
Figure 45 shows that samples from Strathclyde Police comprised the majority of cases
each year and accounted for between 57% (1995 and 2001) and 70% (1996) of all Scottish
samples per annum (with the exception of Lothian and Borders).
Figure 45: Total number of biological samples received from Scotland and
Strathclyde that were taken from drivers suspected of DUID.
350
300
250
~~~eo: 200~
~
Q
0 150
Z
100
50
0
1995 1996 1997 1998
Year
1999 2000 2001
I~ Scotland ..... Strathclyde I
It became apparent, however, that some ofthe cases had been submitted with the request of
an alcohol analyses only. It was therefore necessary to omit the suspected Section 5 cases
from the study. Of a total of 1,329 Strathclyde biological samples received, only 134
(10%) had been sent to our laboratory by mistake. The number of cases to be analysed for
the presence of drugs was 1,195, the majority of which involved blood samples (84%, n =
1,000) as is shown in Figure 46.
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Figure 46: Breakdown of Strathclyde Section 4 Cases by Sample Type.
1995 1996 1997 1998 1999 2000 2001
Year
I.Blood OUrine I
6.6.2 Results of Toxicological Analyses
Over four fifths of blood samples were shown to be true positives (82%, n = 823) and 94%
of urine samples were also found to contain to drugs (n = 184). Of the remaining blood
samples (n = 177), 70% were found to be negative (n = 124) and a further 30% (n = 53)
were found to be positive for alcohol only. Of the remaining urine samples (n = 11), only
five cases were found to be completely negative for alcohol or drugs and a further six cases
were found to be positive for alcohol only. These results are shown year by year in Table
31 below.
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Table 31: Breakdown of Blood and Urine Samples per Year
1995 1996 1997 1998 1999 2000 2001 Total
Blood
Drugs 102 73 89 113 128 106 112 723
Drugs & 20 13 15 12 11 15 14 100
Alcohol
Alcohol 13 19 6 3 3 5 4 53
--
Negative 27 27 26 12 17 8 7 124
Urine
Drugs 13 27 27 24 25 30 19 165
Drugs & 3 1 4 0 4 6 1 19
Alcohol
Alcohol 0 0 0 1 4 1 0 6
Negative 2 1 0 0 0 2 0 5
6.6.3 Number of Drugs Detected in Blood Samples
Figure 47 shows that polydrug use was evident in the majority of drug positive blood cases
(61%, n = 501), with the presence of either two or three drugs being confirmed in 91% (n =
457) of polydrug cases.
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Figure 47: Number of drugs detected in drug positive blood samples
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Figure 48 shows that over the study period, the number of cases where only one drug was
confirmed has decreased and the number of cases involving polydrug use has increased. In
1995, mono drug cases accounted for 45% of all drug positive cases and in 1996, over half
of all drug positive blood cases tested positive for only one drug (55%). However, by 2001
approximately one quarter of drug positive cases involved the presence of one drug (26%).
Figure 48: Changes in frequency of mono drug and polydrug cases over the study
period, 1995 - 2001.
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The effects of poly drug use are summarised in Table 32 below.
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Table 32: Overview of the effects of poly drug use'"
Benzodiazepines Amphetamine Cannabinoids Cocaine
Amphetamines @
Cannabinoids @ @ @
Cocaine @ @ @
Opiates @ @ @
@ Unpredictable effects
@ Additively stimulating effects
Additively / Potentiating depressant effects
6.6.4 Drugs Found to be Positive in Blood Samples
Following confirmation and quantification, all drugs that had been consumed were
ascertained and the incidence of these drugs in drug positive blood samples are shown in
Table 33. It should be noted that metabolites were omitted, for example temazepam has
not been noted if found in combination with diazepam and desmethyldiazepam (DMD) and
the concentration of temazepam was significantly lower than that of DMD, hence
indicating that its presence in the sample was as a metabolite of diazepam. However, the
presence of benzoylecgonine and methylecgonine either alone or in combination was
indicative of cocaine usage.
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The average number of drugs detected amongst all drug blood positive cases was shown to
increase slightly over the years illustrating that polydrug was evident.
Table 33: Number of drugs detected per annum
1995 1996 1997 1998 1999 2000 2001 Total
Cannabis (THC-COOH) 46 26 41 60 22 32 41 268
------------------------------- --------- ---------- --------- ---------- --------- ---------- --------- ----------
THC 6 1 6 16 6 14 11 60
Morphine 15 10 33 38 34 54 53 237
Methadone 12 13 8 2 10 12 24 81
Dihydrocodeine 0 0 10 16 5 l3 5 49
Diazepam 41 42 64 93 118 101 108 567
Temazepam 95 40 20 41 28 11 7 242
Cocaine 2 5 1 1 7 6 19 41
Amphetamine 0 1 2 0 1 1 3 8
MDMA 0 1 1 6 3 8 13 32
Other* 4 6 14 6 6 9 8 53
Total no. of drugs detected 215 144 194 263 234 247 281 1578
Drug Positive cases 122 86 104 125 139 121 126 823
Average no. of drugs per 1.8 1.7 1.9 2.1 1.7 2.0 2.2 1.9
sample
THC-COOH: Tetrahydrocannabinol carboxyhc acid
THC: Tetrahydrocannabinol
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* Table 32a: Other Drugs present per annum
1995 1996 1997 1998 1999 2000 2001 Total
Carbamazepine 2 2 1 1 0 2 2 10
-
Chlordiazepoxide 1 1 5 2 4 2 1 16
--
Caffeine 1 0 0 0 0 0 0 1
Fluoxetine 0 1 2 0 0 0 0 3
Naproxen 0 1 0 0 0 0 0 1
Nitrazepam 0 0 2 0 0 3 0 5
Chloral Hydrate 0 0 1 0 0 0 0 1
Phenobarbitone 0 0 1 0 0 0 0 1
Paracetamol 0 0 1 0 0 1 0 2
Ketamine 0 0 1 0 0 0 0 1
--
Codeine 0 0 0 2 0 1 0 3
Thioridazine 0 0 0 1 0 0 0 1
Gammahydroxybutyric 0 0 0 0 1 0 0 1
Acid
--- -- -
Phenytoin 0 0 0 0 1 0 0 1
Methyldioxyamphetamine 0 0 0 0 0 0 1 1
Amitriptyline 0 0 0 0 0 0 1 1
Sodium Valproate 0 0 0 0 0 0 1 1
Mefenamic Acid 0 1 0 0 0 0 0 1
Oxazepam 0 0 0 0 0 0 1 1
Tramadol 0 0 0 0 0 0 1 1
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Most frequently detected benzodiazepines and stimulants as a percentage of
all blood drug positive cases per annum
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The legislation change regarding temazepam in 1996 and the subsequent substitution for
diazepam was also evident amongst DUID cases in the Strathclyde Police Region as is
shown in Figure 49. This figure also shows that in the latter two years of the study, the
proportion of drug positive cases testing positive for cocaine was also shown to increase
slightly and is consistent with anecdotal reports of an increase usage of this drug within the
area 311. This is further supported by an increase of approximately 136% in the number of
new clients who have self reported their use of cocaine in the Strathclyde region over the
years 1999 to 2001 108. 312 ••
Figure 50 shows that the proportion of drug positive blood samples which contain
morphine (indicative of heroin) have also increased steadily over the years and accounted
for between 12% of all drug positive cases in 1995 compared to 42% in 2001. The graph
also shows a cross over between the use of methadone, which was shown to decrease and
that of DRC, which was shown to increase between the years 1996 and 1998. A similar
drug trend has been noted amongst drug related deaths over the same study period. The
proportion of cases with methadone detected was shown to increase from 1998, however,
there was no evidence as to whether these involved prescribed methadone or illicitly
obtained prescriptions.
6.6.5 Drugs detected, Concentrations and Combinations
6.6.5.1 Mooodrug cases (0 = 322)
Approximately two thirds of all 322 mono-drug cases involved a benzodiazepine (66%,
214) and this was primarily diazepam (68%, n = 145). The next most frequently detected
drug group was the cannabinoids (18% of mono drug cases, n = 57) and this was followed
by the opiates (11% of monodrug cases, n = 37). The mean, median and range of drugs
detected is summarised in Table 34.
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Table 34: Mean, median and range of concentrations for drugs detected in Monodrug
Cases
N Mean (Range) Median Therapeutic Levels
mg/litre mg/litre mg/litre'"
Diazepam 142t 0.83 (0.01 - 5.2) 0.51 0.05 - 2.0
Temazepam 66 2.81 (0.13 - 23.14) 1.45 0.36 - 0.85
THC-COOH 57 27.6 (2.0 - 117)+ 22.0+
THe 21 4.3 (2 -15)1 4'
Morphine 26 O.OS(0.01 - 0.3) 0.06 0.04 - 0.5
Methadone 6 0.13 (0.06 - 0.23) 0.11 0.05 -1.0
Cocaine 5 0.15 (0.01 - 0.6) 0.03
Benzoylecgonine 5 0.62 (0.085 - 1.8) 0.2
Methylecgonine 3 0.24 (0.009 - 0.67) 0.04
Dihydrocodeine 5 0.64 (0.11 - 1.22) 0.77 0.8 - 1.7211
MDMA 3 0.9 (0.67 - 1.2) 0.S3
Nitrazepam 2 0.5 (0.3 - 0.69) 0.5
Other 7 GHB (41.4), Fluoxetine (0.09), Phenobarbitone (34.1),
Carbamazepine (0.71), Naproxen (2.62), Caffeine (0.17),
CDP (0.23)
T There were three cases where diazepam was confirmed by the presence of
desmethyldiazepam, but no diazepam was detected.
t ng/ml
A mean concentration of 0.S3mg/litre of diazepam was detected ranging from 0.01 -
5.2mg/litre, approaching levels associated with toxicity. Morphine, indicative of heroin
misuse was noted in 26 cases and a mean morphine concentration of O.OSmg/litre was
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measured, ranging from 0.01 - O.3mg/litre. While these are in keeping with a therapeutic
dosage, the presence of codeine and 6-MAM in a large number of these cases suggest that
heroin was being misused. Of 66 cases testing positive for temazepam, it can be seen that
over one half of these cases involved a concentration which is above that recommended as
a concentration used in therapy and which is associated with fatal overdose cases. Cocaine
use was confirmed in five cases, all of which can be assumed that the individual was still
under the influence of this drug as cocaine itself was detected. Use of cannabis was
confirmed in 57 cases, however the presence of the active component, THC, was noted in
only 37% (n = 21) of these. This indicates that although the person had consumed
cannabis at some point prior to confrontation with the police (which could have been as
long ago as 4 weeks), the likelihood that they were under the influence of cannabis in the
absence of THC, the principal active constituent, is improbable. Methadone was detected
in only six cases and all concentrations were within the therapeutic range associated with
maintenance therapy. However, it was not possible to ascertain whether this involved
prescribed methadone. Five cases involved DHC with a median concentration approaching
that associated with toxicity. MDMA was detected in three cases and in one case a level
associated with fatal overdose was noted 314. 315. Gammahydroxybutyrate, an anaesthetic
and hypnotic agent which has nowadays been encountered as a drug of misuse was
detected in one case at a level which has been shown to be associated with death 3l(,. The
remaining cases involved mainly medicinal drugs such as anti-depressants, anti-
inflammatories and anti-convulsants all at levels associated with therapeutic usage.
6.6.5.2 Two Drug Polydrug Cases (n = 297)
Benzodiazepines were confirmed either alone or in combination with another drug in 19%
(n = 56) and 77% (n = 228) of cases where two drugs were detected. In cases where
another drug was present in combination with a benzodiazepine, this was primarily either
cannabis (42%) or an opiate (42%). In total, 340 benzodiazepines were detected in this
group and the most frequently detected benzodiazepine accounted for just over two thirds
of these cases and was diazepam (69%, n = 233). Table 35 summarises the combinations
of drugs encountered and Table 36 summarises all drugs detected in this group together
with a breakdown of concentrations detected.
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Table 35: Combinations of drug groups in cases where two drugs were confirmed
Benzodiazepine Opiate Cannabinoid
Benzodiazepine 56
Opiate 95 5
Cannabinoid 96 4
Cocaine 12 1
Amphetamine 1 1
MDMA 9 2
Other 15
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Table 36: Mean, Median and Range of Concentrations for drugs detected in cases
where the presence of two drugs was confirmed.
n Mean (Range) Median Therapeutic levels!"
mg/litre mg/litre
Diazepam 222t 0.91(0.03 - 5.5) 0.61 0.05 - 2.0
Temazepam 97 2.03 (0.11 - 11.7) 1.24 0.36 - 0.85
THC-COOH 101** 44.7 (4.0 - 248)t 29.0t
THe 20 12.4(1-96)1 41
Morphine 81 0.06 (0.004 - 0.65) 0.05 0.04 - 0.5
Methadone 19
I
0.13 (0.01 - 0.4) 0.11 0.05-1.0
Cocaine* 10 0.14 (0.004 - 0.9) 0.04
Benzoylecgonine 11 0.5 (0.011 - 1.95) 0.225
Methylecgonine 12 0.44 (om - 3.6) 0.05
Dihydrocodeine 10 1.06 (0.02 - 7.79) 0.33 0.8-1.7211
MDMA 11 0.46 (0.01 - 2.3) 0.3
CDP 9 1.65 (0.17 - 4.62) 1.2
Carbamazepine 5 9.1 (1.5 - 20.4) 9.8
Fluoxetine 2 0.12 (0.001 - 0.24)
Amphetamine 2 0.66 (0.6 - 0.71)
Other 9 Mefenamic Acid (0.56), Chloral Hydrate (14.2),
Paracetamol (145), Thioridazine (0.64), Phenytoin (2.01),
Codeine (0.01), MDA (0.01), Tramadol (0.19), Oxazepam
(1.83)
t Plus 10 cases that had only DMD and 1 case only a trace of diazepam was
identified.
* Cocaine was present in 13 cases: 9 cases with cocaine, ME and BE, 2 cases with
ME and BE, 1 case with cocaine only and 1 case with ME only
** 83 cases only THC-COOH, 18 cases THC-COOH and THC, 2 cases only THC
ng/ml++
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With respect to the levels encountered, a similar pattern exists for cases with two drugs
present as it does for the monodrug cases. That is, the levels of morphine and methadone
detected tended to be within the therapeutic ranges and the mean concentration of
diazepam and DHC were those associated with therapy, although ranged up to levels
related to toxicity and that the mean concentration for temazepam was outwith therapeutic
usage. However, the combinations of drugs mainly suggest drug misuse. The vast
majority of opiates had been taken concurrently with benzodiazepines (90%), a cocktail of
drugs favoured for many years in the West of Scotland. The concurrent use of methadone
and morphine was evident in three cases which equates to 60% of the cases where two
opiates were detected or 16% of all methadone positive cases in this group. Exposure to
cannabis was noted in 103 cases, however the active constituent, THC was noted in only
20 of these cases. Nevertheless, the majority of cases where exposure to cannabis was
confirmed involved primarily benzodiazepines but also opiates, amphetamine and MDMA.
Exposure to cocaine was noted in 13 cases and the presence of the parent drug was
confirmed in 10 of these cases, implying that the person was most probably under the
influence of the drug at the time of arrest. Whilst determining the effect that one drug may
have on a person can prove difficult, the fact that drugs are often taken in combination
suggests that in some cases, the effects of one drug may be augmented by that of another.
6.6.5.3 Three Drug Polydrug Cases (n = 160)
Benzodiazepines were found to be present in 99% (n = 158) of cases where the presence of
three drugs was confirmed. This comprised of two benzodiazepines in combination with
one other drug in 31% (n = 50) of benzodiazepine positive cases in this group. The
concurrent use of benzodiazepines and opiates accounted for 72% (n = 115) of all cases
within this group and comprised of two opiates and one benzodiazepine in 35 cases; two
benzodiazepines and one opiate in 25 cases and one of each in combination with another
drug in 55 cases. The combinations ofall160 cases are summarised in Table 37 below.
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Table 37: Combinations of drug groups in cases where three drugs were confirmed
Benzo Benzo & Benzo & Benzo Benzo Opiates
Opiates Cannabinoid & &
Cocaine Amphet
MDMA 1 1 4 2 3
Cannabinoid 24
I
41 2
Cocaine
I
10 6
Other 3 2 1
Opiate 60
Table 38 below summarises all drugs detected together with mean concentrations detected
and ranges.
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Table 38: Mean, Median and Range of Concentrations for drugs detected in cases
where the presence of three drugs was confirmed.
n Mean (Range) Median Therapeutic levels'"
mgllitre mgllitre
Diazepam 139* 0.81 (0.01 - 6.7) 0.42 0.05 - 2.0
Temazepam 57
I
2.4 (0.1 - 9.9) 1.9 0.36 - 0.85
THC-COOH 78
I
31.3 (3 - 273) 20
THe 15
I
4.2 (1-11) 4
Morphine 96 0.06 (0.01 - 0.5) 0.04 0.04 - 0.5
Methadone 38 0.13 (0.02 - 0.87) 0.09 0.05 - 1.0
Cocaine** 8 0.05 (0.007 - 0.18) 0.04
BenzoyJecgonine 18 0.49 (0.008 - 2.16) 0.195
MethyJecgonine 10 0.12 (0.02 - 0.9) 0.03
Dihydrocodeine 20 0.54 (0.01 - 5.98) 0.19 0.8 - 1.7211
MDMA 11 0.47 (0.01 - 1.4) 0.14
CDP 3 0.60 (0.41 - 0.97) 0.44
Carbamazepine 3 7.84 (1.3 - 15) 7.24
Amphetamine 4 0.25 (0.01 - 0.71) 0.14
Nitrazepam 2 0.06 (0.03 - 0.08)
I
Other 3 Paracetamol (20.9), Amitriptyline (0.33), Sodium Valproate
(44)
* Plus 8 cases where only DMD was detected
8 cases with cocaine, BE and ME; 2 cases with BE and ME; 8 cases with only BE**
Again, with respect to levels of drugs detected, and drug combinations a similar pattern
was observed as detailed above. The concurrent use of methadone and morphine was
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noted in 21 cases which equates to 57% of cases in this group with two opiates confirmed
(n = 37) or 55% of all methadone positive cases in this group.
6.6.5.4 Four Drug Polydrug Cases (n = 38)
Benzodiazepines were found to be present in 97% (n = 37) of cases in this group. Eight
cases were found to be positive for only benzodiazepines and opiates, seven of which
involved two benzodiazepines and two opiates. This duo drug group combination was also
found, together with other drugs, in 26 cases in this group (68%), 12 cases involved two
benzodiazepines, one opiate and another drug; another 10 cases involved two opiates, one
benzodiazepine and another drug and finally four cases involved one benzodiazepine, one
opiate and two other drugs. The combinations of drugs are summarised in Table 39 and
the mean, median and ranges of concentrations are shown in Table 40 below.
The concurrent use of methadone and morphine was confirmed in 11 cases and is
equivalent to 61% of cases where more than one opiate was positive and 79% of all
methadone positive cases in this group.
Table 39: Combinations of drug groups in cases where four drugs were confirmed
Benzo & Benzo & Opiate Benzodiazepine
Opiates Cannabinoid
MDMA 2
Cannabinoid 19
Cocaine 1
Other 1
Opiate 8
Cannabinoids & MDMA 1
Amphetamine & MDMA 2
Cannabinoid & Cocaine 2 1
MDMA & Cocaine 1
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Table 40: Mean, Median and Range of Concentrations for drugs detected in cases
where the presence of four drugs was confirmed,
n Mean (Range) Median Therapeutic levels'"
mgllitre mgllitre
Diazepam 33* 0.90 (0.04 - 4.29) 0.51 0.05 - 2.0
Temazepam 19 2.1 (0.08 - 9.1) 1.64 0.36 - 0.85
THC-COOH 26 37.5 (0.001 - 190) 23.5
THe 2 4 (3 - 5)
Morphine 28 0.04 (0.007 - 0.12) 0.03 0.04- 0.5
Methadone 14 0.10 (0.01- 0.26) 0.08 0.05 - 1.0
Cocaine** 2 0.02 (0.003 - 0.03)
Benzoylecgonine 4 0.05 (0.007 - 0.1) 0.05
Methylecgonine 1 0.001
Dihydrocodeine 9 0.75 (0.02 - 3.03) 0.25 0.8 - 1.7211
MDMA 6 0.22 (0.11 - 0.29) 0.24
CDP 3 0.27 (0.05 - 0.44) 0.31
Codeine 2 0.06 (0.05 - 0.07)
Amphetamine 2 0.19 (0.18 - 0.21)
Other 2 Nitrazepam (1.0), Ketamine (0.03)
**
Plus 3 cases with DMD only
1 case with cocaine and BE, 1 case with ME and BE, 1 case with cocaine only and
2 cases with BE only
*
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6.6.5.5 Five Drug Polydrug Cases (n = 6)
Each case involved a combination ofbenzodiazepines and opiates either alone (n = 1) or in
combination with other drugs (n = 5). The combinations of drugs are summarised in Table
41 and the concentrations outlined in Table 42.
Table 41: Combinations of drug groups in cases where five drugs were confirmed
Benzo & Opiates Benzo
Cannabinoid 3
Other 1
Opiate 1
Cannabinoids & MDMA 1
Table 42: Mean, Median and Range of Concentrations for drugs detected in cases
where the presence of five drugs was confirmed.
n Mean (Range) Median Therapeutic levels'"
mg/litre mg/litre
Diazepam 6 0.59 (0.13 - 1.79) 0.43 0.05 - 2.0
Temazepam 3 1.63 (1.07 - 2.0) 1.81 0.36 - 0.85
THC-COOH 4 25.5 (6 - 54) 21
THe 2 9.5 (4 - 15)
Morphine 6 0.12 (0.01 - 0.28) 0.105 0.04 - 0.5
Methadone 4 0.76 (0.01 - 2.95) 0.05 0.05 -1.0
Dihydrocodeine 5 0.22 (0.002 - 0.63) 0.13 0.8 - 1.7211
Other 2 Carbamazepine (0.85), MDMA (0.18)
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The concurrent use of methadone and morphine was confinned in four cases and is
equivalent to 67% of cases where more than one opiate was positive and 100% of all
methadone positive cases in this group.
6.6.5.6 Cannabis Levels
Tetrahydrocannabinol is the active component of cannabis and is detectable in blood up to
4 hours after consumption. It's presence at toxicology is thus indicative of recent usage.
In fact a level of between 10 - lSng/ml has been noted as an indicator of recent
consumption. Also, consumption can be estimated to have occurred within 20 - 40
minutes of the sample being obtained if similar concentrations of both THC and THC-
COOH are detected and THC-COOH when found in concentrations in excess of 40ng/ml
can be an indicator of chronic usage 317. However, over the study period, of all THC
positive cases (n = 60), the vast majority had a concentration of less than 10nglml (83%, n
= 50). Also, the THC/THC-COOH ratio in these cases averaged 0.2 and similar
concentrations, indicative of usage within the past 20-40 minutes was only noted in three
cases where an average ration of 1.23 was noted. Hence, in these three cases the levels
would suggest a high probability of intoxication. Finally, THC-COOH concentrations
detected were consistent with those found in chronic users in 28% (n = 76) of cannabis
positive cases.
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6.6.6 Drugs Found to be Positive in Urine Samples
The table below summarises drugs that were found to be positive in the 184 drug positive
urine samples submitted for analyses.
1995 1996 1997 1998 1999 2000 2001
THC-COOH 11 19 20 17 16 19 14
Morphine 12 21 17 14 19 29 18
Methadone 4 14 12 1 10 14 6
Dihydrocodeine 2 2 3 2 8 8 2
Diazepam 7 10 7 11 19 30 15
Temazepam 10 16 9 15 19 23 15
Cocaine 1 1 2 1 7 14 6
Amphetamine 4 2 5 5 6 2 1
MDMA 1 0 5 1 I 7 7
MDEA 1 0 2 0 0 0 0
Chlordiazepoxide 2 3 0 1 1 0 0
- --
Carbamazepine 1 0 0 1 1 0 1
--
Nitrazepam 1 0 1 1 0 3 0
Other* 0 2 1 2 4 7 1
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*Other Drugs
1995 1996 1997 1998 1999 2000 2001
Co-proxamol 0 1 0 0 0 2 0
Paracetamol 0 1 1 0 2 1 0
Ibuprofen 0 0 0 1 0 0 0
Amitriptyline 0 0 0 1 0 0 0
-
Citalopram 0 0 0 0 1 0 0
Trimetheprim 0 0 0 0 1 0 0
Methamphetamine 0 0 0 0 0 2 1
Prothiaden 0 0 0 0 0 1 0
Promethiazine 0 0 0 0 0 1 0
Drug positive urine cases 16 28 31 24 29 36 20
Total Drugs detected 57 90 84 72 111 156 86
Average number of drugs 3.6 3.2 2.7 3.0 3.8 4.3 4.3
per sample
The number and type of drugs detected in urine reveal similar patterns that were noted in
the blood drug positive cases. No concentrations have been noted as the presence of a drug
in urine can only be used as evidence that the person has consumed the drug. The amount
detected cannot be related to the concentration of drugs circulating in the body. However,
polydrug was prevalent and similar trends noted in the blood samples was evident.
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6.7 Discussion
The problem of increasing drug misuse amongst drivers is evident from the number of drug
positive cases investigated in the West of Scotland. Of all cases of drivers suspected of
DUrD, the results of toxicological analyses show that there is a high correlation between
police observations/suspicions and drugs confirmed. Of all samples submitted for
analyses, DUm was corroborated in 82% and 94% of the results from the blood and urine
samples respectively. On a year to year basis, this correlation varied from 71% (1996) to
93%(2001). The latter two years of the study showed the highest correlation and is
possibly a result of increased training and awareness of drug driving by police officers
through the introduction of FIT. The results of this study show that the majority of drugs
involved were those associated with misuse in the Strathclyde Police region of Scotland
and the incidence of purely medicinal drugs amongst drivers suspected of DUrD was
minimal. Benzodiazepines were the most frequently encountered legal drug group,
particularly diazepam and temazepam, a finding shared by other studies of drivers
suspected of DUID282• 284. 318. 319. This group of drugs is frequently prescribed for the
treatment of anxiety and insomnia and is the most widely used psychoactive medicine in
the world. In Scotland, the number of diazepam prescriptions per 1000 population
increased from 98 to 144 between the years 1992 and 2001108• Despite benzodiazepine use
generally increasing with age and being about twice as high among females than males'",
321 the presence ofbenzodiazepines in this study was suggestive of drug misuse particularly
since the concurrent use of benzodiazepines and opiates accounted for one half (50%) of
all polydrug cases. The most frequently encountered drug of misuse group was the
cannabinoids, which was found to be positive in approximately one-third of all drug
positive cases and is similar to fmdings in other countries 322. 323. 324. However, that said, the
majority of cases that were positive for cannabinoids were shown to contain only the
inactive carboxylic acid and therefore an indication that cannabis had been consumed in
the past. The presence of the active component of cannabis was present in only
approximately one fifth of cannabis positive cases. Opiates were the second most
frequently detected illegal drug group and primarily involved morphine, indicative of
heroin misuse and this was followed by methadone. It was not possible to ascertain
whether the methadone had been prescribed to the individual or whether it had been
obtained by the diversion of legitimate supplies. However, the concurrent use of
methadone and morphine was confirmed in approximately one third of all methadone
positive cases which suggests that even if the methadone had been prescribed, the
individual was "topping-up" their prescription with heroin and hence not complying with
the guidelines of the methadone programme. A possible reason for this may be due to sub-
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therapeutic doses being administered. Albery et al reported that illicit drug use and driving
behaviour is common among out-of treatment drug users 325. An emerging trend for the use
of stimulants was observed in this study and in particular cocaine and MDMA. Cocaine
use was also noted to have been consumed as part of a cocktail involving heroin, a mixture
that accounted for 31% of all cocaine positive cases between the years 1999 and 2001.
All these drugs have impairing effects that can be detrimental to an individuals driving
performance. Benzodiazepines for example, produce sedation when administered at low
doses and hypnosis when the dose is increased. It is these sedative effects which are
purported to be conducive to impairment of driving skills by decreasing alertness, slowing
reaction times, reducing visual function and degrading decision-making capacity 326. More
importantly they may also potentiate other eNS depressants when taken concurrently. A
higher accident risk associated with benzodiazepine use has been noted to be higher among
drivers aged less than 30 years and decrease with increasing age, it was also greater when
the breath alcohol test was positive 327. Laboratory studies have shown that diazepam, the
most commonly prescribed benzodiazepine, causes prolonged reaction times, impaired
tracking and divided attention 328. 329.
The "high" associated with cannabis use can vary a great deal depending on the user, the
surroundings the drug is taken in and the company. The use of cannabis results in co-
ordination, tracking, perception and alertness being impaired. A study carried out in
Memphis, USA in 1993 showed that of 50 subjects who screened positive for only
marijuana, 84% (n = 42) were considered to be moderately or extremely intoxicated. This
ranged from the subjects being described as "paranoid, argumentative or cocky", "co-
operative, carefree and happy" to "slow and sleepy" 330. It has also been shown that older
long-term cannabis users perform badly in short-term memory tests and divided attention
tasks associated with working memory 331. The effects of cannabis have reported to
increase variability of longitudinal (speed and headway) and lateral control (lane position),
increase decision times to evaluate a situation and hence determine an appropriate response
and cause the driver to adopt a more cautious style of driving performance. It appears that
drivers who consume cannabis retain insight in their performance and will compensate
where they can, for example, by slowing down or increasing effort 332. Another study
whereby subjects were administered with doses of cannabis varying from IOmg (low dose)
to 20mg (high dose) revealed a reduction of average speed on the motorway when both
low and high dosed participants undertook simulator tests. The high dose population were
unable to control their steering and suggests that cannabis adversely affects drivers'
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tracking ability. That said though, there was a failure to produce significant results on
various driving performance measurements when compared to alcohol which indicates that
a variability of drug effects on individuals exists with cannabis 333.
Controlled studies investigating the effects of heroin on driving impairment are impossible
due to ethical reasons of administering this drug. However, the "high" experienced with
heroin is quickly induced and leads to relaxation, euphoria and sedation. This can effect
driving performance as the individuals concentration is greatly reduced and reaction time is
therefore increased. A known physiological effect of heroin is miosis (constricted pupils)
which results in a negative influence of the eyes to accommodate darkness. Hence driving
at night would present a problem for someone under the influence of heroin.
Varying opinions as to the effects of methadone on driving performance exist in the
literature. For example, a study involving 34 methadone substitution patients who were
subjected to 10 individual performance tests to assess essential functions with regard their
driving ability, showed that they achieved rather lower results in almost all variables when
compared to a control group. However those who tested negative for the presence of any
other psychotropic substances performed better than the methadone group as a whole and
achieved practically the same results as the corresponding control group. It concluded that,
long term methadone maintenance under strict supervision does not have any significant
unfavourable impact on the driving ability 334. This finding was similar to that of Dittert et
al who, after studying 28 methadone patients concluded that in general methadone
substitution does not implicate driving inability although it was noted that the majority of
subjects showed some reduction of their psychomotor skills 335. Friedel et al, on the other
hand, noted that heroin addicts treated with methadone are generally not fit to drive.
Exceptions to this being those patients who show evidence of therapy compliance whereby
they have been in treatment for more than a year and show evidence of cessation of the
consumption of additional psychotropic substances 336. A stronger viewpoint is that any
person receiving regular methadone is ipso facto unfit to hold a drivers licence as it can be
construed as being comparable to an uncontrolled epileptic 337. It has been agreed by
experts with practical experience with methadone treatment that some patient's
psychological condition reaches a state of normality after prolonged use and that they
should be considered fit to drive. However it was also stressed that driver fitness be
checked and verified and that criteria to be applied in assessment should include length of
treatment, cessation of other psychotropic drugs, regular psychosocial therapy and
psychosocial integration 338. The present legislation in the UK with respect to driving
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whilst receiving methadone is somewhat ambiguous. In July 1996 the European Union
licence directive included drug abuse and dependency as a prescribed disability. This
means that physicians who prescribe methadone should advise their patients that the
patient has a duty to inform the DVLA that they are in receipt of treatment 339. However,
having to divulge this information may deter some individuals from seeking access to
treatment.
Cocaine, unlike the CNS depressants leads to increased alertness, self-confidence and a
loss of inhibitions, the latter two variables may be detrimental when driving as this could
lead to increased risk taking. Controlled experimental research is practically impossible
with cocaine due to ethical reasons. Although studies of the effects of cocaine on
psychomotor performance are scarce, one study showed that together with impaired
judgement of distance, volunteers partaking in co-ordination tests were shown to drive in a
considerably more aggressive manner whilst under the influence of cocaine 340. In
European countries, the prevalence of cocaine among drivers is amongst the lowest
compared with other illicit substances 341.
Methylenedioxymethylamphetamine (MDMA) has both stimulant and hallucinogenic
properties with sympathomimetic effects. The composition of the tablets is very variable
and often there are many adulterants added in the manufacturing process such as caffeine,
paracetamol, testosterone and quinine. The main effects of this drug include increased
awareness, suppression of tiredness and hunger, increased performance, rise in blood
pressure and heart beat, euphoric rushes and increased empathy between users. In
addition, it increases self-confidence. However, negative effects experienced include
muscle tension, blurred vision, nausea, confusion, apathy, hyperthermia and hallucinations.
Both these positive and negative effects would have detrimental outcomes to ones ability
to drive a motor vehicle safely. During the high there is a danger of increased self
confidence and hence risk taking, in addition users have reported the effects of MDMA as
a "separation of mind and body" 342. Physiologically, the user may have dilated pupils and
hence be sensitive to blinding light. The exhaustion and overexertion resulting from the
stimulation can also lead to impaired driving. Memory deficits 343 and elevated impulsivity
344 have been reported amongst MDMA users and various studies reviewed by Logan and
Couper revealed that reckless driving, the ability to drive being heavily compromised and
impaired judgement and decision making were all cited as detrimental effects of MDMA
consumption on driving 345.
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Most studies of the effects of a drug on the ability to drive safely have been carried out
when only that sole drug has been administered and at controlled concentrations. In
reality, among the drug using population, this practice is very seldom the case. Polydrug
use is an increasing problem in society and the effects of mixing drugs can be additive or
potentiating. The number of cases where polydrug use was confirmed was shown to
increase over the study period and the drugs detected paralleled the situation of drug
misuse in general. Polydrug use amongst drivers is not a new phenomenon and has been
reported in other countries such as Finland 346, Norway 347 and Switzerland'". However, the
concomitant use of various drugs have been reported to enhance the disruptive effects of an
individual drug or condition 348 and are often highly unpredictable leading to the inability to
drive safely. The most commonly encountered cocktail in the west of Scotland was
benzodiazepines and opiates, which has been a favoured combination in this area for some
time 79.
At present it is not possible to define a critical body fluid concentration above which all
individuals would show impairment and below which all would lack impairment. There
are also many variables that have to be taken into consideration when interpreting the
effects of a specific level of drug in an individual. These include, age, state of health, other
drugs that had been consumed and the individual's tolerance to the drug.
Drug misuse amongst the driving population is, without a doubt, a cause for concern. A
step forward in tackling the problem is to equip law enforcement agencies with the
facilities to recognise drug misuse amongst drivers, particularly those who may provide a
negative breath test but where the police officer may still suspect impairment. One such
way is the use of roadside testing devices, an avenue which has been extensively
researched by the Rosita Project (www.rosita.org) who reported their findings in 2001.
The main objectives of this research were to identify the requirements for roadside testing
equipment and to make an international comparative assessment of existing devices and
prototypes. At the time the report was published, roadside drug testing devices were being
routinely used in only two European countries, namely, Belgium and Germany. In the
Untied Kingdom, there is at present no viable device available to allow roadside testing for
drugs. Another way of facilitating officers with the ability to recognise drug misuse is by
training officers in the use of FIT. The background to FIT has been discussed above and
the following section will concentrate on a study which was used to monitor the
effectiveness of FIT in detecting impairment and differentiating between those who were
impaired through drug use and others who were not impaired.
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Even recent toxicological advances have been used in the fight against drugs and driving.
For example, the use of hair as an alternative matrix has been used in Italy as a means of
proving drug abstinence in drivers whose licence has been refused, revoked or suspended
as a result of their drug addiction 349. Hair analysis forms part of the overall process of
confirming abstinence in addition to a clinical test and urinalysis which is used to
investigate approximately 700 subjects per year 350.
6.8 Conclusion
Despite possible limitations of descriptive epidemiological studies 351, analytical
procedures in place eliminated such restrictions occurring in this study. That is, all cases
of drivers suspected of DUID in the Strathclyde region of Scotland were analysed in the
same laboratory. All matrices were subjected to a full drugs screen for both drugs of abuse
and medicinal drugs and all drugs which screened positive were confirmed.
The data presented in this section provides descriptive information regarding the frequency
of drug use amongst drivers suspected of impaired driving. It gives an indication of the
magnitude of the problem of drug misuse as well as changes in patterns and trends of drugs
experienced over the years in the West of Scotland. These changes have paralleled those
found amongst drug related deaths in the same region, the majority of which have shown to
be possibly associated with concurrent changes to legislation and clinical practices.
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6.9 Monitoring the Effectiveness of the Field Impairment Test
6.9.1 Study Design
The aim of the project was to evaluate the use of field impairment testing as a diagnostic
tool for use by police officers. This was achieved by collating data from drivers who had
participated in the field impairment test throughout Scotland. This data consisted of clues
displayed throughout the battery of tests. The clues were noted on a specially designed
form by the police officer at the time of the test. The data collected also included
toxicological results obtained from biological samples for two groups. Firstly, a blood
/urine specimen (or the laboratory report in the case of Lothian and Borders Police) was
requested in cases where, following completion of FIT by the police officer, impairment
was suspected and the police surgeon agreed that the driver's condition might have been
due to the effects of a drug(s). Cases that were drug positive were considered to be
supportive of the police and medical examiner's opinion and were treated as true positives
in the data analysis. Secondly, a saliva sample was requested in cases where the individual
completed FIT and did not show clues. This specimen was analysed to confirm that these
drivers were in fact drug free (or to detect "missed" drug-related impairment). For this
purpose, insignificant drug levels in saliva, therefore unlikely to cause impairment, were
considered to be negative. The project continued over a 24-month period from August
2001 until July 2003.
6.9.2 Force Participation
All eight police forces in Scotland agreed to participate in the project. Enthusiasm was
initially very high and in the first 6 months, the number of FIT evaluation forms received
averaged 33 forms per month. At the end of the 24-month study period, a total of 736 FIT
evaluation forms had been received. Table 43 below shows the distribution of these forms
by each force area.
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Table 43: Forms received from Scottish Police Forces
Force Area No. of forms % of Scotland
Central Scotland Police 17 2%
--
Dumfries & Galloway Constabulary 17 2%
Fife Constabulary 122 17%
- -
Grampian Police 43 6%
Lothian & Borders Police 208 29%
--
Northern Constabulary 8 1%
~
Strathclyde Police 201 27%
---
Tayside Police 120 16%
Total 736 100%
6.9.3 Demographic information
In summary, of all 736 forms received, information regarding gender and age of the ubje t
was available in 733 and 714 cases respectively. Of these, the majority involved the male
population (89%). An average age of 27 years (range 15-61 years) and 2 year (range
16-64 years) was noted for males and females respectively.
The time at which the test was started was available in 724 cases. Approximately tw -
thirds of these cases (67%, n = 488) occurred between the hours of 18 1 and 00 ( igur
51). There was no statistically significant association between the time of day rh t twa
carried out and whether impairment was suspected (i = 0.608, p = 0.43).
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Figure 51: Time of day at which field impairment test commenced
0001 - 0600hrs 0601 -1200hrs 1201 - 1800hrs 1801 - OOOOhrs
Time when FIT commenced
6.9.4 Study Sample
In 10 cases, the individual refused to carry out the FIT. The extent of refusals, however, is
unascertainable, as there may have been a failure to send forms in some instances, despit
initial requests made to the police asking them to submit a form for every individual who
was asked to participate regardless of the outcome. Therefore a decision as to the pr en e
or absence of impairment could only be made in 726 cases. The majority wer found to be
unimpaired (58%, n = 419) and in the remaining 42% (n = 307), th p ffi er
suspected impairment. A breakdown of cases is summarised in Figure 54.
6.9.4.1 Cases Where Individual was Judged to be Impaired at the Road ide (n = 307)
A biological sample was received in the laboratory in only 51% (n = 15 ) of all impair d
cases. Of the remaining 149 cases, the police surgeon disagreed with th polie offie r that
the effects exhibited may be due to the effects of drugs in 66 cases and in a further
a medical condition was confirmed. No biological sample was obtained in 35 ea and
finally although a sample was obtained in the remaining 40 cases, it wa not sent to th
laboratory for analyses. This is summarised in Table 44 below.
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Table 44: Samples not submitted to the laboratory
Reason why no sample submitted to laboratory No. of samples
Police surgeon disagreed with police officer 74
Sample taken but never sent to laboratory 33*
Subject refused to provide a sample / No consent obtained 30**
-
Drink/Driving procedure pursued 4*
--
No vein located therefore unable to obtain blood 3**
Subject died of a drugs overdose prior to sending sample 2*
Insufficient evidence to prosecute 1**
No police surgeon available 1**
Sent to wrong laboratory, sample never retrieved 1*
Total 149
* denotes those where a sample was taken although never submitted for analyses
denotes cases where no sample was obtained**
6.9.4.2 Cases Where Individual was Judged to be Unimpaired at the Roadside (n =
419)
The DRE form indicated that the individual refused to donate a saliva sample in 104 cases
(25%). In a further 211 cases (50%) it was not known if a saliva sample had been
requested, due to the absence of the DRE form. Consequently, a total of 104 saliva
samples were received from all eight force areas (25%). However, 20 of these samples
were not matched to the FIT paperwork as the DRE form had been sent in the envelope
with the saliva sample. The unimpaired population therefore consisted of the 84 saliva
samples for which analytical results were available.
6.9.4.3 Nature and extent of drug usage observed
Of the 158 samples submitted to the laboratory from impaired drivers, 89% (n = 140) were
blood and 11% (n = 18) were urine. Unfortunately in 9 cases involving blood, there was
an insufficient quantity of sample to allow analyses.
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In 7 cases, there were no drugs detected. Of the remaining 124 blood samples, polydrug
use was evident in 65% (n = 80) of cases comprising the presence of two, three or four
drugs in 45, 29 and six cases respectively. In total, 245 drugs were detected amongst all
blood samples. Figure 52 below shows all drugs detected in drug positive samples.
Figure 52: Frequency of drugs detected in blood drug positive cases
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Table 45 below shows the mean, median and ranges of drug concentrations detected in all
drug positive cases.
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Table 45: Drug concentrations detected in blood samples
Drug n Mean Median Range Therapeutic 352
Diazepam 97 0.92 0.7 (0.02 - 5.5) 0.05 - 2.0
Morphine 43 0.05 0.05 (0.002 - 0.12) 0.04 - 0.5
THC 16 4.3 4.0 (0.1 - 13)
THC-COOH 36 35.3 27.5 (4 - 121)
Cocaine 5 0.06 0.09 (0.01 - 0.1)
Benzoylecgonine 15 0.42 0.2 (0.01 - 1.44)
Methylecgonine 6 0.05 0.05 (0.03 - 0.08)
Methadone 13 0.16 0.1 (0.02 - 0.38) 0.05 - 1.0
Dihydrocodeine 13 0.15 0.07 (0.01 - 1.0) 0.8 - 17
Temazepam 9 1.8 1.5 (0.02 - 4.94) 0.36 - 0.85
MDMA 8 0.33 0.2 (0.01 - 1.25)
Amphetamine 4 0.89 0.93 (0.23 - 1.47)
Nitrazepam 2 0.24 0.24 (0.01 - 0.48)
Tramadol 1 0.19
Oxazepam 1 1.83
Fluoxetine 1 0.04
Codeine 1 0.007
MDEA 1 0.02
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(ii) Monodrug Cases
The presence of one drug was detected in 44 cases and this was primarily diazepam (59%.
n = 26). A mean concentration of 1.06mg of diazepam per litre blood was detected ranging
from 0.2 - 2.67mgllitre, approaching levels associated with toxicity. Morphine, indicative
of heroin misuse was noted in five cases and a mean morphine concentration of
0.05mgllitre was measured. In two cases the presence of 6-monoacetylmorphine (6-
MAM) was also detected which suggested recent usage. There were two cases that tested
positive for temazepam and in one case a therapeutic level of 0.02mgllitre was recorded,
however in the other a level of 2.1mgllitre was noted which is potentially toxic. Although
cocaine use was confirmed in three cases by the presence of the inactive metabolites,
cocaine itself was detected in only one instance. Use of cannabis was confirmed in seven
cases, however the presence of the active component, THC, was noted in only one case.
Finally there was one case where MDMA was detected at a level ofO.Olmgllitre.
(iii) Polydrug cases
Polydrug use was confirmed in 80 cases and involved primarily diazepam which had been
taken concurrently with at least one other drug (89%, n = 71). A mean concentration of
0.87mgllitre was detected, ranging from 0.02 - 5.5mgllitre, the upper scale of which is
associated with toxicity. Temazepam was found in seven cases where a mean
concentration of 1.98mgllitre was detected, ranging from 0.05 - 4.94mgllitre, both the
mean and upper range are potentially toxic. Morphine, indicative of heroin usage was
detected in 38 cases, however the presence of 6-MAM was confirmed in only five of these
cases. Cannabis use was detected in 29 cases, the presence of THC was confirmed in 42%
(n = 15) of these cases. Cocaine use was detected in 12 cases, although the parent drug
was only confirmed in four of these cases. The remaining prescribed drugs all fell within
the therapeutic ranges, however, the drug combinations detected were similar to those
found amongst drug related deaths in the West of Scotland 79. The benzodiazepine and
opiate cocktail was found in over one half of polydrug cases (64%, n = 51). Of these, an
additional drug group was present in 15 cases notably cannabinoids (n = 10), cocaine (n =
4) or MDMA (n = 1). Table 46 shows the various cocktails of drug groups detected in the
blood samples.
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Table 46: Drug combinations in the blood of polydrug users
Drug combination n % of polydrug cases
Benzodiazepines & Opiates 36 45%
Benzodiazepines & Cannabinoids 12 15%
Benzodiazepines, Opiates & Cannabinoids 10 13%
Benzodiazepines, Opiates & Cocaine 4 5%
Benzodiazepines, Cannabinoids & Cocaine 3 4%
Benzodiazepines & Cocaine 2 2%
Benzodiazepines 2 2%
Benzodiazepines, Cocaine & MDMA 1
Benzodiazepines, Amphetamine & MDMA 1
Benzodiazepines, Amphetamine & Cocaine 1
Benzodiazepines, Cannabinoids & MDMA 1
Benzodiazepines, Opiates & MDMA 1
Benzodiazepines, Cannabinoids, Cocaine & MDMA 1 > 14%
----
Opiates, Cannabinoids & Amphetamine 1
Opiates & Tricyclic depressant 1
Opiates &MDMA 1
--
Cannabinoids & MDMA 1
Amphetamines & MDMA 1
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(v) Completed Urine Samples (n = 18)
Polydrug use was confirmed in all 18 urine samples, ranging from two drugs up to seven
drugs. The drugs found to be positive are detailed in Figure 53 below.
Figure 53: Frequency of drugs detected in urine drug positive cases
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The detection of drugs in urine provides evidence that the person has consumed the drug
and does not relate to the concentration of drugs circulating in the body at the time when
the urine sample was collected, and therefore cannot be used to infer impairment.
However, Table 47 shows the mean, median and range of concentrations of drugs detected.
The concurrent use ofbenzodiazepines and opiates was confirmed in all 18 urine samples.
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Table 47: Drug concentrations detected in urine samples
Concentration (mg/l)
Drug n Mean Median Range
Morphine 18 16 8.6 0.17 - 50.0
Diazepam 16 0.12 0.13 0.02 - 0.35
THC-COOH 13 253.1 180.0 35 - 581
Methadone 11 2.9 3.19 0.19 - 8.0
Temazepam 11 35.5 0.56 0.02 - 371.9
Cocaine 11 0.28 0.08 0.7 - 0.71
Benzoylecgonine 5 13.0 2.19 0.002 - 58.2
Methylecgonine 5 2.2 0.41 0.12-9.3
Dihydrocodeine 5 24.7 2.2 0.18 - 99.0)
Amphetamine 3 10.3 3.64 0.03 - 27.4
Nitrazepam 1 Not available
MDMA 1 0.05
MDA 1 0.04
Promethazine 1 0.96
Tramadol 1 0.26
Fluoxetine 1 0.26
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(vi) Completed Saliva Samples (n = 84)
Of all saliva samples obtained from individuals where no impairment was suspected, 81%
(n = 68) were found to be drug positive. Polydrug use was found in 47 cases (69% of drug
positive cases). The presence of 2, 3, or 4 drugs was shown in 21, 13 and 11 cases
respectively. The remaining two cases each tested positive for five and six drugs. A total
of 157 drug positive results was detected in the 68 drug positive saliva samples. Figure 54
shows all the drugs detected in the drug positive samples and Table 48 shows
concentrations measured.
Figure 54: Frequency of drugs detected in saliva samples
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Table 48: Drug concentrations detected in saliva samples
Drugs and Driving
Concentration (mg/l)
Drug n Mean Median Range
Morphine 34 4.04 0.86 0.04 - 77.1
THC** 30 2.42 0.28 0.01- 49.3
Methadone 21 1.13 0.09 0.025 - 16.7
Cocaine 13 0.83 0.33 0.007 - 2.9
Diazepam 12 2.32 0.74 0.107 - 14.0
Norbuprenorphine 12 0.06 0.03 0.001 - 0.169
Amphetamine 10 13.07 2.1 0.325 - 97.09
MDMA 7 6.93 3.3 0.56 - 29.1
Dihydrocodeine 6 1.37 0.54 0.097 - 4.8
Codeine 3 29.5 0.758 0.655 - 87.2
Fluoxetine 2 0.048 0.048 0.006 - 0.09
Desipramine 1 0.316
Imipramine 1 0.049
Cyc1izine 1 0.033
6-MAM 1 0.01
Methamphetamine 1 0.21
MDA 1 0.48
Tramadol 1 0.116
** Results III ng/ml.
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(vii) Monodrug groups detected (n = 21)
Tetrahydrocannabinol (THC) was detected in the majority of cases involving the presence
of one drug (13 cases, 62%) and was followed by opiates which were detected in 5 cases
(24%). The presence of cocaine, MDMA and an anti-depressant accounted for the
remaining 3 cases.
(viii) Polydrug drug groups (n = 47)
The combinations of drugs detected in saliva samples differed from those detected in blood
samples in that the most frequently detected drugs were the opiates, which were found
either alone or in combination with other drugs in 9 and 29 cases respectively (19% and
62% of polydrug cases respectively). The opiates and benzodiazepine cocktail was
confirmed in 10 cases (34% of cases where opiates had been taken concurrently with
another drug group). Opiates had been used with cocaine in 10 cases. Of these, an
additional drug group was present in 4 cases. The drugs detected were MDMA (2 cases),
diazepam (1 case) or amphetamine (1 case). THC was detected with stimulants in 7 cases
(15% of polydrug cases). Table 49 shows the drug combinations detected in saliva
samples collected in Scotland.
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Table 49: Drug combinations detected in saliva samples
Combination Cases % of polydrug cases
Opiates 9 19.1%
-----
Opiates & Cannabinoids 6 12.7%
-
Opiates & Cocaine 6 12.7%
--
Opiates & Benzodiazepines 4 8.5%
Opiates, Benzodiazepines & Cannabinoids 2 4.2%
Opiates, Cocaine & MDMA 2 4.2%
Opiates, Benzodiazepines & Cocaine 1 2.15%
Opiates, Benzodiazepines & Cyclizine 1 2.15%
Opiates & Anti-depressants 1 2.15%
Opiates, Amphetamine & MDMA 1 2.15%
Opiates, Benzodiazepines, Cannabinoids & Amphetamine 1 2.15%
Opiates & MDMA 1 2.15%
Opiates, Amphetamine & MDMA 1 2.15%
- --Opiates, Cocaine & Amphetamine ] 2.15%
-----
Opiates, Cannabinoids, Benzodiazepines & Anti-depressants 1 2.15%
- - - -Cannabinoids & Amphetamine 2 4.2%
- -Cannabinoids, Benzodiazepines & Amphetamine 1 2.15%
--Cannabinoids & Cocaine 1 2.15% -_._
Cannabinoids & Methamphetamine 1 2.15%
-- --
Cannabinoids & MDMA 1 2.15%
-------
Cannabinoids, Cocaine & Amphetamine 1 2.15%
---
Benzodiazepines, Amphetamine & Methamphetamine I 2.15%
- --
Amphetamine & Anti-depressants 1 2.15%
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6.9.4.4 Summary
Benzodiazepines were the most frequently encountered drugs, a finding shared by other
studies of drivers suspected of DUID282, 284,318,319.Opiates were the second most frequently
detected drug group and involved primarily morphine, indicative of heroin use, followed
by methadone. It was not possible to ascertain whether methadone had been prescribed in
the majority of methadone positive cases. Its concurrent use with heroin was confirmed in
56% (n = 10) of urine polydrug cases and in 38% (n = 5) of methadone positive blood
cases. This is suggestive of either the illicit use of methadone or of a driver who was
prescribed methadone "topping-up" with heroin. The next most frequently detected drug
group was the cannabinoids; however the presence of the active component, THe, was
confirmed in only 44% of all cases where cannabis was present. This is in contrast to other
studies where the most frequently detected drug was cannabis'P?".
Polydrug use was evident amongst drivers suspected of DUID in Scotland. This is in
common with studies reported in other countries such as Finland,346 Norway'? and
Switzerland 283.The concomitant use of various drugs has been reported to enhance the
impairing effects of an individual drug or condition 348and hence can be detrimental to the
ability to drive safely. The most commonly encountered cocktail was that of
benzodiazepines and opiates, which is also a favoured combination in the West of Scotland
209. This combination of drugs was found either alone or with other drugs in 64% and
100% of blood and urine polydrug samples respectively.
In general, the drugs detected in this study for Scotland as a whole, were similar to those
recorded in the latter years of the study in the Strathclyde Police region alone in that
benzodiazepines were the most frequently detected drug group which was followed by
opiates and cannabis.
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Figure 55: Breakdown of cases received from Scottish Police Forces
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6.10 Statistical Summary of Field Impairment Testing Procedure
A blood or urine sample was obtained and analysed for 149 individuals who were
suspected to be impaired and a saliva sample was obtained and analysed for 84 individuals
who were suspected to be not impaired.
6.10.1Scotland (n = 233)
True Positive TP 142 61% No. of blood and urine samples obtained from
suspected impaired persons that were found to be
drug positive
--
False Positive FP 7 3% No. of blood and urine samples obtained from
suspected impaired persons that were found to be
drug negative
True Negative TN 16 7% No. of saliva samples obtained from suspected
unimpaired persons that were found to be drug
negative
False Negative FN 68 29% No. of saliva samples obtained from suspected
unimpaired persons that were found to be drug
positive
Sensitivity [TPx 1001(TP+FN)] 68%
Specificity [TNx1 OO/(TN+FP)] 70%
Positive Predictive Value [TPx 100/(TP+FP)] 95%
Negative Predictive Value [TNxlOO/(FN+TN)] 19%
Accuracy [(TP+TN) x 1OO/(TP+TN+FP+ FN)] 68%
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6.11 The Pupillary Examination
Aim: To examine the pupils of the eyes in order to determine if constriction or dilatation
is present. This may give an indication that drugs such as opiates, which are known to
cause pupil constriction, or cannabis, hallucinogens or stimulants which are known to
cause pupil dilatation may be present. Therefore the purpose was to evaluate the number
of cases where drugs detected corresponded with an effect on pupil size. A pupil size of
between 3 and 6.5mm in diameter was considered to be normal.
TP cases where pupil size was either <3mm or >6.5mm and drugs known to cause
constriction or dilatation were present respectively
FP cases where pupil size was either <3mm or >6.5mm and drugs known to cause
constriction or dilatation were absent respectively
TN cases where pupil size was >=3mm and <=6.5mm and drugs known to cause
dilation or constriction were absent
FN cases where pupil size was >=3mm and <=6.5mm and drugs known to cause
dilatation or constriction were present
This test was completed in 229 cases (98%) out of the 233 total included in the study. In
the remaining four cases, the test was not carried out in three cases due to lighting
restrictions and in the remaining case because the individual complained of having a sore
head and was unable to keep his eyes open.
Table 50: Pupil size recorded by police, Scotland
Pupillary size FIT outcome
Eye 1 Eye2 Impaired Not impaired Total
Constricted Constricted 52 22 74
- -- -
Dilated Dilated 29 14 43
- - -Normal Normal 56 43 99
- -- -
Normal Constricted 11 0 1 1
- 1----
Dilated Normal 0 2 2
Total 148 81 229
Both pupils were considered to be of normal size in 99 cases (43% of cases in which the
test was completed) and these included 56 (38%) and 43 (53%) of the impaired and not
impaired cases respectively. However, drugs which are suspected to cause dilatation (i.e.
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stimulants, hallucinogens, cannabis) or constriction of the pupils (i.e. opiates) were present
in 70 of the cases (71%) with normal pupil sizes.
Table 51: Pupillary Examination Overall Statistical Summary, Scotland
Drugs causing constriction / dilatation Row Total
Present Absent
Pupils constricted or dilated 80 50 130
- - -
Pupils normal 70 29 99
Column Total 150 79 229
Sensitivity [TPx 1001(TP+ FN)] 53%
Specificity [TNxlOO/(TN+FP)] 37%
Positive Predictive Value [TPx1 OO/(TP+FP)] 61%
Negative Predictive Value [TNxlOO/(FN+TN)] 29%
Accuracy [(TP+ TN) x 1OO/(TP+TN+FP+FN)] 48%
..
6.11.1 Summary
It is difficult to obtain reproducible conditions for this test in the field. Local variation in
lighting conditions are outwith the control of the police officer. Overall, the accuracy of
the pupillary examination in identifying subjects correctly was low. The sensitivity (53%)
showed that, of all drivers who tested positive for a drug known to cause con triction or
dilatation, the relevant signs were exhibited in only just over one half f the c e.
Similarly, the specificity (37%) showed that in the majority of cases clue w re exhibited
even when no drugs known to cause constriction or dilatation were pr sent. Th e re ult
demonstrate that this test added little to the overall predictive value of the field impairment
test.
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6.12 The Romberg Test
The performance phase can be broken down into the ability to stand as instructed and the
ability to estimate the passage of 30 seconds as instructed. If the passage of 30 seconds is
estimated to be less than 20 seconds, this may be indicative of a stimulant type drug
whereas if it is greater than 40 seconds it may be indicative of a eNS d pressant or
hallucinogen.
The test was attempted by 233 subjects. It was completed by 98% (n = 229) of the drivers.
For the remainder, in three cases, the driver was unable to comply with the instruction and
in the fourth case the test was aborted for safety reasons as the driver was swaying
excessively.
A clue was displayed if the driver was seen to sway, step, raise arm(s), raise their head,
open their eyes and/or was unable to estimate the passage of 30 seconds within the pre-set
limits.
(1) Clues whilst standing
Drugs Present All Negative Total
"0 Yes 94 8 102
QJ -....
Cl> = No 112 15 127-QJ Q.,= Cl>- .• Total 106 23 229u Q
(2) Clues whilst standing plus internal body clock
Drugs Present All Negative Total
"0 Yes 120 13 133
QJ -_....
Cl> = No 86 10 96-QJ Q.,= Cl>0 .• Total 206 23 229Q
210
Drug and Driving
Table 52: Overall Statistical Analysis for the Performance Phase of the Romberg Test
Balance Balance clues
clues & Internal
Clock
Sensitivity [TPx1 OO/(TP+FN)] 46% 58%
Specificity [TNx1 OO/(TN+FP)] 65% 43%
-
Positive Predictive Value [TPxl00/(TP+FP)] 92% 90%
t.,
Negative Predictive Value [TNxl00/(FN+TN)] 12% 10%
- -
Accuracy [(TP+ TN)x 1OO/(TP+TN+FP+ FN)] 48% 57%
Drugs found to be positive in those cases where the passage of 30 seconds was estimated to
be either less than 20 seconds (indicative of a stimulant type drug) or greater than 40
seconds (indicative of a CNS depressant) are summarised below:
Drivers estimating time at less than 20 seconds (n = 41)
Of the 41 cases where the driver estimated the passage of 30 seconds to be Ie than 20
seconds, no drugs were found in 8 cases (20%) and stimulants were found to be pre ent in
11 cases (27%) with the remaining 22 cases involving CNS depre ant and/or
cannabinoids. The stimulant positive cases are tabulated below:
Stimulant No. of cases Concurrently with ..
Amphetamine 1 I x CNS Depre ant
Cocaine metabolites 3 3 x CNS Depre ant
--
Cocaine 2 I x CNS Depre ant
MDMA & Cocaine 2 2 x CNS Depr ant
-
MDMA 2 2 x CNS Depre ant
-
Amphetamine & Cocaine 1 1 x CNS Depr ant
Drivers estimating time at more than 40 seconds (n = 27)
In this group, only one case was found to be negative for drugs. Of the remaining 26
cases, 25 were found to be positive for CNS depressants (primarily benzodiaz pine and
opiates) and one case was positive for MDMA.
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6.12.1 Summary
Overall, the accuracy of the test was higher when both balance and time estimation clues
were taken into consideration. The sensitivity during this performance stage was higher
than specificity (58% versus 43%). This shows that the majority of drug positive cases
displayed one or more clues whereas just over half of the drug negative cases displayed
clues. A high PPV was obtained, illustrating that the majority of cases displaying clues
were positive for drugs. The low NPV showed that, despite showing no clues, a large
proportion of drivers were found to be positive for drugs. This shows that the predictive
value of the test in identifying drug negative subjects is poor, since drivers shown to be
drug positive are able to carry out the test in a satisfactory manner, possibly as a result of
their personal tolerance to the drug(s).
There was no correlation between the estimation of 30 seconds to be outwith the accepted
time range (20 - 40 seconds) and the presence of drugs which might be expected to induce
this effect. This could be due, in the majority of these cases, to polydrug use involving
both stimulants and eNS depressants. In these instances, the pharmacological effects of
drug combinations are usually unpredictable and one type of drug may cancel out the
effects of another, i.e. the drugs behave as agonist/antagonist combinations.
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6.13 The Walk and Turn Test
This test was completed in 97% (n = 227) of the study sample cases. Of the remaining ix
cases, four drivers were unable to comply with the instructions, one individual r fus d to
continue with the FIT and in the last case the form relating to the walk and turn le t wa
missing from the paperwork.
A clue was displayed if during the test: the individual stopped walking, missed heel/toe,
raised arms, stepped off the line, did not turn as instructed, did not count out loud a
instructed and/or did not take nine steps in each direction
(1) Walking in a line
Drugs Present All Negative Total
-e Yes 142 9 151~ --...
Cl> = No 63 13 76~ c..= Cl>- .- Total 205 22 227U Q
(2) Walking in a line and turning
Drugs Present All Negative Total
"0 Yes 172 14 186~ ~--... --
Cl> = No 33 8 41-~ Q..= Cl>- .- Total 205 22 227u Q
.. - ~~
(3) Walking in a line, turning and counting
Drugs Present All Negative Total
~ Yes 178 15 193~... - -
Cl> = No 27 7 4-~ Q..= Cl>U S Total 205 22 227
(4) Walking in a line, turning, counting and number of steps
Drugs Present All Negative Total
~ Yes 181 15 196~... --
Cl> = No 24 7 31~ c..= Cl>- S Total 205 22 227U
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Table 53: Overall Statistical Analysis of the Performance Stage of the Walk and Turn
Test
Walking Walking Walking, Walking, turning,
only and turning and counting and
turning counting correct no. of steps
Sensitivity 69% 84% 87% 88%
l-
Specificity 59% 36% 32% 32%
- I-
Positive Predictive Value 94% 92% 92% 92%
Negative Predictive Value 17% 20% 21% 23%
Accuracy 68% 79% 81% 83%
-
6.13.1 Summary
The sensitivity of this test was seen to increase as more tasks were added, meaning that
more and more drug positive drivers displayed clues and were correct Iy identi fied.
Simultaneously, the specificity decreased, meaning that more drivers who w re drug
negative also displayed clues. Taking the clues exhibited during the walking ta k al ne
shows that the sensitivity and specificity are moderately high. The addition of ta k~, hen e
making the test more difficult, will obviously detect more of those driver wh are under
the influence of a drug. However it should be noted that those who were drug free al
found the test more difficult and displayed clues. The positive predictive value wa high
throughout, meaning that approximately 90% of drivers di playing clue were dru
positive. The overall accuracy of this particular test was the highe t encountered f all the
tests so far.
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6.14 The One Leg Stand
This test was completed in 96% (n = 223) of the study sample. In the remaining 10 ca e
the individual was unable to comply with the instructions (two cases), was stopped f r
safety reasons due to the inability to balance properly (six cases), refused to comply with
the test (one case) or refused to complete the test as a result of being bored with the pro es
(one case).
A clue was displayed if, during the test, the individual swayed, hopped, put a foot down,
raised his/her arms and/or did not count as instructed.
(1) Standing on one leg
Drugs Present All Negative Total
't:I Yes 167 9 176~ .~.;;...
"" cc No 35 12 47~ Q.= "" 223- .- Total 202 21U ~
(2) Standing on one leg and counting
..
Drugs Present All Negative Total
'C Yes 175 10 185~;;...
3""
cc No 27 11-~ Cl.= ""- .• Total 202 21 223U ~
Table 54: Overall Statistical Analysis for the Performance Pha e of th
Test
..
Standing on one leg Standing on ODeleg and
counting
Sensitivity 83% 87%
Specificity 57% 52%
Positive Predictive Value 95% 5%
.~
Negative Predictive Value 26% 29%
Accuracy 80% 3%
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6.14.1 Summary
The sensitivity for one leg stand task was high, showing that a high proportion of driver
who were found to be drug positive also displayed clues and this increased slightly when
the second task (counting) was taken into account. The specificity wa moderat
indicating that most drug-free subjects did not show any clues. However, this d crea d
slightly with the addition of the second task. It should be noted that this increa e wa du
to only one individual. The accuracy of this test was high showing that approximately
eight out often subjects were correctly identified.
6.15 The Finger to Nose Test
This test was completed in 98% (n = 229) of the study sample cases. In the remaining four
cases the individual was unable to carry out the test (three cases) or the te t wa n l d n
due to adverse weather conditions (one case).
A clue was displayed if, during the test, the individual was unable to touch hi !her n c a
instructed and/or swayed, stepped, raised arms, raised head, opened eye whil t tanding.
(1) Unable to touch nose as instructed
~
Drugs Present All Negative Total
"C Yes 150 12 162~;,. I--
Cl) = No 56 11. 7-~ c.= Cl)- Q Total 206 23 229U
(2) Unable to touch nose and stand as instructed
Drugs Present All Negative Total
"C Yes 155 12 167~;,.
Cl) = No 51 11 2-~ c.= CIJ- .• Total 206 23 229U ~
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Table 55: Overall Statistical Analysis for the Performance Phase of the Finger to No e
Test
Clues associated with Clues associated with
touching nose touching nose and standing
as instructed
Sensitivity 73% 75%
--Specificity 48% 48%
--
Positive Predictive Value 93% 93%
- -Negative Predictive Value 16% 18%
- -Accuracy 70% 72%
6.15.1 Summary
The sensitivity for this test was high showing that a high proportion of drug po iti e
drivers also displayed clues and the sensitivity increased slightly when both task were
taken into account. The specificity showed that, amongst drivers who were drug free,
approximately one half did not show any clues and one half did display clue. Overall the
diagnostic accuracy of this test was good in that high proportions of true po itivc and tru
negative cases were correctly identified.
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Figure 56: Summary of Statistical Analyses for Each Test
The Pupillary Test The Romberg Test
The Walk and Turn test The One Leg Stand Test
Figure 57: Sensitivity and Specificity of Each Test
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6.15.2 Statistical Evaluation
Statistical methods can be used to compare the reliability of diagnostic tests such as those
in the field impairment test. One of these methods uses the Youden Index'? which is given
by:
You den Index (J) = sensitivity + specificity-1
The index ranges from a value of 1 for a perfect test to 0 where the test has no diagnostic
value. The Youden Index for FIT as a whole and for the individual tests are given below:
Table 56: Youden Indices for FIT and tbe individual tests
Test Scotland
FIT overall 0.38
Pupillary -0.1
-----~--
Romberg 0.01
Walk and Turn 0.20
One Leg Stand 0.39
1--------- ---------------
Finger to Nose 0.23
The FIT as a whole has a J-value of 0.38 which is similar to the J-value for the One Leg
Stand. This indicates that a reduced set of tests might give the same degree of sensitivity
and specificity as FIT. The indices given in the table are lower than would be desirable for
a diagnostic test. However, this type of statistical evaluation as a measure of a test's
efficiency was primarily developed for medical diagnostic tests, which require a higher
level of accuracy than might be acceptable for the purpose of driver screening. For
example, a higher proportion of false positives and false negatives in FIT will not have the
same effect as if it were screening for a disease state. There is no internationally
recognised threshold for an acceptable test index for which a diagnostic test can be
approved. In addition, the influence of population sample size and characteristics,
incidence of the condition being tested (impairment), lack of knowledge concerning
normal population performance in the test and the uncertainty in relationships between
drug concentrations and impairment affect the usefulness of an Index Score. At present,
FIT is best evaluated on the basis of the parameters given earlier (sensitivity, specificity
etc.). Validation of a scoring system/index is required to establish its usefulness in this
context. However, in order for this to be achieved the performance of individuals from a
control group must first be established.
219
Drugs and Driving
6.16 Drug Recognition Skills
From the 158 cases where impairment was suspected and a sample had been analysed,
information about the drug(s) suspected by the police officer was available for 75 cases
(47%). This information was provided from the DRE sheet:
Hallucinogens 0 Inhalants 0
CNS Depressants 0 CNS Stimulants 0
PolydrugUse 0 Unknown 0
Drug groups suspected:
Opiates 0 Cannabis 0
Figures 58 and 59 summarise the performance of police officers with respect to their drug
recognition skills. Overall, drug use was confirmed in 92% (n = 69) of the 75 cases where
impairment was suspected. In 68 cases, the police officer had noted the drug they
suspected was causing the condition and of these, 69% (n = 47) were correctly confirmed
by toxicological investigations, either wholly or partially. This suggests that the DRE
skills of police officers are generally good. Drugs tentatively identified by the police
officer were confirmed in 30 out of the 45 cases in which a single drug was suspected.
Within these 30 cases, 24 tested positive for another drug group which had not been
suspected. Polydrug use was confirmed in 19 out of 30 cases in which polydrug use was
suspected. Of these 19 cases, specific drugs were mentioned in 16 cases and toxicology
confirmed the presence of all or some of the suspected drugs in 9 and 6 cases respectively.
In the remaining case, drugs were detected which had not been suspected.
This shows that drug use was confirmed in the majority of cases where impairment was
suspected. Drug class decisions were also consistent with results of toxicological
investigations, either partially or wholly, in approximately two-thirds of cases. This
suggests that the DRE skills of police officers in Scotland are generally good. The
implementation of refresher courses may aid the officers with their DRE skills and
encourage them to utilise them.
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Figure 58: Cases where a single drug group was suspected to be causing impairment
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Figure 59:
impairment
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6.17 Discussion
Despite the collation of 736 FIT evaluation forms, a biological sample was received in
only 32% (n = 233) of these cases allowing for the evaluation of the effectiveness of FIT
with respect to diagnosing impairment. In the majority of cases where no impairment was
suspected, a saliva sample had not been obtained. Due to erroneous delivery of
documentation, it was not possible to establish whether the driver had refused to provide a
sample or whether they were not asked to donate a saliva sample. Unfortunately, a
biological sample was not received in a large number of cases whereby the police surgeon
did not suspect the condition exhibited was due to the effect of a drug(s). This population
remains a concern as it could be that the effects of drugs may have worn off between time
of arrest and clinical examination. A study showed that, generally, the police surgeon
arrives at the station within 30 minutes of being requested by police to attend but that this
could be greatly extended if a police surgeon was not available and the time lag was
reported to be up to 3 hours 354. This study also showed that the time delay between a
blood sample being obtained and the time that the driver was observed driving could be as
mush as 7 hours. These time delays are sufficient for the effects of some drugs to wear off.
Drugs were found to be positive in 95% of all cases where impairment was suspected. The
most frequently detected drugs were diazepam, morphine and cannabis. Polydrug use was
evident in approximately two thirds of cases, primarily involving the concurrent use of
benzodiazepines and opiates, a cocktail favoured among drug users in Scotland. It is not
possible to infer the specific effects that drug levels measured would have on each
particular driver but what is of interest is that the types and levels of drugs detected are
indicative of drugs being misused. It is improbable that an impairing effect would result in
the cases involving only cocaine and cannabis, in the absence of the active component of
the drug. However, THe has a very short plasma half-life and is undetectable after
approximately four hours of consumption. This time interval may easily pass before a
police surgeon is contacted and arrives at the police station. Drugs were present in 81% of
drivers who were thought to be unimpaired by the police officer. Polydrug use was evident
in approximately two thirds of saliva samples. The most frequently detected drugs in
saliva samples were morphine and cannabis.
The overall analysis showed that that the use of FIT when dealing with the drugged driver
is effective. This was demonstrated by the sensitivity (proportion of drug positive drivers
who were suspected to be impaired) and the specificity (proportion of drug negative
drivers who were suspected to be not impaired), which were both found to be moderate.
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This shows that satisfactory proportions of true positive cases were identified. A high
positive predictive value was also noted and overall, the accuracy of FIT showed that
approximately seven out of ten individuals were correctly identified.
When evaluating the tests individually, there was no information available on whether or
not the driver had passed or failed anyone particular test. This would be contrary to the
ethos of FIT, whereby a decision on impairment is concluded on the totality of the tests.
Therefore, individual tests were evaluated on clues which had been displayed and whether
or not drugs were present.
Inclusion of more tasks in the tests resulted in the possibility of more clues being
displayed. This in turn resulted in more drug positive drivers displaying clues. However,
simultaneously a higher proportion of drug free drivers displayed clues. The normal FIT
performance for an unimpaired population has yet to be determined but it is likely to
exhibit some clues. In order for a "measurement" of impairment to be established, the
performance of known drug free individuals in FIT must be evaluated.
The sensitivity of the individual tests ranged from 53% for the pupillary examination to
88% for the walk and turn test. While there is no standard to which these tests must
conform, these results would be unsatisfactory if obtained for a medical diagnostic test,
which typically would require sensitivity and specificity to be above 90%. For a field test,
these results were acceptable in that a high proportion of true positive cases were identified
by the use of FIT. However, the specificities were lower, showing that a significant
proportion of drug-free/unimpaired drivers also displayed clues, underlying the future need
to characterise the population norm for these tests. The negative predictive values were
also low. As the aim of FIT is to identify impairment, it is possible that drug positive
drivers who were ''not impaired" were sufficiently tolerant to the effects of the drug(s)
present to avoid showing clues, the presence of a drug in the system does not necessarily
infer impairment. It is also true that FIT comprises only one factor of a series of events
which leads to the police officers decision on impairment. Within the battery of tests, the
Walk and Turn test and the One Leg Stand test were the most effective. A lack of
correlation between drugs detected and pupil size illustrates that the pupillary examination
contributed very little to FIT.
From the 158 drivers where impairment was suspected, information as to the drugs
suspected to be causing impairment was available in just under one half of these cases
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(47%, n = 75). The drug recognition skills of the police officers were very good. Drug
use was confirmed in 92% of cases where this information was available. The drugs
consumed were correctly identified either wholly or partially in 69% of cases.
6.18 Conclusion
Driving under the influence of drugs is without a doubt an increasing problem in society
and may only be reduced by a multi-disciplinary approach involving both police and other
agencies. One way of tackling the problem is by equipping law enforcement personnel
with adequate resources, equipment and training. A deficiency in the ability to recognise
drug impairment at the roadside has been previously highlighted. This study has shown
that Field Impairment Testing is a useful adjunct to earlier assessment procedures used to
detect impairment but could be improved in order to increase sensitivity and specificity. If
nothing else, at present, the use of FIT increases the police officers confidence in
recognising drug misuse and hence increases the capture of drivers who may otherwise go
undetected in the event of passing the evidential breath test. Additonal or alternative, tests
might be included in FIT or roadside instrumental tests could be introduced. An
alternative to an improved FIT would be to change the existing legislation and create
prescribed limits for drugs, as for alcohol.
It would appear that there is definitely a place for FIT in the fight against drugs and
driving. In July 2003, an amendment to the Railway and Transport Act was announced
which empowers a police officer to administer preliminary tests m. It states that:
"A constable shall have the right to require any driver whom he reasonably suspects of
committing a moving traffic offence to take a field impairment test or require a blood or
other bodily sample for analysis, or both, for the purpose of establishing whether or not
that driver is under the influence of any drug."
Although the drug testing device to be used has not yet been confirmed, the use of non-
invasive matrices such as saliva or sweat seem probable. Whilst the legislation enabling
mandatory FIT has been passed, the code of practice to implement these operationally has
yet to be established.
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7 Conclusions
This study focused on two areas of forensic interest; drug-related deaths (DRD) and drivers
suspected of driving whilst under the influence of drugs (DUID). For the first group, the
aim of this study was to analyse the DRDs that occurred in the Strathclyde Police region of
Scotland with intent to provide a timeline of changing patterns and trends of drug misuse.
To do this, a protocol and a definition of a DRD were established and data was collected in
a consistent manner throughout the study period. For the second group, the aim was to
show the prevalence and extent of drug misuse amongst individuals who were suspected to
be driving whilst under the influence of drugs in the Strathclyde police force region of
Scotland. As an adjunct, an evaluation of the field impairment test was carried out. This
technique was recently introduced to aid the Scottish Police Officer in the detection of the
drugged driver. The aim was to establish the nature and extent of drug use by both drivers
who were judged to be impaired and those who were judged to be unimpaired.
Drug-related deaths in the Strathclyde police region of Scotland increased on a year-to-
year basis over the study period 1985 - 2001, the majority of which involved death due to
the overdose of an illicit drug. Deaths due to each of four main drugs were the focus of
this study and each section highlighted various risk factors associated with drug related
deaths. These include the risks of consuming drugs in isolation, decreased tolerance
following a period of abstinence, the dangers of consuming a cocktail of drugs and the
risks of allowing an intoxicated individual to "fall asleep". Some of these deaths may have
been preventable had medical intervention been sought on the first indication of overdose.
Heroin was detected in 72% of all illicit drug overdoses and of these, heroin was the sole
or a contributory factor to death in 95% of cases. When heroin was abused with other
drugs, this was primarily with a benzodiazepine. This combination of drugs was shown to
be favoured in the Strathclyde police region throughout the study period. The
benzodiazepine of choice was temazepam up until a legislation change in 1996 which
resulted in this drug being re-scheduled. This meant that possession of the drug without
the appropriate authority (e.g. a prescription) was illegal. However, whilst the prevalence
of temazepam positive cases decreased subsequent to this, there was an increase in
diazepam positive cases detected in the laboratory. Hence, the heroinibenzodiazepine
cocktail was still being consumed, but a replacement had occurred for the benzodiazepine
of choice, mainly due to a decrease in supply for temazepam.
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Due to an increase in heroin misuse, opiate substitute prescribing was introduced in an
effort to reduce deaths due to heroin. Following the promotion of the methadone
maintenance programme in 1994 in Glasgow there was a sharp increase in deaths
involving methadone, calling into question the efficacy of this drug. Consequently, a
national confidential enquiry was established to investigate the medical care provided by
clinicians prescribing methadone. At this time, there was also an increase in supervised
administration of consumption. This resulted in the number of methadone related deaths
decreasing in the area despite a continued increase in the amount of methadone being
prescribed. This observation indicated that good practice had a positive effect on overall
reduction of methadone deaths.
As methadone positive cases amongst deaths in the laboratory were shown to decrease, an
increase in the number of dihydrocodeine positive cases was highlighted. This observation
suggested that as the supply for one opioid decreases as a result of better clinical practice,
the demand for another emerges. The majority of dihydrocodeine had been obtained by
the diversion of legitimate supplies, a similar situation to that involving methadone in
drug-related deaths.
Finally, the prevalence of cocaine amongst drug-related deaths was shown to increase in
the latter years of the study confirming data obtained from other sources that suggested
cocaine use is on the increase. However, cocaine as the sole cause of death was reported in
only 24% of all cocaine positive drug-related deaths. Heroin was detected in a high
proportion of all cocaine positive drug-related deaths, however, in almost one half of these
cases, cocaine was not considered to be a contributory factor in death. This in addition to
the relatively small number of cases and lack of deaths involving cocaine alone highlights
that it is somewhat premature to start comparing local experiences of cocaine deaths to
other international studies.
For the drivers suspected of driving whilst under the influence of drugs, between 65% and
92% were found to be drug positive on a year-to-year basis. Initially benzodiazepines
were the most frequently encountered legal drug group and cannabinoids were the most
frequently encountered illicit drug group followed by opioids. In the latter years of the
study opioids were more frequently detected than cannabinoids. Over the 7-year study
period, the prevalence of polydrug use was shown to increase and the patterns and trends
of drugs detected were similar to those found in drug-related deaths. That is, a decrease in
temazepam positives was replaced with an increase in diazepam positive cases, methadone
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positive cases increased up until 1996. A decrease in methadone positive cases subsequent
to this overlapped an increase in the number of dihydrocodeine positive cases and finally
there was an increase in the number of cases testing positive for cocaine in the latter years
of the study.
The evaluation of the field impairment test revealed a high positive predictive value which
demonstrates the effectiveness of the test when dealing with the drugged driver. Following
of the technique, a high proportion of drivers suspected to be impaired through drugs,
tested positive for drugs. Since there is no absolute definition of impairment and since it
was not possible to carry out a parallel study on a drug free normal driver population to use
as a control group, it was not possible to achieve an absolute measure of impairment.
Consequently, the test in its current form is only suitable for screening purposes. It
requires confirmation by a suitably qualified medical examiner prior to the collection of a
biological sample. Further testing of this procedure is required in order to improve the low
negative predictive value that was found in this study. That is there was a high percentage
of drivers who were suspected to be unimpaired that tested positive for drugs. The drugs
detected in saliva by type, concentrations and combinations were indicative of drug misuse
and similarly, on the whole for all biological specimens, the nature and extent of drug use
by the drivers reflected drug misuse rather than the medicinal use of prescribed drugs. It
was concluded that whilst there is still scope for future work to be carried out to improve
the accuracy of the field impairment test, it is a useful adjunct to earlier assessment
procedures used to detect impairment by the police officer.
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8 Further Work
Drug-related deaths in the Strathclyde Police region will continue to be collated and
monitored to identify emerging patterns and trends of drug misuse. Further collaboration
with multidisciplinary agencies including the Scottish Prison Service, Clinical Medicine
and Social Care would be beneficial for a complete and thorough investigation into these
otherwise preventable deaths, particularly at a local level, for example by DAT regions.
An area in need of more research is that of recently released prisoners. It is necessary to
ascertain the actual extent of treatment intervention, if any, that the individual had prior to,
during and following release of a custodial sentence as this information is often omitted
from the police sudden death report. Particular attention should be made to cases whereby
the individual had been on a methadone programme prior to imprisonment to ascertain
whether this was continued during and following release from prison. Similarly, if the
individual commenced a methadone programme whilst in prison, the extent to which this
was continued following release must also be established. In cases where this did not
happen, the reasons why there was an inconsistency in care should be investigated.
Corroboration with lSD, Edinburgh could determine the extent, if any, of service contact
by the deceased prior to death. In addition, the retrieval of medical records would allow
the clinical care provided by any treatment programmes to be assessed or indeed, ascertain
if the deceased was known to drug services and if not, the reason why. By plotting the loci
of death or the individual's area of residence, geographical "black spots" may be
identified. From this it would be possible to ascertain the availability and quality of drug
treatment services within specific areas which may identify areas which need to be targeted
by local authorities.
With respect to the drugs and driving cases, again all drugs detected will be monitored to
establish changes in patterns and trends of drug use. In order to validate the use of FIT, it
is necessary to compile data relating to the performance of a drug free population as a
control group. This would involve a control population of individuals of varying ages and
abilities to be tested using FIT possibly conducted in various weather conditions and at
various times of the day and night. This will facilitate the future development of FIT in an
effort to refine the battery oftests to improve sensitivity and specificity. This would enable
the development of a "scoring system" which would allow FIT to be considered as a more
objective indicator for detecting impairment and allow its results to be used as evidence in
a court of law for the prosecuting of the drugged driver.
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ABSTRACT: Drug abuse and its consequence, are everyday
problems encountered globally, and Scotland is no exception. Dur-
ing a study of drug-related deaths in the Strathclyde region of
Scotland it was noted that known drug users who had recently
been released from prison were at high risk of dying from a drug
overdose. The majority of deaths occurred within one week of the
release dale and polydrug use was prevalent. Morphine was the
Illost frequently encountered drug and this was found in cornbina-
tion with benzodiazcpines in a signilicant number of cases. This
paper highlights the dangers of resuming drug consumption fol-
lowing a period of abstinence.
KEYWORDS: forensic science, drug-related deaths, Strathclyde.
recently released prisoners. tolerance
Drug abuse and consequently drug-related fatalities arc recog-
ni/cd problems in the West of Scotland. While the incidence of
both has risen dramatically since the eighties, that of thc latter has
ri...en approximately 13-fold. The Forensic Medicine and Science
Departmcnt. University of Glasgow. is responsible to the Crown
Officc for the provision of pathology and toxicology services in the
Strathclyde Region of Scotland. This area encompasses most of the
Southwesl of Scotland and has a population ol upproximutely two
and a quarter million (Fig. I). During a retrospective study on drug-
rdated deaths (DRDs) in Strathclyde, it became evident that a pop-
Ulation at high risk of dying from drug misuse were recently re-
leased prisoners. This paper presents the results of epidemiological
and toxicological analyses of all DROs among recently released
pri,oncrs over the eight-year study period, 1990 to 1997.
Methods
At the postmortem examination. blood samples arc obtained
from pcriphcral vcins (suhdavide or femoral) and senl to the De-
partment of Forcnsic Mcdicinc and Science for routine analysis for
the presence of alcohol and drugs using immunoassay. gas li4uid
chromatography and high-pressure 1i4uid chromatography. All
positive samples arc confirmed and 4uantified by gas chromatog-
raphy/mass spectrometry following cxtraction from a nonhy-
I Research Assi.stant and Senior Lecturer in lilrcnsic medicine (toxic'ology I,
respectively. Department of Forensic Medicine and Science. University ofGlas-
~"w. (ilasgow. (j 12 XQQ. Scotland. UK.
Presented at the 51st Annual Meeting of the American Academy of Foren-
\Ie Sciences. Orlando. Ft. 15-~1 Feh. 1999. Supported hy a grant from the
Chief Scienti,,, Oilier. Grant Reference: K/OPR/2121D305.
Receivcd IlJMarch IlJlJ'!; and in revised form 26 July 1999; accepted 29 July
IlJ'IlJ.
drolyzed sample. Data relating to age. sex, cause of death and re-
sults of toxicological analysis were obtained from the povunortcm
and toxicology reports, respectively. Information regarding medi-
cal history and circumstances surrounding the death was extracted
from the sudden-death report Issued hy Strathclyde Police. I'or the
purpose of this study. a drug-related death was defined as an unex-
pected death where drugs were implicated as a cause of death either
through circumstance or toxicology.
Results
Throughout Strathclyde. from I'NO to IYI)7, a total 01'670 ()Rlh
were identified of which X7 ( 1.V1r) involved a drug user who died
within one month of release from prison. These deaths accounted
for between .1.4 and 20.1 'Ir of the total number of DR[)s per annum
(Table I). The deceased was known to be an intravenous drug
abuser in 95'lr (II = X3) of cases. The majority of deaths occurred
in the male population (76'lr) and the male.female ratio over the
study period was approximately J: I. The average age observed was
27 years (19to 44 years}.
Modl' of Death
The majority of deaths (IJYk) were unexpected as a result of an
acute fatal overdose. There were a small number of cases (1/ 4)
where the cause of death was recorded as "unascertained." In all
four cases. the deceased was a known drug user: however, toxicol-
ogy analysis was impossible in two cases as the bodies were in an
advanced state of decomposition. making the procurement of a
suitable blood sample impossible. In hoth instances, drug para-
phcrnalia was found at the locus, a used syringe ncar the hody in
one case and a syringe and needle protruding from the dl'l'easc-d'I,
left arm ill the other. In the other two cases, toxicologicnl analysis
did not reveal any trace of drugs. However, in one of these in-
stances, the presence of a used syringe and needle near the body
and fresh needle puncture marks present in both groins strongly
suggested that the death was drug related. In the fourth l·ase. IH'
sign of natural diseasc was identified and no real explanationl'lHlld
he found.
The cireulllstances surroullding two cases where dealh fol-
lowed a significant period of survival are as follows. In the first
case. thc dcceascd was witnessed to he heavily undl'r the infltl-
ence of drugs, unsteady on his feet and had slurred speech. He fell
aslcep 011 a sofa and was found dead 14 hours later. Methadone
and dial.epam were detected at levels within the therapeutic
rangc. The cause of death was certified as hronchopneumonia.
The other case involved an inebriated individual who was thought
to have consumed his week's quota of methadone. lie collapsed
outside his parellt's house and was taken to hospital where he was
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FI(i. I· nil' StratluIvd c rl'gill/I "/S"'!/(/I/"
TAilLE I-Re{'e/HII' relrascd prisoners (RRl's) til {/ /WIH'IH(/g" "(!/II'
!",,,lllllll/h,,r ,,( "mg· rl'illl"" ",'(/lil.l ({)ROs) I'l' I' tI/lllIllII ;/1 S!I'lI/Itc/rtf".
DRDs in DRDs in RRl's in Percentage
Year Strathclyde Str"lhl'lyd~ ('I, )
I'J')O 2') .1,4
Il)l) I 4<; (, 1.1.-'
1')'J2 XI 6 7.4
I')')l 7.1 6 K.2
1'1'14 117 17 14.<;
IlJ'J<; Ill) 24 20.1
1')')(, 116 IX 1<;.<;
1'1'17 l)O l) 10.0
declared brain dead, He died three days later with cause of death
heing rec.:orded as cerebral oedema due to anoxia following drugs
and alcohol intoxication.
Time Period Between Release from Prison and neath
Figure 211 shows that the majority of deaths occurred within one
week of release from prison (62£,1;,). with approximately one third of
these deaths occurring on the day of release or the day following re-
lease from prison (Fig. 2h). Of the 19 deaths occurring on either of
these two days, 47% (n ~~ 9) were due to heroin intoxication and
four (21 %) were due to temazepam and morphine intoxication. The
causes of dc.uh lor the rcmaininu vix ca,c, wen- rl'l'ordcd ;" 101
lows:
Tcma/cpam. morph IIll' and chlonlia/e.:poxllk InIO\ll';II" in
Methadone and morphine Intoxlcallon
Pulmonary congest it In and oedema (nil upluuc llctL·l·tcd In hl,)( Id)
Methadone intoxication
Morphine and diazepam imoxic.uion
Tcmazcpum poi,onlng
Toxicillogy
There were thrl'e l';I'l', when- 110 hlood ""I1I'Il' \\';1' oht;lIl1l'd III
two 01 these GlSl', the hodic were in an .ulv.mccd ,laic 01 dl'«'"1
position. In the third. the del'e.:a,ed vurvived lor a period III tIIlll' 111
hospital and the admission sample was disposed 01 prior h. ,,·I/llIl·.
A total of X4 hlood samplcs were received for toxil'ologll'al analy
sis. In two cases. no drug' were detected and only alcohol wu-, dl'
tccted in another two ca,cs: however. these de.:ath' were -ull COli
sidercd to be drug related due to circurusrantial cvidcncc.
01 the blood samples that te ...ted posuivc for drug, (1/ XI)).2')'1,
(1/ 23) were positive till' one drug. primarily morphine prl"lIlllcd
to he as a re\ull of' the.: misll\c of' heroin (7.1';;' ) generally "1"porlL'"
hy cin:umslalltiall'\'idellcc In thc rl'mainilll,! 71 'I, of' ca"· .... tWII 01
more drugs were.: de.:te.:e.:te.:dCl1loll ...tratillg the prcvale.:llcc of' pol)
drug usc (Fig. 3).
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FIG..I-NII/II"",. o(dmgs detected in !>Iood sumples.
Figure 4 shows the distribution of drugs letected. Morphine was
the most trcqucruly encountered drug (1/ ::: 62. n ff,). next was
tcmuzcpam (II = :Iii. 4l\'7~) followed hy methadone (II = 23.29%)
and diazepam (n "- 23. 29rk). The 1110S1 frequent ly encountered
combination of drugs was morphine (heroin) mixed with bcnzodi-
uzepincs, particularly tcrnazepam. Tcmazeparn was replaced hy di-
azeparn as the benzodiazepine of choice in the latter years follow-
ing a drop in the availability ofthe former as a result ofa legislation
change in 1996 .
Drug Concentrations
Morphine and methadone were mainly detected at levels thut
fall into the therapeutic range for tolerant individuals (0.04 to 0.5
and 0.05 10 1.0 rng/L. respectively) (I). They were found at sig-
nificantly higher levels in 26 and 12.5%. respectively (Figs. 511
and h). The average morphine concentration was shown In he
above the therapeutic level in cases where morphine alone or in
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FIG. 4-Drug.\' detected ill blood samples. Note-Other drugs detected ill blood: alcohol (2] cases]. cannabis (8 cusrs), !I{I/'lIl'l'/{IlIIOI (f> I'{ISI·,I). dt/or-
diaieposide (2 cases}, dihvdrocodeine. buprenorphine and trichloroethanol (I case eacli). NB: Morphine }-I'£lStit'/ectet! in urin« ill 0111'C{ISI' ill 11)1.)4III "'1/1
methadone, There was one case ill 1997 where temarepom. morphine. diazrpam. and chlordiazrpnxide ",ere all tiNt'I'/l'd ill/ill' urine smnpl», ill ,'011111 "'//1
detected ill 7 urine samples.
combination with only one other drug had been detected. There
were no significant differences with regard to the concentration of
methadone detected among those enrolled in a methadone main-
tenance program (MMP) and those who were consuming the drug
illicitly. In 51% of temazepam positive blood samples the con-
centrations measured were consistent with levels reported in fa-
talities (therapeutic range: 0.36 to 0.85 mgt L) (I) and in all di-
azepam positive cases the levels measured were within the
therapeutic range (0.05 to 2.0 mg/L),
Alcohol was found at relatively modest levels. The average
blood alcohol concentration of all 23 alcohol positive cases was
70 mg/IOO mL (range: 8 to 214 mg/IOO rnl.). Morphine was de-
tected in 21 (91%) of these cases and ternazepurn in II (48%)
cases.
Methadone Maintenance Program (MMP) Involvement
From the police sudden death reports it was noted that nine dece-
dents (37%) who tested positive for methadone were enrolled in an
MM Pat the time of death. Seven of these casesoccurred within one
week of the release date. Of these cases, three had recently started
an MMP. In one case, the deceased was prescribed methadone on
the day prior to death after stating to his doctor that he had devel-
oped a heroin habit while in prison. The other two cases involved
the deceased being prescribed methadone on the day they were re-
leased from prison. In all three cases, the decendents were to pick
up the prescription on a daily basis; however, in one case, the de-
ceasedwas issued 320 mL of methadone (four-day quota), two days
prior to death, due to a forthcoming holiday. Prescribing was re-
sumed in three of the remaining four cases. In one instance, the de-
ceased was prescribed methadone at a lower dosage than he had re-
ceived prior to imprisonment and in another instance the dcccu-, 'd
was given a week's supply of methadone IWO days prior to dc.uh.
Of all the decedents in this study who were known 10 he enrolled ill
an MMP at lime of death (1/ = 16).69')', rested positive I'm mor-
phine. confirming the misuse or heroin.
Discussion
There has been an increase in the number or drug-r '1:11 'd dc.uh-
occurring in the Strathclyde region or cntlund over the study pc-
riod and. coincidentally. a rise in the number or prisoners dyillg
from DRO within one month or their release d.u . \V,I~ ol», .rvcd,
The majority of these deaths involved thc male po] ulurion who
were aged in their mid-twenties. Although the overall number-
identified may appear relatively low with respect to 111,' duration (If
the study. they represent one drug-related d ':Ith occurring upprovi-
mutely once per month.
Over half the cases «()2'7t ) occurred within OIlC week of rclc.i-c
from prison and a substantial nurnbcr of theseoccurred cit her Oil the
day of release or the day after release. This highlights the situ.uion
that an enforced period or abstinence can lead to a reduction in all
individual's tolerance for a specific drug of abuxc.
Approximately three-quarters of the deaths were hernin-relale.:d
and toxicological analysis revealed that polydrug use was prev:l-
lent. with the heroin-benzodiazepine combination reported hy
Cassidy et al. (2) remaining a popular choice for the West of SCOI-
land drug user. These findings are nol signiricanlly clilkrenl 10 11ll!
findings in the study of all drug-related deaths in the Stratht.:lydc
region. The preference for diazepam as a mixer in the lalter ycar~
owes itself to the wider availability of this drug. In 1996. Gla,gow
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gelleral practirioncrs regarded the prescribing of ternuzeparn as
"lIot good practice" following the transfer of this fast acting ben-
lodia/cpine from schedule 4 of the Misuse of Drugs Act 1985 to
, xchcdule 3 (3). Alcohol was detected in approximately one qual"
tel' of all cases. albeit at relatively modest concentrations. unlikely
to cause death alone. Morphine was the primary drug found in all
alcohol positive-drug positive comhinutiunx, followed by
tcmazcpum. Alcohol. opiates and hcnzodinzcpincs arc all known
to have all emetic effect and when taken in combination, thi~ cr-
teet is additive. In thc majority otrnerhudone positive cases. the
deceased had not been enrolled in an MMI' (0311,,) and the
methadone was obtained by diversion or legitimate supplies. This
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was similar to the findings of a study on all deaths involving
methadone in Strathclyde (4). These studies underline the need
for tighter controls on methadone dispensing. For example. a re-
quirement for the drug to be consumed under strict supervision on
a daily basis. A substantial number of decedents who were in an
MMP at the time of death tested positive for morphine and were
apparently continuing to abuse heroin.
There appears to be a breakdown in communication between
prison doctors and general practitioners and as a consequence
methadone prescribing is often discontinued upon imprisonment.
Glasgow general practitioners have reported that the adverse con-
sequences of imprisonment include resumption of heroin injecting
and chaotic drug use both in prison and upon release (5).
When a known drug user is released from prison in the West of
Scotland, he or she is advised of the risks of overdose and is issued
with helpline numbers. This study highlights that. in spite of this
advice offered, a significant number of individuals clearly resort to
their old habits without building up a tolerance. Comparison be-
tween the level of morphine detected in relation 10 the period of
time of release and date of death revealed no significant differ-
ences. There is. however. insufficient data uvailublc on ,I day-to-
day basis to draw any real conclusions regarding the level of drug
misuse by the individual.
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INTRODUCTION
Homelessness and drug abuse are two escalating prob-
lems in society today and are often associated with
each other. In Glasgow, UK, with a population of
some 650000 people, there are estimated to be ap-
proximately 8000 single homeless people, of which
roughtly 60% are believed to use drugs. I Whilst there
are numerous causes which lead to a person adopting a
nomadic existence, a contributory factor may take the
form of an individual's untreated addictive disorder.
The exacerbation of drug addiction and consequential
associated debilitating issues may be the catalyst that
impels residential instability. In Glasgow, there has
been a marked increase in the number of single home-
less individuals with a history of drug/alcohol abuse
who present themselves to homeless units." A study in
the USA revealed that approximately 45% of a sample
of homeless people were abusing drugs;' whilst in
London, 39% of subjects involved in a long term
drug management programme were or had been
homeless."
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During a study involving drug related deaths in the
Strathclyde region of Scotland, it became evident that
a significant number of deaths were occurring within
the homeless hostels situated throughout the city of
Glasgow. To date, there is virtually no litera ture on the
prevalence of drug related deaths within such loci. This
paper investigates all drug-related deaths that
occurred in hostels for the homeless over the lO-year
study period 1990-1999.
There are various homeless hostel facilities through-
out the Glasgow area. Eight are owned by the Glasgow
city council and managed by the Hamish Allan Centre
who operate as an emergency-receiving unit for home-
less people in Glasgow and provide a 24 h, 365-day
service. Four of these hostels accommodate males
aged 18 years and over, one is for females, one is for
both sexes, one provides an emergency and assessment
hostel housing 16-18 year olds and one i an emer-
gency assessment hostel for the more vulnera ble home-
less adult. Jointly, the e hostels provide over 1155 bed
spaces that are constantly occupied at full capacity. All
give precedence to individuals of Glasgow origin and
are located within or near to the city centre providing
easy access. Other privately run hostels exist and these
predominantly provide accommodation for indi-
viduals from outwith the Glasgow area. Also, in situa-
tions whereby an individual has been expelled from a
council hostel due to violence or contravening guide-
lines, the assistance of private hostels is called upon to
re-house these offenders.i
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MATERIAL AND METHODS
The protocol for a drug-related death in the
Strathclyde region of Scotland is for an initial report
to be prepared by Strathclyde Police prior to the Pro-
curator Fiscal instructing a post mortem examination.
Biological samples taken for toxicological investiga-
tion are routinely analysed for the presence of alcohol
and drugs using immunoassay, gas liquid chromato-
graphy and high-pressure liquid chromatography.
Positive samples are confirmed and quantified by gas
chromatography mass spectrometry. The results of the
pathological and toxicological investigations are used
to establish the cause of death. For this study, all cases
relating to homeless hostels at the time of their death
were identified. All information pertaining to these
cases were extracted from the police sudden death
report, the toxicology report and the post mortem
report.
RESULTS
During the period 1990-1999, there were 957 drug-
related deaths identified in the Strathclyde region of
Scotland. Of these, 61 involved a hostel dweller (47
resided within a council hostel and 14 within a private
hostel). The locus of death was the deceased's hostel
room in 49 (80%) cases (38 in a council hostel and II in
a private hostel). Approximately four-fifths of all cases
(79(%, n = 48) occurred in the last 5 years of the study,
46% of these cases (n = 22) within the latter 2 years
(Fig. I). The final year accounted for 25% (n = 15) of
the cases over the study period. As with most drug-
related deaths in the region, the majority of subjects
were male (84%, n = 51) and aged in their late twenties
(average age: 29 years (21-44 years». The deceased
was known to be an intravenous drug abuser in all
but two cases. Unemployment prevailed in all cases
except in one instance where it was noted the deceased
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had been employed as an upholsterer at the time of his
death.
Of the 49 cases where death occurred within the
hostel, the circumstances surrounding 47'% (1'1 = 23)
of these involved the deceased being discovered
following routine bed checks carried out by the hostel
attendants. The majority of checks took place before
0945 hours (83%, n = 19) with just over two-thirds of
these taking place before 0900 hours (68%, n = 13). Of
these 23 cases, the deceased was witnessed to enter
their room the previous evening by other residents
and hostel staff in seven and six cases respectively. In
a further seven cases, entry to the room was verified by
access card (two cases) or close circuit television (five
cases). The deceased's demeanour was noted in six of
the 13 cases where the last movements of the deceased
had been physically witnessed. Drug consumption was
admitted in two cases and the deceased appeared in
good spirits in another two cases. One case involved a
member of staff helping the deceased to bed due to his
inebriated state and in the final case the deceased was
witnessed to have injected drugs. No mention of the
deceased's state of health was made in the remaining
seven cases.
The circumstances for the remaining 26 cases
whereby the deceased was found within the hostel
premises are as follows. Another witness associated
with the hostel discovered the deceased in their room
in 10 cases. Discovery within the hallway, dayroorn
and an unoccupied bedroom accounted for one case
each and the hostel toilet was the locus in a further
three deaths. The deceased was witnessed to be intoxic-
ated either through drink or drugs and was left alone
for a short period of time in four cases, on return of the
witness the deceased was dead. Two case involved the
deceased falling asleep in the presence of a witnes
following the consumption of drug, a period of time
later they were found to be dead. The decea ed col-
lapsed immediately following drug injection in three
cases and in one case an anonymous phone call was
made to ambulance control stating that a male had
overdosed in his hostel 1'00111.
For the remaining 12 cases where death occurred
outwith the hostel, the loci are as follows. In four cases,
the deceased died within a friend's house. Drug con-
sumption had been witnessed in these cases, the de-
ceased left alone for a period of time and later found to
be dead. The deceased was discovered within a COIll-
mon close and public toilet area in two cases each. The
loci for the remaining four cases were within hospital
grounds, a street, a lane or waste ground.
Drug paraphernalia was recovered from the locus
in 85% (/1 = 52) of all cases. Used syringes were
retrieved in the majority of these cases (87%, 11 = 45).
The location of the syringes in one third (33%, n = 15)
Drug related deaths amongst Glasgow city hostel dwellers 185
9
8
7
'" 6Q)<II
'"o 5
'0
Cii 4.0
E
:J
Z 3
2
0
I---
I---
!---
- ;-
r- i I--- '"
!--- ;S, -
'.~" -
-
c: .n J::; ,., Q) », Cl 0. U > o
"' Q) t! 0. '" c :; :J Ql 0 0 Ql-, U. ::;; :J -, « z 0'" « --, (fJ::;;
Month
Fig. 2 Time scale of when death occurred by month
of these was strongly indicative of a sudden death. A
needle and syringe was found in situ in 10 cases, a used
syringe was found clenched in the deceased's hand in
two cases and a used syringe was located under the
subjects body in three cases. Sudden death could not
be presumed in the remaining 30 cases as the police
report stated merely that a used syringe was found
either adjacent to the body or within the vicinity of
the body in 24 and six cases respectively. Drugs (either
in powder or tablet/capsule form) were recovered in six
cases, one of which involved a body packer with six
heroin deals concealed in his rectum (all of which were
found to be intact).
The month in which the death occurred was noted,
the results of which can be seen in Figure 2. Just over
half of the cases (54%, n = 33) had occurred either in
the first (n = 10) or last quarter (n = 23) of the year.
Nine cases (15%) involved an individual who had
been released from prison within 1 month prior to
death. Of these, 67% (n = 6) died within I week of
release, one of which involved the deceased overdos-
ing on the day of release. In a further two cases the
deceased had recently undergone a period of drug
rehabilitation. In one case, the deceased had spent 3
days in rehabilitation and overdosed 7 days after
release. In the second case, the deceased overdosed 11
days after release, having spent 23 days in rehabilita-
tion (Fig. 3).
The majority of cases (79%, n = 48) involved the
overdose of a controlled drug. Of the remaining 21%
(n = 13), two cases were due to intoxication of non-
illicit drugs, chlormethiazole in one and co-proxarnol
in the other. Two individuals died as a result of the
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adverse effects of their drug abuse, haemorrhage and
shock resulting from a bleeding leg ulcer ace unted for
one case and bacterial endocarditis, an infection
caused by intravenous drug abuse, was responsible
for the other ea e. The cause of death in sev n cases
was certified as drug related death. Due t the risk of
infection, a full post mortem exarninati n was not
carried out in five of these cases, the ea use of dea th
was assigned following a full external exarninati nand
toxicological investigation. Finally, two cases were
considered to be drug related due to circum tantial
evidence however. the underlying cause of death was
unascertained.
Heroin prevailed as the drug which either alone or
in combination with other drugs led to death amongst
the controlled drugs overdoses. Heroin intoxication
was assigned as the cause of death in 20 cases. The
concurrent use of heroin with other drugs accounted
for 25 cases, 64% (n = 16) of which involved at least
one benzodiazepine. The various combinations of
drugs that were considered to be involved in the
death are listed in Table I. Mono-intoxication was
responsible for three cases, temazepam and metha-
done in two cases and one respectively.
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Table I Combination of drugs in heroin related deaths.
Heroin plus Number of cases
Alcohol
Temazepam
Diazepam
Chlordiazepoxide
Temazepam and diazepam
Temazepam and alcohol
Temazepam and methadone
Temazepam, diazepam and methadone
Temazepam, diazepam and alcohol
Total
9
8
I
I
2
I
I
I
I
25
DISCUSSION
There has been a significant increase in the number of
drug related fatalities in the West of Scotland over the
study period. Within this group, there has also been an
increase in the number of individuals overdosing with-
in various homeless hostels througbout the city of
Glasgow, particularly in the latter 2 years. The demo-
graphic synopsis of this study reflects all known cases
of drug fatalities in the Strathclyde region with respect
to sex, age and employment status, drug history of the
individual as well as the specific drugs that were con-
sidered responsible for the death. Heroin either alone
or in conjunction with other drugs, in particular ben-
zodiazepines was the most prevalent.
The circumstances surrounding a large number of
these deaths indicated that the deceased was alone
prior to drug administration. In the absence of a letter
or note of some kind, it was impossible to establish
whether the death was suicidal or accidental. A study
investigating suicidal intent in non-fatal illicit drug
overdoses revealed that almost one half of respondents
reported to have suicidal thoughts or feelings prior to
overdosing."
The presence of a needle and syringe in situ, grasped
in the deceased's hand or located under the body,
strongly suggests that death occurred almost immedi-
ately following or during drug injection. This applied
to 25% of all cases in this study (n = 15).
Over half of the deaths had occurred in the first and
last quarter of the year, particularly in the months
October-December. In terms of all drug-related
deaths throughout the study period, the distribution
of deaths over the months was constant and showed
no significant variations from month to month.
Therefore, the increased numbers of hostel deaths oc-
curring in the months October-December, although
not statistically significant, suggests that hostel dwel-
lers may be at a slightly higher risk from overdosing
during this period. This time of year can prove to be a
difficult period to cope with for many people, in par-
ticular those who are emotionally or psychologically
unstable, such as drug misusers. The feeling of isola-
tion associated with hostel dwelling may only enhance
this melancholy.
Reduced drug tolerance and increased deaths re-
sulting from a period of abstinence has been previously
reported." Recent prison release or termination of re-
cent drug rehabilitation accounted for a small number
of cases in this study.
CONCLUSION
To date, there is a dearth of literature pertaining to
the extent of drug misuse within homeless hostels.
However, this study highlighted an increase in drug
related fatalities occurring within hostels revealing
that there is indeed a problem with illicit drugs in
such establishments. Drug misuse that is brought to
the attention of hostel staff is not tolerated; however,
in reality many drug users are granted a room and are
able, to a certain extent, to buy, consume and even deal
drugs freely. The only surveillance takes the form of
close circuit television systems or electronic key tag-
ging systems that record the time of entry and exit to
each room. What goes on behind closed door is at the
resident's own discretion.
It has been postulated that due to drug dealers being
moved from their customary vicinity due to policing or
the installation of close circuit television systems, they
are targeting hostels as a means of continuing their
business. This is an area presently being addressed by
the appropriate law enforcement agencies.
The Government has recently addre sed the
problem of homelessness, not only from the aspect
of accommodation deficiency but also highlighted a
need to treat those with mental health, drug and
alcohol problems. As part of a pledge of [25 million,
not only will impersonal dilapidated homeless ho tels
be eradicated making way for modern accom-
modation, but health-related project will als be
financed.8
The results of this study highlight a need to inve r-
igate fully and monitor the number of drug u ers
abusing the hostel system. The number of death pre-
sents a problem in need of address by the relevant
authorities.
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A STUDY OF ALCOHOL AND DRUGS IN IMPAIRED AND FATALLY INJURED
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ABSTRACT
Objective: To ascertain the prevalence of drugs
(both licit and illicit) and alcohol amongst both
drivers suspected of impairment and fatally injured
drivers.
Methods. All 214 relevant cases were identified
and results of toxicological investigation retrieved
using the departmental database.
Results' The prevalence of illicit drugs amongst
living drivers is increasing. in particular the
concurrent use of morphine and benzodiazepines.
A Icohol was found to be present in approximately
one fifth of living drivers at quite significant
concentrations. Drug and alcohol use amongst
fatally injured drivers was shown to be minimal.
Conclusions: The incidence of illicit drugs
amongst drivers suspected of impairment is
increasing in the Strathclyde region and remains a
problem for the authorities.
INTRODUCTION
The misuse of drugs in the West of Scotland has
increased dramatically over the years and at present
shows no signs of subsiding (ScYI11 ur, Bla k,
Oliver 2000). Consequently and in addition 10 an
increase in the number of drug related deaths
occurring in the area. this problem is reflected in the
drugs and driving scene. A recent study highlighted
an increased number of amples received by the
Department of Forensic Medicine and Science.
University of Glasgow requiring analysis of drugs
(Seymour and Oliver, 1(99). These amplcs had
been obtained from drivel'. who were suspected of
impairment. This paper presents the results 01' the
toxicological investigation of biolouical sample
obtained fr m drivers charged lin ler Section LI or
the Road Traffic Act I 88 for tile year 1999. For
comparison purpo cs, the result of toxicology
carried out on samples taken from fmall injure I
drivers that same year arc also in hided.
MATERIAL AND METIIOOS
Following arre l. an individual II I c ted of drivin '
whil t under the influen e of drink and/ r druu is
accompanied to the p lice nation where a police
surgeon i umrnoncd to examine the driver and
ascertain the extent (if any) of impairment. In the
event of diagno cd impairment. tl 0 10 millilitre
blood samples are obtained. ne of these is ..i ell
to the driver h uld they want to pursue
independent analy 'is and the other sample is given
to the police, who submit the 'ample 1'01' analy is t
the Department of Foren ic Medicine and ' icn C,
University ofGla gow. Under the Road Traffic t
1988, it is an offence for an individual to refuse the
assessment and /01' refuse to pro ide a sample or
either blood or urine.
In the cases of fatally injured drivers, biologi al
samples are sent to the aforementioned department
for analysis following completion of a post mortem
examination.
All sample were routinely analysed for the
presence of alcohol and drugs. Bcnzodiazcpines,
opiates, LSD, cannabinoids, amphetamines,
buprenorphine and methadone were analysed using
enzyme-immunoassay. Blood was screened for
acidic, basic and neutral drugs using gas liquid
chromatography and high performance liquid
chromatography. All positive samples were
confirmed and quantified by gas chromatography
mass spectrometry. Drug levels were measured
using stable isotope reference materials where
available or by internal standard procedures.
RESULTS
Drivers Suspected of Impairment
Over the study period 1999, the department
received 312 biological samples from various police
forces throughout Scotland. The majority of these
(69%, n = 214) were submitted by Strathclyde
Police force and were primarily blood samples
(85%, n = 181). The majority of drivers were male
(187male:27 female). Following toxicological
analyses of the blood samples, drugs were found to
be present in 139 cases (77%), II of which also
tested positive for alcohol. Alcohol alone was
detected in 23 blood samples and the remaining 19
cases tested negative for both drugs and alcohol. or
the 33 urine samples, the majority (88%, n = 29)
were positive for drugs, alcohol also being detected
in three of these cases. The presence of alcohol
alone was detected in four urine samples. This is
summarised in Table I.
Drug Involvement
Blood Samples: Polydrug use was evident in just
over one hal f of drug positive blood samples (53%,
n = 73). Table 2 lists all drugs detected. It can be
seen that benzodiazepines were the most frequently
encountered medicinal drug with diazepam and
temazepam found to be present in 83% and 55% of
drug positive cases respectively. Morphine was the
most frequently detected illegal drug followed by
cannabis. The co-administration of morphine and
benzodiazpines accounted for 41 % (n = 30) of all
polydrug blood samples and 88% of all morphine
positive cases. The concurrent use of morphine
with diazepam or temazepam was detected in 15
cases and one case respectively. Morphine in
combination with diazepam and one other drug'
were detected in seven cases and one case involved
morphine, temazepam and methadone. Both
benzodiazepines, diazepam and temazepam were
found in a cocktail with morphine in three cases and
finally all three drugs together with dihydrocodeine
accounted for three cases. The co-administration of
diazepam and temazepam alone accounted for 13
t cannabis (3 cases), cocaine (2 cases), methadone
(I case), dihydrocodeine (I case)
cases. The remaining 30 combinations of drugs
detected are summarised in Table 3, "II of which
involved diazepam and/or ternazepam. Sixty-six
cases involved the presence of one drug and this
was primarily diazepam (74%, n 49).
Ternazepam alone was Found to be present in six
cases, morphine and cannabis in four ea es each and
finally methadone, cocaine and
gammahydroxybutyric acid were detected in one
case each.
From Table 2 it can be seen that whilst the average
concentration of most drugs fell within the expected
therapeutic level, concentrations associated with
death amongst intolerant individual were noted. In
particular, morphine and diazepam were found to be
present at concentrations approximately double that
of the upper therapeutic range level and a
ternazepam concentration more than four and it half
times that was detected. Whilst no medical history
of the deceased was made avai fable. these ranges of
concentrations suggest a potential for impairment.
Urine Samples: The presence of drugs were noted
in the majority of urine samples (88°/r), n == _9) and
are listed in Table 4. Again, polydrug lise \ as
evident with one drug being detected in only two
cases (amphetamine and cannabis). The
concentration of a drug in urine can only be II ecl u
an indication that the individual has been e. posed
to that drug. Whilst rh concentrations 01' drug in
urine can not be equated to a level of impairment.
the number of drugs lcrected per sampl \ as rather
alarming. Four drug accounted for 10 use. lWO.
three and five drugs for four cases ea h and final!
five ea es involved the pre cncc of as many {is six
different drugs. Morphine was detected in 19
polydrug case (70%). with the presence of both
diazepam and tcmazeparn account ing for
approximately two thirds (68%. n ... I ) or
morphine positive cases. Again, no medico I hi tor
was available. however, the variety of druu and
combinations i indicative of drug rnisu e.
Aleohollnvolvcmcnt
Alcohol wa detected in 34 blood samples, 01" \ hi h
I I cases (32%) also tested posit ivc for dru 'So The
average blood alcohol COil cntration BA)
measured in the 23 alcohol only po itive case: was
148mgli00rni (Median: I 6mgliOOml, Range: 41 -
333mg/I001111), which is almost double the legal
driving limit of80mgli00mi. In one en c a BA' of
3331llgll00ml blood was detected, [I le cl
associated with coma and impaired re piration in an
intolerant individual. The a era ie BA
(52mg/I00rnl) observed in the drug-alcohol positive
cases was considerably lower than when alcohol
alone was detected. Only one of the II drug
positive cases had a BA greater than the leual
driving limit. This level of 217mg/1 OOml would
most certainly cause a marked degree of
impairment.
Time Sample was Obtained
In accordance with a previous study carried out in
the region (Seymour and Oliver, 1999), the majority
of samples were obtained between 2100 hours and
0600 hours (56%, n = 120). A further breakdown
shows that 68% (n = 81) of these samples were
taken between midnight and 0600 hours. The
distribution of time when the sample was obtained
is illustrated in Figure I.
Fatally Injured Drivers
In 1999, there were 26 drivers who were fatally
injured in a road traffic accident. Again, the
majority were male (24 male: 2 female). Following
completion of a post mortem examination, a
blood/urine sample was collected and analysed for
the presence of alcohol and drugs. The majority of
samples were void of both alcohol and drugs (19
cases, 73%). Only two samples were found to be
positive for drugs. One sample revealed codeine
(0.023mg/litre) and the other
methylenedioxyamphetam ine (0.006mg/1 itre).
Alcohol was detected in five cases, the average
BAC measured being I04mgll00 millilitre (Range:
5 - 231mg/IOO millilitre). Only two of the five
blood samples were under the legal driving limit.
DISCUSSION AND CONCLUSION
The number of samples submitted to the department
of Forensic Medicine and Science In 1999
requesting drug analysis for individuals suspected
of impaired driving was the highest ever recorded.
The findings of toxicological investigations were
similar to previous years in that polydrug use was
prevalent in particular the concurrent use of
morphine and benzodiazepines. This combination
of drugs has previously been reported to be the
major causative factor conducive to drug related
deaths within the region (Cassidy, Curtis, Muir and
Oliver, 1995) in the early nineties and remains to be
the favoured cocktail of abuse today.
Benzodiazepines remained the most common legal
drug amongst suspected impaired drivers.
However, morphine was the most frequently
encountered illegal drug followed by cannabis,
which is in contrast to previous years where the
latter drug was the most common (Seymour and
Oliver, 1999). Overall, the findings are similar to
that of other countries who seem to experience the
same trends as Scotland (Lillsunde, 1998). The
average drug concentrations measured in blood
were all within the therapeutic range level except
for dihydrocodeine. The frequency of this drug
amongst drug related deaths in the region was seen
to increase over the latter two years and appears to
be emerging as a drug of misuse among t known
drug users (Seymour, Black, Oliver. In Press). In a
few cases, drugs were found to be pre cut al
concentrations associated with fatalities in non-
tolerant individual, most notably morphine,
diazepam and temazepam. Whil t no information
was available with respect to any prescribed
medication the individual may have been receiving.
the combination of drugs, in particular. the
concurrent use of morphine and benzodiazepines i
indicative of drug misuse. For future research it
would be useful if a synopsis of the individuals age
and medical history were documented at the time of
sample procurement in order to distinguish bctv een
legitimate drug consurnpt ion and drug misuse.
Alcohol detected in living drivers was measured at
significant concentrations when enountercd alone.
The median concentration of 136mgliOOmi in this
study is associated with a marked loss of co-
ordination and would undoubtedly have an effect on
an individuals driving ability.
With respect to fatally injured drivers, drugs were
not considered to be a causative factor in the
accident. Drugs were found to be present in only
two cases, one involving codeine in a 6_ ear old
male, pre urnably prescribed and a mernbol ite or
ecstasy in another case although at a vcr low
concentration. A lcohol was suspeered of bcine
conducive to the fatal accident in only tl 0 C;LC~
where BA 5 of r 11l1g!IOOml and 169mgllOOl1l1
were measured. These conccntrru ions nrc
associated with considerable impairment. In order
to bring the United Kingd 111 in line with the
majority of member states ill the European nil n,
the propo <II of lowering the legal drivins limit I
50mgllOOmi has bcen brought to the pubti s
attention ( unclay Mail, 2000). However, a high
profile publicity campaign will have to be initiated
prior to a change in existing lcui lati n. hould this
go ahead, this would be a good opportunit to I arn
the public of the ri ks a sociated with druu nnd
driving and to highlight that it is 1I major I roblem
on Scottish road - one which the poli care
currently addressing. The implem ntarion or II
training prograrnrn lor p lice om er in the West
of Scotland in 1999 ha heightened their ill arcncss
of drug and their effect On drivine ability.
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Table I : Breakdown of Toxicological Investigation of Biological Samples Received by the Department or
Forensic Medicine and Science.
I Blood I Urine
Drugs Only
I
12R
I
26
Alcohol Only 23 "Drugs and Alcohol
I
II 3
All Negative 19 i 0
Total I 181 I 33
Table 2: Drugs detected in Blood Samples.
Drug Detected No. of cases Level Measured (mg/I) Therapeutic Level (,ugll)
Ave (low-high) (Stead lind Momll. I<.IR))
THC" 6 3.5 ( 1.65 -7.0)'
THC-COOH b I 22 611 (10 - 1(0)C
Amphetamine I I I 0.05 0.0- - 2.0
Chlordiazepoxide I 4 I
0.66 (0.05 - 1.2) 1.0 - X.O
Desrnethyldiazepam I III 1.1 (0.<J2 - 8.53)
Diazepam I 115 I
0.91 (0.04 - 3.37) 0.0 -2.0
Temazepam I 76 0.76 (0.05 - 4.02) 0.36 - 0.8
Morphine I 34 I
0.05 (00 I - 1.0) 0.04 - O.
Methadone I 9 0.13 (0.024 - 0.26) 0.05 - 1.0
Dihydrocodeine I 5 I 0.3 (0.18 - 0.-2) 0.0 -0.2 (Rcpcuo and Repetto. 19(7)
Other d 25
Positive Drug Samples 139
Total Drugs Detected I 408
a Delta-v-terrahydrocannabinol
b II-nor-delta-9-tetrahydrocannabinol-9-carboxylic acid
C nanogrammes per rnillitre
d Other drugs included: Benzoytecgonine (7). Mcthyleegonine (7). cocaine (6). Gurnmahy lruxybur, ric acid (I). 1'1i(;1l~ 10111
(I). Methylenedioxymethylarnphctarnine (3).
Table 3: Drug Combinations or 30 drug positive cases Comprising of Bcnzodiuzcpincs and other drugs.
Drug Combinations (Number of Cases)
Diazepam Plus Temazepam PIIIJ DiaZe[!1/1I/ + Tell/l/ze.tJulI/ f""f
Cannabis (II)
I
Phenytoin (I)
I
Cannabis ( I )
Methadone (5) Cannabis (I) Chlordiazepoxide t- Methadone (I)
Cocaine (3) I I
Chlordiazepoxide (3) I I
MDMA (I)
I
I
Cannabis + Cocaine (I) I
Methadone, MDMA + Cannabis (I)
Amphetamine +MDMA (I)
Total = 26 Total = 2 Total = 2
Table 4: Drugs Detected ill Urine Samples.
Drug Detected No. of cases
THC"
I
0
Tl-IC-COOHb 16
Amphetamine I 6
Chlordiazepoxide I
Desmethyldiazepam 18
Diazepam 10
Temazepam I 19
Morphine I 19
Methadone I 10
Dihydrocodeine I 8
Other' I 20
Positive Drug Samples 29
Total Drugs Detected 127
a Delta-9-tetrahvdrocannabmol
b II-nor-delat-9-tetrahYdrocannabinol-9-carboxYlic acid
C Other drugs included: Benzoylecgonine (6), Methylecgonine (6), Cocaine (4). Paracctarnol (I). Citaloprurn (I).
Methylenedioxymethylamphetarnine (I). Trirncthoprim (I).
Figure I: Time When Sample was Taken.
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Abstract
The misuse of drugs, both illicit and prescribed has increased dramatically in the west of Scotland over the last few de ades,
Consequently, the number of drug related deaths has risen as a direct result. Since, discrepancies exist between dam colle ted
by the Department of Forensic Medicine and Science, University of Glasgow and official statistics. this project. was funded to
investigate all known drug related deaths that occurred within the Strathclyde region of Scotland in an effort 10 irnprov the
accuracy of statistics and the dissemination of information pertaining to them. Changes in medical treatment, legislation nd
patterns of drug taking were noted and the effects of these on the year-by-year death lolls evaluated. © 200 I Elsevier S .ience
Ireland Ltd. All rights reserved.
Keywords: Drug related deaths; Strathclyde; Methadone; Heroin
1. Introduction
Drug abuse and its consequences are everyday problems
encountered globally and Scotland is no exception. The
abuse of drugs has a detrimental effect both to the individual
misuser and to society as a whole. In 1968, it became
statutory for general practitioners (GPs) to notify an indi-
vidual to the Home Office addicts index if they were known
to be addicted to any I of 14 specific opiates' and/or cocaine.
As well as monitoring the extent of drug misuse in the UK,
this index acted as an extra source of intelligence to prevent
double prescribing occurring [II. The number of drug
addicts notified to the Chief Medical Officer at the Home
Office rose from 126 for the whole of Scotland in 1980
to 4516 in 1996 [2]. Given that these figures relate to
individuals who have voluntarily presented themselves for
• Corresponding author. Tel.: +44-141-330-4574;
fax: +44-141-330-4602.
E-mail address:a.seymour@formed.gla.ac.uk (A. Seymour).
I Dextromoramide (palfium), diarnorphine (heroin), dipipanone
(diconal), hydrocodone (dimotane DC), hydromorphone, levorpha-
nol (drornoran), methadone. morphine, opium, oxycodone, pethi-
dine, phenazocine (narphen), piritrarnid (dipidolor) and unspecified
opiates.
treatment, it can be assumed that they are an und resrlma: .
For comparison. there arc estimated to be between IPPro, [,
mately 12.000-15,000 adults with 1\ serious dru probl III in
the greater Glasgow area alone. in e mortality is a 'on-
tingency of an individuals dru ubus . thc number of ople
who died directly as a result of their drug abus
dramatically over the above tim period.
Trends and patterns of drug UNe in the west of S otlund
have been well documented in the litcrutu ' { _( I. Drug
abuse as a problem in the rcgi n dm . from the 'urly I RO
when black market heroin and the trend of illj' (in 'Ill 'r "y
in Edinburgh and Glasgow II OJ. Prefer ne '.~ for bupr inor-
phine, heroin and the concurrent usc of heroin with h .nzo-
diazepines have all existed over certain tim' s ·ltl·S ill th'
Strathclyde region. Usually. preferences IW di -tat d b
availability and cost. For example, initially bupr morphir, .
and tcmazeparn were favoured drugs as a r 'sult of Wid"
spread availability due to prescribing pra [ices. hung" ill
legislation led to the availability of these drugs dirnini 'hins
and the street value increasing. As 1I result, th . popularity o
heroin recovered and the s .urcity of tcmuzcparn led to
diazepam being used as a substitut '.
During the decade 1983-1993. there has been u on 'id '1'-
able expansion in the number and runge of services available
to drug users in Glasgow. The Glasgow drug probl III servic
0379-0738/01/$ - see front matter © 2001 Elsevier Science Ireland Ltd. All rights reserved.
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was established in 1993, followed by the General
Practitioner Drug Misuse Clinic Scheme in 1994 whose
objective was to reduce drug related harm to health [11].
The Methadone Maintenance Programme (MMP) was intro-
duced into Glasgow in October 1993 in order to wean addicts
off heroin.
This paper reports on the trends and patterns of drug
taking as found in the drug related deaths of Strathclyde. In
particular, the effects of the MMP, legislation changes and
periods of abstinence are discussed.
2. Methods
The Strathclyde police district encompasses a large
portion of the southwest of Scotland with a population of
approximately two and a quarter million. Any sudden,
unexpected death or one with suspicious circumstances
occurring within this region is reported to the appropriate
Procurator Fiscal. Over the study period, 94% of Strathclyde
drug related deaths were referred to the Department of
Forensic Medicine and Science, University of Glasgow
for post-mortem examination. The remaining 6% were
examined by pathologists from hospitals within one of the
four Strathclyde health board areas. Post-mortem toxicolo-
gical samples obtained from all drug related deaths within
the region are investigated at the Department of Forensic
Medicine and Science Laboratory. For toxicological inves-
tigation, qualitative analyses is routinely carried out to detect
the presence of alcohol, acidic drugs, basic drugs, benzo-
diazepines, opiates and methadone using immunoassay, gas
liquid chromatography and high-pressure liquid chromato-
graphy. All positive samples are then confirmed and quanti-
fied by gas chromatography-mass spectrometry.
Data relating to age, sex, cause of death and results of
toxicological analysis were obtained from the post-mortem
and toxicology reports. Information on medical history and
circumstances surrounding the death was extracted from the
police sudden death report. For the purpose of this study, a
drug related death was defined as a sudden or unexpected
death:
• where illicit drugs were implicated as a cause of death
either through circumstance or toxicology;
• as a result of long-term drug abuse;
• of a known drug abuser as a result of an overdose of non-
illicit drugs;
• due to solvent abuse.
3. Results
3.1. Demographics
A total of 443 DRDs were identified over the study period,
360 (81%) involved males and 83 (19%) involved females.
5
The average age of the subjects was 28 years (range 13 9
years). Although the number of deaths resulting annually
remained relatively consistent at approximately 120 deaths,
a decrease was recorded in 1997. The majority of deaths
resulted from an overdose of illicit drugs (89%, II = 395).
Known drug users who overdosed on non-illicit drugs, such
anti-depressants and distalgesics accounted for 5% (n = 24)
of deaths. Deaths due to the adverse effects of drug abuse
such as septic shock syndrome and other complications of
chronic intravenous drug abuse accounted for 3% (n = 12), a
further 3% (n = 12) of deaths were due to solvent abuse
(Fig. I). The majority of subjects were unemployed (51%),
employment status unknown in 42% and most had a history
of drug abuse (97%, n = 428), of which 77% were kn wn
intravenous drug users.
3.2. Virology status
Virology results were obtained for 84% of all c e
(n = 370) cases and are shown in Table I. Hepatitis
was not routinely analysed for until the latter month of
1997, explaining the increase in hepatitis C po itive cases in
1998. Only 2% (n = 7) of cases were shown to be HIV
positive, which is in sharp contrast to the situation in
Edinburgh [12J.
3.3. Circumstances of death
Approximately four-fifths of subjects (82%, n <= 6)
were found dead within a dwelling abode, two-thirds
(66%, /I = 239) of which involved the d ceas d's own
residence (house or hostel room). The various loeations
where the deceased was discovered arc shown in Pig.
Only 4% (II := 17) of subjects died in hospital having been
admitted for medical intervention. The remaining cas ~
(14%, n := 63) were discovered in fairly publi loci. It sb uld
be noted that, although found in a public place, th locus was,
generally, inconspicuous. Por example, the rear of il ,hop.
cubicles within a public toilet or stairwell/ ommon 10'
within a block of flats. The location f death in ea hIS' w.,
recorded using the postal code. Th majority of deaths
occurred within the city of lasgow (6 %, /I = 88).
these 17% (/I = 48) oecurred within the city centre and 26%
(n = 74) in the north side of ihe city, notably Possitpurk,
Springburn, Milton and Ruchill, all of which are less affluent
areas of Glasgow known locally to be arcus of drug supplyl
abuse, high unemployment and social deprivuti n.
In just under one-third of cases over the study period
(30%, /I = 133), the deceased was seen to be iruoxicmcd
prior to falling asleep and later reponed to be unrousubl '. In
some cases, due to the intoxicated Slat' of th individual.
regular checks were made 10 establish that the deceased was
still alive. Reports of the deceased "groaning". "grunting"
and "gurgling" were not uncommon in th se instanc s, In
contrast, there were 122 cases (28%) which wer considered
to be sudden deaths, due to either a syringe being found in
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Fig. I. Drug related deaths categorised on an annual basis according to the definition used for the purpose of this study (199 -1998),
situ (32 cases), needle and syringe still grasped in the
deceased's hand (10 cases) or syringe found adjacent to
or underneath the deceased's body (80 cases),
3.4. Toxicology
There were 10 cases where no toxicological analysis was
carried DUI. This was due to the body being badly decom-
posed in three cases, making the procurement of a suitable
sample infeasible, In a further seven cases, the deceased died
in hospital after a period of survival and it was not possible to
obtain the relevant admission blood samples. Toxicological
Table I
Virology results of 370 drug related deaths, 1995-1998
analysis was carried out on 4 J il. s of which 4 9 (99%)
tested positive for drugs. No drugs wer dote re I in
cases. In two cases there wa: insufficient sample obt lin
make a comprehensive analysis. Despite the abscn
drugs, these cases were consider d 10 be dru lUI d du
to circumstantial evidence such us rh drug liS history of the
deceased, activities of the d .ccased prior 10 death and/or
drug paraphernalia being I arcd III th I u. indi atln
recent drug administration,
Of the 429 drug positive cases, roxi 010 i III wlllysis
revealed that mono-intoxication ac ountcd for only 29%
(II = 124) of cases over the rudy period and thi~ WU~
Results 1995 Tutol
All negative
HTV positive
HIV positive/hepautis C positive
HIV positive/hepatitis B uninterpretable
Hepatitis B positive
Hepatitis B uninterpretable
Hepatitis B positive/hepatitis C positive
Hepatitis C positive
Sample unsuitable for analysis
Results uninterpretable
No virology results
Total
77
t
o
t
10
9
I
2
o
2
16
119
1996 I(98
74 47
I
t 0 I
0 0 0
II 0 I
2 II 0
2 0
0 10 46
0 5 I
6 0 0
18 17 22
115 89 120
<I
22
4
441
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Fig.2. Locus of body - place of discovery, 1995-1998.
primarily due to the consumption of morphine which in
combination with the circumstances surrounding the death
was indicative of heroin abuse. The presence of two or more
drugs was found in 71% (n = 305) of cases. There were
three cases where as many as six drugs (I %) were detected
at autopsy (Fig. 3). As in similar studies in other countries
[13-15], the drug of abuse most commonly encountered was
morphine, which was identified in 281 (66%) drug positive
samples. The prevalence of this drug increased from 59 to
75% of all drug positive samples between 1995 and 1998
(Fig. 4A). Diazepam (45%, n = 191) and temazepam (33%.
n = 143) were the next most frequently encountered drugs.
The prevalence of temazepam almost halved between
1995 and 1996 and again in 1997 (Fig. 4C). In 1998,
however. temazepam related cases increased by III %. In
contrast, as temazepam positives decreased. there was an
increased incidence of diazepam. Between 1995 and 1996
there was a 38% increase in diazepam numbers and a
further 64% increase over the period 1997-1998 (Fig. 4D).
Methadone was detected in 132 (31 %) of all drug positive
cases. Its incidence decreased by 47% between 1995 and
1997. and was at a similar level in 1998 (Fig. 4B). No
medical history was obtained in 19 of these cases. Of the
remaining 113 cases. methadone had been obtained by the
diversion of legitimate supplies in 62 of the cases (55%).
Cocaine. ecstasy and amphetamine were found to be
present in 12 cases each. It should be noted that not
one death involved the presence of buprenorphine over
the study period.
From Table 2 it can be seen thut the average conccntrn-
lions of morphine. methadone and diaz pam detected nch
year were all within the thcrap 'ulic range for tol ram
individuals (16). However. that ftemazeprun was consistent
with concentrations associated with fatalit] s (161.
Alcohol was detected in 184 samples (4 *'). lOin males
and 24 in females. The concentrations found rnn cl rom
10462 mg/loo ml blood. approximately six times the I 'gal
driving limit (80 mg/ I00 !TIl)lind a concenrration asso it'd
with fatalities in most individuals. A BA gr 'alar than
200 mgll 00 ml blood was dele ted in ju I under tin quurt r
of cases (23%, 11= 43). a level that would result in ~ v r
intoxication in intolerant individuals. M dieat history nUle\
available for 33 (77%) of these cases r v ·tli d that til'
deceased had a known history of alcohol misuse ill 73%
(n = 24) of cases. Heroin was dct .crcd in jll~t over two,
thirds of alcohol p sitive cases (671}().
3.5. Recently released prisoners
Of the 443 drug deaths identified over th study period, 62
occurred in known drug users who had be n released mm
prison within I month prior 10their death. nusc of d iurh wus
drug related in 61 cases with on' cas' being ntificd IS uuu •
certained. Morphine (heroin) was implicat d us u cause 01
death in 44 cases (72%). Fig. 5 shows thut er halfthe C[I.~CS
(63%. n = 39) occurred within 1week of rclea .• from pris n,
the majority of these deaths occurred either on the day or
release(8%.11 = 3)orlhedayrollowingrelease( 1%,/1= 12).
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Fig.3. Number of drugs detected in each drug positive case. 1995-1998.
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Table 2
Blood concentrations of opiates and benzodiazepines
Year Morphine range (mg/l) Methadone range (mgll) Temazepam range (mgll) Diazepam runge (mg/l)
1995 0.45 (0.002-3.1) 0.6 (0.04-5.6) 2.1 (0.05-29.9) OJ7 (0.04-2.64)
1996 036 (0.015-1.16) 0.8 (0013-4.59) 0.92 (0.02-4.23) 0.37 (0.031-1.6)
1997 0.25 (0.014-0.9) 0.55 (0.003-2. II) 0.85 (0.05-6.85) 0.45 (0.0 1.6)
1998 032 (0.025-1.26) 0.29 (O.OS--D.96) 0.87 (0.03-9.2) 0.39 (0.06-1.76)
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4 Weeks
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6%
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4. Discussion
Fig. 5. Time period between release from prison and death in weeks (A) and day. (B). I 9 -199M.
Number of Days Following Release from Prison
The number of drug related deaths in the Strathclyde
region of Scotland has risen dramatically since the mid-1980s.
The characteristics of those most at risk have not changed
since first described by Cassidy et al. [9]. The deaths
occurred predominantly in young unemployed males, aged
between 20 and 30 years. With respect to the epidemiology
of infectious diseases, the incidence of I1IV was shov n IU
be very low in the west of Scotland. Th . I w Ire IU '" of
HIV is attributable 10 the efficacy of ne .dlc alld s nllg'
exchange services which were established ill llusgov ill
1993 enabling drug users access to sterile inj 'cring equip-
ment hence reducing the necessity for drug users to vhnr
I 17J. However, the frequency of hepatitis p lSIlIV' CIISCS
show that Gla gow and the urrounding area is by n III llll~
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void of blood borne infectious diseases and this disease
remains a problem for the individual and society.
Whilst some deaths are obviously sudden, the circum-
stances surrounding a number of deaths suggest that had
prompt medical attention been sought at the first indication
of intoxication, death may possibly have been prevented.
Polydrug abuse was prevalent amongst this study sample
with over two-thirds (71%) of all deaths testing positive for
two or more drugs. Approximately two-thirds of the deaths
were heroin related predominantly in combination with a
benzodiazepine drug. As both heroin and benzodiazepines
cause respiratory depression, co-administration results in an
additive effect and the possibility of death is much greater
than if either drug had been consumed alone. The benzo-
diazepine of choice in the early 1990s was temazepam. A
legislation change in 1996 resulted in temazepam being
moved from schedule 4 to schedule 3 of the Misuse of
Drugs Regulations 1985 [18]. This resulted in tighter con-
trols of its prescribing and as a consequence, the availability
of temazepam decreased which resulted in drug users turn-
ing to the alternative and more widely available diazepam.
This explains the decrease in the number of cases testing
positive for temazepam in 1996 and 1997 and the increase in
diazepam positive cases. The increase in temazepam posi-
tive cases in 1998 was attributable to illicit supplies of
temazepam capsules that Hooded the streets of Glasgow
that year. These capsules were reported to be of very high
quality and were known to originate in Europe [19].
The number of deaths involving methadone has decreased
substantially over the study period. This is encouraging as
the frequency of methadone implicated in deaths since the
introduction of the methadone maintenance programme in
Glasgow was initially seen to increase [20J. Since then, the
number of methadone prescriptions issued in Strathclyde has
risen from 76,391 in 1995-1996 to 123,166 in 1997-1998
[21]. Despite this, the decrease in deaths involving metha-
done demonstrates the effectiveness of increased supervision
of dispensing in relation to the diversion of legitimate
supplies of this drug onto the black market. At present,
approximately 68% of all pharmacies in greater Glasgow
provide supervision of the consumption of methadone on the
premises [22J.
In 1997 there was a 23% decrease in the number of deaths
investigated. This figure increased by 35% to 120 deaths in
1998. Although there are a number of possible reasons for
this, it was most likely due to a change in the purity of heroin
in 1998. In 1997, the average purity of a street deal was
reported to be between 15 and 30%. The purity increased to
between 20 and 60% in 1998 to cater for a cohort of novice
heroin users whose preferred method of administration was
smoking. As a result, intravenous drug users were exposed to
higher strength deals [19J. Many would inject their usual
quantity of heroin unaware of its possible high and poten-
tially lethal purity.
Alcohol was detected in approximately two-fifths (41%)
of all deceased. On its own, the level of alcohol was
insufficient to explain death in the majority of the cases.
However, the additive effect with opiates and/or bcnzodiu-
zepines increases the risk of overdosing.
As previously reported, a small proportion of deaths was
shown to have resulted after recent release from a penal
establishment [23J. The predominant drug involved in these
deaths was heroin. In the majority of these deaths, the
deceased overdosed within the first week of release, parti-
cularly on the day of release or day following release,
highlighting the dangers of initiating old drug habits follow-
ing a prolonged period of abstinence.
S. Conclusions
Drug deaths have significantly increased in the west of
Scotland. This presents a challenge for the health lind law
enforcement agencies. Areas that require to be targeted
include the availability of heroin and the illi it supply of
all drugs, benzodiazepines and methadone in particular,
Stricter controls on the latter within the Glasgow city area
have resulted in a significant decrease in the cases involving
methadone. However, bank holidays and closure of phar-
macies on Sundays still remains II problem that is in need of
address from the authorities. This study has highlighted thar
whilst a change in legislation may decrease the av tilability
of one drug, it docs not take long before it is merely repla ed
by another.
Individuals who have been recently liberated from prison
remain a vulnerable cohort. The requirement for an impro-
ved prisoner through care regime is an urea in need of
assessment by the relevant authorities.
We have demonstrated a high incidenc of hepatitis in
the fatalities investigated suggesting II possible major resi-
dual health problem for individuals who su cessfully man-
age to overcome their drug abuse. In view of thi. it is
surprising to have such a low in idence of HIV when the
figures are compared to those in the cast of Scotland.
An education programme for relative and fri ntis of
known drug users to highlight the basic t chniqu s of first
aid would be advantageous. This could in lude th plucin
an individual in the recovery position whilst in (I dru
slate. An area to be addressed includes th' nee 'ssit
summon medical assistance if the individual is unrousuhl '.
Despite significant numbers and quuntitie or dru , sci-
zures in the west of Scotland by trathclyde poli '. th tina t
problem in the west of Scotland, at present. sh
subsiding.
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THE ROLE OF DIHYDROCODEINE IN CAUSING DEATH AMONG DRUG USERS
IN THE WEST OF SCOTLAND
A. Seymour; M. Black, 1. Jay*, 1. S. Oliver
Department of Forensic Medicine and Science, University of Glasgow
*Glasgow Drug Problem Service, Woodside Health Centre, Barr Street, Glasgow.
Abstract: There has been a wealth of information relating to the role of methadone in fatalities over the past
decade. However, a dearth exists in the literature of deaths involving dihydrocodeine, a substitute that is being
increasingly prescribed by general practitionersfor drug harm reduction purposes. Over the past Jive years ill the
Strathclyde region of Scotland there has been an increase in the number of drug related deaths involving
dihydrocodeine with the largest increase occurring in the latter two years. This in combination with a general
acceptance for this drug as a substitute for methadone amongst general practitioners highlights its potentia I
abuse factor which is addressed in this paper. As the number of methadone deaths in relation 10 the totol number
of accidental drug related deaths per annum decrease, those related to dihydrocodeine are shown 10 be increasing,
Key words: Dihydrocodeine, drug-abuse, Strathclyde
Introduction
The increase in drug misuse in the United Kingdom over thepast decade has resulted in an expansion of services for
drug misusers. Consequently there has been an increase in
substitute prescribing by general practitioners (GPs). Whilst
methadone appears to be the most frequently prescribed
substitute for the management of heroin misuse in Scotland,'
the preference for dihydrocodeine (DHC) by a number of general
practitioners is becoming evident.i-' This opioid analgesic,
which is closely related to codeine, is primarily prescribed for
the relief of moderate pain, especially for terminal cancer
patients. Other indications include that of an antitussive drug,
being effective at doses lower than those employed for analgesia
and as an antidiaorrheal (one of the side effects of DHC being
constipation). GPs who regard DHC as a safe alternative to
methadone in detoxification programmes, may prescribe DHC
to patients whose drug dependence is less severe than those
in receipt of methadone. The acceptance of DHC by many GPs
in the United Kingdom as a substitute is of some concern
particularly since DHC is unlicensed for the management of
drug dependence."
There are a few reasons as to why DHC prescribing is
preferred by some GPs over methadone in the management of
harm reduction. A major factor is that DHC is perceived to be
less addictive than methadone with the manufacturers reporting
that it has a "low addiction potential".' The prescription policy
associated with this Class B drug may seem more favourable to
GPs in that several days supply can be dispensed at the one
time. In addition, there is no need for patient follow up care or
the administrative measures that are associated with methadone
programmes.
Over the years, there has been a certain amount of
unfavourable publicity surrounding methadone and its potential
as a drug of abuse, particularly, in relation to the diversion of
legitimate supplies." As a result of an increase in black market
methadone subsequent to the introduction of the methadone
maintenance programme in Glasgow, the supervision of its
Correspondence to: Alison Seymour. Department of Forensic Medicine
and Science. University of Glasgow, Glasgow G 12 8QQ
consumption was enforced and is common practice in a
substantial number of pharmacies in (he Greater Glasgow area
today.' The supervision of DHC is not con. idercd 10 be
necessary, mainly due to this being a near impossible task to
implement due to multiple doses having to be consumed daily
owing to its short half-life. DHC has been subject to virtually
no media interest as a drug of misuse, despite. its abuse by
drug addicts being widely reportecl.2.Ho Due to this poteruial
for misuse, it has been noted that a DHC detoxification
programme should be managed just as carefully as that of
methadone." The presence of this drug as a .oruributory factor
in deaths from narcotic overdoses has also been report cl in
Germany.":"
The purpose of this research was to a. certain the contribution
of DHC in drug related deaths in the West of Scotland. Previous
work showed that changing trend. in drug taking had occurred
over a number of years with the usc of specific drugs being
influenced by their availability and quality.":" Data tor the years
1995 - 1999 (in the Strathclyde region of Scotland) d .rnonsrrucd
an increasing use ofDHC.
Material and methods
A retrospective search of all DHC positive cases investigat cl
by the Department of Forensic Medicine and Scienc , ov r the
five-year study period, 1995 - 1999 was carried ut. Each cas
was classified according to the manner of death as either
accidental or suicidal. The investigation of all accid ilia I
overdose deaths was instigated, the relevant information being
obtained from police, post mortem and toxicology reports.
In Strathclyde, following a suspected drug related death, the
Department of Forensic Medicine and Science is responsible
to the Crown for the full forensic medical investigation of the
death. On completion of a post mortem examination, all biolo tical
samples taken for tox icological purposes are rout inely anal yscd
for the presence of alcohol and drugs using immunoassay, gas
liquid chromatography and high-pres .urc liquid
chromatography. Positive results are confirmed and quantified
by gas chromatography, mass spectrometry.
In all cases a full police report was available. This provided
information pertaining to the extent of the individuals probable
drug misuse and the identity of any medication that had been
143
Seymour, Black, Jay and Oliver ___ Dihydrocodeinc lind drug users
prescribed at the time of death as well as the sequence of events
prior to the overdose.
Results
Over the five-year study period, 89 cases involving DHC were
identified, increasing from 12 cases in 1995 to 42 cases in 1999.
Males accounted for 80% (n = 71) and females, 20% (n = 18).
Death as a result of an accidental drug intoxication accounted
for 58% (n =51) of cases, followed by death due to suicide,
homicide or natural causes (22%, n = 20). Only a small number
of deaths were considered to be deliberate suicidal overdoses
(20%, n = 18) (Table T). Of all 51 accidental overdose cases,
there were only two cases that were not known drug users. In
the remaining 49 cases the deceased had a history of drug
abuse, 69% (n = 34) of whom were known to be intravenous
drug injectors. The majority were male (86%, n = 42) and the
average age was 27 years (15 -42 years). Most of the cases
occurred over the two-year period, 1998 - 1999 (Figure I).
Toxicological analysis revealed that no deaths involved DHC
alone. The concurrent use of DHC and alcohol was detected in
one case and polydrug use was evident in the remaining cases.
The number of drugs detected in samples is summarised in
Figure 2. It can be seen that approximately two thirds of samples
(65%, n = 32) were found to contain three or four drugs. The
most frequently detected drug was diazepam (80%, n = 39)
followed by morphine (59%, n = 29), a breakdown product of
heroin. Of all morphine positive cases, 83% (n = 24) were also
found to contain at least one benzodiazepine. Morphine in
combination with diazepam, temazepam or both accounted for
16, two and six cases respectively. All drug combinations are
summarised in Table 2. The average blood concentration of
DHC was 1.9mg/litre(Median: 0.7mgllitre, Range: 0.0 1- 19.86mgl
litre).
In just under two thirds of cases (65%, n = 32) DHC had been
illicitly obtained. DHC had been prescribed to the deceased in
only 12cases (24%) and no medical history was included in the
police sudden death report for the remaining five cases. Of
those that had been prescribed the drug, 83% (n = 10) were
intravenous drug users. Of those who had obtained the drug
by diversion of legitimate supplies, 69% (n = 22) were known to
be intravenous drug users. From the police report it was
ascertained that in one case involving illicit DHC the deceased
was attempting self-rehabilitation.
When interpreting the results of the toxicological investigation
both the pathologist and toxicologist have to consider the
individuals tolerance and past history of exposure to the drugs
detected as well as the concentration of drug measured. The
provisional cause of death is amended to incorporate those
drugs that were considered to cause/contribute to death.
Of all 49 cases, DHC was implicated in the cause of death
either alone or in combination with other drugs in II cases
(22%) and eight cases (16%) respectively. Of these cases, the
vast majority had occurred in the latter two years. A cause of
death involving DHC alone accounted for one case and eight
cases in 1998 and 1999 respectively and a cause of death
involving other drugs for two and five cases respectively.
The authors then reviewed the cases and divided the deaths
into three categories depending on the history of the case,
drugs detected and concentration of drugs. Death where DHC
was considered the sole factor in causing death irrespective of
other drugs present were classified as "DHC only" deaths.
"DHC related" deaths were those where the concurrent use of
DHC and other drugs resulted in death and finally cases where
a drug other than DHC was attributed to death were classed as
"non DHC related".
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Table I
Brcllkdown of dihydrocodcinc pusotive cases
Dihydrocodeine posotive cases (II = 89)
Suicidal overdose I 8
Suicide/homicide/Natural causes 20
Accidental overdose 51
Fig.': Accidental overdoses of known drug users involving dihydrocodcinc
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The results revealed that over half of cases were either classed
asDHC only (22%, n = I I) or DHC related (3S%, n = 17).Alcohol
was found to be present in 19 cases (39%). The average blood
alcohol concentration (SAC) measured was I 10mg/ 100mi
(Median: 69mg/ IOOml,Range: S-400mg/l OOm1).[n over one hal f
of these alcohol positive cases (63%, n = 12), morphine was
also detected, 42% (n = 5) of which were also found to contain
benzodiazepines.
DHC is available in the United Kingdom in oral and parenteral
(SOmg/ml injection) formulations. The oral preparations include
an elixir syrup (I Omg/5ml) and tablets of varying strengths
(30mg, 40mg, 6Omg,90mg and I20mg). The 60mg - 120mg tablets
are controlled release formulations allowing one tablet to be
swallowed every twelve hours. Figure 3 shows that the majority
Table II
List of drugs detected in samples----------------
No of Combination of drugs
drugs
I Dihydrocodeine (I *)
No uf
cases
The following relate to dihydrocodcine plus:
2 Fluoxetine
Methadone (I *)
Diazepam (3*)
Morph ine (2 *)
3 Morphine+methadone (I *)
Morphine+diazepam (3*)
Morphine+temazepam (1*)
Diazepam+temazcpam
Diazcparn+diphenhydramiue (1*)
Diazepam+FI uoxct ine
4 Morphinc+diazepatl1+lcmaZCpat1l (2*)
Morph ine--d iuzepnrn-sch lord iuzcpox ide
Morph inc+d iazcpam-sca nnabi s
Morphine+diazepatll+mcthadonc (1*)
Morphine+remazepam-cunnams (1*)
Morphi ne+rncthadonc-scoomne (I *)
Diazepam+melhaclone+co-prox3mol (1*)
Di azepa m+met hacione+te mazepn 111
D iazepam+temazepatn+warfari n
5 Morph ine--di azcpam-scan nahi s+paracctarnol
Diuzcpam+methadone.-c ycl izi nc--prot hi aden
Diazepam-rami tri pi y Iine+diconn I+110rt ri pi y Iine
Total
• Alcohol detected
49
1
X
]
I
10
I
I
1
I
6
2
2
2
of prescriptions dispensed within the Strathclyde area occurred
in the Greater Glasgow region. There was anoverall II % increase
in the number of prescriptions dispensed between 1995 and
1999. Figure 4 illustrates that the formulation of choice appeared
to be that of the 30mg tablet which accounted for thr c-quan rs
(7S%, n = 687,736) of all DHC formulations prescribed. This wa:
followed by the 60mg tablet (20%, n = 183,746), the 90 und
120mg tablet (each 2%). Th 40mg tablet, the lixir syrup and
injection preparations jointly comprised I 0 of the rota) amount
prescribed. rs
DHC positive cases and DHC deaths (those d aths lassificd
as DHC alone and DHC r lated) were compared with all
methadone positive cases and methadone cl aths as a
percentage of all accidental drug related deaths over the study
period. Figures SA and S . hows that on a y ar to y ur basis.
the frequency of methadone positiv ascs and m thadon
deaths have been decreasing in contrast to rhos involving
DHC which were shown to increase .
Discussion
In addition to heroin and benzodiazcpincs, th rol or DH as.t
significant drug of misuse has been detected in the W'SI of
Scotland. Over the latter two years of this study. Iher was a
significant increase in the number of drug related death cases
testing positive for this drug.
Over the past decade pallerns of drug taking as seen in drug
deaths have varied depending on drug availability, 'hanges in
legislation and the quality of the drug. For example, Ihc
rescheduling of temazepam in 1996 from schedule 4 of the
Misuse of Drugs Regulations 1985 to schedule 3 resulted in
diminished availability of this drugl9 and consequcntly
diazepam emerged as its substitute in the heroin-bcnzodiazel in'
cocktail favoured by the Strathclyde drug misuser.2o
It has been speculated that dihydrodocodeinc is used during
periods of heroin deficit either due to personal circumstances
or a lack of availability of street heroin.Y However, this study
revealed that DHC had been taken in combination with heroin
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in over half of all cases. Of all heroin positive cases, 90% were
known to be intravenous drug users.
Similar to all drug related deaths in the West of Scotland, the
presence of a cocktail of drugs presents a problem. DHC like
other narcotics, interacts with other drugs to depress the central
nervous system and consequently leads to acute respiratory
depression and respiratory failure. This is recognised at post
mortem by the presence of pulmonary congestion and oedema
which is often the only significant autopsy finding in a drug
related death. It should also be noted that the depressant effects
of alcohol are enhanced by DHC.
The majority of DHC in this study had been obtained by the
diversion of legitimate supplies. This is similar to findings of a
study investigating methadone deaths in the same region where
black market methadone accounted for the majority of the
methadone involved. It is possible that the increased quantities
of DHC prescribed over the study period have resulted in
increased availability on the streets. This in turn makes DHC a
low cost analgesic, which presently can be bought, on the streets
of Glasgow for between 50 pence and £ 1.00 (Personal
communication with Strathclyde Police Drug Squad). The
pharmacokinetics of the most frequently prescribed 30mg DHC
tablet render a supervised programme almost impossible to
implement as the half-life is significantly shorter than that of
methadone. This in combination with the fast acting properties
of DHC means that often several doses have to be taken
throughout the day.
A review of the contributory factor that DHC had in deaths
revealed that more deaths were considered to be due to DHC
alone or in combination with other drugs when compared to the
causes of death assigned. This is due to the varying practice
by different pathologists when amending a cause of death in
that some will include all drugs detected going on the theory
that they have an additive effect on each other. However, in
other cases, a drug that is detected at low levels may simply be
disregarded. This review highlights that DHC as a drug
contributing to death should not be overlooked.
The decreasing prevalence of methadone deaths with respect
to the total number of accidental drug related deaths per annum
reflects the positive impact of increased supervision of its
consumption. What is of some concern is the fact that as the
figures for methadone decrease, those for DHC increase.
Conclusion
DHC as a suitable, safer alternative to methadone prescribing
is questionable. The increasing prevalence of DHC detected
amongst drug related deaths and the consequent conclusion
that it has attributed to death, particularly over the past two
years has been highlighted. The present situation reveals that
the initial problems encountered with methadone dispensing,
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such as diverted methadone, has been resolved and is reflected
in the decreasing numbers of methadone deaths per annum.
However, an increase in DHC prescribing has resulted in an
increase in DHC related deaths possibly due to this drug bcing
more readily available and inexpensive to buy on the streets.
Whilst in some aspects, DHC may appear to be a good
alternative to that of methadone, its abuse potential should not
be overlooked. The incidence of DHC detected in cases is a
matter of concern and requires monitoring to establish if this is
a "real trend" or "fashionable phase".
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Asymptomatic peripheral
arterial occlusive disease
and erection problems
We would like to report the association
between peripheral arterial occlusive dis-
ease (PAOD) and perceived erection
problems found in the Limburg PAOD
study. I
Intermittent claudication (IC), the first
symptomatic stage of PAOD, is a com-
mon atherosclerotic condition among
mostly elderly subjects. However, the
majority of PAOD cases are asympto-
rnatic.' Symptomatic PAOD is associated
with organic impotence, particularly
when the occlusion involves the aortoili-
ac vascular bed.2 Data on the prevalence
of erectile impairment in asymptomatic
PAOD subjects are non-existent.
Our study population consisted of
3649 male subjects (47%) with a mean
age of 59 years (range = 40 to 78 years),
who were selected out of a group of 26
620 subjects from 18 general practice
centres by means of a stratified sampling
procedure. Strata were formed on the
basis of the number of positive answers
on a short postal screening question-
naire, concerning complaints on walking
and cardiovascular risk.' PAOD was
defined as an ankle-brachial pressure
index (ASPI) <0.95, measured twice in
the same leg with a one-week interval.
The ASPI was calculated as the ratio of
ankle systolic blood pressure to the high-
est arm systolic blood pressure, using a
Doppler device. Reproducibility and
diagnostic accuracy of Doppler ASP I
measurements have been shown to be
adequate.v' IC was assessed according
to a modified version of the Rose ques-
tionnalre.'> Asymptomatic PAOD was
defined as an ASPI <0.95 without IC
complaints. In addition, data were col-
lected on experienced erection prob-
lems, smoking habits, hypertension, dia-
betes, and hypercholesterolaemia.'
Among male asymptomatic PAOD
subjects, 44% (66 out of 150) reported
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erection problems compared with 25%
(358 out of 1405) among male subjects
without PAOD. For claudicants. this num-
ber was 47% (41 outof87).
Logistic regression analysis showed
that experienced erection problems were
significantly associated with asympto-
matic PAOD (odds ratio = 1.6, 95% con-
fidence interval 1.1-2.4). as well as with
symptomatic PAOD (odds ratio = 1.6.
95% confidence interval 1.2-2.9). adjust-
ed for higher age, smoking, diabetes,
hypercholesterolaemia. and hyperten-
sion.
Our findings are consistent with the
notion that subclinical atherosclerosis of
the aorta and distal arteries (aortoiliac,
penile, and testicular arteries) may result
in penile ischaemia. In case of a patient
complaining of erection problems, the
general practitioner could perform a vas-
cular physical examination including
ASPI measurements and assessment of
atherosclerotic risk factors. Positive find-
ings raise the possibility of organic impo-
tence. Conversely, in male subjects with
asymptomatic or symptomatic PAOD,
attention could be paid to the possible
presence of erection problems.
JD Hooi
HEJH STOFFERS
JA KNOTINERUS
PELM RINKENS
JW VANREE
Research Institute for Extramural and
Transmural Health Care (ExTra), and
Department of General Practice,
Universiteit Maastricht, The Netherlands.
References
1. StoffersHEJH.RinkensPELM.Kester
ADM.et al. Theprevalanceof asympto-
maticandunrecognisedperipheralarterial
occlusivedisease.tnt J Epidemio/1996;
25: 282-290.
2. MichalV.Arterialdiseaseasa causeof
impotence.Clin Endocrino/ Metab 1982;
11: 725-748,
3. StoffersHEJH.KaiserV.KesterADM.et at,
PeripheralarterialocclusivediseaseIn
generalpractice:thereproducibilityof the
ankle-armsystolicpresureratio.Scand J
Prim Health Care 1991; 9: 109-114.
4. StoffersHEJH.KesterADM.KaiserV,et al.
Thediagnosticvalueof themeasurement
of theankle-brachialsystolicpressure
indexin primaryhealthcare.J Clin
Epidemio/1996; 49: 1401-1405.
5. RoseGA,BlackburnH.GillumRF,Prineas
RJ.Cardiovascular Survey Methods,
Geneva:WHO,1982.
Dihydrocodelne - drug of
use or misuse?
An increase in drug misuse in the United
Kingdom has resulted in an increase in
substitute prescribing by GPs, While
methadone appears to be the most fre-
quently prescribed substitute for the
management of heroin misuse in
Scotland, I there is evidence of a growing
preference for dihydrocodeine (DHC) by
general practitioners (GPS).2.3GPs. who
regard DHC as a safe alternative to
methadone. may prescribe DHC to
patients whose drug dependence is con-
sidered to be less severe than those in
receipt of methadone. Another factor
affecting their choice is the perception
that DHC Is less addictive than
methadone." In addition, the prescription
policy associated with this Class 8 drug
may seem more favourable in that sever-
al days supply can be dispensed at the
one time without supervision. There is no
need for patient follow-up care or the
administrative measures that are associ-
ated with methadone programmes.
The deaths we investigated revealed
that over the years 199B to 1999. there
was an increase in the number of drug-
related deaths involving primarily illicitly
obtained dihydrocodeine and this is in
contrast to a decline in deaths involving
methadone. Dihydrocodeine-positive
cases have risen from 4% of all acciden-
tal drug overdose cases in 1997 to 15%
between 1998 and 1999. There was an
observed decline in methadone-related
British Journal of General Practice, May 2001
deaths, from 29% to 21%, over the same
time period. Polydrug use was prevalent,
with the most frequently detected drug
being diazepam (80%) which was fol-
lowed by morphine (59%), a breakdown
product of heroin. Of all morphine-posi-
tive cases, 83% were also found to con-
tain at least one benzodiazepine, making
for a potentially lethal combination lead-
ing to acute respiratory depression and
respiratory failure.
It can be speculated that an increase
in DHC prescribing over the study period
has resulted in increased availability on
the streets, This, in turn, makes DHC a
low cost analgesic which presently can
be purchased on the streets of Glasgow
for between 50 pence and £1.00 (per-
sonal communication, Strathclyde
Police, 2000). Its use during periods of
heroin deficit has been highlighted5 and
confirmed during the spate of contami-
nated heroin deaths in Glasgow during
the year 2000 (personal communication,
Glasgow Drug Problem Service, 2000).
While in some aspects, DHC may
appear to be a good alternative to that of
methadone, its abuse potential should
not be overlooked. The incidence of
DHC detected in cases is a matter of
concern and requires monitoring to
establish if this is a 'real trend' or 'fash-
ionable phase'.
ALISONSEYMOUR
MARJORIEBLACK
JOHNS OLIVER
Department of Forensic Medicine and
Science, University of Glasgow, Glasgow
G12800.
JANEJAY
Glasgow Drug Problem Service,
Glasgow G20 7LR.
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A comparison between
patient consultation
satisfaction scores from a
trainer and registrar in a
Nottinghamshire practice
Patients' agendas are often not fully
addressed during the consultation.' This
may lead to low levels of patient satisfac-
tion with consultations, poor compliance,
and poor outcome." With experience,
general practitioners (GPs) may be
expected to become more adept at
addressing these patient agendas and
general practice registrars may be
expected to demonstrate a lower level of
patient satisfaction than their trainers.
We measured patient satisfaction with
their consultations with a general prac-
tice registrar and trainer in a rural
Nottinghamshire practice in 1996, using
the Consultation Satisfaction
Ouestionnaire (CSO, Eli Lilly National
Clinical Audit Centre)." The practice had
six-and-one-half partners and a list size
of 12 000. A personal list system was not
used, although patients were encour-
aged to see the same doctor for a single
episode. The registrar was in the third
training month and the trainer was a prin-
cipal with over 10 years' experience.
The criteria were defined with refer-
ence to a large study of CSO results in
126 GPS.4The csa has four sub-scales
and the audit standards were defined as
an 80% general satisfaction with the
quality of consultations, 82% with profes-
sional care, 73% with depth of relation-
ship, and 72% with perceived time.
Consecutive adult patients and
younger patients accompanied by adults
were asked to complete the csa imme-
diately after their consultation until 75
questionnaires were available for each
doctor, and to give freetext comments.
The trainer and trainee differed signifi-
cantly only in respect of general satisfac-
Letters
tion (Table 1). However, the range of sat-
isfaction scores was greater for the
trainee. These findings suggest that
patients may not discriminate between
doctors on the basis of clinical skill.
Instead, they may value characteristics
such as empathy, the ability to listen,
and an appreciation of their point of view.
The free text comments suggested that
longer consultations and shorter waiting
limes were important to patients.
ANDREWMARTYNTHORNETT
Department of Psychiatry, University of
Southampton, Royal South Hants
Hospital, Southampton S040 8XP. E-
mail: eanador@soton.ac.uk
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Natural history of lower
respiratory tract illness
Holmes et all present pertinent observa-
tional data on the prolonged natural nts-
tory of lower respiratory tract Illness
(LATi) in the community, with or without
antibiotic treatment, an important meso
sage for all general practitioners (GPs),
The paper and the accompanying eonor-
ial2 assume that antibiotics are inappro-
priate for many patients presenting in
this way, although both recognise the dif·
Table 1. CSQ satisfaction scores for the GP trainer and GP registrar compared with the
audit standard (standard deviation in brackets).
Mean score for Mean score for Student's t·tesVANOVA
GP registrar GP trainer P-value (trainer/trainee
(%) (%) comparison)
General satisfaction 75.6 82.2 0.022
(16,9) (13,5)
Professional care 79.6 79.3 0.910
(13.6) (10.5)
Depth of relationship 63.6 68.7 0,072
(15.5) (13.9)
Perceivedtime 66.5 71.1 0.180
(20,2) (17.0)
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INTRODUCTION
ABSTRACT
Aim To explore the recent contact with health and social services by drug
misusers who died of a fatal overdose and identify opportunities for preventive
intervention.
Design Retrospective case analysis.
Subjects Eighty-seven residents of the Greater Glasgow area who died of a drug
misuse-related overdose in ] 999.
Methods Analysis of matched data from several sources; Strathclyde Police;
University of Glasgow Department of Forensic Medicine and Scien .c: the
Scottish Prison Service; general practitioners' medical notes, including records
of accident and emergency attendances and psychiatric assessments; and llvc
specialist agencies for drug misusers or the homeless.
Findings Most of those who died of an overdose were males, long-standing
heroin injectors and resident in a deprived area. Heroin caused most deaths,
either alone or with other drugs. Twenty-three per cent died within 2 weeks of
release from prison. For the 77 whose medical records were available, 90'Y.,had
seen their general practitioner (32% in the month before death), 48% had
attended accident and emergency services and 22% had received a ps chlatrlc
assessment in the year before death, Over 40°Ir,of the 87 used a drug agen in
the year before death and 20% had used more than one agen y,
Conclusions Previous suicidal ideation, attempted suicide and d 'pression wer
common among those who died of an overdose, as was rec nt rei as from
prison. Almost all had been in contact with and several were reeeiving sp Ilk
treatment from health or specialist addiction services in th ilr I(lSI W' .ks or
months. The findings highlight both the nurn irous opportunlu ·s for lntcrv 11-
tion and the challenge of using them to prevent death.
KEYWORDS Drug misuse, fatal overdose, mental health, s rvlc usc,
Deaths due to drug-misuse related overdose are on the
rise in many countries (ACMD 1998). Increases have
been noted in Australia (Hall & Darke 1998: Hall et al.
2000), continental Europe (Risser & Schneider 1994:
Davoli et al. 1997; Seidler et al. 2000). the United King-
dom (Hall et al. 2000; Neeleman & Farrell199 7) and the
United States (CDC 2000). A recent report from the UK
Advisory Council on the Misuse of Drugs concluded that
health and social services could playa role in reducing
ID 2002 Society for the Study or Addiction to Alcohol and Other Drugs
drug misuse-related deaths by engaging more a 'lively
with vulnerable individuals (ACMD 2000).
Studies of both fatal and non-fatal overdoses have
provided information about the corrclat 'S and ir .urn-
stances or drug overdoses. Most fatal ov irdos ·s o· ur
among men with a long history of heroin misuse (Darke
& Zador 1996; Hall & Darke .1998: Risser I't al. lOOO)
who tend to be unemployed (Cassidy et Ill. 1995) or
socially deprived (ACMD 2000). Fatal ovcrdos 's ar . oftell
the result of drug interactions, particularly h roin in
combination with alcohol or benzodlazeplncs (Davoli
Add/crioll. 97, 1517-1522
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etal. 1993; Hammersley etal. 1995; Darke &. Zador
1996; Gossop et al. 1996; Zador et aJ. 1996; Frischer et al.
1997; Hall & Darke 1998; Powis et a1. 1999: White &
Irvine 1999; Risser et al. 2000; Zador & Sunjic 2000:
Seymour et al. 2001). There is an increased risk of over-
dose when tolerance is reduced after a period of absti-
nence. such as those recently discharged from treatment
or released from prison (Davoli etaJ. 1993: Darke, Ross
& Hall 1996: Strang et al. 1996: Groenemeyer 1997:
McGregor et al. 1998; Seaman et al. 1998; Zanis & Woody
1998; Seymour et al. 2000). However, little is known
about the use of general medical or specialist services in
the year before death. In this paper, we describe the resi-
dents of an urban area with a high prevalence of drug
misuse who died of a drug-related overdose in 1999 and
their use of services in the year before their death. We
then consider the potential for the involvement of these
and other services in preventing further deaths.
METHODS
With the consent of the Regional Procurator Fiscal (the
prosecuting authority in Scotland), Strathclyde Police
provided demographic information on all 87 sudden
deaths among drug misusers in the Greater Glasgow area
in 1999 where the cause of death was found to be a drug
overdose. These were defined as deaths with 'prima facie
evidence of a fatal overdose of controlled drugs. Such evi-
dence would be recent drug misuse, for example, con-
trolled drugs and or a hypodermic syringe found in close
proximity to the body and/or the person is known to the
police as a drug misuser, although not necessarily a noti-
fied addict' (Ministerial Drugs Task Force 1994). The
overdose must have been of an apparently accidental
nature without evidence of suicidal intent. All patholog-
ical and toxicological investigations to establish a cause of
death and the drugs implicated were carried out by the
University of Glasgow Department of Forensic Medicine
and Science. Information on recent imprisonment was
obtained from the Scottish Prison Service.
Carstairs deprivation categories (Carstairs & Morris
1991) were assigned to the postcodes of residence of the
deceased. The Carstairs index is a summary measure of
relative deprivation or affluence applied to populations
contained within small geographical areas. These arc
ranked using a combination of socio-economic variables
from the 1991 census (percentage of households with no
car ownership, male unemployment, overcrowding and
social class IV and V). Scores from 1(most affluent) to 7
(most deprived) are then produced for each postcode
sector.
The names and dates of birth of the 87 individuals
were used to obtain general practitioners' medical
© 2002 Society for the Study of Addiction to Alcohol and Other Drugs
records for 77 (89%) cases. Ten records were unavailable
because they were subject to legal proceedings or the
individual had recently moved to Crcuter Glasgow und
had not yet registered with <J general practitloncr In th '
area. Psychiatric diagnoses and attendances at accident
and emergency departments were all verlli 'd by a leucr
from the service in the medical records.
Names and dates of birth were also used 10 rnntch the
deaths with five databases held by agencies providing
services in Glasgow: Glasgow City Council So ial Wurk
Addiction Services, who manage most of the cornmunu
drug services in the city; the Glasgow GP Drug Misuse
Clinic Scheme. a shared-care scheme enabling general
practitioners to prescribe methadone to oplntc-dcpcndcnt
patients: the Glasgow Drug Problem Service, El specialist
medically led service assessing and tr iating opiate
dependent patients referred by general pracuuon .rs: the
Glasgow Drug Crisis Centre, a 24-hour service that pro-
vides assessments, needle exchange, in-patient. rcsldcn-
tial treatment. out-patient methadone treatment and
referrals; and the Hamish Allan Centre. a 'one-door' 24-
hour emergency service lor all homeless indivlduuls and
farnilles in Glasgow. Contact information wa: obtained
[rom each of the five agencies for the 12 months before
death.
RESULTS
Most or the 87 Glasgow residents who dl cl of II drug-
related overdose were single (80'X,), un mplo cd (94%)
and male (83%), with a mean age of 9 years: 8 3n~,II cd
in deprived areas with a arsuurs deprivation s 'or of
either 6 or 7 and 29% had b 'en homeless It some time III
the year before death.
Sixty-nine per cent eli d In a private hOI11 their own
(26%). Cl friend's (25%) 01' II r lutlv 's (1 WYo,). Flflc 'n per
cent died In a hostel <1IIe1 11% dled ln u publl .placc, such
as a hot 'I ( %). publl ' totlet (5%) or Oil lh . stre ts 01' In II
disused building (4%). I'ivc per C nt dl .d In <1 hospital or
on their way to a hospital. Over II third (36%) dlcd 01011',
but most di cl In th ' pres 'n .e of orh 'I' people, who w re
either in the house but not th slime room (14%) or 1111he
same room (25%). In onl ·16%or us's did those pres 'nt
say they were aware thut there was (I pot mtlul probleru.
In only five 'as s was an umbulanc cull 'd while the
deceased was still alive, und in one 01' these the p"'rSOIlWIiS
dead when the Clmbulunce urrlv·'d.
Almost hair (49%) had b' 'n in prison in til' I 'ur
before death. Nine per cenL died within tl w' 'k of l'tlVilll,l
prison and anot.her J 4% di(:d within 2 w'cks or bring
released, Only four individuals (5%) had b 'en In r' -Iden-
tial rehabilitation in the yellr before d'lith und htllf or
those died within J 0 days or release.
AMI tloll. 'l7. 15t7 t52
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The route of administration of the drug(s) was
.'recorded for 74 of the 87 deaths. Of these. the drugs had
been taken by injection in 72%. orally in 16%. smoked in
3%. snorted in 3% and by unknown means in 7'Y.r.
Figure 1shows the drugs considered by the pathologist to
have played a part in causing death. A single drug was
implicated in 53% of the deaths and more than one in
43%. Four cases were unascertained. Heroin was impli-
cated in 74% of deaths, either alone (37'Yc,) or in combi-
nation with other drugs (37%). Diazepam (28%) and
temazepam (17%) were frequently involved. Alcohol and
methadone were each implicated in nine deaths (lO'Y,,).
Recorded contacts with general practitioners. acci-
dent and emergency (A&E) departments. psychiatric
services and specialist services for the treatment or
drug misuse and dependence are presented in Table l. All
recorded attendances at A&E departments. psychiatric
services and specialist services and those in the last year
are shown. the latter as an indicator of the extent of seri-
ous health problems and service contacts leading up to
the death. Over 90% of the deceased had seen their gen-
eral practitioner at least once in the year before death and
almost 60% more than six times. Thirty-two per cent had
been seen within a month of their death. In the year
before death. 48% had gone to an A&E department at
least once. most often for an assault or overdose. Over
half had ever attended for an assault and a quarter after
attempted suicide. Twenty-two per cent had been as-
sessed by a psychiatrist in the previous year and 45% ever.
Suicidal ideation, depression and anxiety-related disorder
were the most common psychiatric diagnoses. Those
assessed by a psychiatrist in the year before death were
much more likely than the others to have attended <In
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Figure I Drugs implicated in 87
fatal drug misuse-related overdoses 20
in Glasgow in 1999 (total exceeds
87 as many deaths were due to
more than one drug). "Other 10
drugs include dihvdrocooeioe .
•f·· ecstasy. cocaine, gamma hydroxy-
i/'i butyrate, chloral hydrate. DMD.~:~~i.~amltryptyhne
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accident and emergency department for a drug ovcrdos '
in the past year (44% and 17%. r .spccuvcly). Twenty-
seven per cent of all cases had received drug counselling
and 3H'X. had been prcscrib 'd substitute drugs in the pre-
vious year. 01' which the most com mnn was methadone,
Six per cent had seen their (;1' in the month before d 'ulll
for Cl prescription 01' substitute drugs.
Over 40% 01' those who died of a drug overdose ill
1999 had used at least one of the lour spcciallst drug
agencies in the year before death (Table 2). Twenty-three
per cent used oniy one service, while 14% and 6% had
used two or at least three drug services, respectively. A
higher proportion or women had used services Ihan men
(73% versus 36%). The Glasgow City Council Social Work
Services were used most by bOIh men uud women. fol-
lowed by the Drug Crisis Centre. Onl 2% had been in
contact with a service in the month before death.
The overlap between use of drug services, accident
and emergency departments and psychlnt rists In Ihe ear
before death is shown in Fig. 2. Three-quarlers 01' I hose
who had had a psychiatric assessment in Ihe year had
also used other services. Iialf or those using specialist
drug services had also attended accident and emergency
departments. Five people had used all three t pes or
service.
DISCUSSION
The majority or the deceased in Ihis st ud were slmtlur tn
those dcscrib 'cl in previous studies or ralai cl ug rnlsuxe-
related overdose: cxp .rtcnccd heroin users, lISUlIlI1 111('11
in their 20s or 30s whu wen: rcsldcnt In soctull deprived
IldlllrllclII, -n. IS 17 I <;~~
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Table I Drug-related medical histories of 77 Glasgow residents
who died of a drug-misuse-related overdose in 1999.
Number
(valid %)
No. of GP visits in year before death
o 7 (9)
1-5 26 (35)
6-15 23 (31)
>15 19 (28)
missing 2
Time between death and last GP visit
<I week 13 (17)
I week-I month II (15)
> I and <3 months 15 (20)
3-6 months 17 (23)
6-12 months 12 (16)
> I year 7 (9)
missing 2
Year before Ever
death
A&E attendances'
All 37 (48) 59 (77)
Assaults 17 (23) 41 (53)
Suicide attempts 7 (9) 20 (26)
Drug overdoses" 17 (22) 29 (38)
Injection-related problems' II (15) 22 (29)
Psychiatric diagnoses'
All 17 (22) 35 (46)
Suicidal ideation 8 (10) 13 (17)
Depression 7 (9) 15 (20)
Anxiety-related disorders 8 (10) 14 (18)
Schizophrenic-related 4 (5) 4 (5)
disorders
Personality disorders 4 (5) 6 (8)
History of abuse 2 (3) 6 (8)
Drug counselling or treatment'
All 27 (35.1) 51 (66.2)
Counselling 21 (27.3) 39 (50.6)
Detoxification I (1.3) 9 (I 1.7)
Residential rehabilitation 4 (5.2) 16 (20.8)
Drug replacement'
All 29 (37.7) 58 (75.3)
Methadone 22 (28.6) 43 (55.8)
Dihydrocodeine 8 (104) 21 (27.3)
Benzodiazepines 15 (19.5) 33 (42.9)
apatients may be included in more than one category.
bDoes not include suicide attempts.
'Injection-related problems include abscesses, deep vein thrombosis, cellulitis
and needles broken ofTin skin.
areas. Heroin was involved in most deaths, usually
injected and often in combination with other drugs. Most
died at home, often in the company of others. However.
the police reports indicated that in only 16% of cases was
anyone present aware of a potential problem once the
<02002 Society for the Study of Addiction to Alcohol and Other Drugs
Table 2 Number of drug agencies coota d In the ye¥ before
death by Glasgow residen who died of drug m.susc-relat
overdose in 1999.
Male Female Towl
Number of services
None 46 (64%) '1 (27%) 50 (58%)
One 16 (22%) 4 (27%) 20 (23%)
Two 7 (10%) 5 (33%) 12 (14%)
Three or mone 3 (4%) 2 (13%) S (6%)
Type of service
Specialist social work 14 (19%) 6 (40%) 20 (23%)
services
GP drug misuse clinic '1 (6%) 4 (27%) 8 ( %)
scheme
Drug problem service 9 (13%) '1 (27%) 13 (15%)
Drug crisis centre 12 (17%) 7 (47%) 19 (22%)
Figure 2 Number of individual~ u nd"'lg drug rVI 5. acod I1t
nd emergency (A& ) d partrn nts , nd p ychlalrtC St;rvlCe5 in the
year before cl ath, *Twcnty- IV of the 7 who died from a dfl,i)l
overdos in 1999 do no appear on this di. gram. For 10. I' • or'(l1
w re not vt ilabl for A& . and psy~hlatnc as sm nts, (her (ore
this m y b an und !"CountFift n of rh 87 (17%) had nOI anend d
a drug service. A& or ne lved psych,atnc ,lSS S m nt In Iht' YNr
before d th.
overdose had occurre I. Thus. If oth 'I' drug users. their
family and friends were train 'd to idcuuf the silins or
overdose and otf 'r mtervenuon. drug d 'ulhs ould poicn-
tially be reduced. ln 2000. It waH 'sllmul'd that there
were betw 'en 6000 and 86()() drug 1nl .tors In (;r'ulCr
Glasgow (Hay et at. 20(1). 'l'h • 87 cl '01 hs Ihus r 'pres 'Ill
an annual inciden .c of I-I. %. 'l'h . male to fcmulc rutlo
among those who died was : 1. .omparcd wlth },; I
among Greater Glasgow tnjectors in g sn 'rul (I ia ('e (/1.
2001). The overdose death rate and the' . 'SS of milk'
deaths are both similar to those r 'porl'd III ( ther stlldlt:S
(ACMD 2000),
One of the limitations 01' lhis stud Is lh IU('k of II
comparison group to determine whether those who died
attended services or received lrealrnenllllur uri'" of'lell
ilrll/lrtloll. 97. 1~ (7-1521
i~{
[:(i' than those who did not fatally overdose, However. it was
(t' beyond the scope of the study to obtain relevant informa-r tion from a representative community-based sample of
i.:' living drug misusers. which could be the subject of future
research, We were also aware of the variable quality of
the medical notes and service databases. It is highly likely
that some service contacts were not recorded: therefore.
our data represents the minimum number. We also did
not have access to certain categories of information. such
as the circumstances of previous overdoses.
Despite these limitations. our study offers new in-
sights into the extent of contact by the deceased with ser-
vices in the weeks and months before death. We found
that almost all the 77 individuals with available medical
Recent contact with services by drug misusers who fatally overdosed
records had seen their general practitioner in the year
before death. often on numerous occasions, Many had
attended an accident and emergency department in the
past year. most often following an assault or overdose.
Over 20% had been seen by a psychiatrist in the previous
year who typically diagnosed suicidal ideation. depres-
sion or anxiety disorder. As we only recorded diagnoses
verified by a mental health professional. the true preva-
lence of mental disorder is likely to be greater. Those
assessed by a psychiatrist in the previous year were also
more likely to have had a non-fatal overdose during the
same period, The depression and suicidal ideation and the
large number of recorded previous suicide attempts make
it unlikely that all the deaths were entirely accidental. In
a recent study in two cities in Scotland. suicidal intent
was expressed by about half of those who had overdosed
but survived and was associated with a history of mental
health problems (Neale 2000). Therefore. drug users
expressing suicidal ideation should be seen as at a par-
ticularly high risk of death from overdose.
Contact with specialist drug services was also com-
mon. Over 40% had used at least one of four specialist
drug agencies in the year before death and 20'1., more
than one. Drug counselling had been given to at least
50% ever and 25% within the previous year, Substitute
prescribing was common. with over 75°/', receiving a pre-
scribed opiate or a benzodiazepine at some time and
almost 40% in the past year,
Despite all these contacts with helping services. the
individuals in this study died. Could their deaths have
been prevented? We do not know enough about the cir-
cumstances of the deceased and the type and quality of
the services they received to be certain. However. we
would agree with the UK Advisory Council on the Misuse
of Drugs (2000) that careful risk assessment should
always be carried out by specialist drug services and
intensive support given. whenever appropriate, That
should include simple and accurate information about
overdose risk and how to recognize and respond to the
danger signs in others (Strang et al. 1999). General prac-
© 2002 Society for the Study of Addiction to Alcohol and Other Drugs
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titioners can play Cl major role in treating drug misusers
themselves and coordtnaung care with specialist servl .es
(Gruer et al.1997; Hutchison 1'1 al. 20(0), A&E depart-
ments clearly often sec drug users in crisis and thus hav '
an opportunity La provide help. Enabllng them to do so
represents Cl major training challenge. 'ocxlsung drug
dependence and other mental health disorders cun be
a very complex combination. Do we have enough stuff
with the expertise 1.0 perform an adequate assessment
and offer the most appropriate treatment? A specialist
'cornorbidity team' was established in Glasgow in 20001.0
begin to fill this gap.
A loss of drug tolerance was a probable contributing
factor in at least 25% of the deaths, Twenty people died
within 2 weeks of release from prison and Iwo within 10
days of leaving residential rehabilitation. The S .oulsh
Prison Service has recently recognized this problem and
has implemented new strategies designed to help reduce
drug deaths. These include provldlng known drug users
with pre-release information about the risks of overdose
and arranging for continued support to be provided b
community drug services after release. However. it is too
early 1.0 say how Widely and iffcctlvelv this approach is
being implemented across the prison service. In particu-
lar. drug misusers who arc remanded in custody or
released at short notice may be more likely 10 miss OUI.
Managers of services providing residential rchablllrat ion
also need to be aware of the risks or loss or tolcranc and
advise their departing lients accordingly,
In conclusion. this stud has shown that. ill Glasgow
in 1999. the weeks and months bcfor drug rnlsusers died
or an overdose were often characterlz cl by nom rous
contacts with services. The DV irall pi ture Ihili 'Ill rges is
largely one or disturb 'cl p sopl lading chaon . lives who
die despite the help they may have re .elvcd. This under-
lines the dim 'ult! 'S in pr venting cl al h. lllt also high-
lights t.he opportunlu S lhul may 'xISII'or 'rI" ·tl c h 'Ip til
be given.
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Death by Obstruction
Sudden Death Resulting from Impromptu Ingestion of Drugs
Alison Seymour, B.Sc., Marjorie Black, M.B., Ch.B.,
Jeanette H. McFarlane, B.Sc., M.B., Ch.B., and John S. Oliver, Ph.D.
Over an 18-month period, the department of Forensic Medicine
and Science at the University of Glasgow investigated four
rather unusual drug-related deaths. In all cases, death was due
to the obstruction of the airway by a foreign body after an
attempt to evade arrest. In all cases, the obstruction was drug
packages of various shapes and sizes. Results of toxicology
revealed levels of drugs that may have had a significant respi-
ratory effect on the deceased in three of the cases. Rupturing of
the packages and hence leakage of drugs being conducive to
death was obvious in only one case.
Key Words: Drug death-Choking-Obstruction-Foreign
body.
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Choking on a foreign body is not an uncommon cause
of sudden death and has been well documented among
young children (1-3). In these cases, the aspirated object
is usually a small toy. a balloon, or sweets. In addition,
accidental aspiration of poorly masticated food i. well
recognized (4). This article reports four cases invol ving
drug users who died as a result of obstruction of the
airway by a foreign body. In these instances, the blo k-
age was caused by packages of illicit drugs. The practi e
of swallowing drugs or concealing them in bod cavities
to avoid detection by law enforcement agencies is not
new (5-9). The lise of drug couriers-also known as
body-packers, higher angels, and mules-pre. 'Ill. a
problem for both law enforcement and customs find
excise authorities. Whereas the concealment of drugs in
this manner conjures up an irnag of a conrrabandcr
involved in the trafficking of illegal drugs ov 'I' national
or international boundaries, the case. described h re
involved drug users who attempted I) lui kly conceal
their drugs during an approach by polic '. Such individ-
uals have also been referred to as mini-packers (7 . The
circumstances of death and the pathologic and toxi 0-
logic findings in the deaths of four mini-packers inv s-
tigated over an 18-month period are des ribed.
MATERIALS AND METHOOS
After a sudden unexpected d iath, a poli t;; r iport is
compiled and submitted to the Procurator Fiscal whose
service provides Scotland's independent public pros' 'u-
tion and death investigation service), who in turn in-
structs a forensic pathologist to investigate the death und
conclude the cause of death.
Between August 1998 and March 2000, four deaths of
known drug users were investigated wherein death was
caused by obstruction of the airways by a for ign bod
The findings are reported here.
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CASE REPORTS
Case 1
In 1998, a 31-year-old man was in a friend's house
abusing illegal drugs. The police arrived at the flat in
relation to an unconnected inquiry. Having seen the
police, the deceased ran into another room and was seen
to stuff something into his mouth. Thereafter the police
attempted unsuccessfully to persuade him to spit it out.
After a struggle, the deceased was handcuffed but col-
lapsed shortly after. He was witnessed to be choking, and
he was released from his handcuffs. Resuscitation was
commenced, and an ambulance was summoned.
On the arrival of the paramedics, the deceased was in
cardiorespiratory arrest. On attempting to insert an air-
way, the paramedics identified a blockage in the de-
ceased's airway: a white powdery substance at the top of
the larynx. An endotracheal intubation was performed.
He was taken to hospital but was found to be dead on
arrival.
At postmortem examination, scattered fine petechial
hemorrhages were present in the conjunctivae, inside the
mouth, and on the eyelids. There were a few small
superficial abrasions on the neck, consistent with resus-
citation attempts, and minor blunt force injuries in keep-
ing with the described scenario, which included the use
of handcuffs. A foreign body was identified at the tra-
cheal bifurcation, which was obstructing the airway. The
foreign body was a crumpled mass of plastic-like mate-
rial containing a brown paste. It formed a Y shape,
molding to the configuration of the tracheal bifurcation.
From its end to the top of its bifurcation, the stem of the
y was 4.5 cm long and :s2 cm wide. It divided into two
branches, one measuring 4 cm X :S1.4 cm and the other
3.5 cm X ~1.5 cm (Fig. I).
The results of toxicologic analysis, as shown in Table
I, revealed the presence of significant levels of mor-
phine, Valium, and metabolites. The low level of co-
deine was indicative of the use of heroin rather than mor-
phine. The levels measured, on their own, were consistent
with those in fatalities from the concurrent use of valium
and heroin. The contents of the package were analyzed and
were found to contain heroin, noscapine, papaverine, and
acetyl codeine.
The cause of death was determined to be asphyxia due
to impaction of foreign body in the trachea.
Case 2
In 1999, a 20-year-old woman had been arrested for
shoplifting. She was being searched in police custody
when she attempted to swallow a plastic bag, which had
been partly concealed in her underwear. During this
procedure, the bag was observed to burst open, emitting
some powder. Shortly afterward, the woman began to
choke and became unable to breathe. She bit a police
Am J Forensic Med POliwi. Vol. 24. No. i. March 2003
FIG. 1. Y-shaped foreign body obstructing the tracheal
bifurcation.
officer who went to her assistance. Police all mptcd
resuscitation and summoned an ambulance.
On the arrival of the ambulance tcchni inns appro i-
mately 9 minutes later, she wns . nnor i an I pulscl ·s),.
Attempts to clear her airway with II hand-held aspirator
resulted in an effusion of while fluid from the airwav. n
oropharyngeal airway was ins 11 d. and cardiopulrnonnr
resuscitation was attempted; however, il was th )ught that
the airway was blocked and that. no air was 'Ill ·ring the
lungs. Life was pronoun ed un ( III the It ·U!..
At postmortem examination, no pete .hinl homer-
rhages were identified. Th I edcrus Inc and neck h:1J
minor abrasions consistent with resus .iuuion, nnd S ·iII.
tered bruises wcr seen on her arms and wrists. rclnt id II)
the restraint in .luding hand uffs. rOI 'igll h(xl \ a~
present at the back of 11'1' mouth C I .nding down In til'
upper trachea. The foreign bod . u crumpl >d. fold 'd mut '.
rial res mbling ling film. mC;ISUI"U 10'111 1.1 'III
I cm and contained a whit's 'mi~(Jlid pa:-I 'Iik' 111m 'rial.
TABLE 1. Results of toxic%glc analysis of blood
sameJes (mg,llitre2
Case 1 Case 2 Case 3 Cas 4
Morphine 0.44 0.0 0.1 NO
Diazepam 0.87 NO 0.6 0.1
Desmethyldiazepam 0.35 NO 0.7 1.1
Temazepam 0.72 5.61 NO 0.1
Codeine 0.05 0.03 0.1 NO
Cocaine NO NO NO 0.1
8enzoyleegonine NO NO NO 7.5
Melhylecgonine NO NO NO 1.4
Propoxyphene NO NO NO Irae
NO, not detected.
IMPROMPTU INCESTION OF DRUCS
Toxicology
The results of toxicologic examination are shown in
Table 1. The levels of morphine and codeine detected
were consistent with the use of street heroin. A signifi-
cant level of temazepam could have had a considerable
respiratory depressant effect on the deceased. This high
level could have been due to the rupture of the package.
Analysis of the white powder confirmed the substance to
be temazepam.
The cause of death was established as choking due to
impaction of foreign body in the larynx and a contribut-
ing factor was temazepam intoxication.
Case 3
In 1999, a 36-year-old man was known to be a drug
abuser and dealer, with a history of swallowing/conceal-
ing drugs in his mouth. While police were searching his
room, the man became agitated, and he was handcuffed.
Shortly afterward he collapsed. The handcuffs were re-
moved, he was placed in the recovery position, and an
ambulance was summoned.
Cardiopulmonary resuscitation was administered, and
the man was conveyed [0 the hospital. En route, the
paramedic discovered a foreign body in the air passages
and removed it with the aid of a laryngoscope. The man
was pronounced dead on arrival at the hospital.
At postmortem examination, a few tiny petechiae were
identified in the mouth. The decedent had several minor
blunt force injuries, which had not contributed to his
death. There was superficial bruising of tongue and con-
gestion and petechiae in the larynx, just below the vocal
cords. The foreign body had been removed during resus-
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citation. It was a crumpled piece of plastic-type mat 'rial
measuring 8.5 cm X 5 cm X 0.5 cm and contained a
lump of soft brown material.
Toxicologic analysis showed the presence of m: r-
phine, codeine, diazepam, and rnctubol ite. These dru '5
were evidence of the use of heroin and valiurn. The soft
brown material was not made available for analysis.
The cause of death was determined to be ohstru ·tion
of the air passages by foreign body.
Case 4
In 2000, during the execution of a search warrant, a
46-year-old man was witnessed to force something into
his mouth and to put his face into the bed in an effort to
prevent its retrieval. A struggle ensued, during whi h
time, because the man refused to spit out the contents of
his mouth, he was handcuffed. An arnbulan e was sum-
moned. Shortly afterward the man became pale and
appeared to be losing consciousness. He was pia ed in
the recovery position, and his handcuffs were rerno eel.
Paramedics commenced resuscitation efforts, during
which time two packages were removed from the man's
upper airways; however, other packages could be s 'en
below this and could not be retrieved. A do tor urri cd,
and after further attempts at resuscitation and the admin-
istration of an opiate antagoni: t. life was pronoun .ed
exGnct at the locus.
At postmortem examination, the fac and neck were
congested, with a fcw fine pet hiu of the conjun tiv IC.
The only significant injuries wer n f w minor s .rm hcs
on the lower part of the face. onsi: t nt with resus 'ita-
FIG. 2. Two p ck 9 s pr S nt
within the low r trachea.
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FIG. 3. Eighteen packages found
within the esophagus.
tion, and bruising and abrasions to both wrists resulting
from the struggle while handcuffs were applied.
Two packages made of material resembling cling film,
at least one of which contained a white substance, com-
pletely occluded the lower part of the trachea, the lower
one extending into the right main bronchus (Fig. 2). The
esophagus was filled from the level of the thyroid carti-
lage to the stomach by 18 similar packages (Fig. 3). A
further 8 packages were retrieved from the stomach.
Toxicologic analysis confirmed the concurrent use of
diazepam and cocaine. Respiratory depression would have
been unlikely in this case, particularly because cocaine is a
stimulant drug. Analysis of the contents of the retrieved
packages identified cocaine. The blood levels, however,
gave evidence of the use of cocaine before the packages
were swallowed, particularly because the concentrations of
the metabolites were significant.
The cause of death was determined to be choking all a
foreign body.
DISCUSSlON
During an 18-month period, four known drug users
died in the west of Scotland as a result of the unpremed-
itated ingestion of drugs. 1n each case the deceased was
attempting to avoid detection of the drugs because of the
proximity of police. The deceased was witnessed to
ingest a package in three cases, and choking followed
shortly afterward in two of these cases. Collapse was
subsequent to ingestion in all cases. This initiated the
summoning of an ambulance. Resuscitation was at-
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tempted in all cases; how ver, life was pronoun cd c -
tinct either at the locus or on arrival at the hospital two
cases each). The recovery of all obsrru lions at the 10 'us
was accomplished in only one 'a~ ( as 3); ill the
remaining cases it was not po: siblc 10 rca h the obstru -
tion before death. In as I, n lorru heal intubation
resulted in the pa kage bein ' push 'd furth 'r down rh ail'
passages, below the lip of the tub .
In additi n 10 the pot ntiul dan) irs of drug 10 i'il
resulting from the rupture of pa knging, th issue of
airway obstru lion by th pa ka ~ il~ 'If has he 'n pre i·
ously reported (10-12). This arti I' has highlighted
cases wher in sudden d ath 0(; urred ufter 111'dclib rill',
impromptu ingestion of drug pa ckugcs in indi i Iunls
who were aucmptin y 1.0 evade atT'SI. III "II cas 'S collapse
was very rapid. We an only emphasize rhru in su '11
cases medical intervention should I 'sou ,hi immcdi.u 'I
and efforts lO clear the individual'x airwa iniri.ucd.
However, it is also important 10 'l11phasi/.' thut r 'MI~ 'i-
ration attempts may carry a si mificunt infcctit n fi~1-.In
police officer. and oth r staff, cspc iall if 111' individual
is already strugglin ' in an arr st situutiun. Wh '11 kn )WIl
drug users are being nfrOl1t d, th' r()s~ibilil Ihul III'Y
will swallow a drug package must always b' 'ollsid 'r 'd.
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INTRODUCTION
ABSTRACT
Aims To determine the incidence of methadone as either the principal cause or
death or as a contributing factor in drug related deaths in the Strathclyde Police
region of Scotland and to assess the impact of supervised consumption of meth-
adone on the number of deaths that occurred within each health board area
within this region.
Design Retrospective analysis of records held within the Department of Foren-
sic Medicine and Science based at the University of Glasgow over the ll-year
period 1991-2001.
Setting The Strathclyde Police region of Scotland (population approximately
2.25 million).
Findings In 1991. there was one death recorded which was attributable to
methadone. Following the introduction of the methadone maintenance pro-
gramme (MMP) in Glasgow during 1.994. there was a '100% in rease in th se
deaths compared to the previous year. Cl trend which continued over the sui se-
quent 2 years. Following a confidential enquiry into these deaths and a greater
compliance from pharmacies supervising methadone consurnpt ion. cl 'at hs
involving methadone had decreased by 48% in 1997. This was part icularly evi-
dent in the Greater Glasgow Health Board Area. where methadone prescriblng
has continued to rise annually. However. some difficulties still exist. Multiple
take home doses are sometimes prescribed when a pharmacy is closed. which
may lead to inadvertent overdose or facilitate diversion of legitimate suppli ·S. In
addition. continued usc of heroin was round in "PI roxlmatcly one-fifth or MMP
patients. suggesting possible underdosing.
Conclusions A growing prevalence or heroin misuse has resulted in till in T 'as .
in the number of individuals entering the MMP.U(!spite a continuing in r .asc III
the amount of methadone prescribed. methadone deaths in Strathclyde have
decreased since] 996 due possibly to chan res in both prescribing and clinical
care. With efficient management to establish that the patient is .ornplylng with
the guidelines of the programme and has stopped heroin misuse. methadon'
can be a safe drug for substitution therapy,
KEYWORDS Drug deaths. methadone. Strathclyde.
tality caused by the overdose of opiates has been reported
previously in Europe 1I-3J. Australia 14-61 and lite
United Stales [7.8.1. The United Kingdom is no exception
[9,] 0]. Illicit heroin appeared in Scotland in the early
Heroin addiction has acquired the proportions of an
international epidemic. The associated premature mor-
© 2003 Society for the Study of Addicnon to Alcohol and Other Drugs Atldiclim,. ')8. 995-1002
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1980s [11] and since then illegal drug use has become
widespread. In response to this problem, various strata-
gems have been devised to reduce the damage caused to
opiate users. These include needle exchanges and substi-
tute prescribing. Presently in the United Kingdom. the
standard substitute drug of choice is methadone [12-15J
and there are reported to be approximately 26 000 opiate
addicts in MMPs in the United Kingdom, comprising
almost one-fifth of all known opiate addicts [14]. The ben-
efits of this drug are well documented and as well as
reducing illicit drug use [16,17] and mortality rates [13].
a reduction in the level of criminal activity among opiate
drug users [14,18] has also been reported. In addition.
this substitute drug appears to be more effective at keep-
ing drug users in contact with health services compared
with other interventions [19]. In the early 1990s, it
became evident to the small group of Glasgow general
practitioners (GPs) who were prescribing methadone that
it would be beneficial for drug misusers to attend clinics
designed specifically for their care [20]. As a result, in
1994 both the Glasgow Drug Problem Service (GDPS)
and a GP Drug Misuse Clinic Scheme were created to
reduce drug-related harm to health and 'promote better
management of drug injectors in general practice
through a system of shared care' [21]. In addition to the
shared care between staff in the GDPS and in general
practice, community pharmacists were recruited to
supervise the consumption of daily doses of methadone.
In early 1994, approximately one-fifth of all Glasgow
community pharmacies had become involved [221 and
this has increased to approximately two-thirds today
[23]. In 1996.99% of all methadone that had been pre-
scribed by the GDPS involved supervised daily dispensing
[21], a figure that remains unchanged [241.
The number of methadone prescriptions dispensed in
the Strathclyde police region increased approximately
ll-fold over the 10-year period 1992-200.1 (personal
communication. Primary Care Information Unit, Infor-
mation and Statistics Division. NHS in Scotland) with the
majority of this methadone being dispensed in the
Greater Glasgow Health board area. The proportion of
methadone prescriptions dispensed in the Greater Glas-
gow area compared with the whole of Strathclyde
increased from 63% in 1992 to 77% in 1.995 and then
decreased from 69% in 1996 to 54% in 2001 (personal
communication, Primary Care Information Unit, Infor-
mation and Statistics Division. NHS in Scotland). These
figures suggest that although confined initially to the
Greater Glasgow area. the establishment of methadone
maintenance in the rest of the Strathclyde area has
increased over the latter years.
Initially, the increase in prescribed methadone was
accompanied by an escalation in methadone-related
deaths which was subject to much public and media
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attention. Consequently, in J 99h the GDPS co-ordinated
a confidential enquiry into methadone-related deaths in
Glasgow in order to assess the medical care provided by
the clinicians who prescribed methadone [2 51. It reported
in 1999 and showed that medical services might have
been deticient in 56% of the methadone deaths. Possible
failures in clinical care were identified in 69% of cases and
included, for example. prescribing 1.00 low or too high a
dose of methadone or failing to examine a patient for con-
tinuing drug misuse. The response from the prescribing
doctors was very positive. wit.h 93'M) 'definitely' intending
to change their future management of drug misusers. In
order to disseminate the findings of this enquiry a booklet
outlining the guidelines for safe methadone pres .rlblng
was distributed to all GPs in the Greater Glasgow area
1261. A separate study in 1999 revealed that the increase
in methadone-related deaths in the Strathclyde region
coincided with the introduction of the methadone main-
tenance programme (MMP) in Glasgow 127]. It was also
revealed that illegal diversion of legitimate supplies of
methadone was found to account for the majorit.y of
deaths and in addition it was noted that many deaths
might have been prevented had the signs of intoxication
been identified and lrnmedlatc medical asslstancc sought.
This paper studies deaths involving met.hadone which
occurred in the Strathclyde Police region of Scotland over
the I l-year study period. 1991-200l. and Investigates
changes in death rates subsequent to improved prescrlb-
ing and clinical care proc idures.
MATERIALS AND METHODS
The St rat hclydo Police r gion en om passes a lurgc pro-
portion of t.he South-west of Scotland und has it populn-
tion of approximately 2.25 million 1281. Tin are four
health board areas thai fall within the boundaries or this
gcographi HI r 'ginn. The population and stlmutcd num-
ber of problem drug users for 2000 wif hin cu h of III ':i
health board areas IIr' outlln 'd in 'l'nbl I.
Current policy is I hal following USUSI' .ctcd drug-
related death, a report ts subrniu 'd 10 th . Pro .urutor Fis-
cal who in turn instruct . Lt post-mort '111 ixamlnatlun.Du
its completion, biological sp icimcns are submtttcd lor f til
toxicological analysis an I histopathological e umluntiou.
All mcthadonc-po 'il ive cases In J 99 J -200 I were
identified from the records held at the Deparuncnt or
Porensic Medicine and Science, Univ irsity of Glasgow.
Information regarding circumstances of the cl .ath WitS
obtained from the police report which in .ludcs th ' med-
ical history of the deceased, the sequcn e of events lead-
ing up to the death und any recent .ustodial seurcnc 'S
that may have been incurred. Once lderullled, th r ilc-
vant cases were classified as 'methadone only' deaths,
Add/rtioll, 911.')'I~-I no..!
Role oj methadolle in drug-related deaths in Scot/find 997
Approximote
populotion [28] %
Table I Approximate populations and
estimated numbers of problem drug users
in each health board area In the Strathclyde
Police region, 2000.
Estimoted number or
problem drug users [29]
,,
.',
.'
Greater Glasgow
Lanarkshire
Argyll and Clyde
Ayrshire and Arran
900000
560000
420000
370000
15975
5076
5405
3058
2%
1%
1%
1%
'methadone-related' deaths or 'not methadone-related'
deaths in accordance with a previous study [27] and
depending on the primary cause of death.
RESULTS
Over the ll-year study period, methadone was detected
in 352 sudden, unexpected deaths in the west of Scot-
land. Of these, 270 cases (77%) were considered to be
associated directly with the toxic effects of drugs either
alone or in combination with alcohol. In the majority of
cases, the deceased was male (79%, n = 213) and the
average age was 27 years (range 15-58 years). A history
of drug abuse was noted in 262 cases (97°/..): approxi-
mately two-thirds were known intravenous drug users
(68%, n = 178),
The drug-related methadone-positive cases (n = 270)
were then divided into one of three groups depending
on the cause of death, Methadone in combination with
other drugs accounted for 140 deaths (52%), Fifty-six
or approximately one-fifth of deaths (21 Oh.) resulted from
the effects of methadone alone. In a further 74 deaths
(27%), although methadone was found to be present it
was not considered to be at a high enough concentra-
tion to have caused or contributed to the death. In these
74 cases the interpretation of toxicological findings and
the conclusion that methadone was not implicated in
the death was stated by the pathologist on completion
of all post-mortem investigations and having taken due
notice of previous medical history. It is recognized that
there is an overlap between therapeutic and fatal meth-
adone concentrations [14]: however, interpretation of
levels is also based on circumstantial evidence, such as
witness statements, provided in the police sudden death
report.
Because this report aims to study drug-related deaths
where methadone was a cause of death either alone or as
a contributory factor in combination with other drugs,
all information that follows will focus on those deaths
which were classed as methadone-only or methadone-
related deaths. Collectively, these two subgroups will be
referred to as 'methadone deaths' (n = 196).
Over the study period, there has been an overall
increase in the number of drug-related deaths occurring
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Figure I Methadone-positive cases and methadone deaths, 1991
2001
in the Strathclyde Police region, Figure 1 shows that th •
number of methadone-posuive ases increased in II simi ..
lar fashion to all drug-related deaths in the years 1991-
96. Following ] 997, when methadone-posluv cases
decreased by almost one-half. all drug-relet 'd d .aths con-
tinued to increase substantially from 1998 onwards:
however, the number of mcthadone-postttv cases and
'methadone deaths' remained relatively uabl QV r the
last 5 years of the study.
Just over one-half of all methadone d .aths o· urrcd
within the Greater Glasgow Health BORrd Area (55%, /1=
] 08). representing seven deaths per 1.000 populatlon of
estimated problem drug users in this area 1291. The 'Of-
responding figures for Ayrshire and Arran, Argyll and
Clyde and Lanarkshire were 2l% (11=41),16% (11= 12)
and 8% (11 = 15) of methadone deaths, respe lively, Th 's
figures correspond to.L deaths, six deaths lind Ihr 'e
deaths per 1000 population within .ach health board
area, respectively.
The medical history section of the poll " sudd 'II death
report was used to ascertain whether or not the de 'cased
was enrolled on an MMP. This WHS not available in 14
cases. Of the remaining 182 cases. ] 0 ( 7%) appeared
to have used methadone which had been obtained
illegally.
The exact number of patienls enrolled on a MMP
within each health board area at anyone time was unob-
tainable, but the following estimate was made in order to
calculate the death rate. On the assumption that the aver-
age prescription for methadone is SO mg per day, Cl patient
ilddictlon, 9t1, ~95- 1002
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Table 2 Methadone death rates 1991-200 I.
Estimated number Number or MMP
Year of MMP patients MMP deaths deaUl rate
1991 unknown I unknown
1992 304 0 0.00%
1993 676 4 0.59%
1994 1512. 9 0.60%
1995 2246 14 0.62.%
1996 2815 13 0.46%
1997 3645 4 0.11%
1998 42.52. 10 0.24%
1999 4714 II 0.2.3%
2.000 5519 7 0.13%
2001 6896 6 0.09%
will receive 18250 mg per annum (50 mg x 365 days).
Consequently, from the knowledge of the amount of meth-
adone prescribed in each health board area (personal
communication, Primary Care Information Unit. Infor-
mation and Statistics Division. NHS in Scotland). it is pos-
sible to attain an indication of the number of patients in
receipt or a methadone prescription.
Table 2 shows that, for individuals on an MMI~ the
methadone death rate lei I sharply after 1996 and
remained low thereafter. Following the distribution of the
guidelines and changes in methadone dispensing there
was a 0.38% absolute reduction in summary death rates
from 0.53% per person-year to 0.15% per person-year.
The numbers of methadone deaths for individuals not on
an MMP decreased slightly from 54 deaths during the
period 1991-96 to 49 deaths during the period 1997-
2001. This was despite a threefold increase in the amount
of methadone being made available via the MMI~ Par
2001, Glasgow had a lower methadone death rate among
individuals on an MMP than the three other health board
areas (0.07% compared to 0.13%. O.l'Yo and 0.13%). I'n
general. rates were low, indicating a good safety profile of
the MMP. A similar pattern was seen for those not on an
MMP where Greater Glasgow had three deaths compared
with a total of 11 from the three other health board areas
(Lanarkshire: two deaths. Argyll and Clyde: three deaths,
Ayrshire and Arran: six deaths). This was despite nearly
twice as much methadone being prescribed in Glasgow
via the MMI'.
Over half the cases (1'1 = 107. 55')!,.) occurred over a
weekend, Friday-Sunday, with 80 deaths occurring on
Saturday or Sunday. OJ' these 107 cases, 46% were
enrolled on an MMP, which compares to 34% of deat.hs
that occurred on a weekday. Despite this, there waS no
Significant evidence of an association between the timing
of the death (weekend or weekday) and MMI' st.at.us
(Fisher's exact test, P = 0.13; 14 individuals whose MMI'
status was unknown were excluded).
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Multipledoses to take home (c.g. due to pharmacy clll-
sure) were known 10 be prescribed in 2. I cases and ranged
from a single extra dose to I month's supply. In the mujor-
ity of cases (55%, ,,= I J) this WHS due to the forthcoming
Sunday and/or Hank Holiday closure of the pharrnac . In
the remaining cases. the dispensing of multiple dos 's had
been the decision of the general practitioner. In a furth r
two cases, while there was no mention of multiple pre-
scribing in the police report. the deceased wus lound to be
in possession of two bottles of methadone prior to dcat h in
one case and an empty 200 ml bottle was found at. the
locus in the other case.
Each case was c1assilied according to when the
death occurred in relation 10 drug cc nsumption, In 13
cases (7%) involving heroin. death was lrnrncdlut
because a needle and syringe were present wit h the
body. In 36 (18%) cases the mode of death was unde-
termined as the deceased had been found dead ut Ihe
locus and had not been seen for a prolonged period.
hence circumstances directly prior 10 death could not
be ascertained. The sequence of events prior 10 death in
most cases (74°,{ r , 1/ = 146) involved the deceased being
seen to be intoxicated prior to falling asleep. Witnesses
often reported heavy uncharacteristic snoring in these
cases. In the final case, the dec ascd attended un accl-
dent and emergency department. Having been attended
to. he was asked to sit in the wultlng area. lie wus
found dead in the toilet area approxtmutcly _ hours
later.
Of Ihe 196 met hadon • cl aths, 2 I Individuals (I 1%)
had died within 2 weeks of' h 'Ing rei 'us 'd from prison.
Methadone was known 1.0 have be n prcscrlh .d In onl
10 cases.
A blood sump) ' was unobtutnubl in 0" 'ens 's h xuuse
of' dccomposlrlon. How .vcr, urin '. IIv r and liver blood
were used as alt 'flHltiV' matrl ·'S. or th r 'Irlillnlng 191
cases. the post-mortem blood J1l ,thadol1l' cone '1ltrutiollS
ranged from 0.0 I 10 3.S4 mg/!. Tabl . 3 lisl.~lhe av 'rug'
and nlnge of 'on' 'ntrations d ,t 'clcd for 'licil ('OIlS' oi'
death group and whelll'r or not Ill' ch.:·til~ed Will'
enroll 'd on a MMP at the Lime (If death. "'lie IIICUI1 C<lll-
centrations 1'01' met hadouc-onl deaths were sigllllkullily
higher than t hosc for IlI'Lhadolle-relulcd denl hs (1111
dealhs. two-sumpl' H'sl, P < O.O(J(J I: I1)cthudonc
prescribed. P = n.ooo I: lI1ethadon nol pre~('rlbcd.
P< 0.000]).
Multiple drug use was preVtlhll.. with twu or ntor'
drugs being detected in 163 cases (85% of blood drug-
positive case'). Th' most frequ 'lilly d 'le·t 'd uddillonlll
drug group was Ihe hemodill:lepines, wilh dlll?CPillTIlind
tcmi1zepam being prescnt in 106 (65%) lind 50 (31') ,j of
these cases. r'spcclively. Heroin wa~ l'oulld to b posllive
in 55 multiple drug casc~ (34'){J). In 16 (2<)%) of tilese
cases the deceased was in receipt of a melhadon ' pr '-
IlcId/rt/fJII. 9H. '19'i-I002
Hole oJ IIII'1,hadolll' ill drll!l-fl'io/I'd dl'lIli1s ill Scotuuu' 99Y
Methodone-only Methadon reloted
Table 3 Methadone conccnu auon ,C<lUS
of d ath cat gory and MMP status.
All cases (n = 187') 52
0,8
0,7
0,08-2,63
21
0,9
0.7
0,28-2,2
25
0.7
0.5
0,08-2,63
6
0,7
0,6
0,26-1.3
Prescribed
'1.
Mean
Median
Range
n
Mean
Median
Range
n
Mean
Median
Range
n
Mean
Median
Range
Not prescr-ibed
No record
135
0,4
0.3
0.01-3.84
49
0.5
0,4
0.067 1.8
78
0.3
0.2
0.01-3,84
8
0,3
0.3
0038-0.8
'In total, the study period involved 196 MO and MR deaths: however; iceocology was earned out on the hver
in one case, liver blood in two cases, urine in two cases and no post-mortem examination was earned out
In four cases, In these foul' instances, the concentrations were high enough to indicate that the blood had
been taken from a source other than the periphery, These concentrations were I 1,),0.83.5.6 and 1,9mg/
I blood.
IiO
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Figure 2 Frequency of drugs detected
scription, Effectively, of all mel hadone paUenls in lhis
study, one-lifth (20%) were round to be non-compliant
with the methadone programme guidelines in lhal they
continued to use illicit drugs, The olher drugs detecl'd
are shown in Fig, 2,
The cocktails of drugs consumed by the subjects of this
study reflect the present' pattern or drug misuse in Stralh-
clyde, which involves primarily the concurrenL use of opi-
ates and benzodiazepines [301,
Alcohol was detected in the blood in 5~ cases with
mean blood alcohol concentrations ranging from 4 Lo
462 mgllOO mL This could have a possible (J(ldilive effect
on other respiratory depressant drugs,
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DISCUSSION
The proliferation of the methadone malntenunce pro-
gramme (MMP) throughout the Strathclyde area is
cvid mt from ihe annual increase In m ,t hudone prescrip-
tions dispensed, Over the study perlo I. I \jill-2()() I, onl
29% (11= 56) of drug-related deaths \ here tllct!lfldone
was detected post-mortem were [udgcd ttl he clue 1.0 111 nh-
adonc ilion ,
This study rev "led that Iatulltlcs from pol drUI: ust,'
involving other opiates lind b nzodluz 'pinos wer much
more common than from III nhndou ' nlon " Thl~ combl-
nation of drugs has h' '11 documcm 'cl pre iOllsly, not 0111
in drug users in til' wesl or S .orlund r )0- 321, but ulsllln
Europ' 13 3,341 and uslrulin r.3 S I, find tbc Ittrr~'IIS 'd rl~"
of overdose from this combtuuuon of drugs nus Ill'l'll
reported by I HI'k 'I'r (11,1361, "$ both groups or drUl-t!lllfl'
rcsplrutor I cl .pr 'SSlJI1Is, (II leflst uu nddlllvc en;,. 't III Iy
result. whcn tuk '11111 comhlnullnn. Other 1111'II drl!~~(c,g,
arnph 'tamin', cocain " cestus ) alld cunltllunl nhusl'd
medi 'inal drugs stich ,IS dih drocud'llll' 111111 r"font!
hydrate were also d'i ,,,tcd,
From the 182 c<tses where !'vi II' stalu~ (1Jltld be Hsecr·
t;]ined, less than on '-hall' of 'uses Illvulv 'd IcgllhlHtI 'Iy
SlI pplied met h<tdOlle, This detl10nst niles I h(' rI~k of diwr-
sion or legit imate supplies or tnetlllldnn', ~lIli1ple 'lUke-
home' doses wcr' !lot 'd ill _I "ases, Whiil.' pl'nnllllll~ II
putienl to uplift Illultiplt: closes l11a), be Il'rceivctl us it 'stell
forward', Ihis pract Ie' should not. be (,Ilt'ollra~ed unless
the patient has b 'en on a stable Jose IQr )0:0111<: signllktllit
period ;rnd test.ed Ilegalivc li)r ot her drugs nr nbus(' hy uri·
nalysis on several Ot' 'aslons,
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There is concern that some MMPpatients continue to
use illicit opiates and there were a number of MMP
patients who tested positive for continued heroin abuse.
This was confirmed by the presence of morphine and
either codeine from the breakdown of monoacetyIco-
delne, an impurity in street heroin and/or 6-monoacetyl-
morphine, the first metabolic product of heroin. A
possible reason for this continued usage may be that the
patient has to 'top-up' as a result of being prescribed too
Iowa dose of methadone. A recommended serum thera-
peutic range of between 0.15 and 0.6 mg/l has been
reported when monitoring methadone maintenance
patients [37] and a therapeutic window for dosage rang-
ing from 60 mg to 120 mg suggested [38]. In Glasgow,an
average dose of 48 mg was recorded, a dose regarded as
being suboptimal [39]. In difficult cases, blood/serum
monitoring would be beneficial in achieving the optimal
dose.
From the circumstances of death it was ascertained
that over three-quarters of deaths (74%, n = 146)
occurred while the deceased was presumed to be sleeping,
following a period of observed Intoxication. Permitting a
'sleep-It-off' period was considered to be beneficial bywit-
nesses, presumably in order to allow the effects of the
drugs to wear off. However, as reported in a previous
study [27], had medical attention been summoned on
first indication of intoxication, some of these deaths may
have been preventable: a conclusion supported by Clark
et al., who found that the toxic effects of methadone are
often delayed [40].
The source of methadone could not be ascertained In
the majority of recently released prisoners In this study
sample. A period of abstinence can result In a loss of tol-
erance for a drug and prisoners are made aware of these
dangers prior to their release. Despite this, some Individ-
uals choose to revert to quantities of drugs to which they
were previously accustomed. hence increasing their risk
of overdose.While some of the recently released prisoners
were enrolled on an MMPat the time of their death. their
MMP status was unobtainable prior to their term of
imprisonment. However. a recent study has highlighted
the adverse effectsof the interruption of methadone treat-
ment by Imprisonment where a number of general prac-
titioners reported chaotic drug use following release from
prison [41].
After 1996. deaths involving methadone have
decreased despite both an increasing number of people
being prescribed methadone and an overall increase in
drug-related deaths. This suggests a positive impact of
both improved medical practice following 1996 and the
dissemination of methadone programmes from Glas-
gow to Strathclyde. Supervision programmes did not
become common practice in the rest of Strathclyde until
1997 onwards and currently the supervision scheme in
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the other three health board areas remains Incomplete
[42]. The death rates for 2001 In Glasgow are particu-
larly encouraging. showing lower rates compared with
the other health board areas despite this area having
nearly double the amount of MMP patients than the
other three health board areas combined. The figures
presented in this paper reflect the success of the super-
vised programme In Glasgow.As the rest of Strathclyde
becomes Increasingly involved In the MMP It Is essen-
tial that pharmacies are recruited to supervise daily
doses of methadone. There are, however, continuing
concerns. For example. In all areas a small proportion of
patients continue to be Issued either daily or weekly
unsupervised scripts. While this may be seen by CoPs
and other agencies as progress In building trust
between the patient and Gp. the potential for diversion
should not be overlooked.
Because this was an observational study. and due to
the potential confounding effect of other factors. we can-
not conclude that the Introduction of the guidelines for
Improved patient management and clinical care together
with increased supervision of consumption were the only
causes of the fall in death rate. However. the death rule
reduction was seen to coincide with these changes. Indi-
cating a possible positive effect on reducing deaths,
CONCLUSIONS
Heroin addiction remains a disturbing cause of prema-
ture death In Scotland. The effectiveness of methadone
as a treatment for oplate addiction received much criti-
cism Initiully. However. the findings of the conlidentiul
enquiry in addition to Increased and wldespreud super-
vision implemented by pharmacists have been malor Iac-
tors in decreasing deaths Involving methadone. The
argument that methadone Is an unsafe ulternutlve ther-
apy for opiate addiction Is not supported by the results of
this study. What has been demonstrated In the west of
Scotland Is that methadone. If not sufflclently super-
vised. can lead to otherwise preventable deaths by diver-
sion of supply. In addition. regular monitoring should be
adhered to as per the guidelines to ascertain the stubilily
. of the patient In order to establish the correct dosage Is
being prescribed. With efficient patient management to
establish compliance with the guidelines of the pro-
gramme. methadone can be a safe drug for substitution
therapy.
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